| Nano-sized zeolite-like metal-organic frameworks induced hematological effects on red blood cell. | Hao F, Yan XP | J Hazard Mater | 2022 |
| Homing in on haemoglobinopathies. | The Lancet Global Health | Lancet Glob Health | 2022 |
| Bloodstream Infections in Children With Sickle Cell Disease: 2010-2019. | Yee ME, Lai KW, Bakshi N, Grossman JK, Jaggi P, Mallis A, Wang YF, Jerris RC, Lane PA, Yildirim I | Pediatrics | 2022 |
| Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization. | Pinto VM, Musallam KM, Derchi GE, Graziadei G, Giuditta M, Origa R, Barella S, Casu G, Pasanisi A, Longo F, Casale M, Miceli R, Merella P, Tartaglione I, Piga A, Cappellini MD, Gianesin B, Forni GL | Blood | 2022 |
| Efficacy and Safety of Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Thalassemia Patients: A Retrospective Observational Study. | Kupesiz FT, Sivrice C, Akinel A, Kintrup GT, Guler E, Kupesiz A | J Pediatr Hematol Oncol | 2022 |
| Telehealth Use Before and During the COVID-19 Pandemic Among Children with Sickle Cell Anemia. | Reeves SL, Patel PN, Madden B, Ng S, Creary SE, Smith D, Ellimoottil C | Telemed J E Health | 2022 |
| Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study. | Bayraktaroglu S, Karadas N, Onen S, Karapinar DY, Aydinok Y | Ann Hematol | 2022 |
| Up-regulation of miR-130a is related to leg ulcers in sickle cell anaemia. | Batista THC, Santana RM, Sobreira MJ, Arcanjo GS, Domingos IF, Pereira-Martins DA, Falcão DA, Oliveira JMF, Batista JVGF, Weinhӓuser I, Hatzlhofer BL, Júnior WLB, Araujo AS, Dos Anjos AC, Costa FF, Saad MJA, Carvalho BM, Vasconcelos LRS, Lucena-Araujo AR, Bezerra MA | Br J Haematol | 2022 |
| Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Series. | Alwaheed AJ, Alqatari SG, AlSulaiman AS, AlSulaiman RS | Am J Case Rep | 2022 |
| Translating research to usual care of children with sickle cell disease in Northern Nigeria: lessons learned from the SPRING Trial Team. | Bello-Manga H, Haliru L, Tabari AM, Farouk B, Suleiman A, Bahago GY, Sani AM, Bauman AA, DeBaun MR, King AA | BMC Res Notes | 2022 |
| A rare case of adrenal extramedullary haematopoiesis in a Cypriot woman with β-thalassaemia. | Georgiou AC, Lisacek-Kiosoglous AB, Mariannis D, Christou S, Hadjianastassiou VG | Ann R Coll Surg Engl | 2022 |
| Liver Transplant in Hemoglobin SC Disease and Autoimmune Hepatitis: A Case Report. | Kim A, Assarzadegan N, Anders RA, Oshima K, Chaturvedi S, Weeks S, Kohli R, Lanzkron S, Gurakar A, Garonzik-Wang J, Chen PH | Exp Clin Transplant | 2022 |
| The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease. | Soulières D, Mercier-Ross J, Fradette C, Rozova A, Tsang YC, Tricta F | Ann Hematol | 2022 |
| Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial. | Boulad F, Maggio A, Wang X, Moi P, Acuto S, Kogel F, Takpradit C, Prockop S, Mansilla-Soto J, Cabriolu A, Odak A, Qu J, Thummar K, Du F, Shen L, Raso S, Barone R, Di Maggio R, Pitrolo L, Giambona A, Mingoia M, Everett JK, Hokama P, Roche AM, Cantu VA, Adhikari H, Reddy S, Bouhassira E, Mohandas N, Bushman FD, Rivière I, Sadelain M | Nat Med | 2022 |
| Perforated Duodenal Ulcer Associated with Deferasirox in a Child with β-Thalassemia Major. | Zahra A, Ragab A, Al-Abboh H, Ismaiel A, Adekile AD | Hemoglobin | 2022 |
| Anti-inflammatory cytokines in sickle cell disease. | Alagbe AE, Domingos IF, Adekile AD, Blotta MHSL, Santos MNN | Mol Biol Rep | 2022 |
| Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major. | Lüftinger R, Zubarovskaya N, Galimard JE, Cseh A, Salzer E, Locatelli F, Algeri M, Yesilipek A, de la Fuente J, Isgrò A, Alseraihy A, Angelucci E, Smiers FJ, La La Nasa G, Zecca M, Fisgin T, Unal E, Kleinschmidt K, Peters C, Lankester A, Corbacioglu S, | Ann Hematol | 2022 |
| Quality of life and challenges experienced by the surviving adults with transfusion dependent thalassaemia in Malaysia: a cross sectional study. | Foong WC, Chean KY, Rahim FF, Goh AS, Yeoh SL, Yeoh AAC | Health Qual Life Outcomes | 2022 |
| Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country. | Lobo C, Moura P, Fidlarczyk D, Duran J, Barbosa R, Oliveira T, do Nascimento EM, Bhakta N, Hankins JS | BMC Health Serv Res | 2022 |
| Biopsychosocial Factors Associated with Parenting Stress in Pediatric Sickle Cell Disease. | Johnson YL, Woodward K, Dampier C, Cohen L, Sil S | J Clin Psychol Med Settings | 2022 |
| Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report. | Leyde S, Suen L, Pratt L, DeFries T | J Gen Intern Med | 2022 |
| l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? | Leibovitch JN, Tambe AV, Cimpeanu E, Poplawska M, Jafri F, Dutta D, Lim SH | Blood Rev | 2022 |
| Clonal hematopoiesis in sickle cell disease. | Liggett LA, Cato LD, Weinstock JS, Zhang Y, Nouraie SM, Gladwin MT, Garrett ME, Ashley-Koch A, Telen M, Custer B, Kelly S, Dinardo C, Sabino EC, Loureiro P, Carneiro-Proietti A, Maximo C, Reiner AP, Abecasis GR, Williams DA, Natarajan P, Bick AG, Sankaran VG | J Clin Invest | 2022 |
| Venous cerebral blood flow quantification and cognition in patients with sickle cell anemia. | Stotesbury H, Hales PW, Koelbel M, Hood AM, Kawadler JM, Saunders DE, Sahota S, Rees DC, Wilkey O, Layton M, Pelidis M, Inusa BP, Howard J, Chakravorty S, Clark CA, Kirkham FJ | J Cereb Blood Flow Metab | 2022 |
| Evolving Strategies in the Management of Sickle Cell Disease in the 21st Century and the Role of the Pediatrician. | Hardit V, Alvarez O, Ziga E, Alperstein W | Pediatr Ann | 2022 |
| Assessing and managing people with sickle cell disease presenting with vaso-occlusive crisis in the emergency department. | De D, Thakur I | Emerg Nurse | 2022 |
| Prevalence of Depression among Iranian Patients with Beta-Thalassemia Major: A Systematic Review and Meta-analysis. | Jaafari Z, Sadidi N, Abdolahinia Z, Shahesmaeili A | Iran J Med Sci | 2022 |
| A Novel Association of HbQ India Trait with Sickle Cell Anemia: a New Insight in Hemoglobinopathies. | Gupta RK, Verma KK, Singh G | SN Compr Clin Med | 2022 |
| Navigating Hemostasis of Bleeding Among Children With β-Thalassemia. | El-Beshlawy A, Rabah F, Hamed HM, Mahmoud AA, Al-Wakeel HA, Abdelhamid EM, El-Sonbaty MM, El Sissy M | J Pediatr Hematol Oncol | 2022 |
| Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease. | Tolu SS, Crouch A, Choi J, Gao Q, Reyes-Gil M, Ogu UO, Vinces G, Minniti CP | Ann Hematol | 2022 |
| Extensive porto-splenic venous thrombosis postsplenectomy in a sickle cell disease: a rare complication. | Al Barhi T, Wali Y, Al Sibai S, Al Balushi Z | BMJ Case Rep | 2022 |
| Effect of Sickle Cell Trait on Total Hip Arthroplasty in a Matched Cohort. | Waters TL, Wilder JH, Ross BJ, Salas Z, Sherman WF | J Arthroplasty | 2022 |
| Gastrointestinal vaso-occlusive crisis in a woman with hemoglobin SC disease. | Clement JM, Li AY, Berg BW, Law JY, Baer MR | Am J Med | 2022 |
| Native cardiac magnetic resonance T1 mapping and cardiac mechanics as assessed by speckle tracking echocardiography in patients with beta-thalassaemia major. | See WS, So EK, Hwang GY, Chin L, Ip L, Lam WW, Ha SY, Cheung YF | Int J Cardiol Heart Vasc | 2022 |
| Spectrum of HBB gene mutations among 696 β-thalassemia patients and carriers in Southern Vietnam. | Xinh PT, Chuong HQ, Ha NTT, Tram HDB, Van Dong C, Thanh LVH, Hoa NTH, Nghia H, Binh NT, Dung PC, Vu HA | Mol Biol Rep | 2022 |
| Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease. | Damlaj M, Alahmari B, Alaskar A, Alhejazi A, Alsadi H, Shehab-Eddine I, Alghamdi A, Almashaqbeh W, Alshobaki H, Mahasneh I, Alotaibi A, Alanazi T, Balili M, Quarshi M, Ahmed M, Alzahrani M | Bone Marrow Transplant | 2022 |
| Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysis. | Lopinto J, Gendreau S, Berti E, Bartolucci P, Habibi A, Mekontso Dessap A | Haematologica | 2022 |
| Correction to: Modern management of iron overload in thalassemia major patients guided by MRI techniques: real‑world data from a long‑term cohort study. | Bayraktaroglu S, Karadas N, Onen S, Karapinar DY, Aydinok Y | Ann Hematol | 2022 |
| Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease. | Schroeder P, Fulzele K, Forsyth S, Ribadeneira MD, Guichard S, Wilker E, Marshall CG, Drake A, Fessler R, Konstantinidis DG, Seu KG, Kalfa TA | J Pharmacol Exp Ther | 2022 |
| De novo mutation rates at the single-mutation resolution in a human gene-region associated with adaptation and genetic disease. | Melamed D, Nov Y, Malik A, Yakass MB, Bolotin E, Shemer R, Hiadzi EK, Skorecki KL, Livnat A | Genome Res | 2022 |
| Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis. | Hodges B, Ivy ZK, Cronin RM, Rodeghier M, DeBaun MR, Willen S | Blood Adv | 2022 |
| Correction to: Macular microvascular changes in children with transfusion-dependent beta-thalassemia. | AttaAllah HR, Mousa SO, Omar IAN | Graefes Arch Clin Exp Ophthalmol | 2022 |
| Newborn Screening and Clinical Profile of Children with Sickle Cell Disease in a Tribal Area of Gujarat. | Dave KK, Desai S, Italia Y, Mukherjee MB, Mehta P, Desai G | Indian Pediatr | 2022 |
| Effects of dual chelation therapy with deferasirox and deferoxamine in patients with beta thalassaemia major. | Zargari A, Wu S, Greenway A, Cheng K, Kaplan Z | Vox Sang | 2022 |
| Epigenomic analysis of KLF1 haploinsufficiency in primary human erythroblasts. | Heshusius S, Grech L, Gillemans N, Brouwer RWW, den Dekker XT, van IJcken WFJ, Nota B, Felice AE, van Dijk TB, von Lindern M, Borg J, van den Akker E, Philipsen S | Sci Rep | 2022 |
| COVID-19 and Sickle Cell Disease-Related Deaths Reported in the United States. | Payne AB, Schieve LA, Abe K, Hulihan M, Hooper WC, Hsu LL | Public Health Rep | 2022 |
| Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective. | Dela-Pena JC, King MA, Brown J, Nachar VR | J Oncol Pharm Pract | 2022 |
| Possible effects of sirolimus treatment on the long‑term efficacy of COVID‑19 vaccination in patients with β‑thalassemia: A theoretical perspective. | Zurlo M, Nicoli F, Borgatti M, Finotti A, Gambari R | Int J Mol Med | 2022 |
| A case of α-chain variant hemoglobin (Hb Chad) with falsely high HbA1c levels measured by immunoassay. | Yoshino K, Hirota Y, Ogawa W, Sugawara K, Kawaguchi A, Yoshino H, Ishibashi M, Yoshino G, Koga M | Diabetol Int | 2022 |
| COVID -19 Precipitating Vaso-Occlusive Crisis in a Patient of Sickle Cell Anemia with Avascular Necrosis of Femur. | Khandual SP, Mallick R, Jhankar SK, Tudu K, Bariha PK, Mohapatra MK | J Assoc Physicians India | 2022 |
| Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management. | Malagù M, Marchini F, Fiorio A, Sirugo P, Clò S, Mari E, Gamberini MR, Rapezzi C, Bertini M | Biology (Basel) | 2022 |
| Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients. | Saad HKM, Abd Rahman AA, Ab Ghani AS, Taib WRW, Ismail I, Johan MF, Al-Wajeeh AS, Al-Jamal HAN | Biomedicines | 2022 |
| Redox-Regulation of α-Globin in Vascular Physiology. | Kiger L, Keith J, Freiwan A, Fernandez AG, Tillman H, Isakson BE, Weiss MJ, Lechauve C | Antioxidants (Basel) | 2022 |
| Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients. | Edwards O, Burris A, Lua J, Wilkie DJ, Ezenwa MO, Doré S | Genes (Basel) | 2022 |
| Importance of Sequencing , and Genes to Confirm the Diagnosis of High Oxygen Affinity Hemoglobin. | Filser M, Gardie B, Wemeau M, Aguilar-Martinez P, Giansily-Blaizot M, Girodon F | Genes (Basel) | 2022 |
| Clinical phenotypes of three children with sickle cell disease caused by HbS/Sicilian (δβ) -thalassemia deletion. | Aygun B, Bello A, Thompson AA, Davis L, Sun Y, Luo HY, Cui S, Chui DHK | Am J Hematol | 2022 |
| Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease. | Yee ME, Francis RO, Luban NLC, Easley KA, Lough CM, Roback JD, Josephson CD, Fasano RM | Transfusion | 2022 |
| Acoustic radiation force impulse elastography for liver iron overload in β-thalassemia major: Is it going to cut it? | Alessandrino F, Cantisani V | J Clin Ultrasound | 2022 |
| Ultra-rare Hb Regina (:c.289C>G) with coinherited β-thalassaemia trait: solving the puzzle for extreme erythrocytosis. | Mallik N, Jamwal M, Sharma R, Singh N, Sharma P, Bansal D, Trehan A, Chhabra S, Das R | J Clin Pathol | 2022 |
| Successful use of veno-venous extracorporeal membrane oxygenation for acute chest syndrome in a child with sickle cell disease and SARS-CoV-2. | Koh W, Malik P, Whitehead J, Morales DLS, Hayes D | Pediatr Pulmonol | 2022 |
| Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange. | Wade J, Yee MEM, Easley KA, Pahz S, Butler H, Zerra PE, Josephson CD, Fasano RM | Transfusion | 2022 |
| A Case Study in Process Improvement to Minimize Delays from Obtaining Blood for Red Cell Exchange for a Patient with Sickle Cell Disease and Multiple Red Blood Cell Alloantibodies. | Narayanan D, Hogan NB, Schaser KA, Ruegsegger P, Rose WN | Case Rep Hematol | 2022 |
| Transfusion Practice, Post-Transfusion Complications and Risk Factors in Sickle Cell Disease in Senegal, West Africa. | Seck M, Senghor AB, Loum M, Touré SA, Faye BF, Diallo AB, Keita M, Bousso SE, Guèye SM, Gadji M, Sall A, Touré AO, Diop S | Mediterr J Hematol Infect Dis | 2022 |
| The Effect of Alpha Thalassemia, HbF and HbC on Haematological Parameters of Sickle Cell Disease Patients in Ibadan, Nigeria. | Fasola FA, Babalola OA, Brown BJ, Odetunde A, Falusi AG, Olopade O | Mediterr J Hematol Infect Dis | 2022 |
| Benefit of Pulmonary Subspecialty Care for Children with Sickle Cell Disease and Asthma. | Saxena S, Afolabi-Brown O, Ballester L, Schmucker N, Smith-Whitley K, Allen J, Bhandari A | Pediatr Pulmonol | 2022 |
| Rare co-inherited alpha-thalassemia minor and beta-thalassemia minor with heterozygous H63D mutation mistaken as iron deficiency anemia: a case report. | Chaudhry AF, Malik Z, Shegos CJ | AME Case Rep | 2022 |
| Endothelial Activation Markers in Polytransfused Children with Beta Thalassemia: Study from a Tertiary Care Centre in India. | Pallewar TS, Sharma K, Sharma S, Chandra J, Nangia A | Indian J Hematol Blood Transfus | 2022 |
| Impact of HFE-2 and HAMP Gene Variations on Iron Overload in Pediatric Patients with Non-Transfusion Dependent Thalassemia: A Pilot Study. | Bharadwaj N, Peyam S, Bhatia P, Bhatia A, Das R, Singh M, Bansal D, Trehan A, Jain R | Indian J Hematol Blood Transfus | 2022 |
| [Study on Thalassemia in Han Population in Sanya of Hainan Province]. | Xu YY, Li M, Guan LX, Xiang SH, Cheng LC, Yang YH, Gao XN, Ning HM | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Genetic Analysis and Prenatal Diagnosis of Thalassemia in Couples of Childbearing Age in Quanzhou Region Fujian Province, China]. | Zhuang JL, Zhang N, Wang YB, Jiang YY | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Hematological Characteristics of Different Genotypes of Thalassemia among Reproductive Population in Chongqing]. | Li SY, Li QH, Yi SW, Li CL | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Genetic Analysis of Thalassemia in 22 940 Pregnant Women in Xiangxi Tujia and Miao Autonomous Prefecture]. | Yu H, Yang QX, Liu C, Peng LY, Zhou XB, Shao L, Huang N | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| Revascularization Is Associated With a Reduced Stroke Risk in Patients With Sickle Cell-Associated Moyamoya Syndrome. | Newman S, McMahon JT, Boulter JH, Malcolm JG, Revuelta Barbero JM, Chern JJ, Barrow DL, Pradilla G | Neurosurgery | 2022 |
| Thrombospondin-1, Platelet Factor 4, and Galectin-1 are Associated with Engraftment in Patients with Sickle Cell Disease Who Underwent Haploidentical HSCT. | Shaikh A, Olkhanud PB, Gangaplara A, Kone A, Patel S, Gucek M, Fitzhugh CD | Transplant Cell Ther | 2022 |
| Therapeutic plasma exchange in the management of acute complications of sickle cell disease: A single centre experience. | Tsitsikas DA, Mihalca D, Hibbs S, Freeman T, Bello-Sanyaolu O, Orebayo F, Lewis N, Green L | Transfus Apher Sci | 2022 |
| The Importance of Functional and Feature-Tracking Cardiac MRI Parameters in Prediction of Adverse Cardiac Events and Cardiac Mortality in Thalassemia Patients. | Asadian S, Hosseini L, Rezaeian N | Acad Radiol | 2022 |
| Main Complications during Pregnancy and Recommendations for Adequate Antenatal Care in Sickle Cell Disease: A Literature Review. | Figueira CO, Surita FG, Fertrin K, Nobrega GM, Costa ML | Rev Bras Ginecol Obstet | 2022 |
| Omega 3 fatty acids - Potential modulators for oxidative stress and inflammation in the management of sickle cell disease. | Khan SA, Damanhouri GA, Ahmed TJ, Halawani SH, Ali A, Makki A, Khan SA | J Pediatr (Rio J) | 2022 |
| Hybrid bone SPECT/CT reveals spleen calcification in sickle cell mutation and beta-thalassemia. | Sakellariou K, Charalampidou S, Fotopoulos A, Sioka C | Nucl Med Rev Cent East Eur | 2022 |
| Challenges in the Diagnosis of Beta-thalassemia Syndrome: The Importance of Molecular Diagnosis. | Rameli N, Ramli M, Zulkafli Z, Hassan MN, Yusoff SM, Noor NHM, Hussin S, Kamarudin NKM, Yusoff YM, Bahar R | Oman Med J | 2022 |
| Sudden Death in Diabetic Ketoacidosis Complicated by Sickle Cell Trait. | Dau GE, Shah JJ, Walsh JC, Berran PJ | Am J Forensic Med Pathol | 2022 |
| Sideroblastic anaemia in a patient with sickle cell disease. | Vobugari N, Chaturvedi M, Schlam-Camhi IM, Smith HP | BMJ Case Rep | 2022 |
| GRNDaD: big data and sickle cell disease. | Lanzkron S, Manwani D, Desai P, Kanter J, Little J | Blood Adv | 2022 |
| Pharmacologic induction of PGC-1α stimulates fetal haemoglobin gene expression. | Sun Y, Habara A, Le CQ, Nguyen N, Chen R, Murphy GJ, Chui DHK, Steinberg MH, Cui S | Br J Haematol | 2022 |
| Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations. | Longoria JN, Heitzer AM, Hankins JS, Trpchevska A, Porter JS | Br J Haematol | 2022 |
| Description of Hb Évora (: c.106T>C) on an Unexpected Allele in a Swiss Family. | Truttmann R, Schmidt A, Hartmann B, Rusch S, Mendez A | Hemoglobin | 2022 |
| Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition. | Brito PL, Dos Santos AF, Chweih H, Favero ME, Gotardo EMF, Silva JAF, Leonardo FC, Franco-Penteado CF, de Oliveira MG, Ferreira WA, Zaidan BC, Billis A, Baldanzi G, Mashima DA, Antunes E, Saad STO, Costa FF, Conran N | PLoS One | 2022 |
| From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies. | Oliveira CM, Soares VJ, Rechenmacher C, Daudt LE, Michalowski MB | Clinics (Sao Paulo) | 2022 |
| Cerebral oxygen metabolic stress is increased in children with sickle cell anemia compared to anemic controls. | Fields ME, Mirro AE, Binkley MM, Guilliams KP, Lewis JB, Fellah S, Chen Y, Hulbert ML, An H, Ford AL, Lee JM | Am J Hematol | 2022 |
| Efficacy and Safety of Gene Therapy for β-Thalassemia. | Payen E | N Engl J Med | 2022 |
| Determinants of the point of sickling measured by oxygen gradient ektacytometry in sickle cell anaemia. | Joly P, Boisson C, Renoux C, Caillat N, Robert M, Gauthier-Vasserot A, Poutrel S, Cibiel A, Nader E, Connes P | Br J Haematol | 2022 |
| Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review. | Arzoun H, Srinivasan M, Sahib I, Fondeur J, Escudero Mendez L, Hamouda RK, Mohammed L | Cureus | 2022 |
| Sickle cell nephropathy: A review of novel biomarkers and their potential roles in early detection of renal involvement. | Safdar OY, Baghdadi RM, Alahmadi SA, Fakieh BE, Algaydi AM | World J Clin Pediatr | 2022 |
| Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review. | Jiao B, Basu A, Ramsey S, Roth J, Bender MA, Quach D, Devine B | Value Health | 2022 |
| Experiences of African Americans Living With Sickle Cell Disease. | Wickersham KE, Dawson RM, Becker KP, Everhart KC, Miles HS, Schultz BE, Tucker CM, Wright PJ, Jenerette CM | J Transcult Nurs | 2022 |
| Size and density measurements of single sickle red blood cells using microfluidic magnetic levitation. | Goreke U, Bode A, Yaman S, Gurkan UA, Durmus NG | Lab Chip | 2022 |
| Sickle cell disease and COVID-19 in pregnant women. | Kolanska K, Vasileva R, Lionnet F, Santin A, Jaudi S, Dabi Y, Chabbert-Buffet N, Daraï E, Bornes M | J Gynecol Obstet Hum Reprod | 2022 |
| CRISPR/Cas9-based multiplex genome editing of BCL11A and HBG efficiently induces fetal hemoglobin expression. | Han Y, Tan X, Jin T, Zhao S, Hu L, Zhang W, Kurita R, Nakamura Y, Liu J, Li D, Zhang Z, Fang X, Huang S | Eur J Pharmacol | 2022 |
| Process and strategies for patient engagement and outreach in the Sickle Cell Disease (SCD) community to promote clinical trial participation. | Byrnes C, Botello-Harbaum M, Clemons T, Bailey L, Valdes KM, Coleman-Cowger VH | J Natl Med Assoc | 2022 |
| Nrf2 expands the intracellular pool of the chaperone AHSP in a cellular model of β-thalassemia. | Han G, Cao C, Yang X, Zhao GW, Hu XJ, Yu DL, Yang RF, Yang K, Zhang YY, Wang WT, Liu XZ, Xu P, Liu XH, Chen P, Xue Z, Liu DP, Lv X | Redox Biol | 2022 |
| Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far. | Meenan J, Hall R, Badle S, Chatterjee B, Win N, Tsitsikas DA | Transfusion | 2022 |
| Documented Viral Illness at the Time of Splenic Sequestration Does Not Affect the Odds of Recurrence in Children With Sickle Cell Disease. | Clement O, Fishbein J, Appiah-Kubi A, Aygun B | J Pediatr Hematol Oncol | 2022 |
| Haemoglobin Bristol-Alesha in a child with non-spherocytic severe haemolytic anaemia and marked anisochromic poikilocytosis with basophilic stippling and amorphous intracellular content. | Corrons JV, Bain BJ | Blood Cells Mol Dis | 2022 |
| [Associations, key players in the sickle cell patient's journey]. | Mbebi-Liégeois C | Rev Infirm | 2022 |
| [Pregnancy planning and follow-up of a pregnant woman with sickle cell disease]. | Bornes M | Rev Infirm | 2022 |
| [The place of therapeutic education in the care of the sickle cell patient]. | Doumdo L, Bibrac A, Italique C, Petras M, Bernit E | Rev Infirm | 2022 |
| [Long-term nursing care of the adult sickle cell patient]. | Vasseur V, Barbin C | Rev Infirm | 2022 |
| [Psychology and culture in sickle cell disease]. | Faure J | Rev Infirm | 2022 |
| [Management of the adult with sickle cell disease]. | Mattioni S, Santin A | Rev Infirm | 2022 |
| [Care pathway for the sickle cell child]. | Holvoet L, Keohavong A, Traore K | Rev Infirm | 2022 |
| [Sickle cell disease, a genetic haemoglobin disease]. | Girot R | Rev Infirm | 2022 |
| Disrupting the adult-globin promoter alleviates promoter competition and reactivates foetal-globin gene expression. | Topfer S, Feng R, Huang P, Ly L, Martyn G, Blobel GA, Weiss MJ, Quinlan K, Crossley M | Blood | 2022 |
| The ektacytometric elongation Index (EI) of erythrocytes, validation of a prognostic, rheological biomarker for patients with sickle cell disease. | Franck P, Buijs P, Meenhuis A, Dane M, Postma C, Spaans A, Gijsbertha N, Kuypers FA, Hudig C, Kerkhoffs JL | Eur J Haematol | 2022 |
| Action on sickle cell retinopathy: the time is now. | Dinah C, Greystoke B, Mueller I, Talks J | Eye (Lond) | 2022 |
| Efficiency and management factors: finding the balance in Thalassaemia care centres. | Shafie AA, Mohammed NS, See KF, Ibrahim HM, Wong JHY, Chhabra IK | Health Econ Rev | 2022 |
| Rare unstable and low oxygen affinity haemoglobin variant, Hb Hazebrouck, detected on Sysmex XN-9000. | Adam AS, Benyaich S, Colard M, Benghiat FS, Cotton F, Gulbis B | Clin Chem Lab Med | 2022 |
| Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial. | Magrin E, Semeraro M, Hebert N, Joseph L, Magnani A, Chalumeau A, Gabrion A, Roudaut C, Marouene J, Lefrere F, Diana JS, Denis A, Neven B, Funck-Brentano I, Negre O, Renolleau S, Brousse V, Kiger L, Touzot F, Poirot C, Bourget P, El Nemer W, Blanche S, Tréluyer JM, Asmal M, Walls C, Beuzard Y, Schmidt M, Hacein-Bey-Abina S, Asnafi V, Guichard I, Poirée M, Monpoux F, Touraine P, Brouzes C, de Montalembert M, Payen E, Six E, Ribeil JA, Miccio A, Bartolucci P, Leboulch P, Cavazzana M | Nat Med | 2022 |
| Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. | Ravi NS, Wienert B, Wyman SK, Bell HW, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BP, Devaraju N, Rajendiran V, Syedbasha N, Pai AA, Nakamura Y, Kurita R, Narayanasamy M, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR, Srivastava A, DeWitt MA, Crossley M, Corn JE, Mohankumar KM | Elife | 2022 |
| Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: A case series. | Ngwube A, Franay C, Shah N | Pediatr Hematol Oncol | 2022 |
| Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experience. | Cregan M, Puri L, Kang G, Anghelescu D | Pediatr Blood Cancer | 2022 |
| A predictive algorithm for identifying children with sickle cell anemia among children admitted to hospital with severe anemia in Africa. | Olupot-Olupot P, Connon R, Kiguli S, Opoka RO, Alaroker F, Uyoga S, Nakuya M, Okiror W, Nteziyaremye J, Ssenyondo T, Nabawanuka E, Kayaga J, Williams Mukisa C, Amorut D, Muhindo R, Frost G, Walsh K, Macharia AW, Gibb DM, Walker AS, George EC, Maitland K, Williams TN | Am J Hematol | 2022 |
| Diagnostic value of fetal hemoglobin Bart's for evaluation of fetal α-thalassemia syndromes: application to prenatal characterization of fetal anemia caused by undiagnosed α-hemoglobinopathy. | Singha K, Yamsri S, Chaibunruang A, Srivorakun H, Sanchaisuriya K, Fucharoen G, Fucharoen S | Orphanet J Rare Dis | 2022 |
| Hb Mizuho (: c.206T>C): Pitfalls of Screening Tests in an Unstable Hemoglobin Variant Diagnosed after Targeted Next-Generation Sequencing. | Yadav DD, Jamwal M, Singh N, Sharma R, Das R, Trehan A, Bansal D, Chhabra S, Sharma P | Hemoglobin | 2022 |
| Voxelotor and albuminuria in adults with sickle cell anaemia. | Han J, Molokie RE, Hussain F, Njoku F, Gordeuk VR, Saraf SL | Br J Haematol | 2022 |
| COVID-19 Vaccine Perception and Hesitancy Among Patients With Sickle Cell Disease in the Western Region of Saudi Arabia. | Jan H, Waheeb A, AlAhwal H, Almohammadi A, Al-Marzouki A, Barefah A, Bahashawan S, Radhwi O | Cureus | 2022 |
| Awareness and Acceptance of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Jazan Province, Saudi Arabia. | Hurissi E, Hakami A, Homadi J, Kariri F, Abu-Jabir E, Alamer R, Mobarki R, Jaly AA, Alamer E, Alhazmi AH | Cureus | 2022 |
| Neonatal Screening for Sickle Cell Disease in Congo. | Dokekias AE, Ocko Gokaba LT, Louokdom JS, Ocini LN, Galiba Atipo Tsiba FO, Ondzotto Ibatta CI, Kouandzi QN, Tamekue ST, Bango JC, Nziengui Mboumba JV, Kobawila SC | Anemia | 2022 |
| Pas-de-deux: African Plasmodium falciparum adaptations to sickle hemoglobin. | Matuschewski K, Maier AG | Trends Parasitol | 2022 |
| Genes modulating intestinal permeability and microbial community are dysregulated in sickle cell disease. | Poplawska M, Dutta D, Jayaram M, Chong NS, Salifu M, Lim SH | Ann Hematol | 2022 |
| Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana. | Zempsky WT, Yanaros M, Sayeem M, Boruchov D, Piccone CM, Manwani D, Strunk C, Tartaglione I, Colombatti R, Akatue S, Oteng B, Owda A, Bamfo R, Wilson S, Rivers A, Farooq F, Urbonya R, Boatemaa GD, Rao S, Inusa B, Antwi-Boasiako C, Segbefia C, Sey F, Andemariam B, Asare EV, Campbell AD | Pain Med | 2022 |
| A Systematic Review on the Management of Transfusion-Related Acute Lung Injury in Transfusion-Dependent Sickle Cell Disease. | Arzoun H, Srinivasan M, Adam M, Thomas SS, Lee B, Yarema A | Cureus | 2022 |
| Circulating Small Extracellular Vesicles May Contribute to Vaso-Occlusive Crises in Sickle Cell Disease. | Gemel J, Zhang J, Mao Y, Lapping-Carr G, Beyer EC | J Clin Med | 2022 |
| Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence. | Gentinetta T, Belcher JD, Brügger-Verdon V, Adam J, Ruthsatz T, Bain J, Schu D, Ventrici L, Edler M, Lioe H, Patel K, Chen C, Nguyen J, Abdulla F, Zhang P, Wassmer A, Jain M, Mischnik M, Pelzing M, Martin K, Davis R, Didichenko S, Schaub A, Brinkman N, Herzog E, Zürcher A, Vercellotti GM, Kato GJ, Höbarth G | J Clin Med | 2022 |
| MicroRNAs miR-451a and Let-7i-5p Profiles in Circulating Exosomes Vary among Individuals with Different Sickle Hemoglobin Genotypes and Malaria. | Oxendine Harp K, Bashi A, Botchway F, Dei-Adomakoh Y, Iqbal SA, Wilson MD, Adjei AA, Stiles JK, Driss A | J Clin Med | 2022 |
| Shear-Stress-Gradient and Oxygen-Gradient Ektacytometry in Sickle Cell Patients at Steady State and during Vaso-Occlusive Crises. | Boisson C, Nader E, Renoux C, Gauthier A, Poutrel S, Bertrand Y, Stauffer E, Virot E, Hot A, Fort R, Cannas G, Joly P, Connes P | Cells | 2022 |
| Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia. | Ma SP, Gao XX, Zhou GQ, Zhang HK, Yang JM, Wang WJ, Song XM, Chen HY, Lu DR | Gene | 2022 |
| Evolutionary race: Malaria evolves to evade sickle cell protection. | Gómez-Díaz E, Ranford-Cartwright L | Cell Host Microbe | 2022 |
| Acute chest syndrome of sickle cell disease: genetics, risk factors, prognosis, and management. | Klings ES, Steinberg MH | Expert Rev Hematol | 2022 |
| Phenotypic variation in sickle cell disease: the role of beta globin haplotype, alpha thalassaemia and fetal haemoglobin in HbSS. | Serjeant GR | Expert Rev Hematol | 2022 |
| Pregnancy outcomes with hydroxyurea use in women with sickle cell disease. | Kroner BL, Hankins JS, Pugh N, Kutlar A, King AA, Shah NR, Kanter J, Glassberg J, Treadwell M, Gordeuk VR, | Am J Hematol | 2022 |
| Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia. | Sheehan VA, van Beers EJ, Connes P, van Wijk R, Rab MAE | Br J Haematol | 2022 |
| Long-read sequencing on the SMRT platform enables efficient haplotype linkage analysis in preimplantation genetic testing for β-thalassemia. | Wu H, Chen D, Zhao Q, Shen X, Liao Y, Li P, Chiu PCN, Zhou C | J Assist Reprod Genet | 2022 |
| Association and Risk Factors of Osteonecrosis of Femoral Head in Sickle Cell Disease: A Systematic Review. | Leandro MP, De Sá CKC, Filho DPS, De Souza LAA, Salles C, Tenório MCC, Paz CLDSL, Matos MAA | Indian J Orthop | 2022 |
| Multiplex Quantitative Real-Time Polymerase Chain Reaction and High-Resolution Melting Analysis for Identification of a Couple At-Risk of Having a Newborn with Severe Thalassemia. | Ruengdit C, Punyamung M, Khamphikham P, Pongpunyayuen P, Intasai N, Pornprasert S | Hemoglobin | 2022 |
| Fetal-like Hemoglobin in Sickle Cell Anemia. | Steinberg MH | N Engl J Med | 2022 |
| Scalable manufacturing platform for the production of methemoglobin as a non-oxygen carrying control material in studies of cell-free hemoglobin solutions. | Gu X, Hickey R, Rath A, Palmer AF | PLoS One | 2022 |
| The distinct longitudinal impact of pain catastrophizing on pain interference among youth living with sickle cell disease and chronic pain. | Schneider MB, Manikowski A, Cohen L, Dampier C, Sil S | J Behav Med | 2022 |
| Purinergic signaling is essential for full Psickle activation by hypoxia and by normoxic acid pH in mature human sickle red cells and in vitro-differentiated cultured human sickle reticulocytes. | Vandorpe DH, Rivera A, Ganter M, Dankwa S, Wohlgemuth JG, Dlott JS, Snyder LM, Brugnara C, Duraisingh M, Alper SL | Pflugers Arch | 2022 |
| An Evaluation for the Causes of Reduced Hb A and the Molecular Characterization of Variants in Hong Kong. | Chan NCN, Wong THY, Cheng KCK, Chan NPH, Ng MHL | Hemoglobin | 2022 |
| Direct antiglobulin test-negative autoimmune hemolytic anemia in a patient with β-thalassemia minor during pregnancy: A case report. | Zhou Y, Ding YL, Zhang LJ, Peng M, Huang J | World J Clin Cases | 2022 |
| Anaesthetic management of patients with sickle cell disease in obstetrics. | Stoddard K, Sohal M, Bedson R | BJA Educ | 2022 |
| Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience. | Yesilipek MA, Uygun V, Kupesiz A, Karasu G, Ozturk G, Ertem M, Şaşmaz İ, Daloğlu H, Güler E, Hazar V, Fisgin T, Sezgin G, Kansoy S, Kuşkonmaz B, Akıncı B, Özbek N, İnce EÜ, Öztürkmen S, Küpesiz FT, Yalçın K, Anak S, Bozkurt C, Karakükçü M, Küpeli S, Albayrak D, Öniz H, Aksoylar S, Okur FV, Albayrak C, Yenigürbüz FD, Bozkaya İO, İleri T, Gürsel O, Karagün BŞ, Kintrup GT, Çelen S, Elli M, Aksoy BA, Yılmaz E, Tanyeli A, Akyol ŞT, Siviş ZÖ, Özek G, Uçkan D, Kartal İ, Atay D, Akyay A, Bilir ÖA, Çakmaklı HF, Kürekçi E, Malbora B, Akbayram S, Demir HA, Kılıç SÇ, Güneş AM, Zengin E, Özmen S, Antmen AB | Bone Marrow Transplant | 2022 |
| Factors associated with blood pressure variation in sickle cell disease patients: a systematic review and meta-analyses. | Nguweneza A, Oosterwyk C, Banda K, Nembaware V, Mazandu G, Kengne AP, Wonkam A | Expert Rev Hematol | 2022 |
| Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center. | Varelas C, Gavriilaki E, Sakellari I, Klonizakis P, Koravou EE, Christodoulou I, Mavrikou I, Kourelis A, Chatzopoulou F, Chatzidimitriou D, Touloumenidou T, Papalexandri A, Anagnostopoulos A, Vlachaki E | J Clin Med | 2022 |
| Comparison of Ultra-Wide Field Photography to Ultra-Wide Field Angiography for the Staging of Sickle Cell Retinopathy. | Torres-Villaros H, Fajnkuchen F, Amari F, Janicot L, Giocanti-Aurégan A | J Clin Med | 2022 |
| Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review. | Mulas O, Mola B, Caocci G, La Nasa G | J Clin Med | 2022 |
| Use of Deferasirox Film-Coated Tablets in Pediatric Patients with Transfusion Dependent Thalassemia: A Single Center Experience. | Adramerina A, Printza N, Hatzipantelis E, Symeonidis S, Tarazi L, Teli A, Economou M | Biology (Basel) | 2022 |
| Health-Related Quality of Life Assessments by Children and Adolescents with Sickle Cell Disease and Their Parents in Portugal. | Abadesso C, Pacheco S, Machado MC, Finley GA | Children (Basel) | 2022 |
| A Description of the Hemolytic Component in Sickle Leg Ulcer: The Role of Circulating miR-199a-5p, miR-144, and miR-126. | Santos EDC, Melo GIV, Santana PVB, Quadros IGS, Yahouédéhou SCMA, Guarda CCD, Santiago RP, Fiuza LM, Carvalho SP, Adorno EV, Kaneto CM, Fonseca TCC, Goncalves MS, Aleluia MM | Biomolecules | 2022 |
| Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and | Amid A, Barrowman N, Odame I, Kirby-Allen M | Br J Haematol | 2022 |
| The hematopoietic saga of clonality in sickle cell disease. | Stonestrom AJ, Levine RL | J Clin Invest | 2022 |
| A microfluidic-informatics assay for quantitative physical occlusion measurement in sickle cell disease. | Zhang X, Chan T, Carbonella J, Gong X, Ahmed N, Liu C, Demandel I, Zhang J, Pashankar F, Mak M | Lab Chip | 2022 |
| GBT1118, a voxelotor analog, protects red blood cells from damage during severe hypoxia. | Tarasev M, Ferranti M, Herppich A, Hines P | Am J Transl Res | 2022 |
| Sickle cell disease as an accelerated aging syndrome. | Idris IM, Botchwey EA, Hyacinth HI | Exp Biol Med (Maywood) | 2022 |
| Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor. | Vora SM, Boyd S, Denny N, Jackson E, Roy NBA, Howard J, Lugthart S | Br J Haematol | 2022 |
| Coinheritance of HbO Arab/β0-thalassemia with Severe Manifestation in Newborn. | Kalai M, Moumni I, Ouragini H, Chaouechi D, Boudriga I, Menif S | Am J Perinatol | 2022 |
| Black Americans' willingness to participate in pediatric sickle cell clinical trials: A retrospective, systematic review. | Zanfardino S, Mazziotto V, Bodas P | Pediatr Blood Cancer | 2022 |
| Diagnosis of α-thalassemia Chiang Rai (--) deletion by melt curve analysis in Northern Thailand. | Ruengdit C, Khamphikham P, Punyamung M, Pongpunyayuen P, Pornprasert S | Scand J Clin Lab Invest | 2022 |
| An impact evaluation of two modes of care for sickle cell disease crises. | Skinner R, Breck A, Esposito D | J Comp Eff Res | 2022 |
| Extra-Medullary Hematopoiesis in Sickle Cell Disease Presenting as a Right Adrenal Mass. | Ajayi F, Nali MS, Ali R, Patel A, Shaaban H | Cureus | 2022 |
| The clinical and radiological effectiveness of autologous bone marrow derived osteoblasts (ABMDO) in the management of avascular necrosis of femoral head (ANFH) in sickle cell disease (SCD). | Sadat-Ali M, Al-Omran AS, AlTabash K, Acharya S, Hegazi TM, Al Muhaish MI | J Exp Orthop | 2022 |
| Two trade names of deferasirox (Osveral® and Exjade®) in reduction of iron overload parameters in major beta-thalassemia patients: A randomized open labeled clinical trial. | Rafati M, Karami H, Lashtoo-Aghaee B, Lashtoo-Aghaee B, Dabirian M, Avan R | Caspian J Intern Med | 2022 |
| A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. | Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S | Sci Rep | 2022 |
| Effect of age, cerebral infarcts, vasculopathy and haemoglobin on cognitive function, in Tanzanian children with sickle cell anaemia. | Jacob M, Stotesbury H, Kija E, Saunders D, Mtei RJ, Tutuba H, Masanu U, Kilonzo M, Kazema R, Hood AM, Kirkham F, Dimitriou D, Makani J | Eur J Paediatr Neurol | 2022 |
| Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation. | Patel A, Wilkerson K, Chen H, Sharma D, Byrne M, Green J, Sengsayadeth S, Dholaria B, Savani B, Chinratanalab W, Jayani R, Gatwood K, Engelhardt BG, Kitko C, Connelly J, Kassim A | Transplant Cell Ther | 2022 |
| Third-generation sequencing: A novel tool detects complex variants in the α-thalassemia gene. | Long J, Sun L, Gong F, Zhang C, Mao A, Lu Y, Li J, Liu E | Gene | 2022 |
| Correlation of Asymmetric Dimethyl Arginine Level to Sickle Retinopathy in Children With Sickle Cell Disease. | Elhawary EE, Khedr SF, Nagy HM, El-Bradey MH, Elshanshory MR | J Pediatr Hematol Oncol | 2022 |
| Assessment of Liver Fibrosis by Transient Elastography in Children and Young Adults With Sickle Cell Disease With and Without Iron Overload. | Alvarez O, Cumming V, Fifi AC | J Pediatr Hematol Oncol | 2022 |
| Introduction of Hydroxyurea Therapy to a Cohort of Sickle Cell Patients in Northern Haiti. | Paul-Hanna M, Joseph W, Mondesir W, Faustino EVS, Canarie MF | J Pediatr Hematol Oncol | 2022 |
| Peripheral Blood Smear Detection of Asymptomatic Central Line Infection in a Patient With Sickle Cell Disease. | Carll TC, Mariani R, Schafernak K, Snowberger T, Jacobsen J, Gomez E, Su L | J Pediatr Hematol Oncol | 2022 |
| Enuresis and Hyperfiltration in Children With Sickle Cell Disease. | Zahr RS, Ding J, Kang G, Wang WC, Hankins JS, Ataga KI, Lebensburger JD, Porter JS | J Pediatr Hematol Oncol | 2022 |
| Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trial. | George EC, Uyoga S, M'baya B, Kyeyune Byabazair D, Kiguli S, Olupot-Olupot P, Opoka RO, Chagaluka G, Alaroker F, Williams TN, Bates I, Mbanya D, Gibb DM, Walker AS, Maitland K, | Lancet Glob Health | 2022 |
| Globin vector regulatory elements are active in early hematopoietic progenitor cells. | Cabriolu A, Odak A, Zamparo L, Yuan H, Leslie C, Sadelain M | Mol Ther | 2022 |
| The unexpected impact of cabozantinib on red blood cells consumption in patients with transfusion-dependent thalassemia. | Costantini S, Meloni A, Spasiano A, Cinque P, Ricchi P | Ann Hematol | 2022 |
| Retinal and choroidal thickness in pediatric patients with sickle cell disease: a cross-sectional cohort study. | Prazeres J, Lucatto LF, Ferreira A, Moraes N, Braga JAP, Lima LH, Regatieri C, Maia M | Int J Retina Vitreous | 2022 |
| The Sickle Cell Disease Functional Assessment (SCD-FA) tool: a feasibility pilot study. | Oyedeji CI, Hall K, Luciano A, Morey MC, Strouse JJ | Pilot Feasibility Stud | 2022 |
| Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study. | Alshamsi S, Hamidi S, Narci HO | BMC Health Serv Res | 2022 |
| Accuracy of transcranial Doppler in detecting intracranial stenosis in patients with sickle cell anemia when compared to magnetic resonance angiography. | Krementz NA, Gardener HE, Torres L, Alkhalifah M, Campo-Bustillo I, Campo N, Koch S, Alvarez O, Rundek T, Romano JG | J Clin Ultrasound | 2022 |
| Nursing Education for the Acute Care Nurse on Pain Mechanisms of Sickle Cell Disease. | Evelyn AE, Kittelson S, Mandernach MW, Black V, Duckworth L, Wilkie DJ | J Contin Educ Nurs | 2022 |
| Autoimmune disease and sickle cell anaemia: 'Intersecting pathways and differential diagnosis'. | Piccin A, O'Connor-Byrne N, Daves M, Lynch K, Farshbaf AD, Martin-Loeches I | Br J Haematol | 2022 |
| Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience. | Gagliardi I, Celico M, Gamberini MR, Pontrelli M, Fortini M, Carnevale A, Napoli N, Zatelli MC, Ambrosio MR | Calcif Tissue Int | 2022 |
| Erythrocyte (red blood cell) dataset in thalassemia case. | Tyas DA, Ratnaningsih T, Harjoko A, Hartati S | Data Brief | 2022 |
| Advances in the diagnosis and treatment of sickle cell disease. | Brandow AM, Liem RI | J Hematol Oncol | 2022 |
| Growth Hormone/Insulin-Like Growth Factor 1 Axis Associated with Modifiers Factors in Children with Sickle Cell Anemia. | Costa-Júnior DAD, Santos APP, da Silva CM, Velloso-Rodrigues C | Endocr Metab Immune Disord Drug Targets | 2022 |
| Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study. | Ranque B, Kitenge R, Ndiaye DD, Ba MD, Adjoumani L, Traore H, Coulibaly C, Guindo A, Boidy K, Mbuyi D, Ly ID, Offredo L, Diallo DA, Tolo A, Kafando E, Tshilolo L, Diagne I | Lancet Haematol | 2022 |
| Filling the data gaps on sickle cell anaemia in sub-Saharan Africa. | Williams TN | Lancet Haematol | 2022 |
| Assessment of serum endocan levels in patients with beta-thalassemia minor. | Khanmammadov N, Zorlu M, Ozer OF, Karatoprak C, Kıskaç M, Çakırca M | Rev Assoc Med Bras (1992) | 2022 |
| A Rare Hemoglobin Variant (β51Pro → His) Causing Misleading Measurements of Hemoglobin A. | Mackley MP, Morgenthau A, Elnenaei M, MacKenzie H | J Endocr Soc | 2022 |
| Hair-on-End Sign in a 9-Year-Old Girl Presenting with Acute Stroke in Sickle Cell Disease. | Ogwang E, Odongo CN, Namusisi J, Okello PA, Acan M | Int Med Case Rep J | 2022 |
| Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. | Derchi G, Musallam KM, Pinto VM, Graziadei G, Giuditta M, Barella S, Origa R, Casu G, Pasanisi A, Longo F, Casale M, Miceli R, Merella P, Gianesin B, Ameri P, Tartaglione I, Perrotta S, Piga A, Cappellini MD, Forni GL | Haematologica | 2022 |
| Prevalence and risk factors of hepatitis E virus infection among patients with β-thalassemia major in South of Iran. | Farshadpour F, Taherkhani R, Shaeri M | J Immunoassay Immunochem | 2022 |
| Relation between haptoglobin polymorphism and oxidative stress status, lipid profile, and cardiovascular risk in sickle cell anemia patients. | Kengne Fotsing CB, Pieme CA, Biapa Nya PC, Chedjou JP, Dabou S, Nguemeni C, Teto G, Mbacham WF, Gatsing D | Health Sci Rep | 2022 |
| Healthcare professionals' perceptions of implementing a decision support intervention for cascade screening for beta-thalassemia in Pakistan. | Ahmed S, Jafri H, Ahmed WN, Faran M, Rashid Y, Ehsan Y, Ahmed M | Eur J Hum Genet | 2022 |
| ETV6 Regulates Hemin-Induced Erythroid Differentiation of K562 Cells through Mediating the Raf/MEK/ERK Pathway. | Li Z, Sun MZ, Lv X, Guo C, Liu S | Biol Pharm Bull | 2022 |
| Outcomes of kidney donors with sickle cell trait: A preliminary analysis. | Hebert SA, Gandhi NV, Al-Amin S, Edwards AR, Murad DN, Nguyen DT, Graviss EA, Ibrahim HN | Clin Transplant | 2022 |
| Two co-inherited hemoglobin variants revealed by capillary electrophoresis during quantification of glycated hemoglobin. | Antonello G, Lo Monaco C, Napoli P, Solimando D, Curcio C, Barberio G, Maoggi S, Ivaldi G, Nigra M | Clin Chem Lab Med | 2022 |
| Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies. | Radhwi OO, Jan H, Waheeb A, Alamri SS, Alahwal HM, Denetiu I, Almanzlawey A, Al-Marzouki AF, Almohammadi AT, Bahashwan SM, Barefah AS, Qari MH, Abuzenadah AM, Hashem AM | Vaccines (Basel) | 2022 |
| Fetal Hemoglobin in β Hemoglobinopathies: Is Enough Too Much? | Steinberg MH | Am J Hematol | 2022 |
| High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients. | Matsagos S, Verigou E, Kourakli A, Alexis S, Vrakas S, Argyropoulou C, Lazaris V, Spyropoulou P, Labropoulou V, Georgara N, Lykouresi M, Karakantza M, Alepi C, Symeonidis A | Front Med (Lausanne) | 2022 |
| Editorial: Red Blood Cell Vascular Adhesion and Deformability, Volume II. | Guizouarn H, Barshtein G | Front Physiol | 2022 |
| Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent -Thalassemia. | Che J, Luo T, Huang L, Lu Q, Yan D, Meng Y, Xie J, Chen W, Chen J, Long L | Front Pharmacol | 2022 |
| Comparison of the programmed freezer method and deep freezer method in the manufacturing of frozen red blood cell products. | Fuchizaki A, Yasui K, Tanaka M, Mitsuhashi H, Shimogaki K, Kimura T, Takihara Y, Hirayama F | Vox Sang | 2022 |
| Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review. | A Subahi E, Ata F, Choudry H, Iqbal P, A AlHiyari M, T Soliman A, De Sanctis V, A Yassin M | Ann Med | 2022 |
| Risk and protective factors for severe COVID-19 infection in a cohort of patients with sickle cell disease. | Cai J, Chen-Goodspeed A, Idowu M | J Investig Med | 2022 |
| Lower Muscle and Blood Lactate Accumulation in Sickle Cell Trait Carriers in Response to Short High-Intensity Exercise. | Messonnier LA, Oyono-Enguéllé S, Vincent L, Dubouchaud H, Chatel B, Sanchez H, Malgoyre A, Martin C, Galactéros F, Bartolucci P, Thiriet P, Féasson L | Nutrients | 2022 |
| Endothelial superoxide dismutase 2 is decreased in sickle cell disease and regulates fibronectin processing. | Dosunmu-Ogunbi A, Yuan S, Shiwarski DJ, Tashman JW, Reynolds M, Feinberg A, Novelli EM, Shiva S, Straub AC | Function (Oxf) | 2022 |
| α-thalassemia in affected fetuses with hemoglobin E-β-thalassemia disease in a high-risk population in Thailand. | Yamsri S, Prommetta S, Srivorakun H, Taweenan W, Sanchaisuriya K, Chaibunruang A, Fucharoen G, Fucharoen S | Am J Transl Res | 2022 |
| Acute complications in children with sickle cell disease: Prevention and management. | Beck CE, Trottier ED, Kirby-Allen M, Pastore Y | Paediatr Child Health | 2022 |
| Reflex single-gene non-invasive prenatal testing is associated with markedly better detection of fetuses affected with single-gene recessive disorders at lower cost. | Riku S, Hedriana H, Carozza JA, Hoskovec J | J Med Econ | 2022 |
| Rheological Abnormalities in Human Erythrocytes Subjected to Oxidative Inflammation. | Maruyama T, Hieda M, Mawatari S, Fujino T | Front Physiol | 2022 |
| Letter to the Editor: Role of Ketamine in Vaso-Occlusive Crisis of Sickle Cell Disease. | Raghuraman MS | Saudi J Med Med Sci | 2022 |
| Adiponectin and Disease Severity in Sickle Cell Anemia Patients Attending a Tertiary Health Institution in Nnewi, Southeast Nigeria. | Okocha CE, Manafa PO, Igwe CN, Okite UP, Onah CE, Efobi C | Front Genet | 2022 |
| Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana. | Paintsil V, Amuzu EX, Nyanor I, Asafo-Adjei E, Mohammed AR, Yawnumah SA, Oppong-Mensah YG, Nguah SB, Obeng P, Dogbe EE, Jonas M, Nembaware V, Mazandu G, Ohene-Frempong K, Wonkam A, Makani J, Ansong D, Osei-Akoto A, | Front Genet | 2022 |
| Moyamoya syndrome in a child with HbEβ-thalassemia. | Zahra A, Al-Abboh H, Habeeb Y, Adekile A | Clin Case Rep | 2022 |
| A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders. | Tucci F, Galimberti S, Naldini L, Valsecchi MG, Aiuti A | Nat Commun | 2022 |
| XMN polymorphism along with HU administration renders alterations to RBC membrane lipidome in β-thalassemia patients. | Khan MBN, Iftikhar F, Ali M, Danish A, Shamsi T, Musharraf SG, Siddiqui AJ | Chem Phys Lipids | 2022 |
| Noninvasive prenatal testing of beta-thalassemia for common Pakistani mutations: a comparative study using cell-free fetal DNA from maternal plasma and chorionic villus sampling. | Afzal M, Naeem MA, Ahmed S, Amin N, Rahim A, Munawar M, Ishaq M, Rathore A, Maria K | Hematology | 2022 |
| Web Exclusive. Annals for Hospitalists Inpatient Notes - Clinical Pearls-Acute Pain Episodes in Sickle Cell Disease. | Strouse JJ, Brandow AM | Ann Intern Med | 2022 |
| The role of immature granulocyte percentage in predicting acute chest syndrome and the severity of the vaso-occlusive crisis in sickle cell disease. | Karahan F, Ünal S, Topçu DB, Öztaş Y, Bozlu G | Turk J Pediatr | 2022 |
| 50 Years Ago in TheJournalofPediatrics: Newborn Screening for Sickle Cell Disease: A Promise (Un)Fulfilled. | Strumph K, Manwani D | J Pediatr | 2022 |
| In Memoriam: Haig H. Kazazian, Jr. (1937-2022). | Cutting GR | Hum Mutat | 2022 |
| Early prenatal diagnosis of Hb Lepore Boston-Washington and β-thalassemia on fetal celomatic DNA. | Giambona A, Leto F, Cassarà F, Tartaglia V, Marchese G, Orlandi E, Cigna V, Picciotto F, Maggio A, Vinciguerra M | Int J Lab Hematol | 2022 |
| Heterozygosity of the Complex Corfu δβ Thalassemic Allele ( Deletion and HBB:c.92+5G>A) Revisited. | Kattamis C, Skafida M, Delaporta P, Vrettou C, Traeger-Synodinos J, Sofocleous C, Kattamis A | Biology (Basel) | 2022 |
| Elevated tricuspid regurgitation velocity is associated with increased adverse haematologic events during pregnancy in women with sickle cell disease. | Marshall WH, Cleary EM, Della-Moretta S, Li R, Samuels P, Desai PC, Rajpal S | Br J Haematol | 2022 |
| Epigenetic and Transcriptional Control of Erythropoiesis. | Wells M, Steiner L | Front Genet | 2022 |
| Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia. | Meloni A, Pistoia L, Ricchi P, Putti MC, Gamberini MR, Cuccia L, Messina G, Massei F, Facchini E, Righi R, Renne S, Peritore G, Positano V, Cademartiri F | J Pers Med | 2022 |
| Vulnerability of β-Thalassemia Heterozygotes to COVID-19: Results from a Cohort Study. | Sotiriou S, Samara AA, Lachanas KE, Vamvakopoulou D, Vamvakopoulos KO, Vamvakopoulos N, Janho MB, Perivoliotis K, Donoudis C, Daponte A, Gourgoulianis KI, Boutlas S | J Pers Med | 2022 |
| Disseminated spp. Endocarditis in a Beta-Thalassemia Patient after Asymptomatic COVID-19 Infection. | Cinteza E, Nicolescu A, Ciomartan T, Gavriliu LC, Voicu C, Carabas A, Popescu M, Margarint I | Diagnostics (Basel) | 2022 |
| Hsp90 in Human Diseases: Molecular Mechanisms to Therapeutic Approaches. | Sumi MP, Ghosh A | Cells | 2022 |
| Neuroimaging Findings in Pediatric Patients with Thalassemia Major. | Akbaş Y, Aydın S, Tunçer GÖ, Köker A, Çoban Y, Oktay G, Yeral H | Hematol Rep | 2022 |
| COVID-19 in Patients with Transfusion Dependent Thalassemia (TDT) in Indonesia: Characteristics of the Disease and Patients, and Comparison between Epidemiological Data for COVID-19 and Thalassemia in Indonesia and Southeast Asia. | Atmakusuma TD | Hematol Rep | 2022 |
| HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response. | Nekhai S, Kumari N | Expert Rev Hematol | 2022 |
| A Novel Hemoglobin Variant Hb Liaobu [α107(G14)Val→Leu, : c.322G>C] Detected by Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry. | Tan XM, Liu YH, Shang X, Ye YH, Xu XM | Hemoglobin | 2022 |
| Cognitive Impairment in Thalassemia and Associated Factors. | Limpawattana P, Juntararuangtong T, Teawtrakul N, Wanitpongpun C, Lanamtieng T, Phiphitaporn P, Chansung K | Dement Geriatr Cogn Disord | 2022 |
| Perspectives of individuals with sickle cell disease on barriers to care. | Phillips S, Chen Y, Masese R, Noisette L, Jordan K, Jacobs S, Hsu LL, Melvin CL, Treadwell M, Shah N, Tanabe P, Kanter J | PLoS One | 2022 |
| Perspective on newborn screening (NBS): Evidence sharing on conditions to be included in NBS in Pakistan. | Majid H, Jafri L, Ahmed S, Humayun K, Kirmani S, Ali N, Moiz B, Khan AH, Afroze B | J Pak Med Assoc | 2022 |
| Association of early donor chimerism status with survival outcomes in post allogeneic haematopoietic stem cell transplant patients of nonmalignant diseases. | Sial N, Ahmed P, Wattoo FH, Ali N | J Pak Med Assoc | 2022 |
| Can We Perform the Maximal Treadmill Test on Individuals with Sickle Cell Disease? | Ahner MM, Motta SBD, Franzoni L | Arq Bras Cardiol | 2022 |
| Exercise Testing In Patients with Sickle Cell Disease: Safety, Feasibility and Potential Prognostic Implication. | Araújo CG, Resende MBS, Tupinambás JT, Dias RCTM, Barros FC, Vasconcelos MCM, Januário JN, Ribeiro ALP, Nunes MCP | Arq Bras Cardiol | 2022 |
| An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia. | Real FJ, Hood AM, Davis D, Cruse B, Klein M, Johnson Y, McTate E, Brinkman WB, Hackworth R, Hackworth K, Quinn CT, Crosby LE | J Pediatr Hematol Oncol | 2022 |
| Transition Preparation and Satisfaction of Care Among Adolescents and Young Adults With Sickle Cell Disease at the Ghana Institute of Clinical Genetics. | Kwarteng-Siaw M, Benneh-Akwasi Kuma A, Green NS | J Pediatr Hematol Oncol | 2022 |
| Genotype-phenotype correlation in patients with deletional and nondeletional mutations of Hb H disease in Southwest of Iran. | Hamid M, Keikhaei B, Galehdari H, Saberi A, Sedaghat A, Shariati G, Mohammadi-Anaei M | Sci Rep | 2022 |
| An unusual left atrial Rosai-Dorfman involvement in sickle cell disease patient. | Hritani R, Ramsey Z, Lee R, Bates WB, Williams H, Garcia D, Kutlar A, Aljaroudi W | J Nucl Cardiol | 2022 |
| Bloodstream Infections in Children With Sickle Cell Disease: 2010-2019. | Yee ME, Lai KW, Bakshi N, et al. | Pediatr Infect Dis J | 2022 |
| Feature tracking microfluidic analysis reveals differential roles of viscosity and friction in sickle cell blood. | Szafraniec HM, Valdez JM, Iffrig E, Lam WA, Higgins JM, Pearce P, Wood DK | Lab Chip | 2022 |
| Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience. | De Sanctis V, Daar S, Soliman AT, Tzoulis P, Karimi M, Di Maio S, Kattamis C | Acta Biomed | 2022 |
| Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population. | StMartin A, Hebert KM, Serret-Larmande A, Jouhet V, Hughes E, Stedman J, DeSain T, Pillion D, Lyons JC, Steinert P, Avillach P, Eapen M | Transplant Cell Ther | 2022 |
| GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study. | Gagliardi I, Mungari R, Gamberini MR, Fortini M, Dassie F, Putti MC, Maffei P, Aliberti L, Bondanelli M, Zatelli MC, Ambrosio MR | J Endocrinol Invest | 2022 |
| Acute kidney injury in hospitalized children with sickle cell anemia. | Batte A, Menon S, Ssenkusu J, Kiguli S, Kalyesubula R, Lubega J, Mutebi EI, Opoka RO, John CC, Starr MC, Conroy AL | BMC Nephrol | 2022 |
| Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia. | Heitzer AM, Longoria J, Rampersaud E, Rashkin SR, Estepp JH, Okhomina VI, Wang WC, Raches D, Potter B, Steinberg MH, King AA, Kang G, Hankins JS | Curr Res Transl Med | 2022 |
| Mitochondrial function in sickle cell disease. | Messonnier LA | Blood | 2022 |
| Hemogen /BRG1 cooperativity modulates promoter and enhancer activation during erythropoiesis. | Guo X, Dean A, Zhao Y, Kim J | Blood | 2022 |
| Gonadal Status and Sexual Function at Long-Term Follow-up after Allogeneic Stem Cell Transplantation in Adult Patients with Sickle Cell Disease. | Boga C, Asma S, Ozer C, Bulgan Kilicdag E, Kozanoglu I, Yeral M, Korur A, Gereklioglu C, Ozdogu H | Exp Clin Transplant | 2022 |
| Sickle Cell Intrahepatic Cholestasis: Extremely Rare but Fatal Complication of Sickle Cell Disease. | Khan A, Nashed B, Issa M, Khan MZ | Cureus | 2022 |
| Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease. | Carullo V, Morrone K, Weiss M, Choi J, Gao Q, Pisharoty S, Moody K, Manwani D | Pediatr Blood Cancer | 2022 |
| Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol. | Lobitz S, Frömmel C, Brose A, Blankenstein O, Turner C, Dalton RN, Daniel Y, Klein J | Ann Hematol | 2022 |
| Difficulties in the diagnosis of HbS/beta thalassemia: Really a mild disease? | Uçucu S, Karabıyık T, Azik F | J Med Biochem | 2022 |
| Doppler US and Leg Ulcer Prevention in Children with Sickle Cell Disease. | Paltiel HJ | Radiology | 2022 |
| Abnormal Lower Extremity Hemodynamics at Doppler US in Children with Sickle Cell Anemia. | Komolafe OO, Adetiloye VA, Ayoola OO, Adefehinti O, Onwuka C | Radiology | 2022 |
| Alpha- and Beta-thalassemia: Rapid Evidence Review. | Baird DC, Batten SH, Sparks SK | Am Fam Physician | 2022 |
| Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model. | Quezado ZMN, Kamimura S, Smith M, Wang X, Heaven MR, Jana S, Vogel S, Zerfas P, Combs CA, Almeida LEF, Li Q, Quezado M, Horkayne-Szakaly I, Kosinski PA, Yu S, Kapadnis U, Kung C, Dang L, Wakim P, Eaton WA, Alayash AI, Thein SL | Blood Cells Mol Dis | 2022 |
| Characteristics and Prevalence of Antibiotic Allergies in Patients with Sickle Cell Disease: A Single Center Retrospective Study. | Wong KH, Soffer GK | Am J Hematol | 2022 |
| Pulmonary hypertension in thalassemia: a call to action. | Wood JC | Blood | 2022 |
| A landscape analysis and discussion of value of gene therapies for sickle cell disease. | Quach D, Jiao B, Basu A, Bender MA, Hankins JS, Ramsey SD, Devine B | Expert Rev Pharmacoecon Outcomes Res | 2022 |
| The Sickle Cell Disease Ontology: recent development and expansion of the universal sickle cell knowledge representation. | Mazandu GK, Hotchkiss J, Nembaware V, Wonkam A, Mulder N | Database (Oxford) | 2022 |
| β-thalassemia, and the advent of new Interventions beyond Transfusion and Iron chelation. | Chauhan W, Shoaib S, Fatma R, Zaka-Ur-Rab Z, Afzal M | Br J Clin Pharmacol | 2022 |
| Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy. | Graziadei G, De Franceschi L, Sainati L, Venturelli D, Masera N, Bonomo P, Vassanelli A, Casale M, Lodi G, Voi V, Rigano P, Pinto VM, Quota A, Notarangelo LD, Russo G, Allò M, Rosso R, D'Ascola D, Facchini E, Macchi S, Arcioni F, Bonetti F, Rossi E, Sau A, Campisi S, Colarusso G, Giona F, Lisi R, Giordano P, Boscarol G, Filosa A, Marktel S, Maroni P, Murgia M, Origa R, Longo F, Bortolotti M, Colombatti R, Di Maggio R, Mariani R, Piperno A, Corti P, Fidone C, Palazzi G, Badalamenti L, Gianesin B, Piel FB, Forni GL | Front Med (Lausanne) | 2022 |
| Case Report: Clinical and Hematological Characteristics of ε Thalassemia in an Italian Patient. | Fotzi I, Pegoraro F, Chiocca E, Casini T, Mogni M, Veltroni M, Favre C | Front Pediatr | 2022 |
| Plasma Interleukin-33 Cannot Predict Hip Osteonecrosis in Patients With Sickle Cell Disease: A Case-Control Study. | Agrawal AC, Mohapatra E, Nanda R, Bodhey NK, Sakale H, Garg AK | Cureus | 2022 |
| A Huge Subcapsular Splenic Cyst Like Hematoma in Sickle Cell Anemia. | Odeh AM, Boumarah KA, Alsumaien WA, Al-Abbad MT, Al-Ali AH, Alammar ZA, Alsuqair H, Albeladi AM, Alsuwaigh A, Omrani A, Almuhanna MM, Busbaih Z, Al-Shaban HR, Aldhameen AA | Cureus | 2022 |
| An Interesting and Rare Case of Hemoglobin D-Punjab Variant in Tamil Nadu. | Spandana R, Panneerselvam K, Mani S, Krishnamoorthy N | Cureus | 2022 |
| Transcranial Doppler sonography and the effect of haematopoietic stem cell transplantation in sickle cell disease. | Thurn S, Kleinschmidt K, Kovacic I, Wendl C, Linker RA, Corbacioglu S, Schlachetzki F | Neurol Res Pract | 2022 |
| Spinal cord compression: An unusual sequela of sickle cell disease. | Shekar M, Casini G, Donoho D, Mohila C, Kim TO, Fasipe T, Porea T | Pediatr Blood Cancer | 2022 |
| Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series. | Karsenty C, Tubman VN, Liu CJ, Fasipe T, Wyatt KEK | Pediatr Blood Cancer | 2022 |
| Healthcare utilization and the quality of life of children and adolescents with sickle cell disease. | Moody KL | Pediatr Blood Cancer | 2022 |
| Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia. | Creary SE, Beeman C, Stanek J, King K, McGann PT, O'Brien SH, Liem RI, Holl J, Badawy SM | Pediatr Blood Cancer | 2022 |
| Essential thrombocythemia complicating hemoglobin SC disease and presenting with priapism. | Nwogbo OV, Loghavi S | Blood | 2022 |
| β-Thalassemia Intermedia: Interaction of α-Globin Gene Triplication With β-thalassemia Heterozygous in Spain. | Ropero P, González Fernández FA, Nieto JM, Torres-Jiménez WM, Benavente C | Front Med (Lausanne) | 2022 |
| Bacteraemia and Septic Arthritis in a Sickle Cell Disease Patient. | Alqurashi M, Madani B, Mursi M, Eltayeb N | Eur J Case Rep Intern Med | 2022 |
| Favorable outcomes of patients with sickle cell disease hospitalized due to COVID-19: A report of three cases. | Tentolouris A, Stafylidis C, Siafarikas C, Dimopoulou MN, Makrodimitri S, Bousi S, Papalexis P, Damaskos C, Trakas N, Sklapani P, Spandidos DA, Epameinondas Georgakopoulou V | Exp Ther Med | 2022 |
| Outcome of Hydroxyurea Use in SCD and Evaluation of Patients' Perception and Experience in Nigeria. | Chianumba RI, Ofakunrin AOD, Morrice J, Olanrewaju O, Oniyangi O, Kuliya-Gwarzo A, Nnebe-Agumadu U, Isa HA, Nnodu OE | Front Genet | 2022 |
| Strategies to increase access to basic sickle cell disease care in low- and middle-income countries. | Dua M, Bello-Manga H, Carroll YM, Galadanci AA, Ibrahim UA, King AA, Olanrewaju A, Estepp JH | Expert Rev Hematol | 2022 |
| Molecular spectrum of thalassemia in tropical Hainan Island of southern China：high allele frequency with low health burden. | Lai Y, Tao F, Zou Y, Huang M, Lin K, Li Y, Huang W, Zhou W | J Genet Genomics | 2022 |
| Unstable hemoglobin Montreal II uncovered in an adult with unexplained hemolysis exacerbated by a presumed viral infection: a case report. | Medri C, Méndez A, Hammerer-Lercher A, Rovó A, Angelillo-Scherrer A | J Med Case Rep | 2022 |
| Successful haploidentical hematopoietic stem cell transplantation (HSCT) and durable engraftment by repeated donor lymphocyte infusions for a Chinese patient with transfusion-dependent hemoglobin (Hb) Hammersmith and massive splenomegaly. | Chan WYK, Chan NCN, So JCC, Lee PPW, Cheuk DKL, Ha SY, Chan GCF, Leung W | Pediatr Transplant | 2022 |
| Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department. | Cooper-Sood JB, Hagar W, Marsh A, Hoppe C, Agrawal AK | Br J Haematol | 2022 |
| [Thalassemia Gene Detection Results and Application Value of Hematological Indexes Among Pregnant Women in Xindu District of Chengdu City]. | Zhou XP, Liu T, Huang YS | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Comparision of Allogeneic Hematopoietic Stem Cell Transplantation between Children with Thalassemia of Different Ages]. | Kang DL, Tan YH, Chen YM, Lu JY, Shi J, Yan XZ, Lu QY | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [The Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation by Using Parental Donors in Patients with Thalassemia]. | Ou HB, Lin JZ, Hong XL, Lu JY, Lu QY | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| [Clinical Diagnosis and Prenatal Screening of Hb Lepore-BW Associated with IVS-II-654 Heterozygous Mutation]. | Bai HL, Cheng W, Cui J, Li R, Li Y, Xiao J, Zhang YH | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| Zinc in sickle cell disease: A narrative review. | Miranda CTOF, Vermeulen-Serpa KM, Pedro ACC, Brandão-Neto J, Vale SHL, Figueiredo MS | J Trace Elem Med Biol | 2022 |
| Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease. | Sayin ES, Sobczyk O, Poublanc J, Mikulis DJ, Fisher JA, Kuo KHM, Duffin J | Front Physiol | 2022 |
| and Studies for the Investigation of γ-Globin Gene Induction by : A Pre-Clinical Study of HbF Inducers for β-Thalassemia. | Iftikhar F, Rahman S, Khan MBN, Khan K, Khan MN, Uddin R, Musharraf SG | Front Pharmacol | 2022 |
| Blood Component Requirements and Erythrocyte Transfusion and Mortality Related to Hemoglobin Deficit in Phase III Trial of Hemoglobin-Based Oxygen Carrier: HBOC-201. | Jahr JS, Williams JP | Am J Ther | 2022 |
| DNA testing for sickle cell anemia in Africa: Implementation choices for the Democratic Republic of Congo. | Ngole M, Race V, Mbayabo G, Lumbala P, Songo C, Lukusa PT, Devriendt K, Matthijs G, Lumaka A | J Clin Lab Anal | 2022 |
| How Would You Treat This Patient With Acute and Chronic Pain From Sickle Cell Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center. | Kanjee Z, Achebe MO, Smith WR, Burns RB | Ann Intern Med | 2022 |
| Hb New York, preliminary results concerning the hematologic characteristics and the effects on thalassemia. | Cheng Z, Zhu X, Zeng D, Feng Q, Tian B, Zheng H, Tan S, Zhu C | Mol Biol Rep | 2022 |
| Arginine Therapy and Cardiopulmonary Hemodynamics in Hospitalized Children with Sickle Cell Anemia: A Prospective Double-Blinded Randomized Placebo-Controlled Trial. | Onalo R, Cilliers A, Cooper P, Morris CR | Am J Respir Crit Care Med | 2022 |
| Validation of single-gene noninvasive prenatal testing for sickle cell disease. | Westin ER, Tsao DS, Atay O, Landry BP, Ye PP, Chandler-Brown D, Alford B, Hoskovec J, Subramaniam A, Pawlik KM, Kuper SG, Goldman FD, Townes TM, Sheehan VA | Am J Hematol | 2022 |
| A decade of molecular preimplantation genetic diagnosis of 350 blastomeres for beta-thalassemia combined with HLA typing, aneuploidy screening and sex selection in Iran. | Keshvar Y, Sabeghi S, Sharifi Z, Fatemi KS, Fouladi P, Younesi Khah S, Rahiminejad F, Joudaki A, Amini M, Bagherian H, Ghaffari Novin M, Movahedin M, Mojbafan M, Zeinali S | BMC Pregnancy Childbirth | 2022 |
| Attitudes and practices of unmarried adults towards sickle cell disease: emergent factors from a cross sectional study in Nigeria's capital. | Adigwe OP, Onavbavba G, Onoja SO | Hematology | 2022 |
| Hemoglobinopathies and preimplantation diagnostics. | Mamas T, Kakourou G, Vrettou C, Traeger-Synodinos J | Int J Lab Hematol | 2022 |
| Translational control by heme-regulated elF2α kinase during erythropoiesis. | Chen JJ, Zhang S | Curr Opin Hematol | 2022 |
| Clinical profile of sickle cell disease in children treated at | Bianga VF, Nangunia M, Oponjo FM, Itongwa JM, Mushubusha JI, Colombe MM, Walemba CM, Wembonyama O | Pan Afr Med J | 2022 |
| Distribution of HbS Allele and Haplotypes in a Multi-Ethnic Population of Guinea Bissau, West Africa: Implications for Public Health Screening. | Martella M, Campeggio M, Pulè G, Wonkam A, Menzato F, Munaretto V, Viola G, Da Costa SP, Reggiani G, Araujo A, Cumbà D, Liotta G, Sainati L, Riccardi F, Colombatti R | Front Pediatr | 2022 |
| Incidental Detection of Hemoglobin Variants During Evaluation of HbA1c. | Kulkarni JD, Shivashanker S | Indian J Clin Biochem | 2022 |
| Evaluation of Paper-Based Point of Care Screening Test for Sickle Cell Disease. | Kumar R, Mishra S, Gwal A, Shanmugam R | Indian J Clin Biochem | 2022 |
| Sickle Cell Trait and Risks for Common Diseases: Evidence from the UK Biobank. | Hulsizer J, Resurreccion WK, Shi Z, Wei J, Ladson-Gary S, Zheng SL, Helfand BT, Billings L, Caplan MS, Xu J | Am J Med | 2022 |
| Real-World Data On Voxelotor To Treat Patients With Sickle Cell Disease. | Muschick K, Fuqua T, Stoker-Postier C, Anderson AR | Eur J Haematol | 2022 |
| Left atrial deformation indices in β-thalassemia major patients. | Patsourakos D, Aggeli C, Gatzoulis KA, Delicou S, Dimitroglou Y, Xydaki K, Fragodimitri C, Androulakis A, Tsioufis K | Ann Hematol | 2022 |
| Hepatitis C virus (HCV) infection among patients with sickle cell disease at the Korle-Bu teaching hospital. | Mawuli G, Dzudzor B, Tachi K, Kuma AAB, Odame-Aboagye J, Obeng BM, Boateng AT, Edu-Quansah EP, Attiku KO, Agbosu E, Arjarquah A, Bonney JHK | Virol J | 2022 |
| Isolation and Characterisation of Quercitrin as a Potent Anti-Sickle Cell Anaemia Agent from . | Adeniyi O, Baptista R, Bhowmick S, Cookson A, Nash RJ, Winters A, Shen J, Mur LAJ | J Clin Med | 2022 |
| Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries. | Halim-Fikri BH, Lederer CW, Baig AA, Mat-Ghani SNA, Syed-Hassan SR, Yusof W, Abdul Rashid D, Azman NF, Fucharoen S, Panigoro R, Silao CLT, Viprakasit V, Jalil N, Mohd Yasin N, Bahar R, Selvaratnam V, Mohamad N, Nik Hassan NN, Esa E, Krause A, Robinson H, Hasler J, Stephanou C, Raja-Sabudin RZ, Elion J, El-Kamah G, Coviello D, Yusoff N, Abdul Latiff Z, Arnold C, Burn J, Kountouris P, Kleanthous M, Ramesar R, Zilfalil BA, On Behalf Of The Global Globin Network Ggn | J Pers Med | 2022 |
| Motivators and Barriers to Physical Activity among Youth with Sickle Cell Disease: Brief Review. | Olorunyomi OO, Liem RI, Hsu LL | Children (Basel) | 2022 |
| Hemoglobin Oxidation Reactions in Stored Blood. | Alayash AI | Antioxidants (Basel) | 2022 |
| Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: A systemic review. | Riaz M, Abbas M, Rasool G, Baig IS, Mahmood Z, Munir N, Mahmood Tahir I, Ali Shah SM, Akram M | Int J Immunopathol Pharmacol | 2022 |
| Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years. | Estepp JH, Kalpatthi R, Woods G, Trompeter S, Liem RI, Sims K, Inati A, Inusa BPD, Campbell A, Piccone C, Abboud MR, Smith-Whitley K, Dixon S, Tonda M, Washington C, Griffin NM, Brown C | Pediatr Blood Cancer | 2022 |
| Sickle cell disease and fat embolism: a rare complication of vaso-occlusive crisis. | Filippatou AG, Naveed M, Barry DP, Deboer SR, Haas CJ | Pract Neurol | 2022 |
| Red Cell Alloimmunization and Autoimmunization Among Sickle Cell Disease and Thalassemia Patients in Jazan Province, Saudi Arabia. | Halawani AJ, Mobarki AA, Arjan AH, Saboor M, Hamali HA, Dobie G, Alsharif KF | Int J Gen Med | 2022 |
| Microcytic Anemia: An Insidious Presentation of Sickle Cell Beta+ Thalassemia, a Rare Sickle Cell Variant. | Shankar M, Gousy N, Chowdhury T | Cureus | 2022 |
| Outcomes of Patients With Sickle Cell Disease and Trait After Congenital Heart Disease Surgery. | Misra A, Halas R, Kobayashi D, Walters HL, Bondarenko I, Thomas R, Vener DF, Aggarwal S, Safa R | Ann Thorac Surg | 2022 |
| Loop-mediated isothermal amplification (LAMP) colorimetric phenol red assay for rapid identification of α0-thalassemia: Application to population screening and prenatal diagnosis. | Jomoui W, Srivorakun H, Chansai S, Fucharoen S | PLoS One | 2022 |
| Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease. | Johnson KM, Jiao B, Bender MA, Ramsey SD, Devine B, Basu A | PLoS One | 2022 |
| Extinguishing the fire in sickle cell anemia. | Novelli EM | Blood | 2022 |
| Pulmonary Dysfunction in Transfusion-Dependent Thalassemia and Response to Intensive Chelation Therapy. | Panwar N, Gomber S, Dewan P, Kumar R | Indian Pediatr | 2022 |
| Pulmonary Function in Children with Transfusion-Dependent Thalassemia and Its Correlation with Iron Overload. | Baruah A, Bhattacharjee J | Indian Pediatr | 2022 |
| Prevalence of Hemoglobin-S and Baseline Level of Knowledge on Sickle Cell Disease Among Pregnant Women Attending Antenatal Clinics in Dar-Es-Salaam, Tanzania. | Tutuba HJ, Jonathan A, Lloyd W, Luoga F, Marco E, Ndunguru J, Kidenya BR, Makani J, Ruggajo P, Minja IK, Balandya E | Front Genet | 2022 |
| Automating Pitted Red Blood Cell Counts Using Deep Neural Network Analysis: A New Method for Measuring Splenic Function in Sickle Cell Anaemia. | Nardo-Marino A, Braunstein TH, Petersen J, Brewin JN, Mottelson MN, Williams TN, Kurtzhals JAL, Rees DC, Glenthøj A | Front Physiol | 2022 |
| Human Hemoglobin S Erythrocyte-Stabilizing and Antisickling Potential of Extract of Wood Ear Mushroom, Auricularia auricula (Agaricomycetes). | Ohiri RC, Odey OP | Int J Med Mushrooms | 2022 |
| Does size matter? Two new deletions in the HBB gene cause β-thalassemia. | Ropero P, González Fernández FA, Nieto JM, Recasens V, Montañés Á, Murúzabal MJ, Sarasa M, Fernández C, Villegas A, Benavente CC | Ann Hematol | 2022 |
| Out Of Pocket Expenditure On Thalassemia Major And Its Implications On The Household Economics. | Qamar MK, Shaikh BT | J Ayub Med Coll Abbottabad | 2022 |
| Knowledge and attitude of Engaged and Recently Married Couples Toward Premarital Screening: A Cross-Sectional Study. | Almoliky MA, Abdulrhman H, Safe SH, Galal M, Abdu H, Towfiq B, Abdullah S, Waleed M, Sultan MA | Inquiry | 2022 |
| Modifying priming techniques in cardiopulmonary bypass circuit in known case of sickle-cell trait undergoing open heart surgery. | Bishnoi S, Yadav P, Shah P | Perfusion | 2022 |
| Structural origin of cooperativity in human hemoglobin: a view from different roles of α and β subunits in the αβ tetramer. | Nagatomo S, Nagai M, Kitagawa T | Biophys Rev | 2022 |
| Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies. | Liu B, Brendel C, Vinjamur DS, Zhou Y, Harris C, McGuinness M, Manis JP, Bauer DE, Xu H, Williams DA | Mol Ther | 2022 |
| Impact of Ketamine in the Management of Painful Sickle Cell Disease Vaso-Occlusive Crisis. | Froomkin J, Knoebel RW, Dickerson D, Soni H, Szwak J | Hosp Pharm | 2022 |
| [HemoTypeSC screening for sickle cell disease in the Democratic Republic of Congo (DRC): a case from the city of Kindu]. | Aimé AK, Etienne SM, Mbongi D, Nsonso D, Serrao E, Léon TMM, Oscar LN, Stanis WO | Pan Afr Med J | 2022 |
| Genome Engineering of Hematopoietic Stem Cells Using CRISPR/Cas9 System. | Devaraju N, Rajendiran V, Ravi NS, Mohankumar KM | Methods Mol Biol | 2022 |
| [Sickle cell retinopathy]. | Budnikova V, Rougier MB, Korobelnik JF, Delyfer MN, Gattoussi S | J Fr Ophtalmol | 2022 |
| Sickle cell disease prevention: How prepared are the senior secondary school students in Surulere Local Government Area, Lagos, Nigeria? | Kanma-Okafor OJ, Abolarinwa AO, Ojo OY, Ekanem EE | Afr J Prim Health Care Fam Med | 2022 |
| The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-ischemic Priapism: An AUA/SMSNA Guideline. | Bivalacqua TJ, Allen BK, Brock GB, Broderick GA, Chou R, Kohler TS, Mulhall JP, Oristaglio J, Rahimi LL, Rogers ZR, Terlecki RP, Trost L, Yafi FA, Bennett NE | J Urol | 2022 |
| Mutations in Thalassemia Carrier Couples: The Importance of Prenatal Diagnostic Tests. | Kiani AA, Mohamadinejad M, Shokrgozar N, Abbasian S | Clin Lab | 2022 |
| Understanding the roots of mistrust in medicine: Learning from the example of sickle cell disease. | LaMotte JE, Hills GD, Henry K, Jacob SA | J Hosp Med | 2022 |
| Expression, functional mechanism and therapy application of long noncoding RNA in thalassemia. | Pan Y, Xu L, Huang H | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2022 |
| The Unique Magnetic Signature of Sickle Red Blood Cells: A Comparison Between the Red Blood Cells of Transfused and Non-Transfused Sickle Cell Disease Patients and Healthy Donors. | Weigand M, Gomez-Pastora J, Strayer J, Wu X, Choe H, Lu S, Plencner E, Landes K, Palmer A, Zborowski M, Desai P, Chalmers J | IEEE Trans Biomed Eng | 2022 |
| Diagnostic challenges posed by a rare unstable hemoglobin variant Hb Southampton [HBB: c.320T → C] with pyrimidine 5' nucleotidase deficiency and the response to HU therapy. | Gorivale M, Hariharan P, Kargutkar N, Mehta P, Sawant P, Nadkarni A | Blood Cells Mol Dis | 2022 |
| Analysis of circRNAs and circRNA-associated competing endogenous RNA networks in β-thalassemia. | Yang F, Ruan H, Li S, Hou W, Qiu Y, Deng L, Su S, Chen P, Pang L, Lai K | Sci Rep | 2022 |
| A Phase 1 Dose Escalation Study of the Pyruvate Kinase Activator Mitapivat (AG-348) in Sickle Cell Disease. | Xu JZ, Conrey AK, Frey IC, Gwaabe E, Menapace LA, Tumburu L, Lundt M, Lequang T, Li Q, Glass KE, Dunkelberger EB, Iyer V, Mangus H, Kung C, Dang L, Kosinski PA, Hawkins P, Jeffries N, Eaton WA, Thein SL | Blood | 2022 |
| Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. | Johnson KM, Jiao B, Ramsey SD, Bender MA, Devine B, Basu A | Blood Adv | 2022 |
| A Triple-Heterozygous β-Thalassemia Patient Demonstrated an Unusual Electrophoresis Pattern Due to a Novel β Mutation [an IVS-II-654 (C>T) mutation with a Hb Zürich-Langstrasse (: c.151A>T) mutation ]. | Liao J, Li Q, Ling LQ, Liu CN, Huang XB, Zhou J | Hemoglobin | 2022 |
| Development and Validation of The Sickle Cell Stress Scale-Adult. | Smith WR, McClish DK, Bovbjerg VE, Singh HK | Eur J Haematol | 2022 |
| Sickle cell disease: an update. | Conway O'Brien E, Ali S, Chevassut T | Clin Med (Lond) | 2022 |
| How to approach haemolysis: Haemolytic anaemia for the general physician. | Palmer D, Seviar D | Clin Med (Lond) | 2022 |
| Polymorphisms and avascular necrosis in patients with sickle cell disease - A systematic review. | Leandro MP, Almeida ND, Hocevar LS, Sá CKC, Souza AJ, Matos MA | Rev Paul Pediatr | 2022 |
| Identification of a Novel Hb H Disease with Glucose-6-Phosphate Dehydrogenase Deficiency Using Whole Genome Sequencing. | Ren ZM, Xing ZH, Chen SL, Fu XY, Chen YS, Li DF | Hemoglobin | 2022 |
| Iron Chelation Therapy With Deferasirox in Sickle Cell Disease With End-Stage Renal Disease. | Raj A, McGowan K, Knapp E, Zhao J, Shah S | Cureus | 2022 |
| Stroke in sickle cell disease in association with bilateral absence of the internal carotid arteries. Case report. | Markovic I, Milenkovic Z, Jocic-Jakubi B, Futaisi AA, Kakaria KA, Walli Y | BMC Neurol | 2022 |
| Rare paediatric case of agenesis of the vermiform appendix, ileal duplication and sickle cell disease. | Laezza N, Gião N, Borges C, Knoblich M | BMJ Case Rep | 2022 |
| Hb Westport [β121 (GH4) Glu>Asp; HBB:c.366A>C]: A novel β-globin variant interfering with HbA1c measurement. | Moore JA, Li BV, Wang D, Chan B, King RI, Florkowski CM | Clin Biochem | 2022 |
| Procalcitonin as a diagnostic marker for infection in sickle cell disease. | Maharaj S, Chang S | Expert Rev Hematol | 2022 |
| Polisomographic Investigation of Sleep Disorders in Patients with Sickle Cell Anemia and Evaluation of the Effect on the Prognosis. | Dikmen N, Okuyucu EE, Güntel M, Uçar E, İlhan G, Babayiğit C, Karadağ M | Turk Thorac J | 2022 |
| IVS I-5 (G > C) is associated with changes to the RBC membrane lipidome in response to hydroxyurea treatment in β-thalassemia patients. | Khan MBN, Iftikhar F, Khan T, Danish A, Shamsi T, Musharraf SG, Siddiqui AJ | Mol Omics | 2022 |
| Hematological Parameters in Individuals with Beta Thalassemia Trait in South Sumatra, Indonesia. | Sari DP, Wahidiyat PA, Setianingsih I, Timan IS, Gatot D, Kekalih A | Anemia | 2022 |
| HLA-E*01:01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E*01:03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients. | Hosseini E, Sarraf Kazerooni E, Azarkeivan A, Sharifi Z, Shahabi M, Ghasemzadeh M | Hum Immunol | 2022 |
| Validation of Patient-reported Vaso-occlusive Crisis Day as an Endpoint in Sickle Cell Disease Studies. | Coyne KS, Currie BM, Callaghan M, Wyrwich KW, Pease S, Baker CL, Arkin S, Pittman DD | Eur J Haematol | 2022 |
| L-glutamine for sickle cell disease: more than reducing redox. | Jafri F, Seong G, Jang T, Cimpeanu E, Poplawska M, Dutta D, Lim SH | Ann Hematol | 2022 |
| Hepato-splenic abscesses in a sickle cell disease patient. | Le Monnier O, Joseph L, Bodard S, Boudhabhay I | Am J Hematol | 2022 |
| Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care. | Nickel RS, Maher JY, Hsieh MH, Davis MF, Hsieh MM, Pecker LH | J Clin Med | 2022 |
| Epidemiologic Trends of Thalassemia, 2006-2018: A Nationwide Population-Based Study. | Lee JS, Rhee TM, Jeon K, Cho Y, Lee SW, Han KD, Seong MW, Park SS, Lee YK | J Clin Med | 2022 |
| Prime Editor 3 Mediated Beta-Thalassemia Mutations of the Gene in Human Erythroid Progenitor Cells. | Zhang H, Zhou Q, Chen H, Lu D | Int J Mol Sci | 2022 |
| Translation, cross-cultural adaptation and validation of the sickle cell self-efficacy scale (SCSES). | de Sousa IA, Reis IA, Pagano AS, Telfair J, Torres HC | Hematol Transfus Cell Ther | 2022 |
| Unstable hemoglobin Bicêtre, NM_000518.4(HBB):C.191A>C (p.His64Pro), with slightly decreased P50 and no polycythemia after splenectomy. | Sakamoto A, Nakadate H, Iguchi A, Tsumura Y, Tsuruta T, Yamashiro Y, Hattori Y, Ishiguro A | Pediatr Blood Cancer | 2022 |
| Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait. | Gaartman AE, Strijdhorst A, van Es N, Tang MW, Heijmans J, Biemond BJ, Nur E, | Br J Haematol | 2022 |
| Manifestations of Sickle Cell Disorder at Abdominal and Pelvic Imaging. | Solomon N, Segaran N, Badawy M, Elsayes KM, Pellerito JS, Katz DS, Moshiri M, Revzin MV | Radiographics | 2022 |
| High-Throughput Assay to Screen Small Molecules for Their Ability to Prevent Sickling of Red Blood Cells. | Nakagawa A, Cooper MK, Kost-Alimova M, Berstler J, Yu B, Berra L, Klings ES, Huang MS, Heeney MM, Bloch DB, Zapol WM | ACS Omega | 2022 |
| Evaluation of Individualized Pain Plans for Children With Sickle Cell Disease Admitted for Vaso-occlusive Crisis at Riley Hospital for Children. | Arends AM, Perez A, Wilder C, Jacob SA | J Pediatr Pharmacol Ther | 2022 |
| First Experience in Living Liver Donation From Donors With Sickle Cell Trait. | Schulze M, Zidan A, Sturdevant M, Aljudaibi S, Shagrani M, Bzeizi K, Alqahtani S, Broering DC | Transplant Direct | 2022 |
| The Sickle Cell Pain Action Plan: A low health literacy, pictographic tool to enhance self-management, and guideline concordance. | Reeves PT, Rogers PL, Hipp SJ, Zanetti RC, Echelmeyer S, Rees DJ, Parekh DS | Pediatr Blood Cancer | 2022 |
| Korean clinical practice guidelines for the diagnosis of hereditary hemolytic anemia. | Chueh HW, Hwang SM, Shim YJ, Lee JM, Park HS, Lee JH, Nam Y, Kim N, Jung HL, Choi HS, | Blood Res | 2022 |
| Testosterone Deficiency in Sickle Cell Disease: Recognition and Remediation. | Musicki B, Burnett AL | Front Endocrinol (Lausanne) | 2022 |
| A Case of Congenital Methemoglobinemia: Rare but Real. | Paudel S, Adhikari N, Mandal S, Srivatana P | Cureus | 2022 |
| Individual Watershed Areas in Sickle Cell Anemia: An Arterial Spin Labeling Study. | Stotesbury H, Hales PW, Hood AM, Koelbel M, Kawadler JM, Saunders DE, Sahota S, Rees DC, Wilkey O, Layton M, Pelidis M, Inusa BPD, Howard J, Chakravorty S, Clark CA, Kirkham FJ | Front Physiol | 2022 |
| A rapid evidence assessment of sickle cell disease educational interventions. | Oti AE, Heyes K, Bruce F, Wilmott D | J Clin Nurs | 2022 |
| Sickle cell disorder-it's time to level up. | Gbangbola K | Med (N Y) | 2022 |
| Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. | Fuja C, Kothary V, Carll TC, Singh S, Mansfield P, Wool GD | Transfusion | 2022 |
| Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches. | Xu JZ, Thein SL | Blood | 2022 |
| From Mendel to a Mendelian disorder: towards a cure for sickle cell disease. | Makani J, Nkya S, Collins F, Luzzatto L | Nat Rev Genet | 2022 |
| Influence of hydroxyurea on the severity of acute chest syndrome in patients with sickle cell disease. | González-Pérez C, Gómez-Carpintero García A, Cervera Bravo Á | An Pediatr (Engl Ed) | 2022 |
| Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening. | Noomuna P, Hausman JM, Sansoya R, Kalfa T, Risinger M, Low PS | FASEB J | 2022 |
| Emotional reaction to pain as predictor of depression among selected Nigerians living with sickle cell disease in Ile-Ife. | Olasupo MO, Fagbenro DA, Oluwagbamila B, Olasupo MG | Psychol Health Med | 2022 |
| Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia. | Piriyakhuntorn P, Tantiworawit A, Kasitanon N, Louthrenoo W | Ann Hematol | 2022 |
| Value of a cure for sickle cell disease in reducing economic disparities. | Graf M, Tuly R, Gallagher M, Sullivan J, Jena AB | Am J Hematol | 2022 |
| A New Case of Hb Headington (: c.217A>C) Due to a New DNA Transversion, Found in a Patient with Type 2 Diabetes Mellitus. | Liu Y, Liu B, Qiao YC, Niu WY | Hemoglobin | 2022 |
| Kidney Transplantation in Sickle Cell Disease Patients: Case Series and Experience from a Nigerian Kidney Transplant Center. | Igbokwe M, Olatise O, Faponle A, Aremu A, Revanur V, Jiwoh H, Obajolowo O, Ameh I | Indian J Nephrol | 2022 |
| Acute chest syndrome and COVID-19 in hydroxyurea naïve sickle cell disease patient in a low resource setting. | Mawalla WF, Nasser A, Jingu JS, Joseph H, Mmbaga LG, Shija E, Kakumbula H, Lubuva NB, Meda C, Chamba C | EJHaem | 2022 |
| A Smart Chatbot for Interactive Management in Beta Thalassemia Patients. | Alturaiki AM, Banjar HR, Barefah AS, Alnajjar SA, Hindawi S | Int J Telemed Appl | 2022 |
| Case Report: Abnormally Low Glycosylated Hemoglobin A1c Caused by Clinically Silent Rare β-Thalassemia in a Tujia Chinese Woman. | Gao W, Jin Y, Wang M, Huang Y, Tang H | Front Endocrinol (Lausanne) | 2022 |
| Cerebral Vasculopathy in Children With Sickle Cell Disease in an Amazonian Population. | Alcolumbre Tobelem FL, de Andrade GALR, Paschoal JKSF, de Oliveira Cardoso MDS, Sarmento Trindade SM, Paschoal EHA, Paschoal-Jr FM, Bor-Seng-Shu E | J Child Neurol | 2022 |
| A feasibility study of risk prediction modelling for vasoocclusive crisis in children with sickle cell disease. | Şengül MT, Taşdelen B, Ünal S, Akbey V | Turk J Pediatr | 2022 |
| Effects of Senegal haplotype (-rs7412844), alpha-thalassemia (3.7kb deletion), -rs11248850 and -rs4671393 variants on sickle cell nephropathy. | Ndour EHM, Mnika K, Guèye Tall F, Seck M, Dème Ly I, Nembaware V, Sagna-Bassène HAT, Dione R, Ndongo AA, Diop JPD, Barry NOK, Djité M, Ndiaye Diallo R, Guèye PM, Diop S, Diagne I, Cissé A, Wonkam A, Lopez Sall P | Int J Biochem Mol Biol | 2022 |
| Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia. | Lu D, Xu Z, Peng Z, Yang Y, Song B, Xiong Z, Ma Z, Guan H, Chen B, Nakamura Y, Zeng J, Liu N, Sun X, Chen D | Front Genet | 2022 |
| An overview of sickle cell disease from the socio-demographic triangle - a Nigerian single-institution retrospective study. | Nwabuko OC, Onwuchekwa U, Iheji O | Pan Afr Med J | 2022 |
| Sickle cell disease: a year in review. | The Lancet Haematology | Lancet Haematol | 2022 |
| The successful strategy of comprehensive pre-implantation genetic testing for beta-thalassaemia-haemoglobin E disease and chromosome balance using karyomapping. | Piyamongkol S, Mongkolchaipak S, Charoenkwan P, Sirapat R, Suriya W, Pantasri T, Tongsong T, Piyamongkol W | J Obstet Gynaecol | 2022 |
| Resveratrol-nitric oxide donor hybrid effect on priapism in sickle cell and nitric oxide-deficient mouse. | Pinheiro AK, Pereira DA, Dos Santos JL, Calmasini FB, Alexandre EC, Reis LO, Burnett AL, Costa FF, Silva FH | PLoS One | 2022 |
| Bone mineral density in primarily preadolescent children with hemoglobin E/β-thalassemia with different severities and transfusion requirements. | Nakavachara P, Weerakulwattana P, Pooliam J, Viprakasit V | Pediatr Blood Cancer | 2022 |
| Optimized Droplet Digital PCR Assay on Cell-Free DNA Samples for Non-Invasive Prenatal Diagnosis: Application to Beta-Thalassemia. | Constantinou CG, Karitzi E, Byrou S, Stephanou C, Michailidou K, Makariou C, Hadjilambi G, Christofides A, Kleanthous M, Papasavva T | Clin Chem | 2022 |
| The mutual crosstalk between iron and erythropoiesis. | Camaschella C, Pagani A, Silvestri L, Nai A | Int J Hematol | 2022 |
| Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells. | Qin K, Huang P, Feng R, Keller CA, Peslak SA, Khandros E, Saari MS, Lan X, Mayuranathan T, Doerfler PA, Abdulmalik O, Giardine B, Chou ST, Shi J, Hardison RC, Weiss MJ, Blobel GA | Nat Genet | 2022 |
| Tenofovir disoproxil fumarate-mediated γ-globin induction is correlated with the suppression of trans-acting factors in CD34 progenitor cells: A role in the reactivation of fetal hemoglobin. | Khan F, Ali H, Musharraf SG | Eur J Pharmacol | 2022 |
| The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children. | Sugiarto SR, Bwire GM, Moore BR, Page-Sharp M, Manning L, Batty KT, Minzi OMS, Ngasala B, Davis TME, Makani J, Salman S | Int J Parasitol Drugs Drug Resist | 2022 |
| Does glucose-6-phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease? A multi-hospital-based cross-sectional study. | Kambale-Kombi P, Marini Djang'eing'a R, Alworong'a Opara JP, Minon JM, Atoba Bokele C, Bours V, Azerad MA, Tonen-Wolyec S, Kayembe Tshilumba C, Batina-Agasa S | Hematology | 2022 |
| Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients. | Ionescu F, Anusim N, Zimmer M, Jaiyesimi I | Eur J Haematol | 2022 |
| Hb Laibin [β96(FG3)Leu→Arg; : c.290T>G]: A Novel Hemoglobin Variant Described in a Chinese Family. | Huang YY, Huang J, Ye LH, Liang L, Li YQ | Hemoglobin | 2022 |
| Molecular heterogeneity of β-thalassemia variants in the Eastern region of Morocco. | Belmokhtar I, Lhousni S, Elidrissi Errahhali M, Ghanam A, Elidrissi Errahhali M, Sidqi Z, Ouarzane M, Charif M, Bellaoui M, Boulouiz R, Benajiba N | Mol Genet Genomic Med | 2022 |
| Pain mechanisms in sickle cell disease. Are we closer to a breakthrough? | Conran N | Haematologica | 2022 |
| Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease. | Khasabova IA, Gable J, Johns M, Khasabov SG, Kalyuzhny AE, Golovko MY, Golovko SA, Kiven S, Gupta K, Seybold VS, Simone DA | Haematologica | 2022 |
| Impact of Superoxide Dismutase Genetic Polymorphism (SOD2 Val16Ala) and Superoxide Dismutase Level on Disease Severity in a Cohort of Egyptian Sickle Cell Disease Patients. | Khorshied MM, Shaheen IA, Selim YMM, Elshahawy AO, Youssry I | Mediterr J Hematol Infect Dis | 2022 |
| The Clinical Significance of the Spectrum of Interactions of the Rare IVS-II-5 G>C () Variation with Other β-Thalassemia Mutations in Southern China. | Liao G, Zhou Y, Yin X, He S, Wu Y, Xiao J, Geng Z, Huang Q, Luo G, Yang K | Mediterr J Hematol Infect Dis | 2022 |
| Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID-19 pandemic. | Green NS, Manwani D, Smith-Whitley K, Aygun B, Appiah-Kubi A, Smaldone AM | Pediatr Blood Cancer | 2022 |
| Symphysis morphology and mandibular alveolar bone thickness in patients with β-thalassemia major and different growth patterns. | Khojastepour L, Naderi A, Akbarizadeh F, Movahhedian N, Ahrari F | Dental Press J Orthod | 2022 |
| Emergency department visits and hospitalizations among patients with sickle cell disease in illinois, 2016-2020. | Barriteau CM, Feinglass J, Kayle M, VonAchen P, Liem RI, Badawy SM, Kan K | Pediatr Hematol Oncol | 2022 |
| Association of Beta-Thalassaemia and Hypogonadotropic Hypogonadism. | Vidal A, Dhakal C | Case Rep Obstet Gynecol | 2022 |
| Comparative evaluation of efficacy and safety of automated versus manual red cell exchange in sickle cell disease: A systematic review and meta-analysis. | Mukherjee S, Sahu A, Ray GK, Maiti R, Prakash S | Vox Sang | 2022 |
| Genotype and phenotype characteristics of homozygous and compound heterozygous β-thalassemia with 3.4 kb deletion. | Soontornpanawet C, Singha K, Fuchareon S | Int J Lab Hematol | 2022 |
| [Heavy metal! A case of severe iron overload and supraventricular arrhythmias in a thalassemia major patient]. | Marchini F, Fiorio A, Sirugo P, Gamberini MR, Mari E, Bertini M, Malagù M | G Ital Cardiol (Rome) | 2022 |
| Voxelotor for the treatment of sickle cell disease in pediatric patients. | Brown C, Tonda M, Abboud MR | Expert Rev Hematol | 2022 |
| Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease. | Moriconi C, Dzieciatkowska M, Roy M, D'Alessandro A, Roingeard P, Lee JY, Gibb DR, Tredicine M, McGill MA, Qiu A, La Carpia F, Francis RO, Hod EA, Thomas T, Picard M, Akpan IJ, Luckey CJ, Zimring JC, Spitalnik SL, Hudson KE | Br J Haematol | 2022 |
| Sex as an Independent Risk Factor for Venous Thromboembolism in Sickle Cell Disease: A Cross-Sectional Study. | Roe AH, McAllister A, Kete C, Pishko A, Whitworth H, Schreiber CA, Sayani FA | J Womens Health (Larchmt) | 2022 |
| Oxidative stress and associated clinical manifestations in malaria and sickle cell (HbSS) comorbidity. | Aninagyei E, Tettey CO, Kwansa-Bentum H, Boakye AA, Ghartey-Kwansah G, Boye A, Acheampong DO | PLoS One | 2022 |
| In transfusion-dependent thalassemia children, increased iron overload is associated with lower serum alpha-klotho, which is strongly associated with lower total and ionized calcium concentrations. | Moustafa SR, Al-Hakeim HK, Alhillawi ZH, Maes M | Curr Mol Med | 2022 |
| Epicatechin exerts dual action to shield sickling and hydroxyurea-induced myelosuppression: Implication in sickle cell anemia management. | Gour A, Kour D, Dogra A, Manhas D, Wazir P, Digra SK, Kumar A, Nandi U | Toxicol Appl Pharmacol | 2022 |
| Ulcerative colitis in patients with sickle cell disease: a rare but important co-morbidity. | Rankine-Mullings AE | Paediatr Int Child Health | 2022 |
| Thalassaemia. | Kattamis A, Kwiatkowski JL, Aydinok Y | Lancet | 2022 |
| Suboptimal vancomycin levels in critically ill children with sickle cell disease and acute chest syndrome. | Al-Eyadhy A, Al-Jelaify MR | J Infect Chemother | 2022 |
| [Gallstone complications in sickle cell patients]. | Rambaud E, Ranque B, Pouchot J, Arlet JB | Rev Med Interne | 2022 |
| Extramedullary haematopoiesis presenting as an adnexal mass in a patient with β-thalassaemia. | Filippi V, Reina H, Monod C, Manegold-Brauer G | BMJ Case Rep | 2022 |
| Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients. | Okoye HC, Ezekekwu C, Nwagha TU, Korubo K, Omunakwe HE, Nnachi OC, Madu AJ, Nwogoh B, Efobi CC, Muoghalu EA, Nonyelu C, Okoye Ae AE, Obodo OI, Ugwu CS, Egolum MC, Nnachi OA, Okpala I | Eur J Haematol | 2022 |
| New therapeutics for children with sickle cell disease: A time for celebration, caution, or both? | Quinn CT, Ware RE | Pediatr Blood Cancer | 2022 |
| Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: an Italian multicenter study. | Pistoia L, Meloni A, Allò M, Spasiano A, Messina G, Sorrentino F, Gamberini MR, Ermini A, Renne S, Fina P, Peritore G, Positano V, Pepe A, Cademartiri F | Eur J Haematol | 2022 |
| Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients. | Eziefula C, Shah FT, Anie KA | Patient Prefer Adherence | 2022 |
| Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives. | Aramayo-Singelmann C, Halimeh S, Proske P, Vignalingarajah A, Cario H, Christensen MO, Yamamoto R, Röth A, Reinhardt D, Reinhardt HC, Alashkar F | Sci Rep | 2022 |
| The association between sleep disturbances and neurocognitive function in pediatric sickle cell disease. | Tucker T, Alishlash AS, Lebensburger JD, Clay OJ, Oates GR, Nourani A, Bhatia S, Murdaugh DL | Sleep Med | 2022 |
| Longitudinal Study of Glomerular Hyperfiltration in Adults with Sickle Cell Anemia: A Multicenter Pooled Analysis. | Ataga KI, Zhou Q, Saraf SL, Hankins JS, Ciccone EJ, Loehr LR, Ashley-Koch AE, Garrett M, Cai J, Telen MJ, Derebail VK | Blood Adv | 2022 |
| A case of G6PD Utrecht associated with β-thalassemia responding to splenectomy. | Yang K, Liu X, Chen K, Luo S, Kong W, Huang W, Xiao J | Pediatr Blood Cancer | 2022 |
| Pulmonary Functions in Transfusion-Dependent Thalassemia. | Chandra J, Rohatgi S | Indian Pediatr | 2022 |
| Multi-organ Dysfunction Secondary to Abrupt Discontinuation of Voxelotor in a Patient with Severe Sickle Cell Disease. | Nagalapuram V, Kanter J | Am J Hematol | 2022 |
| SARS-CoV-2 omicron variant may present with severe sickle cell painful crisis: A report of two cases. | Ali E, Hatim A, Yassin M | Clin Case Rep | 2022 |
| Analysis of rare thalassemia genetic variants based on third-generation sequencing. | Peng C, Zhang H, Ren J, Chen H, Du Z, Zhao T, Mao A, Xu R, Lu Y, Wang H, Chen X, Liu S | Sci Rep | 2022 |
| One-step genotyping of α-thalassaemia by multiplex symmetric PCR melting curve. | Qin J, He J, Li Y, Liu N, Tao F, Zhang P, Guo W, Qin Q, Zhou W | J Clin Pathol | 2022 |
| Transitioning Adolescents With Sickle Cell Disease From Pediatric to Adult Care: Results From a New Survey of Health Care Professionals. | Shah NR, Treadwell MJ, Vichinsky E | J Pediatr Hematol Oncol | 2022 |
| Primary Prevention of Stroke in Children With Sickle Cell Anemia in Nigeria: Protocol for a Mixed Methods Implementation Study in a Community Hospital. | Bello-Manga H, Haliru L, Ahmed KA, Tabari AM, Farouk BU, Bahago GY, Kazaure AS, Muhammad AS, Gwarzo SA, Baumann AA, DeBaun MR, King AA | JMIR Res Protoc | 2022 |
| Iron overload disorders. | Hsu CC, Senussi NH, Fertrin KY, Kowdley KV | Hepatol Commun | 2022 |
| Novel Bis-phosphoglycerate Mutase Modulators for Treating Sickle Cell Disease. | Sabnis RW | ACS Med Chem Lett | 2022 |
| The Efficacy of Marijuana Use for Pain Relief in Adults With Sickle Cell Disease: A Systematic Review. | Paulsingh CN, Mohamed MB, Elhaj MS, Mohamed N, Ahmed TH, Singh T, Mohammed Z, Khan S | Cureus | 2022 |
| Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review. | Dick MH, Abdelgadir A, Kulkarni VV, Akram H, Chatterjee A, Pokhrel S, Khan S | Cureus | 2022 |
| Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes. | Dissanayake R, Samarasinghe N, Waidyanatha S, Pathirana S, Neththikumara N, Dissanayake VHW, Wetthasinghe K, Gooneratne L, Wickramasinghe P | BMC Pediatr | 2022 |
| Sickle cell disease in children: an update of the evidence for WHO guideline development. | Odame I | Arch Dis Child | 2022 |
| Aortic Intima Media Thickness is Increased and Closely Related to Elevated Oxidative Stress Increases in Beta Thalassemia Minor. | Tumer C, Saler T, Aslan MZ, Koc AS, Koc M, Erel O, Neselioglu S, Gulumsek E, Avci BS, Avci A, Sumbul HE | Arq Bras Cardiol | 2022 |
| Economic burden of sickle cell disease in Brazil. | Silva-Pinto AC, Costa FF, Gualandro SFM, Fonseca PBB, Grindler CM, Souza Filho HCR, Bueno CT, Cançado RD | PLoS One | 2022 |
| Uptake and usage of proguanil as malaria chemoprophylaxis and the socio-economic determinants of proguanil usage in children with sickle cell anemia in Benin City. | Enato IG, Odunvbun ME | Niger J Clin Pract | 2022 |
| Hyperkalemia and Metabolic Acidosis Occur at a Higher eGFR in Sickle Cell Disease. | Saraf SL, Derebail VK, Zhang X, Machado RF, Gordeuk VR, Lash JP, Little J | Kidney360 | 2022 |
| Evaluation of thyroid hormones and ferritin level in patients with β-thalassemia. | Hussein SZ | Med Pharm Rep | 2022 |
| Sickle cell trait and multisystem trauma: an unaddressed urgent knowledge gap. | Tessema FA, Lapping-Carr G, Affini MI, Selkridge IK, Oppong AY, Jones TA, Zakrison T | Trauma Surg Acute Care Open | 2022 |
| Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy. | Ogbenna AA, Akinsete AM, Kalejaiye OO, Matthew OK, Sharma D, Andrews J, Kassim AA | Br J Haematol | 2022 |
| Bcl11a and the Correlated Key Genes Ascribable to Globin Switching: An In-silico Study. | Motlagh FM, Soleimanpour-Lichaei HR, Emami A, Kadkhoda S, Shamsara M, Rasti A, Modarresi MH | Cardiovasc Hematol Disord Drug Targets | 2022 |
| Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality. | Batte A, Menon S, Ssenkusu JM, Kiguli S, Kalyesubula R, Lubega J, Berrens Z, Mutebi EI, Ogwang R, Opoka RO, John CC, Conroy AL | Kidney Int | 2022 |
| High risk and low prevalence diseases: Acute chest syndrome in sickle cell disease. | Koehl JL, Koyfman A, Hayes BD, Long B | Am J Emerg Med | 2022 |
| Examining resilience of individuals living with sickle cell disease in the COVID-19 pandemic. | Buscetta AJ, Abdallah KE, Floyd KJ, Wossenseged FS, Conn CA, Ramirez HC, Bonham VL | BMC Psychol | 2022 |
| Assessment of biochemical bone markers of osteoporosis in children with thalassemia major. | Çelik T, Sangün Ö, Ünal Ş, Balcı A, Motor S | Ital J Pediatr | 2022 |
| Dual gradient echo in-phase and out of phase sequences in assessment of hepatic iron overload in patients with beta-thalassemia, would be better? | Ali Mohamed Aboughonaim A, Naguib Ettaby A, Ibrahim El-Noueum K, Hassab H, Emara DM | Eur J Radiol | 2022 |
| COVID19 vaccination in adults with sickle cell disease is not associated with increases in rates of pain crisis. | Friedman E, Minniti C, Campbell S, Curtis S | Hematology | 2022 |
| Understanding the EKG changes in methemoglobinemia. | Arun Kumar P, Dasari M, Sahu KK, Al-Seykal I, Mishra AK | Ann Hematol | 2022 |
| Effects of pregnancy on cardiac structure and function in women with sickle cell anemia: a longitudinal comparative study. | Aliyu Z, Kushimo OA, Oluwole AA, Amadi C, Oyeyemi N, Mbakwem A, Afolabi BB | J Matern Fetal Neonatal Med | 2022 |
| Application of validated mapping algorithms between generic PedsQL scores and utility values to individuals with sickle cell disease. | Jiao B, Hankins JS, Devine B, Barton M, Bender M, Basu A | Qual Life Res | 2022 |
| The oral ferroportin inhibitor vamifeport improved hemodynamics in a mouse model of sickle cell disease. | Nyffenegger N, Zennadi R, Kalleda N, Flace A, Ingoglia G, Buzzi RM, Doucerain C, Buehler PW, Schaer DJ, Dürrenberger F, Manolova V | Blood | 2022 |
| The Association Between Plasma MicroRNA-451 Expression Levels and Chronic Kidney Disease in Children with β-Thalassemia Major. | Ahmed HM, Georgy DB, Meabed MH, Abd El Kareem RM, Botrous OE | Iran J Kidney Dis | 2022 |
| Exploring the crosstalk between long non-coding RNAs and microRNAs to unravel potential prognostic and therapeutic biomarkers in β-thalassemia. | Rahaman M, Mukherjee M, Bhattacharya S, Mukherjee B, Shukla PC, Dolai TK, Chakravorty N | Mol Biol Rep | 2022 |
| Neurocognitive screening in sickle cell disease. | Lance EI, Cannon AD, Casella JF, Shapiro BK | Pediatr Blood Cancer | 2022 |
| Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital. | Reparaz P, Serrano I, Adan-Pedroso R, Astigarraga I, de Pedro Olabarri J, Echebarria-Barona A, Garcia-Ariza M, Lopez-Almaraz R, Del Orbe-Barreto RA, Vara-Pampliega M, Gonzalez-Urdiales P | An Pediatr (Engl Ed) | 2022 |
| Sickle cell disease in pediatric intensive care. | Cieza-Asenjo R, García-Morín M, Escobar-Fernández L, Cela-de Julián E, Slöcker-Barrio M, Herrera-Castillo L | An Pediatr (Engl Ed) | 2022 |
| Direct Oral Anticoagulants in Sickle Cell Disease: A Systematic Review and Meta-Analysis. | Rozi WM, Rahhal A, Ali EA, Al-Mashdali AF, Hilan Y, Khamees I, Fernyhough LJ, Yassin MA | Blood Adv | 2022 |
| Provider Communication and Fever Protocol for Children With Sickle Cell Disease in the Emergency Department. | Awe M, Robbins A, Chandi M, Cortright L, Tumin D, Whitfield A | Pediatr Emerg Care | 2022 |
| Patient perception of voxelotor treatment benefit in sickle cell disease. | Idowu M, Haque A, Williams EM, Sridhar A | J Investig Med | 2022 |
| New agents for sickle cell disease: patient perceptions of benefit in the real world. | Means RT | J Investig Med | 2022 |
| Transition for Adolescents and Young Adults With Sickle Cell Disease in a US Midwest Urban Center: A Multilevel Perspective on Barriers, Facilitators, and Future Directions. | Calhoun C, Luo L, Baumann AA, Bauer A, Shen E, McKay V, Hooley C, James A, King AA | J Pediatr Hematol Oncol | 2022 |
| First Trimester Noninvasive Prenatal Diagnosis of Maternally Inherited Beta-Thalassemia Mutations. | Madgett TE | Clin Chem | 2022 |
| Innate Variability in Physiological and Omics Aspects of the Beta Thalassemia Trait-Specific Donor Variation Effects. | Anastasiadi AT, Tzounakas VL, Dzieciatkowska M, Arvaniti VZ, Papageorgiou EG, Papassideri IS, Stamoulis K, D'Alessandro A, Kriebardis AG, Antonelou MH | Front Physiol | 2022 |
| Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin). | Zuccato C, Cosenza LC, Zurlo M, Gasparello J, Papi C, D'Aversa E, Breveglieri G, Lampronti I, Finotti A, Borgatti M, Scapoli C, Stievano A, Fortini M, Ramazzotti E, Marchetti N, Prosdocimi M, Gamberini MR, Gambari R | Ther Adv Hematol | 2022 |
| Exploring the relationship of sleep, cognition, and cortisol in sickle cell disease. | Kölbel M, Kirkham FJ, Iles RK, Stotesbury H, Halstead E, Brenchley C, Sahota S, Dimitriou D | Compr Psychoneuroendocrinol | 2022 |
| Stroke propensity in the Th3+/ mouse model of β-thalassemia intermedia. | Sun YY, Yao HW, Chen HR, Chen CW, Kinkaid MM, Kuan CY | Neurobiol Dis | 2022 |
| Contribution of ADAMTS13-independent VWF regulation in sickle cell disease. | Hunt RC, Katneni U, Yalamanoglu A, Indig FE, Ibla JC, Kimchi-Sarfaty C | J Thromb Haemost | 2022 |
| Sickle cell disease: challenging the past, looking to the future. | Cela E | An Pediatr (Engl Ed) | 2022 |
| A case of congenital methaemoglobinaemia with secondary polycythemia. | Kanwal S, Aamir M, Irum S, Haroon Z, Munir MU, Bibi A | J Pak Med Assoc | 2022 |
| Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia. | Haghpanah S, Zekavat OR, Safaei S, Ashraf MA, Parand S, Ashraf H | BMC Ophthalmol | 2022 |
| Determinants of severity in sickle cell disease. | Rees DC, Brousse VAM, Brewin JN | Blood Rev | 2022 |
| Comprehensive assessment of cognitive function in adults with moderate and severe sickle cell disease. | Portela GT, Butters MA, Brooks MM, Candra L, Rosano C, Novelli EM | Am J Hematol | 2022 |
| Beta Thalassemia Carrier rate: Problem Burden Among High School Children. | El-Shanshory MR, Sherief LM, Yahia S, Ragab SM, Mansour AK, Hassab HM, Hesham MA, Ahmed AS, Beshir MR, El Fotoh WMA, El Naby SAA, Alllah AMG, Khalifa NA, Soliman MA, El-Dahtory F, El-Farahaty RM, Osman E, Elhabyan A, El-Lateef AEA, Kamal NM, Kabbash IA, Saied SM, Eid AR | Curr Pediatr Rev | 2022 |
| Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine is not influenced by AB0 blood group in subjects with transfusion-dependent thalassemia. | Sgherza N, Zucano S, Vitucci A, Palma A, Campanale D, Larocca AMV, Visceglie D, Acquafredda A, Musto P | Acta Biomed | 2022 |
| The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network. | De Sanctis V, Soliman A, Tzoulis P, Daar S, Kattamis A, Delaporta P, Karimi M, Yassin MA, Zarei T, Saki F, Sapunarova K, Banchev A, Galati MC, Raiola G, Messina G, Campisi S, Kattamis C | Acta Biomed | 2022 |
| Cardio-protective effect of regular transfusion in children with non-transfusion dependent thalassemia (NTDT): A cohort study. | Al Senaidi K, Maveda S, Joshi N, Nazir H, Elshinawy M, Al Zadjali S, Al Rawas A, Elghamry I, Wali Y, Khater D | Acta Biomed | 2022 |
| Pharmacogenomics of hydroxyurea therapy and fetal hemoglobin levels in sickle cell anemia. | Sales RR, Nogueira BL, Luizon MR | Pharmacogenomics | 2022 |
| Expanding a Regional Sickle Cell Disease Project ECHO to Rapidly Disseminate COVID-19 Education. | Shook LM, Farrell CB, Mosley C | Adv Med Educ Pract | 2022 |
| Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study. | Fares MY, Hegazy MA, El-Sayed GM, Abdelrahman MM, Abdelwahab NS | RSC Adv | 2022 |
| Assessment of functional shunting in patients with sickle cell disease. | Afzali-Hashemi L, Václavů L, Wood JC, Biemond BJ, Nederveen AJ, Mutsaerts HJMM, Schrantee A | Haematologica | 2022 |
| Characterization of a novel HBB:c.194dup variant of the -globin gene combined with six alpha genes. | Huang J, Ding L, Chen J, Chen S, Tian P, Xie J, Huang X, Xin X | J Int Med Res | 2022 |
| Revisiting Arginine Therapy for Sickle Cell Acute Vasoocclusive Painful Crisis. | Hopper RK, Gladwin MT | Am J Respir Crit Care Med | 2022 |
| Dysregulated Serum Cytokine Production in Pediatric Patients with β-Thalassemia Major. | Zhang L, Bao LJ, Hong ZD, Yan MX, Zhang ZH, Li YM, Ye Q, Wang YQ | Hemoglobin | 2022 |
| Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital. | Binding A | Hemoglobin | 2022 |
| Association of Sickle Cell Pain & Symptoms on Health-Related Quality of Life Among Pediatric Patients. | Moody KL | J Pain Symptom Manage | 2022 |
| BACTERIAL MENINGITIS IN CHILDREN WITH SICKLE-CELL DISEASE IN ANGOLA. | Pelkonen T, Roine I, Bernardino L, Jahnukainen K, Peltola H | Pediatr Infect Dis J | 2022 |
| Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option. | Starlard-Davenport A, Gu Q, Pace BS | Mol Diagn Ther | 2022 |
| Sickle Cell Disease: A Review. | Kavanagh PL, Fasipe TA, Wun T | JAMA | 2022 |
| Is Severity Score Associated with Indication for Hematopoietic Stem Cell Transplantation in Individuals with Sickle Cell Anemia? | Flor-Park MV, Ozahata MC, Moura ICG, Blatyta P, Kelly S, Oliveira CDL, Capuani L, Belisário AR, Carneiro-Proietti ABF, Araujo AS, Loureiro P, Maximo C, Rodrigues DOW, Mota RA, Sabino E, Custer B, Rocha V, On Behalf Of The Recipient Epidemiology And Donor Evaluation Study-Iii Reds-Iii International Component Brazil | Transplant Cell Ther | 2022 |
| Health status of patients with β-thalassemia in the West Bank: a retrospective study. | Dwaik RK, Mohor TIA, Ithyabi II, Warasna SS, Abdeen SM, Karmi B, Seir RA. | Lancet | 2022 |
| Interplay between sickle cell anaemia and Plasmodium falciparum malaria. | Talisuna AO, D'Alessandro U | Lancet Child Adolesc Health | 2022 |
| Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT). | Uyoga S, Olupot-Olupot P, Connon R, Kiguli S, Opoka RO, Alaroker F, Muhindo R, Macharia AW, Dondorp AM, Gibb DM, Walker AS, George EC, Maitland K, Williams TN | Lancet Child Adolesc Health | 2022 |
| Genetic Manipulation Strategies for β-Thalassemia: A Review. | Zakaria NA, Bahar R, Abdullah WZ, Mohamed Yusoff AA, Shamsuddin S, Abdul Wahab R, Johan MF | Front Pediatr | 2022 |
| Molecular Spectrum, Ethnic and Geographical Distribution of Thalassemia in the Southern Area of Hainan, China. | Yu Y, Lu C, Gao Y, Li C, Li D, Wang J, Wei H, Lu Z, You G | Front Pediatr | 2022 |
| Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia. | Isa Tafreshi R, Radgoodarzi M, Arjmandi Rafsanjani K, Soheilipour F | Front Pediatr | 2022 |
| Prevalence and Genetic Analysis of Thalassemia and Hemoglobinopathy in Different Ethnic Groups and Regions in Hainan Island, Southeast China. | Wang M, Zhang X, Zhang Y, Xiao M | Front Genet | 2022 |
| Skills Capacity Building For Health Care Services and Research Through the Sickle Pan African Research Consortium. | Nnodu OE, Osei-Akoto A, Nembaware V, Kent J, Nwegbu M, Minja I, Mazandu GK, Makani J, Wonkam A | Front Genet | 2022 |
| Spontaneous bilateral intraorbital hematoma: A particular form of sickle cell disease complications in children. | Andriamiarintsoa H, Ramanandafy H, Andriamiadanalisoa OA, Randriantianarisoa K, Randrianarivelo PH, Andrianah EPG, Rajaonarison LHNON, Raobela L, Rakotoson JL, Vololontiana HMD, Ahmad A | Clin Case Rep | 2022 |
| Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high risk. | Mehta P, Kapoor J, Singh A, Yadav N, Singh R, Halder R, Verma M, Agrawal N, Ahmed R, Bhurani D | Eur J Haematol | 2022 |
| Does TGFBR3 Polymorphism Increase the Risk of Silent Cerebral Infarction in Egyptian Children with Sickle Cell Disease? | Hassab H, Hanafi M, Elbeheiry A, Hassan M, Chazli YE | Indian J Pediatr | 2022 |
| Integrating artificial intelligence into haematology training and practice: Opportunities, threats and proposed solutions. | Chai SY, Hayat A, Flaherty GT | Br J Haematol | 2022 |
| Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement. | Covington ML, Cone-Sullivan JK, Andrzejewski C, Lu W, Thomasson RR, O'Brien K, Brunker PAR, Stowell SR | Transfusion | 2022 |
| Resveratrol plus low-dose hydroxyurea compared to high-dose hydroxyurea alone is more effective in gene expression and ROS reduction in K562 cells. | Alipour M, Nasiri N, Kazemi F, Zare F, Sharifzadeh S | Nat Prod Res | 2022 |
| Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania. | Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S | Int J Lab Hematol | 2022 |
| The evolution of glucose-insulin homeostasis in children with β-thalassemia major (β -TM): A twenty-year retrospective ICET- A observational analysis from early childhood to young adulthood. | De Sanctis V, Daar S, Soliman AT, Tzoulis P, Karimi M, Kattamis C | Acta Biomed | 2022 |
| Evolution of Combined Impaired Fasting Glucose and Impaired Glucose Tolerance in β-Thalassemia Major: Results in 58 Patients with a Mean 7.7- year Follow-Up. | De Sanctis V, Daar S, Soliman AT, Tzoulis P, Yassin MA, Kattamis C | Acta Biomed | 2022 |
| Dilemma in approach to stroke in sickle cell disease patient: A case report. | Okar L, Ali Alzoubi H, Shukur Mahmud S, Elyas A, Yassin MA | Medicine (Baltimore) | 2022 |
| Assessment of depression in children and adolescents with sickle cell anemia in a low-resource setting: a comparative study. | Ezenwosu OU, Chukwu BF, Uwaezuoke NA, Ezenwosu IL, Urom KO, Udorah MI, Ikefuna AN, Emodi IJ | Pediatr Hematol Oncol | 2022 |
| Low Stroke Risk in Children With Sickle Cell Disease in French Guiana: A Retrospective Cohort Study. | Gargot J, Parriault MC, Adenis A, Clouzeau J, Dinh Van KA, Ntab B, Defo A, Nacher M, Elenga N | Front Med (Lausanne) | 2022 |
| Early hydroxyurea use is neuroprotective in children with sickle cell anemia. | Karkoska K, Pfeiffer A, Beebe DW, Quinn CT, Niss O, McGann PT | Am J Hematol | 2022 |
| Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort. | Padrão EMH, Bustos B, Mahesh A, Fonseca GHH, Taniguchi LU | Ann Hematol | 2022 |
| Chronic inflammation persistence after regular blood transfusion therapy in sickle cell anemia. | Dembélé AK, Hermand P, Missud F, Lesprit E, Holvoet L, Brousse V, Ithier G, Odievre MH, Benkerrou M, Le Van Kim C, Koehl B | Blood Adv | 2022 |
| Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study. | Conran N, de Alvarenga Maximo C, Oliveira T, Fertrin KY, Lobo C, Costa FF | Br J Haematol | 2022 |
| Does Fetal Hemoglobin inhibit the malarial parasite Plasmodium falciparum? | Archer NM, Pasvol G, Wilson I, Duraisingh MT | Am J Hematol | 2022 |
| Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations. | Gehrie EA, Petran L, Young PP | Transfusion | 2022 |
| Elevated Selenoprotein P Levels in Thalassemia Major Patients. | Talibova G, Ozturk Z, Parlak M, Kupesiz A | Arch Med Res | 2022 |
| IOX1 fails to reduce α-globin and mediates γ-globin silencing in adult β-thalassemia/HbE erythroid progenitor cells. | Khamphikham P, Wongborisuth C, Pornprasert S, Tantiworawit A, Tangprasittipap A, Songdej D, Hongeng S | Exp Hematol | 2022 |
| Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells. | Mehta S, Buyanbat A, Kai Y, Karayel O, Goldman SR, Seruggia D, Zhang K, Fujiwara Y, Donovan KA, Zhu Q, Yang H, Nabet B, Gray NS, Mann M, Fischer ES, Adelman K, Orkin SH | Cell Chem Biol | 2022 |
| Correlation between Myocardial Iron Overload Detected by CMRT2* and Left Ventricular Function Assessed by Tissue Doppler Imaging in Patients with Thalassemia Major. | Najimi M, Ghandi Y, Mehrabi S, Eghbali A, Habibi D | J Cardiovasc Echogr | 2022 |
| PUM1 mediates the posttranscriptional regulation of human fetal hemoglobin. | Elagooz R, Dhara AR, Gott RM, Adams SE, White RA, Ghosh A, Ganguly S, Man Y, Owusu-Ansah A, Mian OY, Gurkan UA, Komar AA, Ramamoorthy M, Gnanapragasam MN | Blood Adv | 2022 |
| Prevalence and molecular characterization of common thalassemia among people of reproductive age in the border area of Guangxi-Yunnan-Guizhou province in Southwestern China. | Xu G, Wang C, Wang J, Lin M, Chang Z, Liang J, Chen X, Zhong S, Nong X, Wei W, Deng Y | Hematology | 2022 |
| Management of acute chest syndrome in patients with sickle cell disease: a systematic review of randomized clinical trials. | Niazi MRK, Chukkalore D, Jahangir A, Sahra S, Macdougall K, Rehan M, Odaimi M | Expert Rev Hematol | 2022 |
| Primary myelofibrosis with thrombophilia as first symptom combined with thalassemia and Gilbert syndrome: A case report. | Wufuer G, Wufuer K, Ba T, Cui T, Tao L, Fu L, Mao M, Duan MH | World J Clin Cases | 2022 |
| Ferroptosis is involved in the benzene-induced hematotoxicity in mice via iron metabolism, oxidative stress and NRF2 signaling pathway. | Sun R, Liu M, Xu K, Pu Y, Huang J, Liu J, Zhang J, Yin L, Pu Y | Chem Biol Interact | 2022 |
| Optical absorbance-based rapid test for the detection of sickle cell trait and sickle cell disease at the point-of-care. | Srinivasan R, Eugene Christo VR, Nambannor Kunnath R, Katare P, Venukumar A, Nambison NKM, Gorthi SS | Spectrochim Acta A Mol Biomol Spectrosc | 2022 |
| Health related quality of life in children with sickle cell disease: A systematic review and meta-analysis. | Stokoe M, Zwicker HM, Forbes C, Abu-Saris NELH, Fay-McClymont TB, Désiré N, Guilcher GMT, Singh G, Leaker M, Yeates KO, Russell KB, Cho S, Carrels T, Rahamatullah I, Henry B, Dunnewold N, Schulte FSM | Blood Rev | 2022 |
| Liver Transplantation After Hematopoietic Stem Cell Transplant for the Treatment of Sickle Cell Disease: A Case Report. | de Sousa Arantes Ferreira G, Ferreira CA, Watanabe ALC, Trevizoli NC, Murta MCB, Figueira AVF, de Fatima Couto C | Transplant Proc | 2022 |
| Grab regulates transferrin receptor recycling and iron uptake in developing erythroblasts. | Chen M, Zhang Y, Jiang K, Wang W, Feng H, Zhen R, Moo C, Zhang Z, Shi J, Chen C | Blood | 2022 |
| Hematologist Encounters Among Medicaid Patients who have Sickle Cell Disease. | Horiuchi SS, Zhou M, Snyder A, Paulukonis S | Blood Adv | 2022 |
| Sickle Cell Disease and Kidney. | Amarapurkar P, Roberts L, Navarrete J, El Rassi F | Adv Chronic Kidney Dis | 2022 |
| Impact of COVID-19 pandemic on access to online therapeutic education programs for children with sickle cell disease. | Sterlin A, de Montalembert M, Taylor M, Mensah S, Vandaele M, Lanzeray A, Poiraud L, Allali S | J Pediatr Nurs | 2022 |
| Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease. | Chopra M, Byrd J, Wuichet K, DeBaun MR | Blood Adv | 2022 |
| Incidence and Predictors of Priapism Events in a Sickle Cell Anemia: A Diary-Based Analysis. | Idris IM, Abba A, Galadanci JA, Aji SA, Jibrilla AU, Rodeghier M, Adetola K, Burnett AL, DeBaun MR | Blood Adv | 2022 |
| Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center. | Bade NA, Giri U, Wang H, Ershler WB | Transfusion | 2022 |
| Practices of sickle cell disease genetic screening and testing in the prenatal population. | Prince A, Cruz-Bendezú A, Gunawansa N, Wade J, Coleman-Cowger VH, Schulkin J, Macri CJ | J Neonatal Perinatal Med | 2022 |
| Ten-year Longitudinal Analysis of Hydroxyurea Implementation in a Pediatric Sickle Cell Program. | Phan V, Park JA, Dulman R, Lewis A, Briere N, Notarangelo B, Yang E | Eur J Haematol | 2022 |
| [Genotypic and hematological characteristics of 83 β-thalassemia mutation carriers and patients from Henan Province]. | Wang W, Zhao X, Bai S, Wang L, Wang C, Yao Q, Li B, Wang D | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2022 |
| [Acute chest syndrome in adult sickle cell patients]. | Cheminet G, Mekontso-Dessap A, Pouchot J, Arlet JB | Rev Med Interne | 2022 |
| Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease. | Limerick E, Abraham A | J Clin Med | 2022 |
| Gender Differences in Knowledge and Perception of Cardiovascular Disease among Italian Thalassemia Major Patients. | Meloni A, Pistoia L, Maffei S, Marcheschi P, Casini T, Spasiano A, Bitti PP, Cuccia L, Corigliano E, Sanna PMG, Massei F, Positano V, Cademartiri F | J Clin Med | 2022 |
| Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities. | Alramadhani D, Aljahdali AS, Abdulmalik O, Pierce BD, Safo MK | Int J Mol Sci | 2022 |
| LRF Promotes Indirectly Advantageous Chromatin Conformation via -lncRNA Expression and Switch from Fetal to Adult Hemoglobin. | Chondrou V, Shaukat AN, Psarias G, Athanasopoulou K, Iliopoulou E, Damanaki A, Stathopoulos C, Sgourou A | Int J Mol Sci | 2022 |
| Temperature-dependent self-assembly of biofilaments during red blood cell sickling. | Behera A, Sharma O, Paul D, Sain A | J Chem Phys | 2022 |
| HLA-matched related donor hematopoietic stem cell transplantation is a suitable treatment in adolescents and adults with sickle cell disease: Comparison of myeloablative and non-myeloablative approaches. | Dhedin N, Chevillon F, Castelle M, Lavoipière V, Vasseur L, Dalle JH, Joseph L, Beckerich F, Buchbinder N, Coman T, Garban F, Ferster A, Nguyen S, Boissel N, Arlet JB, Pondarre C, | Am J Hematol | 2022 |
| The pleiotropic effects of α-thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survival. | Brewin JN, Nardo-Marino A, Stuart-Smith S, El Hoss S, Hanneman A, Strouboulis J, Menzel S, Gibson JS, Rees DC | Am J Hematol | 2022 |
| Evaluation of coagulation parameters and impact of transfusion on coagulation in patients with beta thalassemia major. | Kurt ZDÇ, Sönmez Ç, Kaçar D, Eker İ, Bayhan T, Yarali N, Özbek NY | Blood Coagul Fibrinolysis | 2022 |
| Inhaled nitric oxide for treating pain crises in people with sickle cell disease. | Aboursheid T, Albaroudi O, Alahdab F | Cochrane Database Syst Rev | 2022 |
| Cerebral hemodynamics in children with sickle cell disease in India: An observational cohort study. | Gajjar B, Sharma S, Khan E, Sharma P, Jain P, Goel V, Neral A, Patel J, Parmar M, Sharma K, Sharma VK, Sharma AK | Medicine (Baltimore) | 2022 |
| Fulminant dengue hepatitis in sickle cell disease: Recovery against the odds. | Shah D, Talwar D, Kumar S, Acharya S, Hulkoti V | J Family Med Prim Care | 2022 |
| Killer hiding under normal oxygen saturation: a case report about methemoglobinemia. | Sun Q, Yue J, Liang P | Transl Pediatr | 2022 |
| Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease. | Hood AM, Crosby LE, Stotesbury H, Kölbel M, Kirkham FJ | Front Neurol | 2022 |
| CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease. | Rangarajan HG, Crowell SA, Towerman AS, Shenoy SS | Bone Marrow Transplant | 2022 |
| Unusual coexistence of Stewart-Treves syndrome and sickle cell anaemia: a case of dual pathology. | Walke VA, Datar S, Kowe B, Chaurasia JK | BMJ Case Rep | 2022 |
| A novel mutation Hb jiangnan[β3(NA3) Leu→Lys, :c.10-_11delinsAA] causing elevated Hb A level. | Liang L, Ning S, Lu X, Li Y, Tian M, Qin T, Li Y | Hematology | 2022 |
| Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations. | Woodard KJ, Doerfler PA, Mayberry KD, Sharma A, Levine R, Yen J, Valentine V, Palmer LE, Valentine M, Weiss MJ | Dis Model Mech | 2022 |
| Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study. | Krishnamurti L, Arnold SD, Haight A, Abraham A, Guilcher GM, John T, Bakshi N, Shenoy S, Syrjala K, Martin PL, Chaudhury S, Eames G, Olowoselu OF, Hsieh M, De La Fuente J, Kasow KA, Stenger E, Mertens A, El-Rassi F, Lane P, Shaw BE, Meacham L, Archer D | JMIR Res Protoc | 2022 |
| Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000-2019. | Nascimento MID, Przibilski ALF, Coelho CSG, Leite KFA, Makenze M, Jesus SB | Rev Saude Publica | 2022 |
| A novel 15.8 kb deletion α-thalassemia confirmed by long-read single-molecule real-time sequencing: Hematological phenotypes and molecular characterization. | Zhong Z, Zhong G, Guan Z, Chen D, Wu Z, Yang K, Chen D, Liu Y, Xu R, Chen J | Clin Biochem | 2022 |
| Platelet volume parameters as a tool in the evaluation of acute ischemic priapism in patients with sickle cell anemia. | Adawi EA, Ghanem MA | Arch Ital Urol Androl | 2022 |
| Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease? | Tayyaba Rehan S, Hussain HU, Malik F, Usama RM, Tahir MJ, Asghar MS | Health Sci Rep | 2022 |
| A Curative DNA Code for Hematopoietic Defects: Novel Cell Therapies for Monogenic Diseases of the Blood and Immune System. | Porteus MH, Pavel-Dinu M, Pai SY | Hematol Oncol Clin North Am | 2022 |
| Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease. | Leonard A, Tisdale JF, Bonner M | Hematol Oncol Clin North Am | 2022 |
| Outcomes of pregnancies complicated by haemoglobin H-constant spring and deletional haemoglobin H disease: A retrospective cohort study. | Ake-Sittipaisarn S, Sirichotiyakul S, Srisupundit K, Luewan S, Traisrisilp K, Tongsong T | Br J Haematol | 2022 |
| Consideration of Splenectomy in Unstable Hemoglobinopathy: A Case Report of Hb Hammersmith (: c.128T>C). | Pesce MM, Atkinson MM, Sridhar V, Edwards EG | Hemoglobin | 2022 |
| Transcranial doppler as screening method for sickling crises in children with sickle cell anemia: a latin America cohort study. | Modolo GP, Luvizutto GJ, Hamamoto Filho PT, Braga GP, Bazan SGZ, Ferreira NC, de Souza JT, Winckler FC, Macedo de Freitas CC, Hokama NK, Vidal EIO, Bazan R | BMC Pediatr | 2022 |
| Improvement of Hemolytic Anemia with GBT1118 is Reno-protective in Transgenic Sickle Mice. | Ren G, Setty S, Zhang X, Susma A, Ruiz MAD, Minshall RD, Lash JP, Gordeuk VR, Saraf SL | Blood Adv | 2022 |
| Molecular Mechanisms of Hepatic Dysfunction in Sickle Cell Disease: Lessons From The Townes Mouse Model. | Pradhan-Sundd T, Kato GJ, Novelli EM | Am J Physiol Cell Physiol | 2022 |
| Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City. | Green NS, Van Doren L, Licursi M, Billings DD, Sandoval LA, Feit YMZ, Hod EA | Br J Haematol | 2022 |
| Recurrent spinal cord compression due to extramedullary hematopoiesis in thalassemia patient: Case report. | Abbarh S, Al-Mashdali AF, Abdelrazek M, Gurusamy VM, Yassin MA | Medicine (Baltimore) | 2022 |
| Sickle cell-related fat embolism syndrome and the need for therapeutic plasma exchange. | Nicholls JR, Leonard A, Garcia M, Sadasivam N, Charlesworth M | J Cardiothorac Vasc Anesth | 2022 |
| The effects of glutamine supplementation on markers of apoptosis and autophagy in sickle cell disease peripheral blood mononuclear cells. | Walter PB, Hohman LS, Rokeby A, Lum JJ, Hagar R, Lavrisha L, Saulys A, Kuypers FA, Vichinsky E, Morris CR | Complement Ther Med | 2022 |
| Hydroxyurea decouples persistent F-cell elevation and induction of γ-globin. | Walker AL, Crosby D, Miller V, Weidert F, Ofori-Acquah S | Exp Hematol | 2022 |
| Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study. | Heeney MM, Abboud MR, Githanga J, Inusa BP, Kanter J, Michelson AD, Nduba V, Musiime V, Apte M, Inati A, Taksande AM, Andersson M, Åstrand M, Maklad N, Niazi M, Himmelmann A, Berggren AR | Blood | 2022 |
| Influenza Vaccine Booster Stimulates Antibody Response in Beta Thalassemia Major Patients. | Sheikh M, Ahmadi-Vasmehjani A, Atashzar MR, Karbalaie Niya MH, Ebrahimian A, Baharlou R | Lab Med | 2022 |
| Urgent use of voxelotor in sickle cell disease when immediate transfusion is not safe. | Ferlis M, Lipato T, Roseff SD, Smith WR | Eur J Haematol | 2022 |
| From the investigation of RHD-CE hybrid genes to the recognition of RHCE variants and RHD zygosity. Expanding the analysis by QMPSF in Brazilian donors and in patients with sickle cell disease. | de Paula Vendrame TA, Arnoni CP, Latini FRM, Pereira Cortez AJ, Bénech C, Fichou Y, Castilho L | Blood Transfus | 2022 |
| Quantification of Silent Cerebral Infarction on High-Resolution FLAIR and Cognition in Sickle Cell Anemia. | Stotesbury H, Kawadler JM, Clayden JD, Saunders DE, Hood AM, Koelbel M, Sahota S, Rees DC, Wilkey O, Layton M, Pelidis M, Inusa BPD, Howard J, Chakravorty S, Clark CA, Kirkham FJ | Front Neurol | 2022 |
| GDF-15 is associated with atherosclerosis in adults with transfusion-dependent beta-thalassemia. | Efat A, Wahb R, Shoeib SAA, Dawod AAE, Abd ElHafez MA, Abd ElMohsen EA, Elkholy A | EJHaem | 2022 |
| Sickle Cell Disease in Children: Knowledge and Home-Based Management Strategies among Caregivers at a Tertiary Facility in Northern Ghana. | Ajinkpang S, Anim-Boamah O, Bimpong KA, Kanton FJ, Pwavra JBP, Abdul-Mumin A | Biomed Res Int | 2022 |
| Current landscape of gene-editing technology in biomedicine: Applications, advantages, challenges, and perspectives. | Zhou W, Yang J, Zhang Y, Hu X, Wang W | MedComm (2020) | 2022 |
| RANK/RANKL/OPG axis genes relation to cognitive impairment in children with transfusion-dependent thalassemia: a cross-sectional study. | Mousa SO, Abd El-Hafez AH, Abu El-Ela MA, Mourad MA, Saleh RN, Sayed SZ | BMC Pediatr | 2022 |
| Nursing protocol for children with sickle cell disease in emergency room: a convergent-care approach. | Teixeira JBC, Morais AC, Santos VEP, Santos DVD, Carvalho ESS, Miranda JOF, Brito LS, Martins LA | Rev Bras Enferm | 2022 |
| Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia. | Niss O, Detterich JA, Wood JC, Coates TD, Malik P, Taylor M, Quinn CT | Blood | 2022 |
| "Death is as Much Part of Life as Living": Attitudes and Experiences Preparing for Death from Older Adults with Sickle Cell Disease | Oyedeji CI, Strouse JJ, Masese R, Gray N, Oyesanya TO | Omega (Westport) | 2022 |
| Pediatric hematology providers' contraceptive practices for female adolescents and young adults with sickle cell disease: A national survey. | Askew MA, Smaldone AM, Gold MA, Smith-Whitley K, Strouse JJ, Jin Z, Green NS | Pediatr Blood Cancer | 2022 |
| Health-related quality of life of patients with sickle cell disease aged 8-17 years at Kamuzu Central Hospital, Malawi. | Wachepa S, Bvalani R, Namubiru T, Namugerwa S, Kaudha G, Mpasa A, Munube D, Rujumba J, Ozuah N, Kiguli S | Pediatr Blood Cancer | 2022 |
| [Socio-demographic and economic profile of adult patients with sickle cell disease followed up on a regular basis at the University Hospital Center of Libreville]. | Igala M, Helley Ondo GD, Lentombo LEL, Rerambiah LK, Lacombe SD, Ba JI, Boguikouma JB | Pan Afr Med J | 2022 |
| Micronutrient levels and haemato-biochemical status of patients with sickle cell anaemia at a tertiary hospital in Abakaliki, south-eastern Nigeria: a cross-sectional study. | Nnachi OC, Orih MC, Edenya OO, Okoye AE, Ezenwenyi IP | Pan Afr Med J | 2022 |
| An Integrative Review: The Evolution of Provider Knowledge, Attitudes, Perceptions and Perceived Barriers to Caring for Patients with Sickle Cell Disease 1970-Now. | Reich J, Cantrell MA, Smeltzer SC | J Pediatr Hematol Oncol Nurs | 2022 |
| Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19. | Clarke K, Benameur K, Wiley Z, Shin YM, Moussa M, El Rassi F, McLemore M | J Investig Med High Impact Case Rep | 2022 |
| Hematopoietic Stem Cell Transplantation and Results in Pediatric Patients with Thalassemia Major: Single-Center Study. | Ayçiçek A, Kalkan Ş, I Paslı Uysalol E, Tekgündüz S, Salcıoğlu OZ, Özdemir G, Arslantaş E, Bayram C | Turk Arch Pediatr | 2022 |
| The Correlation Between Ineffective Erythropoiesis Biomarkers and Development of Extramedullary Hematopoiesis in Patients with Thalassemia. | Chansai S, Yamsri S, Fucharoen S, Fucharoen G, Teawtrakul N | Mediterr J Hematol Infect Dis | 2022 |
| Renal Abnormalities among Sickle Cell Disease Patients in a Poor Management Setting: A Survey in the Democratic Republic of the Congo. | Kambale-Kombi P, Djang'eing'a RM, Alworong'a Opara JP, Mbo Mukonkole JP, Bours V, Tonen-Wolyec S, Mbumba Lupaka DM, Bome LB, Tshilumba CK, Batina-Agasa S | Mediterr J Hematol Infect Dis | 2022 |
| Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients. | Sgherza N, Zucano S, Vitucci A, Palma A, Tarantini F, Campanale D, Vimercati L, Larocca AMV, Visceglie D, Acquafredda A, Ostuni A, Di Gennaro D, Vitucci C, Tafuri S, Musto P | Mediterr J Hematol Infect Dis | 2022 |
| Identification of Alpha Thalassemia, p.R4810K and p.R189W among Children with Moyamoya Disease/Syndrome. | Thampratankul L, Okuno Y, Komvilaisak P, Wattanasirichaigoon D, Sirachainan N | Mediterr J Hematol Infect Dis | 2022 |
| Role of Radiotherapy in Spinal Cord Compression Due to Extramedullary Hematopoiesis in Thalassemia Intermedia. | Pandey A, Mishra H, Mishra R | Neurol India | 2022 |
| NGS4THAL, a One-Stop Molecular Diagnosis and Carrier Screening Tool for Thalassemia and Other Hemoglobinopathies by Next-Generation Sequencing. | Cao Y, Yin Ha S, So CC, For TM, Sze-Man Tang C, Zhang H, Liang R, Yang J, Hon-Yin Chung B, Chi-Fung Chan G, Lau YL, Garcia-Barcelo MM, Shiu-Kwan Ma E, Sucharitchan P, Hirankarn N, Yang W | J Mol Diagn | 2022 |
| Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors. | Gallego-Murillo JS, Iacono G, van der Wielen LAM, van den Akker E, von Lindern M, Wahl SA | Biotechnol Bioeng | 2022 |
| MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease. | Belcher JD, Nguyen J, Chen C, Abdulla F, Conglin R, Ivy ZK, Cummings J, Dudler T, Vercellotti GM | Transl Res | 2022 |
| No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis. | Saleem A, Waqar E, Shuja SH, Naeem U, Moeed A, Rais H, Ahmed J | Transfus Clin Biol | 2022 |
| Fetal Hemoglobin and Cerebral Tissue Oxygenation during Immediate Postnatal Transition. | Suppan E, Urlesberger B, Schwaberger B, Höller N, Wolfsberger CH, Avian A, Pichler G | Neonatology | 2022 |
| The altered expression of homing factors in CD34 hematopoietic stem cells following G-CSF injection and its effects on transplantation quality in ALL patients. | Shafiei SL, Movassaghpour A, Hosseini SF, Talebi M, Edalati M, Torabi Goudarzi S, Soltani-Zangbar MS, Mehdizadeh A, Yousefi M | Cell Biol Int | 2022 |
| Emerging drugs for the treatment of sickle cell disease: a review of phase II/III trials. | Ross JM, Forté S, Soulières D | Expert Opin Emerg Drugs | 2022 |
| Analysis of Common Beta-Thalassemia (β-Thalassemia) Mutations in East Java, Indonesia. | Hernaningsih Y, Syafitri Y, Indrasari YN, Rahmawan PA, Andarsini MR, Lesmana I, Moses EJ, Abdul Rahim NA, Yusoff NM | Front Pediatr | 2022 |
| Plasma Levels of Acyl-Carnitines and Carboxylic Acids Correlate With Cardiovascular and Kidney Function in Subjects With Sickle Cell Trait. | Nemkov T, Skinner S, Diaw M, Diop S, Samb A, Connes P, D'Alessandro A | Front Physiol | 2022 |
| Oxygen Saturation in Primary Teeth of Individuals With Sickle Cell Disease and Sickle Cell Trait. | Wilson EM, Minja IK, Machibya FM, Jonathan A, Makani J, Ruggajo P, Balandya E | J Blood Med | 2022 |
| Research knowledge transfer to improve the care and support of adolescents with sickle cell disease in Ghana. | Poku BA, Pilnick A | Health Expect | 2022 |
| Empowering children and adolescents with sickle cell disease: a transition journey to adult care. | Badawy SM | Lancet Haematol | 2022 |
| Hemoglobin I-Toulouse: A rare hemoglobinopathy presenting with low oxygen saturations. | Xu Z, Masters IB, Barbaro P, Miller S, Kapur N | Clin Case Rep | 2022 |
| Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review. | Yang M, Elmuti L, Badawy SM | Biomed Res Int | 2022 |
| Inflammasomes-New Contributors to Blood Diseases. | Tomasik J, Basak GW | Int J Mol Sci | 2022 |
| A Stress and Pain Self-management mHealth App for Adult Outpatients With Sickle Cell Disease: Protocol for a Randomized Controlled Study. | Ezenwa MO, Yao Y, Mandernach MW, Fedele DA, Lucero RJ, Corless I, Dyal BW, Belkin MH, Rohatgi A, Wilkie DJ | JMIR Res Protoc | 2022 |
| Sickle cell bone disease and response to intravenous bisphosphonates in children. | Grimbly C, Escagedo PD, Jaremko JL, Bruce A, Alos N, Robinson ME, Konji VN, Page M, Scharke M, Simpson E, Pastore YD, Girgis R, Alexander RT, Ward LM | Osteoporos Int | 2022 |
| Frequency of Hereditary Hemochromatosis Gene Variants in Sri Lankan Transfusion-Dependent Beta-Thalassemia Patients and Their Association With the Serum Ferritin Level. | Padeniya P, Goonasekara H, Abeysekera G, Jayasekara R, Dissanayake V | Front Pediatr | 2022 |
| ADaPTS | Bruce AAK, Guilcher GMT, Desai S, Truong TH, Leaker M, Alaazi DA, Pedersen SJV, Salami B | Health Qual Life Outcomes | 2022 |
| Two large novel alpha-globin gene cluster deletions causing alpha(0)-thalassemia in two Chinese families. | Jiwu L, Manna S, Ying Z, Youqing F, Haiyang C, Wanfang X, Yanhui L | Gene | 2022 |
| Meteorological parameters and hospitalizations of patients with sickle cell anemia: a 20-year retrospective study in Campinas, São Paulo, Brazil. | Alagbe AE, Corozolla W, Samejima Teixeira L, Peres Coelho R, Heuminski de Avila AM, Paro Costa PD, Fatima Sonati M, de Faria EC, Nunes Dos Santos MN | Int J Environ Health Res | 2022 |
| Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Following Implementation of the 13-Valent Pneumococcal Conjugate Vaccine in France. | Assad Z, Michel M, Valtuille Z, Lazzati A, Boizeau P, Madhi F, Gaschignard J, Pham LL, Caseris M, Cohen R, Kaguelidou F, Varon E, Alberti C, Faye A, Angoulvant F, Koehl B, Ouldali N | JAMA Netw Open | 2022 |
| Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death. | Slomski A | JAMA | 2022 |
| Comparative effectiveness of adding Omega-3 or Vitamin D to standard therapy in preventing and treating episodes of painful crisis in pediatric sickle cell patients. | Abdelhalim SM, Murphy JE, Meabed MH, Elberry AA, Gamaleldin MM, Shaalan MS, Hussein RRS | Eur Rev Med Pharmacol Sci | 2022 |
| The -α subtype of α-thalassemia was identified in China. | Bao X, Wang J, Qin D, Zhang R, Yao C, Liang J, Liang K, Du L | Hematology | 2022 |
| Iron status of blood donors. | Spencer BR, Mast AE | Curr Opin Hematol | 2022 |
| Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and β-Thalassemia: A biotin label approach. | Gerritsma JJ, van der Bolt N, van Bruggen R, Ten Brinke A, van Dam J, Guerrero G, Vermeulen C, de Bruin S, Vlaar APJ, Biemond BJ, Nur E, van der Schoot E, Fijnvandraat K, | Transfusion | 2022 |
| CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric β/β transfusion-dependent β-thalassemia. | Fu B, Liao J, Chen S, Li W, Wang Q, Hu J, Yang F, Hsiao S, Jiang Y, Wang L, Chen F, Zhang Y, Wang X, Li D, Liu M, Wu Y | Nat Med | 2022 |
| Hb Kalundborg [β79(EF3)Asp→Glu; : c.240C>a], a Possible Low-affinity Hemoglobin Variant Detected during Hb A Measurement. | Ahmad-Nielsen EB, Szecsi PB, Bratholm PS, Petersen J, Glenthøj A | Hemoglobin | 2022 |
| Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia. | Anurathapan U, Pakakasama S, Songdej D, Pongphitcha P, Chuansumrit A, Andersson BS, Hongeng S | Hemoglobin | 2022 |
| Myocardial Iron Overload Causes Subclinical Myocardial Dysfunction in Sickle Cell Disease. | Fujikura K, Cheng AL, Suriany S, Detterich J, Arai AE, Wood JC | JACC Cardiovasc Imaging | 2022 |
| Splenectomy in sickle cell disease: do benefits outweigh risks? | Nardo-Marino A, Brousse V | Haematologica | 2022 |
| [Renal infarction in an adolescent carrier of the sickle cell trait]. | Guffens A, Lombet J, Pirotte I | Rev Med Liege | 2022 |
| Tailored Parenting Plans of Young Adults With Sickle Cell Disease or Sickle Cell Trait. | Oguntoye AO, Eades NT, Aldossary D, Kuenzli G, Gehling G, Ezenwa MO, Johnson-Mallard V, Yao Y, Gallo AM, Wilkie DJ | Comput Inform Nurs | 2022 |
| A New Mutation, Hb A-Canakkale [δ10(A7)Ala→Val; : c.32C>T], and Other Well-Known δ Variants Identified in a Selected Cohort with Low Hb A Levels. | Karakaya T, Silan F, Ozdemir O | Hemoglobin | 2022 |
| Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in β-Thalassemia Major Patients. | Zaman BA, Ibrahim SA | Hemoglobin | 2022 |
| Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review. | Locke M, Reddy PS, Badawy SM | Hemoglobin | 2022 |
| Bringing Sickle-Cell Treatments to Children in Sub-Saharan Africa. | Zhou AE, Travassos MA | N Engl J Med | 2022 |
| The effect of intensity of conditioning regimen on the outcome of HSCT in children with sickle cell disease. | Alsultan A, Abujoub R, Elbashir E, Essa MF | Clin Transplant | 2022 |
| 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia. | Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A | Hemasphere | 2022 |
| Clinical characteristics and risk factors of relative systemic hypertension and hypertension among sickle cell patients in Cameroon. | Nguweneza A, Ngo Bitoungui VJ, Mnika K, Mazandu G, Nembaware V, Kengne AP, Wonkam A | Front Med (Lausanne) | 2022 |
| Pulmonary function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic cell transplantation. | Monagel DA, Guilcher GMT, Nettel-Aguirre A, Bendiak GN | Pediatr Blood Cancer | 2022 |
| Advances in screening of thalassaemia. | Gao J, Liu W | Clin Chim Acta | 2022 |
| Impact of IFN-β1a in treatment of a COVID-19 patient with beta thalassemia and diabetes mellitus: A case report. | Gholinataj Jelodar M, Mirzaei S, Dehghan Chenari H | Clin Case Rep | 2022 |
| The Evaluation of Results of Twenty Common Equations for Differentiation of Beta Thalassemia Trait from Iron Deficiency Anemia: A Cross-Sectional Study. | Ebrahimpour Sadagheyani H, Sharafkhani R, Sakhaei S, Jafaralilou H, Shahmirzalou P | Iran J Public Health | 2022 |
| Hemoglobin Wayne: A Rare Variant That Can Cause Falsely Elevated Hemoglobin A1c. | Ao X, Ganta N, Choe S, Patel P, Turro J, Cheriyath P | Cureus | 2022 |
| Bioinformatic Tools for the Identification of MicroRNAs Regulating the Transcription Factors in Patients with β-Thalassemia. | Kalaigar SS, Rajashekar RB, Nataraj SM, Vishwanath P, Prashant A | Bioinform Biol Insights | 2022 |
| Sickle cell disease patients with COVID-19 in Guadeloupe: Surprisingly favorable outcomes. | Bernit E, Romana M, Alexis-Fardini S, Tarer V, Roger PM, Doumdo L, Petras E, Charneau C, Tressières B, Dessources MDH, Etienne-Julan M | EJHaem | 2022 |
| Newborn screening for abnormal haemoglobins in Jamaica: Practical issues in an island programme. | Serjeant GR, Serjeant BE, Mason KP, Gibson F, Gardner RA, Warren L, Hambleton IR, Thein SL, Happich M, Kulozik AE | J Med Screen | 2022 |
| Effective therapies for sickle cell disease: are we there yet? | Crossley M, Christakopoulos GE, Weiss MJ | Trends Genet | 2022 |
| What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel. | Gül M, Luca B, Dimitropoulos K, Capogrosso P, Milenkovic U, Cocci A, Veeratterapillay R, Hatzichristodoulou G, Modgil V, Russo GI, Tharakan T, Kalkanli A, Omar MI, Bettocchi C, Carvalho J, Corona G, Jones TH, Kadioglu A, Martinez-Salamanca JI, Serefoglu EC, Verze P, Minhas S, Salonia A, | Int J Impot Res | 2022 |
| HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription. | Huang P, Peslak SA, Ren R, Khandros E, Qin K, Keller CA, Giardine B, Bell HW, Lan X, Sharma M, Horton JR, Abdulmalik O, Chou ST, Shi J, Crossley M, Hardison RC, Cheng X, Blobel GA | Nat Genet | 2022 |
| [The Management of Endocrine Complications in Patients with Haemoglobinopathies: Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE).] | Casale M, Baldini M, Del Monte P, Gigante A, Grandone A, Origa R, Poggi M, Gadda F, Lai R, Marchetti M, Forni GL | Recenti Prog Med | 2022 |
| First-in-human phase 1 trial of artificial red blood cells and hemoglobin vesicles developed as a transfusion alternative. | Azuma H, Amano T, Kamiyama N, Takehara N, Jingu M, Takagi H, Sugita O, Kobayashi N, Kure T, Shimizu T, Ishida T, Matsumoto M, Sakai H | Blood Adv | 2022 |
| A novel, effective, and efficient strategy for treating sickle cell vaso-occlusive events in the infusion center setting. | Peslak SA, Akins-Msn Crnp AB, Foxwell AM, Iannelli M, Grande C, Breen D, Russell JE, Uritsky TJ, Sayani F | Blood Adv | 2022 |
| Contributions of von Willebrand factor to clinical severity of sickle cell disease: a systematic review and metanalysis. | Nwagha TU, Nweke M, Ezigbo ED | Hematology | 2022 |
| First study to describe a novel : c.400A > C mutation and Hb Dongguan heterozygote in two unrelated Chinese families. | Yao C, Qin D, Wang J, Bao X, Liang J, Du L | Hematology | 2022 |
| Pairing parents and offspring's HemoTypeSC Test to validate results and confirm sickle cell pedigree: a case study in Kisangani, the Democratic Republic of the Congo. | Kasai ET, Kadima JN, Alworong'a Opara JP, Boemer F, Dresse MF, Makani J, Bours V, Marini Djang'eing'a R, Paul KK, Batina Agasa S | Hematology | 2022 |
| The incidence and prevalence of unruptured intracranial aneurysms in sickle cell disease patients: a systematic review. | Essiet E, Shapey J, Kailaya-Vasan A | Br J Neurosurg | 2022 |
| Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis. | El-Amin N, Iness A, Cyrus JW, Sisler I, Karam O | Ann Hematol | 2022 |
| Exercise Capacity and Biomarkers Among Children and Adolescents With Sickle Cell Disease. | Silva LBPD, Mercês de Jesus G, Bessa Junior J, Silva VAPD, Mattos IG, Jenerette CM, Carvalho ESS | Pediatr Exerc Sci | 2022 |
| High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine. | Tessema FA, Sarpatwari A, Rand LZ, Kesselheim AS | J Law Med Ethics | 2022 |
| Underutilized legumes, Cajanus cajan and Glycine max may bring about antisickling effect in sickle cell disease by modulation of redox homeostasis in sickled erythrocytes and alteration of its functional chemistry. | Elemo GN, Erukainure OL, Okafor JNC, Banerjee P, Preissner R, Nwachukwu Nicholas-Okpara VA, Atolani O, Omowunmi O, Ezeanyanaso CS, Awosika A, Shode F | J Food Biochem | 2022 |
| Extended Spectrum β-Lactamase Producing Lactose Fermenting Bacteria Colonizing Children with Human Immunodeficiency Virus, Sickle Cell Disease and Diabetes Mellitus in Mwanza City, Tanzania: A Cross-Sectional Study. | Said MM, Msanga DR, Mtemisika CI, Silago V, Mirambo MM, Mshana SE | Trop Med Infect Dis | 2022 |
| Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature. | Menakuru SR, Priscu A, Dhillon V, Salih A | Hematol Rep | 2022 |
| Neuropsychological, behavioral, and quality-of-life outcomes in children and adolescents with sickle cell disease treated with nonmyeloablative matched sibling donor hematopoietic cell transplantation: A case series. | Fay-McClymont TB, Monagel DA, Singh G, Schulte F, Brooks BL, MacAllister WS, Désiré N, Mineyko A, Vasserman M, Leaker MT, Truong TH, Shah R, Lewis VA, Yeates KO, Guilcher GMT | Pediatr Blood Cancer | 2022 |
| Risks and Benefits of Prophylactic Transfusion before Cholecystectomy in Sickle Cell Disease. | Rambaud E, Ranque B, Tsiakyroudi S, Joseph L, Bouly N, Douard R, François A, Pouchot J, Arlet JB | J Clin Med | 2022 |
| Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation. | Alashkar F, Aramayo-Singelmann C, Böll J, Hoferer A, Jarisch A, Kamal H, Oevermann L, Schwarz M, Cario H | J Pers Med | 2022 |
| A Simple, Cost-Effective, and Extraction-Free Molecular Diagnostic Test for Sickle Cell Disease Using a Noninvasive Buccal Swab Specimen for a Limited-Resource Setting. | Thakur P, Gupta P, Bhargava N, Soni R, Varma Gottumukkala N, Goswami SG, Kharya G, Saravanakumar V, Gunda P, Jain S, Dass J, Aggarwal M, Ramalingam S | Diagnostics (Basel) | 2022 |
| Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease. | Plonski KS | Children (Basel) | 2022 |
| Deep venous thrombosis and acute pericarditis associated with severe acute respiratory syndrome coronavirus 2 infection in a Congolese infant with sickle cell disease: a case report. | Lubala TK, Kayembe-Kitenge T, Makinko P, Kalenga L, Kachil H, Kayembe A, Mutombo A, Shongo M | J Med Case Rep | 2022 |
| Detection of maternal carriers of common α-thalassemia deletions from cell-free DNA. | Doan PL, Nguyen DA, Le QT, Hoang DT, Nguyen HD, Nguyen CC, Doan KPT, Tran NT, Ha TMT, Trinh THN, Nguyen VT, Bui CT, Lai NT, Duong TH, Mai HL, Huynh PV, Huynh TTT, Le QV, Vo TB, Dao TH, Vo PA, Le DN, Tran NNT, Tran QNT, Van YT, Tran HT, Nguyen HT, Nguyen PU, Do TT, Truong DK, Tang HS, Cao NT, Lam TT, Tran LS, Nguyen HN, Giang H, Phan MD | Sci Rep | 2022 |
| A novel rearrangement of the α-globin gene cluster containing both the -α and αααα crossover junctions in a Chinese family. | Ning S, Luo Y, Liang Y, Xie Y, Lu Y, Meng B, Pan J, Xu R, Liu Y, Qin Y | Clin Chim Acta | 2022 |
| Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease. | Vunnam N, Hansen S, Williams DC, Been MO, Lo CH, Pandey AK, Paulson CN, Rohde JA, Thomas DD, Sachs JN, Wood DK | Biomacromolecules | 2022 |
| Blood Donors with Thalassemic Trait, Glucose-6-Phosphate Dehydrogenase Deficiency Trait, and Sickle Cell Trait and Their Blood Products: Current Status and Future Perspective. | Noulsri E, Lerdwana S | Lab Med | 2022 |
| Hb Narges Lab, a Novel Hemoglobin Variant of the β-Globin Gene. | Hamid M, Shahbazi Z, Keikhaei B, Galehdari H, Saberi A, Sedaghat A, Shariati G, Mohammadi-Anaei M | Arch Iran Med | 2022 |
| Transmembrane Protein ANTXR1 Regulates -Globin Expression by Targeting the Wnt/-Catenin Signaling Pathway. | Jin T, Zhang Z, Han Y, Li D, Liu J, Jiang M, Zhu J, Kurita R, Nakamura Y, Hu F, Xu Y, Fang X, Huang S, Sun Z | J Immunol Res | 2022 |
| Global longitudinal strain for detection of cardiac iron overload in patients with thalassemia: a meta-analysis of observational studies with individual-level participant data. | Attar A, Hosseinpour A, Hosseinpour H, Rezaeian N, Abtahi F, Mehdizadeh F, Parsaee M, Akiash N, Behjati M, Meloni A, Pepe A | Cardiovasc Ultrasound | 2022 |
| Electrocardiographic findings in Nigerian athletes with the sickle cell trait. | Ilodibia TF, Odigwe CO, Anugweje KC | J Electrocardiol | 2022 |
| Hb Wanjiang: A New β-Globin Chain Variant with Two Amino Acid Substitutions (: c.255_264delinsTTTTTCTCAG). | Wu SM, Jiang F, Li C, Guo ZT, Huang SR, Li DZ | Hemoglobin | 2022 |
| Thalassemia in Thailand. | Paiboonsukwong K, Jopang Y, Winichagoon P, Fucharoen S | Hemoglobin | 2022 |
| Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam. | Chong SC, Metassan S, Yusof N, Idros R, Johari N, Zulkipli IN, Ghani H, Lim MA, Taib S, Lu ZH, Abdul-Hamid MRW | Hemoglobin | 2022 |
| Clinical Severity of β-Thalassemia Pediatric Patients in Myanmar. | Khaing AA, Myint PP, Paiboonsukwong K, Win N, Fucharoen S, Sripichai O | Hemoglobin | 2022 |
| Thalassemia in India. | Colah RB, Seth T | Hemoglobin | 2022 |
| Thalassemia in Sri Lanka. | Premawardhena AP, Madushanka HDP | Hemoglobin | 2022 |
| Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh. | Chowdhury MA, Sultana R, Das D | Hemoglobin | 2022 |
| Thalassemia Status in Cambodia. | Sophâl C | Hemoglobin | 2022 |
| Introduction to the Special Issue. | Fucharoen S, Ping C, Paiboonsukwong K | Hemoglobin | 2022 |
| Thalassemia in Pakistan. | Khaliq S | Hemoglobin | 2022 |
| Thalassemia in the Philippines. | Yuson ED, Naranjo MLT | Hemoglobin | 2022 |
| Thalassemia in Indonesia. | Wahidiyat PA, Sari TT, Rahmartani LD, Iskandar SD, Pratanata AM, Yapiy I, Setianingsih I, Atmakusuma TD, Lubis AM | Hemoglobin | 2022 |
| Current Status of Thalassemia in Lao People's Democratic Republic. | Phengsavanh A, Sengchanh S, Souksakhone C, Souvanlasy B, Sychareun V | Hemoglobin | 2022 |
| Thalassemia in Viet Nam. | Bach KQ, Nguyen HTT, Nguyen TH, Nguyen MB, Nguyen TA | Hemoglobin | 2022 |
| Thalassemia in Malaysia. | Alwi ZB, Syed-Hassan SR | Hemoglobin | 2022 |
| THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China. | Chen P, Lin WX, Li SQ | Hemoglobin | 2022 |
| Pregnancy in the Sickle Cell Disease and Fetomaternal Outcomes in Different Sickle cell Genotypes: A Systematic Review and Meta-Analysis. | Aghamolaei T, Pormehr-Yabandeh A, Hosseini Z, Roozbeh N, Arian M, Ghanbarnezhad A | Ethiop J Health Sci | 2022 |
| A model of painful vaso-occlusive crisis in mice with sickle cell disease. | Khasabova I, Juliette J, Rogness VM, Khasabov SG, Golovko MY, Golovko SA, Kiven SB, Gupta K, Belcher JD, Vercellotti GM, Seybold V, Simone DA | Blood | 2022 |
| Efficacy and Safety of Hydroxyurea as Adjuvant Therapy in Pediatric Patients of Transfusion-Dependent Beta-Thalassemia Major at Zhob, Balochistan. | Akram S, Khan Khattak SA, Khan MA | Cureus | 2022 |
| Bone Mineral Density, Serum Calcium, and Vitamin D Levels in Adult Thalassemia Major Patients: Experience From a Single Center in Eastern India. | Santra S, Sharma K, Dash I, Mondal S, Mondal H | Cureus | 2022 |
| Phosphatidylserine-exposed red blood cells and ineffective erythropoiesis biomarkers in patients with thalassemia. | Chansai S, Yamsri S, Fucharoen S, Fucharoen G, Teawtrakul N | Am J Transl Res | 2022 |
| Hb Kirikiriroa [α57(E6)Gly→Cys; : c.172G>T]: A Novel Unstable α-Globin Variant with Oxidized Derivatives Interfering with Hb A. | Moore JA, Pullon BM, Wang D, Monaghan J, Moore H | Hemoglobin | 2022 |
| Relationship between Serum Ferritin and Outcomes in β-Thalassemia: A Systematic Literature Review. | Shah F, Huey K, Deshpande S, Turner M, Chitnis M, Schiller E, Yucel A, Moro Bueno L, Oliva EN | J Clin Med | 2022 |
| Does G6PD deficiency cause further damage to red blood cells of patients with sickle cell anaemia? | Esperti S, Boisson C, Robert M, Nader E, Cibiel A, Renoux C, Horrand F, Gauthier A, Poutrel S, Joly P, Connes P | Br J Haematol | 2022 |
| Inpatient palliative care use by patients with sickle cell disease: a retrospective cross-sectional study. | Nwogu-Onyemkpa E, Dongarwar D, Salihu HM, Akpati L, Marroquin M, Abadom M, Naik AD | BMJ Open | 2022 |
| High incidence of suicidal ideation in a series of sickle cell patients after hematopoietic stem cell transplantation. | Mishkin AD, Cheung SG, Hoffman A, Leimbach EJ, Dosovitz SM, Mapara MY | Blood Adv | 2022 |
| Reassessing the Need for Preoperative Transfusions in Sickle Cell Disease Patients with an Elevated Baseline Hemoglobin-a Retrospective Study. | Yan A, Tole S, Bair L, Wagner A, Tang K, Kirby-Allen M, Simpson E, Williams S | J Pediatr Hematol Oncol | 2022 |
| Evaluation of Glutamine Utilization in Patients With Sickle Cell Disease. | Wu HW, Gannon M, Hsu LL | J Pediatr Hematol Oncol | 2022 |
| Preoperative Transfusion and Surgical Outcomes for Children with Sickle Cell Disease. | Salvi PS, Solomon DG, Cowles RA | J Am Coll Surg | 2022 |
| The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine. | An HH, Gagne AL, Maguire JA, Pavani G, Abdulmalik O, Gadue P, French DL, Westhoff CM, Chou ST | Blood | 2022 |
| Elucidating Parasite and Host Cell Factors Enabling Babesia Infection in Sickle Red Cells under Hypoxic/Hyperoxic Conditions. | Beri D, Singh M, Rodriguez MA, Barbu-Stevanovic M, Rasquinha G, Mendelson A, An X, Manwani D, Yazdanbakhsh K, Lobo CA | Blood Adv | 2022 |
| High incidence of malaria in patients with sickle cell disease. | Mkombachepa M, Khamis B, Rwegasira G, Urio F, Makani J, Luzzatto L | Am J Hematol | 2022 |
| Sleep quality and pain in adolescents and young adults with sickle cell disease. | Schlenz AM, Thomas SJ, Gloston G, Lebensburger J, Maxwell SL, Kanter J | J Clin Sleep Med | 2022 |
| Prognosis and Overall Survival of Thalassemia Patients using Semi-Parametric Mixture Cure-Rate Model: a 30-Year Retrospective Cohort Study. | Zekavat OR, Bozorgi H, Bordbar M, Shakibazad N, Ebrahimi V | Clin Lab | 2022 |
| study of the effect of high temperature on erythrocytes in sickle cell trait. | Aljohani MM | Niger J Clin Pract | 2022 |
| Depression among patient with sickle cell disease: Prevalence and prediction. | Alsalman M, Alhabrati A, Alkuwaiti A, Alramadhan N, AlMurayhil N, Althafar A, Alsaad A | Niger J Clin Pract | 2022 |
| Red Blood Cell Immunization and Contributing Factors in 685 Thalassemia Patients. | Shaiegan M, Moghaddam M, Maghsudlu M, Azarkeivan A, Zolfaghari S, Pourfatollah AA, Soleimanzadeh P, Shahverdi E | Int J Hematol Oncol Stem Cell Res | 2022 |
| RS12574989 and haplotype associated with α/β-chain imbalance and population HbA2 reduction. | Lin Q, Xie Y, Zhong X, Sun X, Wang D | BMC Med Genomics | 2022 |
| Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease. | Shi H, Shao B, Gao L, Venkatesan T, McDaniel JM, Zhou M, McGee S, Yu P, Ahamed J, Journeycake J, George JN, Xia L | Proc Natl Acad Sci U S A | 2022 |
| Life beyond alpha-thalassaemia: We are moving forward. | Torti L | Br J Haematol | 2022 |
| Co-occurrence of oculocutaneous albinism type 2 and mild sickle cell disease explained by HbS/βthal genotype in an individual from the Democratic Republic of Congo. | Aquaron R, Lasseaux E, Kelekele J, Bonello-Palot N, Badens C, Arveiler B, Tshilolo L | Eur J Med Genet | 2022 |
| Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study. | Kuo KHM, Layton DM, Lal A, Al-Samkari H, Bhatia J, Kosinski PA, Tong B, Lynch M, Uhlig K, Vichinsky EP | Lancet | 2022 |
| Characteristics and outcomes of stroke hospitalizations in patients with sickle cell disease and moyamoya syndrome. | Rallo MS, Akel O, Kalakoti P, Sun H | J Stroke Cerebrovasc Dis | 2022 |
| Screening for sickle-cell retinopathy. | Ashwin PT, Sivaraj R | Eye (Lond) | 2022 |
| Simple open-heart surgery protocol for sickle-cell disease patients: a retrospective cohort study comparing patients undergoing mitral valve surgery. | Epis F, Chatenoud L, Somaschini A, Bitetti I, Cantarero F, Salvati AC, Rocchi D, Lentini S, Giovanella E, Portella G, Langer M | Interact Cardiovasc Thorac Surg | 2022 |
| Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years. | Elalfy MS, Hamdy M, El Beshlawy A, Ebeid FSE, Badr M, Kanter J, Inusa BP, Adly A, Williams S, Kilinc Y, Lee D, Fradette C, Rozova A, Toiber Temin N, Tricta F, Kwiatkowski JL | Blood Adv | 2022 |
| A case-control and seven-year longitudinal neurocognitive study of adults with sickle cell disease in Ghana. | Ampomah MA, Drake JA, Anum A, Amponsah B, Dei-Adomakoh Y, Anie K, Mate-Kole CC, Jonassaint CR, Kirkham FJ | Br J Haematol | 2022 |
| Hypothesis: Low Vitamin A and D Levels Worsen Clinical Outcomes When Children with Sickle Cell Disease Encounter Parvovirus B19. | Penkert RR, Azul M, Sealy RE, Jones BG, Dowdy J, Hayden RT, Tang L, Ross AC, Hankins JS, Hurwitz JL | Nutrients | 2022 |
| Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy. | Kassim AA, Leonard A | J Clin Med | 2022 |
| How Hydroxyurea Alters the Gut Microbiome: A Longitudinal Study Involving Angolan Children with Sickle Cell Anemia. | Delgadinho M, Ginete C, Santos B, Fernandes C, Silva C, Miranda A, Vasconcelos JN, Brito M | Int J Mol Sci | 2022 |
| Genetic Background Studies of Eight Common Beta Thalassemia Mutations in Thailand Using β-Globin Gene Haplotype and Phylogenetic Analysis. | Karnpean R, Tepakhan W, Suankul P, Thingphom S, Poonsawat A, Thanunchaikunlanun N, Ruangsanngamsiri R, Jomoui W | Genes (Basel) | 2022 |
| Feasibility and Quality Validation of a Mobile Application for Enhancing Adherence to Opioids in Sickle Cell Disease. | Sop DM, Crouch T, Zhang Y, Lipato T, Wilson J, Smith WR | Healthcare (Basel) | 2022 |
| New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement. | Carsote M, Vasiliu C, Trandafir AI, Albu SE, Dumitrascu MC, Popa A, Mehedintu C, Petca RC, Petca A, Sandru F | Diagnostics (Basel) | 2022 |
| Significance of Cardiac Magnetic Resonance Feature Tracking of the Right Ventricle in Predicting Subclinical Dysfunction in Patients with Thalassemia Major. | Das KM, Baskaki UMA, Pulinchani A, Ali HM, Almanssori TM, Gorkom KV, Das A, Dewedar H, Sharma S | Diagnostics (Basel) | 2022 |
| Quantification of human embryonic ζ-globin chains in Southeast Asian deletion (--) carriers. | Ye Y, Sun G, Ren Z, Liang Y, Luo H, Lin P, Wang X, Dong Z, Huang L, Qin L, Yu W, Wang G, Zhou Y, Tang J, Lou J, Liu Y, Zeng X, Chen Y, Li Y, Zhang Q, Huang J, Zhu P, Lin L, Zhang X, Xu X | J Clin Pathol | 2022 |
| Luspatercept in patients with non-transfusion dependent β-thalassaemia. | Platzbecker U, Morison JK | Lancet Haematol | 2022 |
| Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial. | Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V, | Lancet Haematol | 2022 |
| Paracentral Acute Middle Maculopathy with Sickle Cell Trait. | Baker M, Neuhouser A, Nazari H | Retin Cases Brief Rep | 2022 |
| In vivo base editing by a single intravenous vector injection for treatment of hemoglobinopathies. | Li C, Georgakopoulou A, Newby GA, Everette KA, Nizamis E, Paschoudi K, Vlachaki E, Gil S, Anderson AK, Koob T, Huang L, Wang H, Kiem HP, Liu DR, Yannaki E, Lieber A | JCI Insight | 2022 |
| Haptoglobin 1 Allele Predicts Higher Serum Haptoglobin and Lower Multiorgan Failure Risk in Sickle Cell Disease. | Ruiz MAD, Shah BN, Ren G, Hussain F, Njoku F, Machado RF, Gordeuk VR, Saraf SL | Blood Adv | 2022 |
| Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-Thalassemia: additional dose role. | Carsetti R, Agrati C, Pinto VM, Gianesin B, Gamberini MR, Fortini M, Barella S, Denotti AR, Perrotta S, Casale M, Maggio A, Pitrolo L, Tartaglia E, Piano Mortari E, Colavita F, Puro V, Francalancia M, Marini V, Caminati M, Mazzi F, De Franceschi L, Forni GL, Locatelli F | Blood | 2022 |
| Identification of a rare compound heterozygous hemoglobin variant β0-thal [β17(A14) Lys>Stop, HBB: c.52A>T] and Hb J-Lome [β59(E3) Lys>Asn, HBB: c.180G>C]. | Chen Z, Shao L, Jiang M, Ma R, Ping H, Wang Z, Ba X, Ma B, Zhou T | Hematology | 2022 |
| Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major. | Santarone S, Angelini S, Natale A, Vaddinelli D, Spadano R, Casciani P, Papola F, Di Lembo E, Iannetti G, Di Bartolomeo P | Bone Marrow Transplant | 2022 |
| PATTERN DYSTROPHY-LIKE CHANGES ASSOCIATED WITH A VERY HIGH SERUM FERRITIN LEVEL IN β-THALASSEMIA MAJOR. | Kurnia KH, Elvioza E, Sidik M, Sari TT, Sitorus RS | Retin Cases Brief Rep | 2022 |
| Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation. | Farmakis D, Angastiniotis M, El Ghoul MM, Cannon L, Eleftheriou A | Hemoglobin | 2022 |
| Rare Pathogenic β-Thalassemia Mutation, Codon 7 (AG>AG) (: c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece. | Zarkada E, Yfanti E, Teli A, Balassopoulou A, Sinopoulou K, Theodoridou S | Hemoglobin | 2022 |
| Effect of deletions in the α-globin gene on the phenotype severity of β-thalassemia. | Saha D, Chowdhury PK, Panja A, Pal D, Nayek K, Chakraborty G, Sharma P, Das R, Basu S, Chatterjee R, Basu A | Hemoglobin | 2022 |
| A New Hemoglobin Variant, Hb Natal (: c.423C>A), Found in a Greek Family. | Efstathiou A, Boutou E, Teli A, Drikos I, Balassopoulou A, Theodoridou S | Hemoglobin | 2022 |
| The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major. | Carnevale A, Pellegrino F, Bravi B, Gamberini MR, Gagliardi I, Reverberi R, Zatelli MC, Giganti M, Ambrosio MR | Eur J Haematol | 2022 |
| Sickle Cell Disease Presenting as Extradural Hematoma: An Extremely Rare Fatal Crisis. | Shah D, Reddy H, Kumar S, Acharya S | Cureus | 2022 |
| Precision Medicine and Sickle Cell Disease. | El Hoss S, El Nemer W, Rees DC | Hemasphere | 2022 |
| Hyperbilirubinemia Following Retroperitoneal Mass Resection in a Patient with Sickle Cell Anemia. | de la Calle CM, Young ED, Singla N | Urology | 2022 |
| Economic burden and catastrophic cost among people living with sickle cell disease, attending a tertiary health institution in south-east zone, Nigeria. | Amarachukwu CN, Okoronkwo IL, Nweke MC, Ukwuoma MK | PLoS One | 2022 |
| Identifying Chronic Pain Subgroups in Pediatric Sickle Cell Disease: A Cluster-Analytic Approach. | Sil S, Manikowski A, Schneider M, Cohen LL, Dampier C | Clin J Pain | 2022 |
| Age- and sex-specific rates of gall bladder disease in children with sickle cell disease. | Agawu A, Shults J, Smith-Whitley K, Feudtner C | Pediatr Blood Cancer | 2022 |
| Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU Sexual and Reproductive Health Panel. | Capogrosso P, Dimitropolous K, Russo GI, Tharakan T, Milenkovic U, Cocci A, Boeri L, Gül M, Bettocchi C, Carvalho J, Kalkanlı A, Corona G, Hatzichristodoulou G, Jones HT, Kadioglu A, Martinez-Salamanca JI, Modgil V, Serefoglu EC, Verze P, Salonia A, Minhas S, | Int J Impot Res | 2022 |
| Comparison of anti-Mullerian hormone levels pre- and post-hematopoietic cell therapy in pediatric and adolescent females with sickle cell disease. | George SA, Lai KW, Lewis RW, Bryson EW, Haight AE, Meacham LR | Transplant Cell Ther | 2022 |
| Sickle cell disease and the incidence and etiology of preterm birth. | Fashakin V, Weber JM, Truong T, Craig A, Wheeler SM, James AH | Am J Obstet Gynecol MFM | 2022 |
| Essential strategies and tactics for managing sickle cell disease. | Perkins RA, Payne-Johnson A, Jefferson R | J Fam Pract | 2022 |
| Combined Gap-Polymerase Chain Reaction and Targeted Next-Generation Sequencing Improve α- and β-Thalassemia Carrier Screening in Pregnant Women in Vietnam. | Lam TT, Nguyen DT, Le QT, Nguyen DA, Hoang DT, Nguyen HD, Nguyen CC, Doan KPT, Tran NT, Ha TMT, Trinh THN, Nguyen VT, Lam DT, Le MT, Nguyen XT, Ho TT, Tran TH, Ho VT, Bui TV, Nguyen VT, Hoang PB, Nguyen HT, Nguyen MH, Vo TB, Le DN, Truong TN, Dao HT, Vo PN, Nguyen TV, Tran NT, Tran QT, Van YT, Nguyen TT, Huynh BT, Nguyen TT, Tran KT, Nguyen CT, Doan PL, Nguyen TD, Do TT, Truong DK, Tang HS, Cao NT, Phan MD, Giang H, Nguyen HN | Hemoglobin | 2022 |
| Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination. | Eyssette-Guerreau S, Khimoud D, Michaux K, Odièvre MH, Allali S, Pertuisel S, Guillaumat C, Monfort M, Guitton C, Miquel A, Runel C, Gauthier A, Arlet JB | Br J Haematol | 2022 |
| Incidence of Deep Venous Thrombosis and Sickle Cell Disease in Patients Undergoing Spinal Surgery in South Gujarat, India: A Prospective Observational Study. | Menon HJ, Khanna AP, Patel YB | Malays Orthop J | 2022 |
| Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania. | Mutagonda RF, Bwire G, Sangeda RZ, Kilonzi M, Mlyuka H, Ndunguru J, Jonathan A, Makani J, Minja IK, Ruggajo P, Balandya E, Kamuhabwa AAR | Infect Drug Resist | 2022 |
| Lidocaine and Ketamine Infusions as Adjunctive Pain Management Therapy: A Retrospective Analysis of Clinical Outcomes in Hospitalized Patients Admitted for Pain Related to Sickle Cell Disease. | Zavala NA, Knoebel RW, Anitescu M | Front Pain Res (Lausanne) | 2022 |
| Folate levels in children with sickle cell anaemia on folic acid supplementation in steady state and crises at a tertiary hospital in Enugu, Nigeria: a prospective, comparative study. | Nnajekwu UC, Nnajekwu CO, Onukwuli VO, Chukwu BF, Ikefuna AN, Emodi IJ | Malawi Med J | 2022 |
| Identifying Gingival Pigmentation Patterns and Skin Color and Its Co-relation With Serum Ferritin Levels in Thalassemic Patients. | Gajjar S, Kaur H, Girdhar G, Kaur A, Patel C, Mehta R, Bhakkand S, Hirani T, Joshi S, Irfan M, Binti Wan Ahmad Fakuradzi WFS, Sinha S, Haque M, Kumar S | Cureus | 2022 |
| The Day I Relearned the Sickle Cell Crisis. | Hibbs S, Shaniqua M | Hemasphere | 2022 |
| Prevalence of hypogonadism in transfusion-dependent β-thalassemia patients of Bangladesh: investigating the role of serum ferritin level as a diagnostic tool. | Chowdhury R, Iktidar MA, Ahmed MN, Hasan MM, Tapan MMH, Shaheen SSI, Rahman A, Khatun A | Hematol Transfus Cell Ther | 2022 |
| Cervical Joint Position Sense in Individuals With Type 2 Diabetes and Its Correlations With Glycated Hemoglobin Levels: A Cross-Sectional Study. | Reddy RS, Alshahrani MS, Tedla JS, Asiri F, Nambi G, Kakaraparthi VN | J Manipulative Physiol Ther | 2022 |
| Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand. | Teawtrakul N, Songdej D, Hantaweepant C, Tantiworawit A, Lauhasurayotin S, Torcharus K, Sripornsawan P, Sutcharitchan P, Surapolchai P, Komvilaisak P, Saengboon S, Pongtanakul B, Charoenkwan P, | Transfusion | 2022 |
| Doing more with less: Patient blood management meets sickle cell disease management. | Lauridsen L, Campbell-Lee SA | Transfusion | 2022 |
| HbS promotes TLR4-mediated monocyte activation and pro-inflammatory cytokine production in sickle cell disease. | Allali S, Rignault-Bricard R, De Montalembert M, Taylor M, Bouceba T, Hermine O, Maciel TT | Blood | 2022 |
| Retrospective Analysis of Thalassemia Patients in Secondary Care Hospital: Ras Al Khaimah, United Arab Emirates. | Assadi RR, Sadhu S, Fatima F, Bhat R, Shivappa P | Adv Biomed Res | 2022 |
| The Long-Term Efficacy of Deferiprone in Thalassemia Patients With Iron Overload: Real-World Data from the Registry Database. | Kittipoom T, Tantiworawit A, Punnachet T, Hantrakun N, Piriyakhuntorn P, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Fanhchaksai K, Charoenkwan P | Hemoglobin | 2022 |
| A Randomized Clinical Trial of the Efficacy and Safety of Rivipansel for Sickle Cell Vaso-occlusive Crisis (VOC). | Dampier CD, Telen MJ, Wun T, Brown C, Desai PC, El Rassi F, Fuh B, Kanter J, Pastore YD, Rothman J, Taylor JG, Readett D, Sivamurthy KM, Tammara B, Tseng LJ, Lozier JN, Thackray HM, Magnani JL, Hassell K | Blood | 2022 |
| [Molecular Epidemiological Characteristics and Differential Diagnosis of Common δβ-Thalassemia/HPFH]. | Ju AP, Li N, Lin K, Huang HH, Liu SX, Jiang F | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 |
| P-selectin deficiency promotes liver senescence in sickle cell disease mice. | Vats R, Kaminski TW, Ju E-M, et al. | Blood | 2022 |
| Internalizing Symptoms in Adolescents With Sickle Cell Disease. | Heitzer AM, Longoria J, Porter JS, MacArthur E, Potter B, Ding J, Gossett J, Kang G, Hankins JS | J Pediatr Psychol | 2022 |
| β-Thalassemia Intermedia Caused by the β-Globin Gene 3' Untranslated Region: Another Case Report. | Jiang F, Chen GL, Li J, Tang XW, Li DZ | Hemoglobin | 2022 |
| Molecular Epidemiology and Hematologic Characterization of Thalassemia in Guangdong Province, Southern China. | Xian J, Wang Y, He J, Li S, He W, Ma X, Li Q | Clin Appl Thromb Hemost | 2022 |
| Special issue: Pediatric pain and sickle cell disease. | Brown M, Anheyer D, Morris CR | Complement Ther Med | 2022 |
| Amino acid signature during sickle cell pain crisis shows significant alterations related to nitric oxide and energy metabolism. | Zhou Y, Yu X, Nicely A, Cunningham G, Challa C, McKinley K, Nickel R, Campbell A, Darbari D, Summar M, Majumdar S | Mol Genet Metab | 2022 |
| Metabolic Bone Disease in Children with Transfusion-Dependent Thalassemia. | Handattu K, Aroor S, Kini P, Bhat Y R, Shivakumar G, Shastry P, Shetty S | Indian Pediatr | 2022 |
| Parvovirus b19 infection in children with sickle cell disease, watch out for splenomegaly! A case report. | de la Hoz JA, Otones LL, Sáenz MH, Martín MJR | Afr Health Sci | 2022 |
| Clinical Study of Mobile Application- (App-) Based Family-Centered Care (FCC) Model Combined with Comprehensive Iron Removal Treatment in Children with Severe Beta Thalassemia. | Chen Y, Huang X, Lu Q, Lu J, Huang X, Luo Y, Huang F | Appl Bionics Biomech | 2022 |
| Neurocognitive functioning in children with sickle cell anemia and history of abnormal transcranial doppler ultrasonography. | Longoria JN, Wang W, Kang G, Gossett J, Krull K, King AA, Raches D, Schreiber J, Heitzer AM, Hankins JS | Pediatr Blood Cancer | 2022 |
| Breaking the Cycle: Care Coordination Interventions and Sickle Cell Readmissions. | No authors listed | Prof Case Manag | 2022 |
| Breaking the Cycle: Care Coordination Interventions and Sickle Cell Readmissions. | Edge NB | Prof Case Manag | 2022 |
| BEHAVIORAL CHARACTERISTICS OF CHILDREN WITH SICKLE CELL DISEASE. | Pereira FB, Pedroso GC, Resegue RM, Ribeiro MVV, Hokazono M, Braga JAP | Rev Paul Pediatr | 2021 |
| Correction of Hemoglobin E/Beta-Thalassemia Patient-Derived iPSCs Using CRISPR/Cas9. | Wattanapanitch M | Methods Mol Biol | 2021 |
| The spectrum of beta-thalassemia mutations in the 22 Arab countries: a systematic review. | Khan AM, Al-Sulaiti AM, Younes S, Yassin M, Zayed H | Expert Rev Hematol | 2021 |
| Recommendation to reality: Closing the transcranial Doppler screening gap for children with sickle cell anemia. | Singh A, Danda V, Van Swol L, Scott JP, Brandow AM, Panepinto JA | Pediatr Blood Cancer | 2021 |
| The Theoretical Basis of In Utero Hematopoietic Stem Cell Transplantation and Its Use in the Treatment of Blood Disorders. | Tai-MacArthur S, Lombardi G, Shangaris P | Stem Cells Dev | 2021 |
| Automatic identification of abnormal blood smear images using color and morphology variation of RBCS and central pallor. | Rahman S, Azam B, Khan SU, Awais M, Ali I, Ul Hussen Khan RJ | Comput Med Imaging Graph | 2021 |
| Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect. | Evans BA, Ansari AK, Kamyszek RW, Salvagno M, Welsby J, Fuller M, Welsby I | Blood Cells Mol Dis | 2021 |
| MicroRNA expression patterns in HbE/β-thalassemia patients: The passwords to unlock fetal hemoglobin expression in β-hemoglobinopathies. | Das SS, Das S, Byram PK, Rahaman M, Dolai TK, Chatterjee A, Chakravorty N | Blood Cells Mol Dis | 2021 |
| Marrow Fat Content and Composition in β-Thalassemia: A Study using H-MRS. | Ismail UN, Azlan CA, Khairullah S, Azman RR, Omar NF, Md Shah MN, Yeong CH, Jackson N, Ng KH | J Magn Reson Imaging | 2021 |
| Use of Wise Device Technology to Measure Adherence to Hydroxyurea Therapy in Youth With Sickle Cell Disease. | Ingerski LM, Loew M, Porter JS, Su Y, Zhang H, Hankins JS, Wang WC | J Pediatr Hematol Oncol | 2021 |
| Thrombin generation in vivo and ex vivo in sickle cell disease patients. | Ladeira VS, de Oliveira Toledo SL, Ferreira LGR, Oliveira MM, Silva APF, de Oliveira WV, Duarte RCF, Renó CO, Dusse LMS, Dos Santos HL, Carvalho MDG, Pinheiro MB, Rios DRA | Thromb Res | 2021 |
| Induction of therapeutic levels of HbF in genome-edited primary β 39-thalassaemia haematopoietic stem and progenitor cells. | Mingoia M, Caria CA, Ye L, Asunis I, Marongiu MF, Manunza L, Sollaino MC, Wang J, Cabriolu A, Kurita R, Nakamura Y, Cucca F, Kan YW, Marini MG, Moi P | Br J Haematol | 2021 |
| Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders. | Santos MEHP, Olops L, Vendrame F, Tavares AHJ, Leonardo DP, de Azevedo PC, Piovesana LG, Costa FF, Fertrin KY | Blood Cells Mol Dis | 2021 |
| Swaying sickle cell research forward in support of patient reported outcomes. | Lanzkron S, Smith-Whitley K | Am J Hematol | 2021 |
| Rare Disorders of Painful Erection: A Cohort Study of the Investigation and Management of Stuttering Priapism and Sleep-Related Painful Erection. | Johnson MJ, McNeillis V, Chiriaco G, Ralph DJ | J Sex Med | 2021 |
| If you Can't Assess It, How Can you Treat It? Improving Pain Management in Sickle Cell Disease. | Jonassaint CR | J Emerg Nurs | 2021 |
| Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients. | Hatairaktham S, Masaratana P, Hantaweepant C, Srisawat C, Sirivatanauksorn V, Siritanaratkul N, Panichkul N, Kalpravidh RW | Ann Hematol | 2021 |
| Krüppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities. | Kumar R, Yadav R, Mishra S, Singh MPSS, Gwal A, Bharti PK, Rajasubramaniam S | Ann Hematol | 2021 |
| MRI-based R2* mapping in patients with suspected or known iron overload. | Aslan E, Luo JW, Lesage A, Paquin P, Cerny M, Chin AS, Olivié D, Gilbert G, Soulières D, Tang A | Abdom Radiol (NY) | 2021 |
| A painless, sudden loss of vision in sickle cell anaemia: central retinal artery occlusion. | Guillaume M, Lahary A, Zourdani L, Malandain E, Ozkul-Wermester O | Lancet | 2021 |
| Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation. | Lertkovit O, Anurathapan U, Hongeng S, Thokanit NS, Pakakasama S | Int J Hematol | 2021 |
| Mortality in sickle cell disease: A population-based study in an aboriginal community in the Gudalur Valley, Nilgiris, Tamil Nadu, India. | Sheshadri V, Shabeer P, Santhirapala V, Jayaram A, Krishnamurti L, Menon N | Pediatr Blood Cancer | 2021 |
| A Sickle-Cell Patient Displaced by the Pandemic: Is a Request for Opioids Legitimate, or Sign of a Deeper Problems? | Eisenberg L | Am J Bioeth | 2021 |
| "I'm in Pain; Why Don't You Believe Me?" Pain Management in Sickle Cell Disease. | Ellis G | Am J Bioeth | 2021 |
| Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion. | Ziemba Y, Xu C, Fomani KM, Nandi V, Yuan T, Rehmani S, Sachais BS, Appiah-Kubi AO, Aygun B, Louie JE, Shi PA | Transfusion | 2021 |
| Hemoglobinopathy and pediatrics in the time of COVID-19. | Vilela TS, Braga JAP, Loggetto SR | Hematol Transfus Cell Ther | 2021 |
| Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE). | Ibemere SO, Dubbs SB, Barnhart HX, Brown JL, Freiermuth CE, Kavanagh P, Paice JA, Strouse JJ, Wilkerson RG, Tanabe P, | Contemp Clin Trials | 2021 |
| Long noncoding RNA CCDC26 as a modulator of transcriptional switching between fetal and embryonic globins. | Hirano T, Tsuruda T, Tanaka Y, Harada H, Yamazaki T, Ishida A | Biochim Biophys Acta Mol Cell Res | 2021 |
| CRISPR/Cas9 gene editing for curing sickle cell disease. | Park SH, Bao G | Transfus Apher Sci | 2021 |
| Increased zinc and albumin but lowered copper in children with transfusion-dependent thalassemia. | Alhillawi ZH, Al-Hakeim HK, Moustafa SR, Maes M | J Trace Elem Med Biol | 2021 |
| CD14+ monocytes repress gamma globin expression at early stages of erythropoiesis. | Heshusius S, Heideveld E, von Lindern M, van den Akker E | Sci Rep | 2021 |
| Anxiety level and clinical course of patients with sickle cell disease during the COVID-19 outbreak. | Tezol O, Unal S | Arch Pediatr | 2021 |
| Association of sickle cell disease with anthropometric indices among under-five children: evidence from 2018 Nigeria Demographic and Health Survey. | Islam MR, Moinuddin M, Ahmed A, Rahman SM | BMC Med | 2021 |
| Undernutrition: a major but potentially preventable cause of poor outcomes in children living with sickle cell disease in Africa. | Williams TN | BMC Med | 2021 |
| Co-transcriptional splicing regulates 3' end cleavage during mammalian erythropoiesis. | Reimer KA, Mimoso CA, Adelman K, Neugebauer KM | Mol Cell | 2021 |
| Early genetic screening uncovered a high prevalence of thalassemia among 18 309 neonates in Guizhou, China. | Tan M, Bai Y, Zhang X, Sun J, Huang C, Tian R, Yang Y, Luo X, Su Q, Wu L, Zheng L, Xia J, Murong H, Zhu P, Yang F, Zhong X, Chen J, Chen Y | Clin Genet | 2021 |
| Postoperative acute multiple organ failure after hepatectomy in a Nigerian male with sickle cell trait: a case report. | Iwasaki T, Nara S, Nishimura Y, Ueda H, Kishi Y, Esaki M, Shimada K, Hiraoka N | Surg Case Rep | 2021 |
| Addressing unmet basic needs for children with sickle cell disease in the United States: clinic and staff perspectives. | Loo S, Brochier A, Wexler MG, Long K, Kavanagh PL, Garg A, Drainoni ML | BMC Health Serv Res | 2021 |
| Promising Strategies for Sickle Cell Disease and β-Thalassemia. | Abbasi J | JAMA | 2021 |
| Factors affecting Thai pregnant women's decisions concerning prenatal diagnosis and termination of pregnancy for β-thalassemia. | Phaophan A, Mongkolchat N, Chuenwattana P, Viboonchart S | J Obstet Gynaecol Res | 2021 |
| Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review. | Alshahrani MS, Alghamdi MA | Saudi J Med Med Sci | 2021 |
| Nitric oxide and sickle cell disease-Is there a painful connection? | Hallmark L, Almeida LE, Kamimura S, Smith M, Quezado ZM | Exp Biol Med (Maywood) | 2021 |
| Transfusion and sickle cell anemia in Africa. | Diop S, Pirenne F | Transfus Clin Biol | 2021 |
| Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice. | Wilkinson AC, Dever DP, Baik R, Camarena J, Hsu I, Charlesworth CT, Morita C, Nakauchi H, Porteus MH | Nat Commun | 2021 |
| Coronavirus Disease 2019 (COVID-19) Infection in Children With Sickle Cell Disease: Case Series From Oman. | Al Sabahi A, Al Maskari N, Al Busaidi I, Albiroty KA, Alkhamisy A, Al Hinai K, Al Hinai M, Al Mashaikhi N, Alkendi J | J Pediatr Hematol Oncol | 2021 |
| Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease. | Ansari J, Senchenkova EY, Vital SA, Al-Yafeai Z, Kaur G, Sparkenbaugh EM, Orr AW, Pawlinski R, Hebbel RP, Granger DN, Kubes P, Gavins FNE | Blood | 2021 |
| Dietary iron restriction improves markers of disease severity in murine sickle cell anemia. | Parrow NL, Violet PC, George NA, Ali F, Bhanvadia S, Wong R, Tisdale JF, Fitzhugh C, Levine M, Thein SL, Fleming RE | Blood | 2021 |
| Markers of ineffective erythropoiesis in non-transfusion dependent β-thalassaemia. | Khairullah S, Jackson N | Med J Malaysia | 2021 |
| Diverse manifestations of a sickle cell crisis. | Hashemzehi T, Bertok S, Figaszewska MJ, Batura D | BMJ Case Rep | 2021 |
| Epigenetic activities in erythroid cell gene regulation. | Wang Y, Yu L, Engel JD, Singh SA | Semin Hematol | 2021 |
| Epigenetic regulation of hemoglobin switching in non-human primates. | Molokie R, DeSimone J, Lavelle D | Semin Hematol | 2021 |
| Epigenetic modifier directed therapeutics to unleash healthy genes in unhealthy cells. | Jha BK, Saunthararajah Y | Semin Hematol | 2021 |
| Bayesian spatial modeling of transfusion-dependent β-thalassemia incidence rate in Fars Province, Southern Iran. | Haghpanah S, Asmarian N, Zekavat OR, Bordbar M, Karimi M, Zareifar S, Ramzi M, Safaei S | Spat Spatiotemporal Epidemiol | 2021 |
| Validity of the Malay EQ-5D-3L in the Malaysian Transfusion-Dependent Thalassemia Population. | Shafie AA, Chhabra IK, Hui Yi JW, Mohammed NS, Ibrahim HM | Value Health Reg Issues | 2021 |
| Skewed intracellular cytokine production of iNKT cells toward Th2-related responses in alloimmunized thalassemia patients. | Amirian N, Ranjbaran R, Shokrgozar N, Ataei S, Bazrafshan A, Sharifzadeh S | Cytokine | 2021 |
| It takes a village to raise a sickle cell warrior. | Power-Hays A | Pediatr Blood Cancer | 2021 |
| A phenotypic risk score for predicting mortality in sickle cell disease. | Sachdev V, Tian X, Gu Y, Nichols J, Sidenko S, Li W, Beri A, Layne WA, Allen D, Wu CO, Thein SL | Br J Haematol | 2021 |
| Extramedullary hematopoiesis in the facial sinus in a patient homozygous for Hemoglobin Lepore: the first case in literature. | Talarico V, Muraca L, Arcuri PP, Gigliotti F, Fortugno C, Miniero R, Raiola G, Galati MC | Eur Rev Med Pharmacol Sci | 2021 |
| Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing. | Tampaki A, Gavriilaki E, Varelas C, Anagnostopoulos A, Vlachaki E | Blood Rev | 2021 |
| [Maculopathy in sickle cell disease]. | Bachmeier I, Blecha C, Föll J, Wolff D, Jägle H | Ophthalmologe | 2021 |
| Screening of HbE by the New Screening Test: Alcohol HbE Test (AET). | Tatu T, Anusak K, Jawannatoom C | J Appl Lab Med | 2021 |
| Compensated hypogonadism in men with sickle cell disease. | Ribeiro APMR, Silva CS, Zambrano JCC, Miranda JOF, Molina CAF, Gomes CM, Miranda EP, de Bessa J | Clin Endocrinol (Oxf) | 2021 |
| Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic. | Ballas SK | J Clin Med | 2021 |
| CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE Activity. | Bou-Fakhredin R, Dia B, Ghadieh HE, Rivella S, Cappellini MD, Eid AA, Taher AT | Int J Mol Sci | 2021 |
| A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy. | Badawy SM, Beg U, Liem RI, Chaudhury S, Thompson AA | Blood Adv | 2021 |
| PPARγ increases HUWE1 to attenuate NF-κB/p65 and sickle cell disease with pulmonary hypertension. | Jang AJ, Chang SS, Park C, Lee CM, Benza RL, Passineau MJ, Ma J, Archer DR, Sutliff RL, Hart CM, Kang BY | Blood Adv | 2021 |
| [Diaphyseal humeral infarction in a patient with sickle cell anemia]. | Monteagudo Vilavedra E, García Fernández ME, Escolar Martín JM, Sánchez Domínguez A | An Pediatr (Engl Ed) | 2021 |
| Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease. | Zheng Y, Chou ST | Clin Lab Med | 2021 |
| Successful four-factor preimplantation genetic testing: α- and β-thalassemia, human leukocyte antigen typing, and aneuploidy screening. | Chen D, Shen X, Xu Y, Ding C, Ye Q, Zhong Y, Xu Y, Zhou C | Syst Biol Reprod Med | 2021 |
| Genetic determinants of ferritin, haemoglobin levels and haemoglobin trajectories: results from Donor InSight. | Timmer T, Tanck M, Penkett C, Stirrups K, Gleadall N, de Kort W, van der Schoot E, van den Hurk K | Vox Sang | 2021 |
| [The Danish screening programme for haemoglobinopathies]. | Glenthøj A, Samson M, Toft N, Diness BR, Askj R N, Vojdeman FJ, Birgens H, Sørensen MB, Petersen J | Ugeskr Laeger | 2021 |
| Risk Factors and Complications Among Pediatric Patients With Sickle Cell Anemia: A Single Tertiary Center Retrospective Study. | Alzahrani F, Fallatah AM, Al-Haddad FM, Khayyat ST, AlMehmadi WM, AlQahtani BG, Alamri RS | Cureus | 2021 |
| Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study. | Koehl B, Aupiais C, Schinckel N, Mornand P, Odièvre MH, Niakate A, Brousse V, Ithier G, Missud F, Holvoet L, Benkerrou M, Sorge F, Faye A | J Travel Med | 2021 |
| The Rh blood group system and its role in alloimmunization rate among sickle cell disease and sickle thalassemia patients in Iran. | Jalali Far MA, Oodi A, Amirizadeh N, Mohammadipour M, Keikhaei Dehdezi B. | Mol Genet Genomic Med | 2021 |
| Core decompression with autologous bone marrow aspirate injection in humeral head osteonecrosis in adults with sickle cell disease. | Guerin G, Habibi A, Hernigou P, Zilber S | Int Orthop | 2021 |
| Noninvasive prenatal testing of α-thalassemia and β-thalassemia through population-based parental haplotyping. | Chen C, Li R, Sun J, Zhu Y, Jiang L, Li J, Fu F, Wan J, Guo F, An X, Wang Y, Fan L, Sun Y, Guo X, Zhao S, Wang W, Zeng F, Yang Y, Ni P, Ding Y, Xiang B, Peng Z, Liao C | Genome Med | 2021 |
| Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major. | Mahmoud AA, Elian DM, Abd El Hady NM, Abdallah HM, Abdelsattar S, Khalil FO, Abd El Naby SA | Children (Basel) | 2021 |
| Hematopoietic-Stem-Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies. | Drysdale CM, Nassehi T, Gamer J, Yapundich M, Tisdale JF, Uchida N | Cell Stem Cell | 2021 |
| Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds. | Tartaglione I, Manara R, di Concilio R, Quarta A, Ruffo GB, De Michele E, Ammendola F, Foderini MV, Raimo S, Santangelo G, Perrotta S | Ann Hematol | 2021 |
| Tranexamic acid use in a patient with sickle cell disease undergoing posterior scoliosis correction surgery: safely mitigating bleeding and vaso-occlusive crises. | Newall M, Hamdan TA, Lui DF, Ajayi B, Bishop T, Weil S | J Surg Case Rep | 2021 |
| Parameters affecting successful stem cell collections for genetic therapies in sickle cell disease. | Justus DG, Manis JP | Transfus Apher Sci | 2021 |
| On the possibility of a disabled life in capitalist ruins: Black workers with sickle cell disorder in England. | Dyson SM, Atkin KM, Berghs MJ, Greene AM | Soc Sci Med | 2021 |
| Neutrophil extracellular trap regulators in sickle cell disease: Modulation of gene expression of PADI4, neutrophil elastase, and myeloperoxidase during vaso-occlusive crisis. | Hounkpe BW, Chenou F, Domingos IF, Cardoso EC, Costa Sobreira MJV, Araujo AS, Lucena-Araújo AR, da Silva Neto PV, Malheiro A, Fraiji NA, Costa FF, Bezerra MAC, Santos MNN, De Paula EV | Res Pract Thromb Haemost | 2021 |
| ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease. | Demagny J, Driss A, Stepanian A, Anguel N, Affo L, Roux D, Habibi A, Benghezal S, Capdenat S, Coppo P, Driss F, Veyradier A | Res Pract Thromb Haemost | 2021 |
| Simultaneous diagnosis of severe SARS-CoV-2 infection and sickle cell disease in two infants. | Parodi E, Voi V, Vania B, Lonardi P, Saracco P, Longobardo A, Grassitelli S, Peruzzi L, Scolfaro C, Piga A | Blood Transfus | 2021 |
| Detection and follow-up of a soluble alpha-haemoglobin pool in the red cells of stored blood units. | Domingues-Hamdi E, Vasseur C, Bodivit G, Jouard A, de Ménorval MA, Pirenne F, Chadebech P, Baudin-Creuza V | Blood Transfus | 2021 |
| Longitudinal Assessment of Retinal Thinning in Adults With and Without Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography. | Lim JI, Niec M, Sun J, Cao D | JAMA Ophthalmol | 2021 |
| Sickle Cell Disease and the Eye-Everything Old Is New Again. | Scott AW | JAMA Ophthalmol | 2021 |
| Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres. | Alzahrani M, Damlaj M, Jeffries N, Alahmari B, Singh A, Rondelli D, Tisdale JF, Saraf SL, Hsieh MM | Br J Haematol | 2021 |
| Thalassemia Patients from Baluchistan in Pakistan Are Infected with Multiple Hepatitis B or C Virus Strains. | Ahmed S, Ayub M, Naeem M, Nazir FH, Hussain A, Ghilzai D, Magnius LO, Sajjad A, Norder H | Am J Trop Med Hyg | 2021 |
| Hydroyxurea improves cerebral oxygen saturation in children with sickle cell anemia. | Karkoska K, Quinn CT, Niss O, Pfeiffer A, Dong M, Vinks AA, McGann PT | Am J Hematol | 2021 |
| Guideline on the peri-operative management of patients with sickle cell disease: Guideline from the Association of Anaesthetists. | Walker I, Trompeter S, Howard J, Williams A, Bell R, Bingham R, Bankes M, Vercueil A, Dalay S, Whitaker D, Elton C | Anaesthesia | 2021 |
| Are current interventions for preventing silent cerebral infarcts in people with sickle cell disease effective and safe? A Cochrane Review summary with commentary. | Gimigliano F | Dev Med Child Neurol | 2021 |
| Effects of red blood cell transfusion on global oxygenation in anemic critically ill patients. | Themelin N, Biston P, Massart J, Lelubre C, Piagnerelli M | Transfusion | 2021 |
| Quantification of pancreatic iron overload and fat infiltration and their correlation with glucose disturbance in pediatric thalassemia major patients. | Huang J, Shen J, Yang Q, Cheng Z, Chen X, Yu T, Zhong J, Su Y, Guo H, Liang B | Quant Imaging Med Surg | 2021 |
| Sofosbuvir/Ledipasvir for Treatment of Chronic Hepatitis C Infection in Adult Patients with β- Thalassemia Major: A Real-Life Study. | Elbedewy TA, Abd-Elsalam S, Mostafa SM, Abdellatif RS, Fouad A, Youssef M, Abo-Amer YE, Elsebaey MA | Endocr Metab Immune Disord Drug Targets | 2021 |
| Identification of Circulating Endocan-1 and Ether Phospholipids as Biomarkers for Complications in Thalassemia Patients. | Botta A, Forest A, Daneault C, Pantopoulos K, Tantiworawit A, Phrommintikul A, Chattipakorn S, Chattipakorn N, Des Rosiers C, Sweeney G | Metabolites | 2021 |
| Neuropathic Pain in Children with Sickle Cell Disease: The Hidden Side of the Vaso-Occlusive Crisis. | Sigalla J, Duparc Alegria N, Le Roux E, Toumazi A, Thiollier AF, Holvoet L, Benkerrou M, Dugue S, Koehl B | Children (Basel) | 2021 |
| Transcutaneous monitoring of hemoglobin derivatives during methemoglobinemia in rats using spectral diffuse reflectance. | Khatun F, Aizu Y, Nishidate I | J Biomed Opt | 2021 |
| Loss of alpha globin genes is associated with improved microvascular function in patients with sickle cell anemia. | Romana M, Reminy K, Moeckesch B, Charlot K, Hardy-Dessources MD, Doumdo L, Tressieres B, Etienne-Julan M, Lemonne N, Denton C, Coates T, Petras M, Antoine-Jonville S, Connes P | Am J Hematol | 2021 |
| Adaptable stewardship during a pandemic: a multifaceted approach to sustaining the blood supply for individuals with sickle cell disease. | Godby RC, Kornbrust A, Noubouossie D, Kanter J, Ogunsile FJ, Lima JLO, Singh N, Marques MB, Siniard RC | Int J Lab Hematol | 2021 |
| Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia. | Musallam KM, Cappellini MD, Taher AT | Ann Hematol | 2021 |
| Orofacial manifestations of sickle cell disease: implications for dental clinicians. | Girgis S, Cheng L, Tsitsikas D, Sproat C | Br Dent J | 2021 |
| The use of luspatercept for thalassemia in adults. | Cappellini MD, Taher AT | Blood Adv | 2021 |
| Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection. | Minniti CP, Zaidi AU, Nouraie M, Manwani D, Crouch GD, Crouch AS, Callaghan MU, Carpenter S, Jacobs C, Han J, Simon J, Glassberg J, Gordeuk VR, Klings ES | Blood Adv | 2021 |
| Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia. | Rai P, Joshi VM, Goldberg JF, Yates AM, Okhomina VI, Penkert R, Ataga KI, Kang G, Hankins JS | Blood Adv | 2021 |
| Cognitive performance as a predictor of healthcare transition in sickle cell disease. | Saulsberry-Abate AC, Partanen M, Porter JS, Podila PSB, Hodges JR, King AA, Wang WC, Schreiber JE, Zhao X, Kang G, Jacola LM, Hankins JS | Br J Haematol | 2021 |
| Absence of hydroxyurea-induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia. | Ware RE, Dertinger SD | Br J Haematol | 2021 |
| Web-based expert system with quick response code for beta-thalassemia management. | Banjar HR, Zaher GF, Almutiry HS, Alshamarni ASA, Almouhana GI, Alahwal HM, Bahashwan S, Barefah AS, Alnajjar SA, Alharbi HM | Health Informatics J | 2021 |
| Differential diagnosis of thalassemia and iron deficiency anemia in pregnant women using new formulas from multidimensional analysis of red blood cells. | Xiao H, Wang Y, Ye Y, Yang C, Wu X, Wu X, Zhang X, Li T, Xiao J, Zhuang L, Qi H, Wang F | Ann Transl Med | 2021 |
| OCCURRENCE OF UNUSUAL HAEMOGLOBINOPATHIES IN BALOCHISTAN: HB SD AND HB SE - PRESENTATION WITH OSTEOMYELITIS. | Tauseef U, Anjum M, Ibrahim M, Baqai HS, Tauseef A, Tauseef M, Asghar MS, Zafar M, Rasheed U, Shaikh N | Rev Paul Pediatr | 2021 |
| Correlation of hepcidin and serum ferritin levels in thalassemia patients at Chiang Mai University Hospital. | Tantiworawit A, Khemakapasiddhi S, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Charoenkwan P, Srichairatanakool S, Fanhchaksai K | Biosci Rep | 2021 |
| Left ventricular deformation mechanics over time in patients with thalassemia major with and without iron overload. | Bonios MJ, Fountas E, Delaporta P, Kyrzopoulos S, Kattamis A, Adamopoulos SN, Tsiapras D | BMC Cardiovasc Disord | 2021 |
| Quality of life in Patients with β-thalassemia Major: Short-term and Long-term Effects after Haematopoietic Stem Cell Transplantation. | Zhai L, Liu Y, Huo R, Pan Z, Bin J, Li Z, Tang Q, Fan J | Curr Stem Cell Res Ther | 2021 |
| Sickle cell anemia/sickle cell disease and pregnancy outcomes among ethnic tribes in India: an integrative mini-review. | Ganesh B, Rajakumar T, Acharya SK, Kaur H | J Matern Fetal Neonatal Med | 2021 |
| Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report. | Kalter JA, Gupta R, Greenberg MR, Miller AJ, Allen J | Clin Pract Cases Emerg Med | 2021 |
| Allogeneic stem cell transplantation with omidubicel in sickle cell disease. | Parikh S, Brochstein JA, Galamidi E, Schwarzbach A, Kurtzberg J | Blood Adv | 2021 |
| Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions. | Waldis SJ, Uter S, Kavitsky D, Flickinger C, Vege S, Friedman DF, Westhoff CM, Chou ST | Blood Adv | 2021 |
| Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review. | Knight LMJ, King AA, Strouse JJ, Tanabe P | J Pediatr Hematol Oncol | 2021 |
| Psychometric Impact of Priapism on Lives of Adolescents and Adults With Sickle Cell Anemia: A Sequential Independent Mixed-Methods Design. | Idris IM, Bonnet K, Schlundt D, Abba A, Galadanci J, Burnett AL, DeBaun MR | J Pediatr Hematol Oncol | 2021 |
| Quality and Reliability of YouTube Videos on Sickle Cell Disease. | Om A, Mathew N, Nawaz A | J Pediatr Hematol Oncol | 2021 |
| Musculoskeletal imaging manifestations of beta-thalassemia. | Hajimoradi M, Haseli S, Abadi A, Chalian M | Skeletal Radiol | 2021 |
| Sickle cell disease-Under pressure. | Halabi CM, Hulbert ML | Pediatr Blood Cancer | 2021 |
| Genetics background of β-thalassemia (3.5 kb deletion) in Southern Thailand: Haplotype analysis using novel reverse dot blot hybridization. | Tepakhan W, Srewaradachpisal K, Kanjanaopas S, Jomoui W | Ann Hum Genet | 2021 |
| Usefulness of NGS for Diagnosis of Dominant Beta-Thalassemia and Unstable Hemoglobinopathies in Five Clinical Cases. | Rizzuto V, Koopmann TT, Blanco-Álvarez A, Tazón-Vega B, Idrizovic A, Díaz de Heredia C, Del Orbe R, Pampliega MV, Velasco P, Beneitez D, Santen GWE, Waisfisz Q, Elting M, Smiers FJW, de Pagter AJ, Kerkhoffs JH, Harteveld CL, Mañú-Pereira MDM | Front Physiol | 2021 |
| MRI detection of brain abnormality in sickle cell disease. | Stotesbury H, Kawadler JM, Saunders DE, Kirkham FJ | Expert Rev Hematol | 2021 |
| Efficient Clinical Counseling for Sickle Cell Disease. | Morrone KA, Manwani D, Cabana MD | J Natl Med Assoc | 2021 |
| Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India. | Jain M, Chakrabarti P, Dolai TK, Ghosh P, Mandal PK, Baul SN, De R | Blood Cells Mol Dis | 2021 |
| Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome. | Lai X, Liu L, Zhang Z, Shi L, Yang G, Wu M, Huang R, Liu R, Lai Y, Li Q | Bone Marrow Transplant | 2021 |
| Chronic osteo-articular changes in patients with sickle cell disease. | Ferreira TFA, Dos Santos APT, Leal AS, de Araújo Pereira G, Silva SS, Moraes-Souza H | Adv Rheumatol | 2021 |
| Evaluation of the Significance of Tear Ferning Patterns in beta-Thalassemia Patients. | Fagehi R, Abbadi IM, Abusharha A, Alanazi MA, Malhan H, El-Hiti GA, Masmali AM | Klin Monbl Augenheilkd | 2021 |
| Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore. | Lam JCM, Lee SY, Koh PL, Fong SZ, Abdul-Kadir NI, Lim CY, Zhang X, Bhattacharyya R, Soh SY, Chan MY, Tan AM, Kuperan P, Ang AL | Blood Cells Mol Dis | 2021 |
| Sickle cell disease in India: a scoping review from a health systems perspective to identify an agenda for research and action. | Raman V, Seshadri T, Joice SV, N Srinivas P | BMJ Glob Health | 2021 |
| Evaluation of the High Resolution Melting Approach for Detection of β-Thalassemia Gene Mutations. | Tariq A, Khurshid S, Sajjad M | Hemoglobin | 2021 |
| Voxelotor for the treatment of sickle cell disease. | Vissa M, Vichinsky E | Expert Rev Hematol | 2021 |
| Emotion regulation, pain interference and affective symptoms in children and adolescents with sickle cell disease. | Miller M, Balsamo L, Pashankar F, Bailey CS | J Affect Disord | 2021 |
| Integrative holistic approaches for children, adolescents, and young adults with sickle cell disease: A single center experience. | Mahmood LA, Thaniel L, Martin B, Marguiles S, Reece-Stremtan S, Idiokitas R, Bettini E, Hardy SJ, Cohen I, Connolly M, Darbari DS | Complement Ther Med | 2021 |
| MicroRNAs in β-thalassemia. | Wang F, Ling L, Yu D | Am J Med Sci | 2021 |
| Clinical presentations and outcomes of COVID-19 infection in sickle cell disease patients: Case series from Komfo Anokye teaching hospital, Ghana. | Hardy YO, Amenuke DAY, Abukari Y, Oti-Acheampong A, Hutton-Mensah K, Amoah-Dankwah J, Amoabeng Kontoh S, Danso KA, Berchie PO, Otu-Ansah C | Clin Case Rep | 2021 |
| mutations and HbA2 level: Escaping the carrier screening programs. | Sharifi A, Mahdieh N | Clin Case Rep | 2021 |
| Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentary. | Gyamfi J, Ojo T, Iwelunmor J, Ogedegbe G, Ryan N, Diawara A, Nnodu O, Wonkam A, Royal C, Peprah E | Global Health | 2021 |
| Characterisation of two unusual cases of haemoglobin Bart's hydrops foetalis caused by - and large novel α-globin gene cluster deletions. | Wang Y, Xiong Y, Liu C, Lu J, Wang J, Qin D, Liu L, Wu J, Zhao X, Fang L, Du L, Yin A | J Int Med Res | 2021 |
| Evidence-based interventions implemented in low-and middle-income countries for sickle cell disease management: A systematic review of randomized controlled trials. | Gyamfi J, Ojo T, Epou S, Diawara A, Dike L, Adenikinju D, Enechukwu S, Vieira D, Nnodu O, Ogedegbe G, Peprah E | PLoS One | 2021 |
| Patient Perspectives of Sickle Cell Management in the Emergency Department. | Crego N, Masese R, Bonnabeau E, Douglas C, Rains G, Shah N, Tanabe P | Crit Care Nurs Q | 2021 |
| Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo. | Kambale-Kombi P, Marini Djang'eing'a R, Alworong'a Opara JP, Minon JM, Boemer F, Bours V, Tonen-Wolyec S, Kayembe Tshilumba C, Batina-Agasa S | Hematology | 2021 |
| A Rare Case of Hb H Disease and Systemic Lupus Erythematosus. | Lin QY, Chen DY, Kong S, Liu WQ, Sun XF, Li DZ | Hemoglobin | 2021 |
| Prevalence and distribution of major β-thalassemia mutations and HbE/β-thalassemia variant in Nepalese ethnic groups. | Lama R, Yusof W, Shrestha TR, Hanafi S, Bhattarai M, Hassan R, Zilfalil BA | Hematol Oncol Stem Cell Ther | 2021 |
| CRISPR/Cas9-mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia. | Yang Y, Kang X, Hu S, Chen B, Xie Y, Song B, Zhang Q, Wu H, Ou Z, Xian Y, Fan Y, Li X, Lai L, Sun X | J Biol Chem | 2021 |
| Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells. | Pavani G, Fabiano A, Laurent M, Amor F, Cantelli E, Chalumeau A, Maule G, Tachtsidi A, Concordet JP, Cereseto A, Mavilio F, Ferrari G, Miccio A, Amendola M | Blood Adv | 2021 |
| Ineffective erythropoiesis in sickle cell disease: new insights and future implications. | El Nemer W, Godard A, El Hoss S | Curr Opin Hematol | 2021 |
| Heterogeneity of fetal hemoglobin production in adult red blood cells. | Khandros E, Blobel GA | Curr Opin Hematol | 2021 |
| A Unique Monocyte Transcriptome Discriminates Sickle Cell Disease From Other Hereditary Hemolytic Anemias and Shows the Particular Importance of Lipid and Interferon Signaling. | van Vuren AJ, van Straaten S, Mokry M, van Wijk R, van Beers EJ | Hemasphere | 2021 |
| Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 months. | Duniva Inusa BP, Inati A, Maes P, Githanga J, Ogutu B, Abboud MR, Miano M, Cela E, Nduba V, Niazi M, Åstrand M, Persson K, Berggren A, Carlson G | Pediatr Blood Cancer | 2021 |
| Oxidative stress, inflammation, blood rheology, and microcirculation in adults with sickle cell disease: Effects of hydroxyurea treatment and impact of sickle cell syndrome. | Connes P, Möckesch B, Tudor Ngo Sock E, Hardy-Dessources MD, Reminy K, Skinner S, Billaud M, Nader E, Tressieres B, Etienne-Julan M, Guillot N, Lemonne N, Hue O, Romana M, Antoine-Jonville S | Eur J Haematol | 2021 |
| Varied Age of First Presentation of Sickle Cell Disease: Case Presentations and Review. | Claeys A, Van Steijn S, Van Kesteren L, Damen E, Van Den Akker M | Case Rep Med | 2021 |
| Efficacy and Tolerance of Vascular Electrical Stimulation Therapy in the Management of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: A Phase II Single-Centre Randomized Study in Ivory Coast. | Botti RP, Bokoum SS, L'Hermite E, Silue DA, Kouakou B, Bognini SA, Agoua SA, Mandeng Ma Linwa E, Ayemou R, Koffi KG | Adv Hematol | 2021 |
| Erythrocytes 3D genome organization in vertebrates. | Ryzhkova A, Taskina A, Khabarova A, Fishman V, Battulin N | Sci Rep | 2021 |
| Chronic organ injuries in children with sickle cell disease. | Allali S, Taylor M, Brice J, Montalembert M | Haematologica | 2021 |
| Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. | Kanter J, Phillips S, Schlenz AM, Mueller M, Dooley M, Sirline L, Nickel R, Brown RC, Hilliard L, Melvin CL, Adams RJ | J Pediatr Hematol Oncol | 2021 |
| Cognitive Functioning and Educational Support Plans in Youth With Sickle Cell Disease. | Connolly ME, Bills SE, Hardy SJ | J Pediatr Hematol Oncol | 2021 |
| First Observation of HbM-Saskatoon at the Origin of Neonatal Cyanosis in a Tunisian Baby. | Bouatrous E, Nouira S, Ben Khaled M, Ouederni M, Abbes S, Menif S, Ouragini H | J Pediatr Hematol Oncol | 2021 |
| Erythropoietin Concentration in Boys With p.His63Asp Polymorphism of the HFE Gene. | Kaczorowska-Hac B, Luszczyk M, Wasilewska E, Antosiewicz J, Kaczor JJ | J Pediatr Hematol Oncol | 2021 |
| Association of Anemia and Blood Pressure With Novel Markers of Diastolic Function in Pediatric Sickle Cell Disease. | Jhaveri S, Choueiter N, Manwani D, Ranabothu S, Morrone K, Hafeman M, Reidy K, Kaskel F, Mahgerefteh J | J Pediatr Hematol Oncol | 2021 |
| Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice. | Taylor CM, Kasztan M, Sedaka R, Molina PA, Dunaway LS, Pollock JS, Pollock DM | Am J Physiol Regul Integr Comp Physiol | 2021 |
| Re 'Liver transplantation for sickle cell disease: a systematic' Feli et al. | Azoulay D, Habibi A, Galacteros F, Bartolucci P, Feray C | HPB (Oxford) | 2021 |
| Determinants of the Outcome of the Transition of Children with Sickle Cell Disease to Adult Programs. | Ballas SK, Riddick-Burden G, Congdon-Martin E | Hemoglobin | 2021 |
| Hb S (: c.20A>T) Characteristics by High Performance Liquid Chromatography in Patients with Sickle Cell Disease Receiving the Novel Agent Voxelotor. | Tsitsikas DA, Kamal M, Braimoh A, Benson S, Abukar J | Hemoglobin | 2021 |
| In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice. | Li C, Georgakopoulou A, Mishra A, Gil S, Hawkins RD, Yannaki E, Lieber A | Blood Adv | 2021 |
| Major Thalassemia, Screening or Treatment: An Economic Evaluation Study in Iran. | Esmaeilzadeh F, Ahmadi B, Vahedi S, Barzegari S, Rajabi A | Int J Health Policy Manag | 2021 |
| Assertiveness in the patients with thalassaemia major: A qualitative study. | Valizadeh L, Zamanzadeh V, Ghahramanian A, Hasani Narenjbaghi S | Nurs Open | 2021 |
| P-selectin deficiency promotes liver senescence in sickle cell disease mice. | Vats R, Kaminski TW, Ju EM, Brozska T, Tutuncuoglu E, Tejero J, Novelli EM, Sundd P, Pradhan-Sundd T | Blood | 2021 |
| The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial. | Abdel Monem MS, Farid SF, Abbassi MM, Youssry I, Andraues NG, Hassany M, Selim YMM, El-Sayed MH | Int J Clin Pract | 2021 |
| Characteristics of sickle cell patients with frequent emergency department visits and hospitalizations. | Kidwell K, Albo C, Pope M, Bowman L, Xu H, Wells L, Barrett N, Patel N, Allison A, Kutlar A | PLoS One | 2021 |
| Adherence to hydroxyurea, health-related quality of life domains and attitudes towards a smartphone app among Irish adolescents and young adults with sickle cell disease. | Fogarty H, Gaul A, Syed S, Aleksejenko N, Geoghegan R, Conroy H, Crampton E, Ngwenya N, Tuohy E, McMahon C | Ir J Med Sci | 2021 |
| Long noncoding RNA HBBP1 enhances γ-globin expression through the ETS transcription factor ELK1. | Ma SP, Xi HR, Gao XX, Yang JM, Kurita R, Nakamura Y, Song XM, Chen HY, Lu DR | Biochem Biophys Res Commun | 2021 |
| Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease. | Pace BS, Perrine S, Li B, Makala L, Xu H, Takezaki M, Wolf RF, Wang A, Xu X, Huang J, Alimardanov A, Tawa GJ, Sangerman J, Faller A, Zheng W, Toney L, Haugabook SJ | Blood Cells Mol Dis | 2021 |
| A pause in gene therapy: Reflecting on the unique challenges of sickle cell disease. | Leonard A, Tisdale JF | Mol Ther | 2021 |
| The Crisis of Sickle Cell Disease in Africa from Insights into Primary Prevention in Ghana and Nigeria: Notes from the Field. | Ezenwa MO, Dennis-Antwi JA, Dallas CM, Amarachukwu C, Ezema CI, Yao Y, Gallo AM, Wilkie DJ | J Immigr Minor Health | 2021 |
| The comfort ability program for adolescents with sickle cell pain: Evaluating feasibility and acceptability of an inpatient group-based clinical implementation. | Sil S, Lee JL, Klosky J, Vaz A, Mee L, Cochran S, Thompson B, Coakley R | Pediatr Blood Cancer | 2021 |
| Implementation of near-universal hydroxyurea uptake among children with sickle cell anemia: A single-center experience. | Karkoska K, Todd K, Niss O, Clapp K, Fenchel L, Kalfa TA, Malik P, Quinn CT, Ware RE, McGann PT | Pediatr Blood Cancer | 2021 |
| Sickle cell disease and ventricular myocardial strain: A systematic review. | Whipple NS, Joshi VM, Naik RJ, Mentnech T, McFarland MM, Nolan VG, Hankins JS | Pediatr Blood Cancer | 2021 |
| Red blood cell mannoses as phagocytic ligands mediating both sickle cell anaemia and malaria resistance. | Cao H, Antonopoulos A, Henderson S, Wassall H, Brewin J, Masson A, Shepherd J, Konieczny G, Patel B, Williams ML, Davie A, Forrester MA, Hall L, Minter B, Tampakis D, Moss M, Lennon C, Pickford W, Erwig L, Robertson B, Dell A, Brown GD, Wilson HM, Rees DC, Haslam SM, Alexandra Rowe J, Barker RN, Vickers MA | Nat Commun | 2021 |
| Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia. | Alkindi S, Elsadek RA, Al-Madhani A, Al-Musalhi M, AlKindi SY, Al-Khadouri G, Al Rawahi B, Al-Ruqeishi S, Al-Yazeedi J, Wali YA, Al Shamakhi S, Al Rawahi M, Pathare AV | Int J Infect Dis | 2021 |
| Novel retinal findings in β-thalassemia major: older age and higher ferritin level as the risk factors. | Kurnia KH, Elvioza , Sidik M, Sari TT, Prihartono J, Sitorus RS | Graefes Arch Clin Exp Ophthalmol | 2021 |
| Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells. | Cromer MK, Camarena J, Martin RM, Lesch BJ, Vakulskas CA, Bode NM, Kurgan G, Collingwood MA, Rettig GR, Behlke MA, Lemgart VT, Zhang Y, Goyal A, Zhao F, Ponce E, Srifa W, Bak RO, Uchida N, Majeti R, Sheehan VA, Tisdale JF, Dever DP, Porteus MH | Nat Med | 2021 |
| The value of the red cell distribution width index versus other parameters in the differentiation between iron deficiency anemia and beta thalassemia trait among children in Mosul, Iraq. | Al-Numan AH, Al-Obeidi RA | Expert Rev Hematol | 2021 |
| Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia. | Bao X, Zhang X, Wang L, Wang Z, Huang J, Zhang Q, Ye Y, Liu Y, Chen D, Zuo Y, Liu Q, Xu P, Huang B, Fang J, Lao J, Feng X, Li Y, Kurita R, Nakamura Y, Yu W, Ju C, Huang C, Mohandas N, Li D, Zhao C, Xu X | Am J Hum Genet | 2021 |
| Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study. | Gerardin M, Rousselet M, Couec ML, Masseau A, Guerlais M, Authier N, Deheul S, Roussin A, Micallef J, Djezzar S, , Feuillet F, Jolliet P, Victorri-Vigneau C | PLoS One | 2021 |
| Clinical Guideline Highlights for the Hospitalist: Management of Acute and Chronic Pain in Sickle Cell Disease. | Pham CD, Hua DT | J Hosp Med | 2021 |
| Molecular and Hematological Analysis of Alpha- and Beta-Thalassemia in a Cohort of Mexican Patients. | Rizo-de la Torre LDC, Rentería-López VM, Sánchez-López JY, Magaña-Torres MT, Ibarra-Cortés B, Perea-Díaz FJ | Genet Test Mol Biomarkers | 2021 |
| Characterization and identification of Prachinburi β -thalassemia: A novel-60 kb deletion in beta globin gene related to high levels of Hb F in heterozygous state. | Jomoui W, Tepakhan W | Int J Lab Hematol | 2021 |
| Relation of Serum Ferritin Level with Serum Hepcidin and Fucose Levels in Children with β-Thalassemia Major. | Al-Zuhairy SH, Darweesh MA, Othman MA | Hemoglobin | 2021 |
| Iatrogenic arteriovenous fistula in patient with sickle cell disease undergoing red blood cell exchange. | Guarente J, Palladino M, Babariya S, Hayes C, Blumhof B, Peedin AR, Karp JK | Transfusion | 2021 |
| Author Correction: Transcription factor competition at the γ-globin promoters controls hemoglobin switching. | Liu N, Xu S, Yao Q, Zhu Q, Kai Y, Hsu JY, Sakon P, Pinello L, Yuan GC, Bauer DE, Orkin SH | Nat Genet | 2021 |
| Gross and radiographic appearance of porotic hyperostosis and cribra orbitalia in thalassemia affected skulls. | Chaichun A, Yurasakpong L, Suwannakhan A, Iamsaard S, Arun S, Chaiyamoon A | Anat Cell Biol | 2021 |
| Nutritional perspectives on sickle cell disease in Africa: a systematic review. | Nartey EB, Spector J, Adu-Afarwuah S, Jones CL, Jackson A, Ohemeng A, Shah R, Koryo-Dabrah A, Kuma AB, Hyacinth HI, Steiner-Asiedu M | BMC Nutr | 2021 |
| Silent cerebral infarcts in sickle cell disease: Really silent? | Garnier-Crussard A, Cotton F, Desestret V, Krolak-Salmon P, Fort R | J Neuroradiol | 2021 |
| WALANT and sickle cell disease: A cautionary tale. | Thakkar M, Bednarz B | J Plast Reconstr Aesthet Surg | 2021 |
| Insight of fetal to adult hemoglobin switch: Genetic modulators and therapeutic targets. | Hariharan P, Nadkarni A | Blood Rev | 2021 |
| Effects of a positive thinking program on hope and sleep quality in Iranian patients with thalassemia: a randomized clinical trial. | Makaremnia S, Dehghan Manshadi M, Khademian Z | BMC Psychol | 2021 |
| Psychosocial risk factors for increased emergency hospital utilization by sickle cell disease patients: a systematic review protocol. | Rech JS, Getten P, Dzierzynski N, Lionnet F, Boëlle PY, Ranque B, Steichen O | JBI Evid Synth | 2021 |
| Mitochondrial reactive oxygen species scavenging attenuates thrombus formation in a murine model of sickle cell disease. | Annarapu G, Nolfi-Donegan D, Reynolds M, Wang Y, Shiva S | J Thromb Haemost | 2021 |
| Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. | Rankine-Mullings AE, Owusu-Ofori S | Cochrane Database Syst Rev | 2021 |
| Assessment of cystatin C in pediatric sickle cell disease and β-thalassemia as a marker of subclinical cardiovascular dysfunction: a case-control study. | Hanna D, Beshir M, Khalifa N, Baz E, Elhewala A | Pediatr Hematol Oncol | 2021 |
| Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias. | Vinchi F, Sparla R, Passos ST, Sharma R, Vance SZ, Zreid HS, Juaidi H, Manwani D, Yazdanbakhsh K, Nandi V, Silva AMN, Agarvas AR, Fibach E, Belcher JD, Vercellotti GM, Ghoti H, Muckenthaler MU | Br J Haematol | 2021 |
| Pain-Related Injustice Appraisals in Youth with Sickle Cell Disease: A Preliminary Investigation. | Miller MM, Rumble DD, Hirsh AT, Vervoort T, Crosby LE, Madan-Swain A, Lebensburger J, Hood AM, Trost Z | Pain Med | 2021 |
| Professionally responsible management of the ethical and social challenges of antenatal screening and diagnosis of β-thalassemia in a high-risk population. | Corda V, Murgia F, Dessolis F, Murru S, Chervenak FA, McCullough LB, Monni G | J Perinat Med | 2021 |
| Pseudothrombocytosis in a Case of Beta-thalassaemia Intermedia Masquerading as Myeloproliferative Neoplasm. | Purohit AHL, Bharti S, Kumar D, Bohra GK, Khichar S | Curr Med Imaging | 2021 |
| Calibration of T oximetry MRI for subjects with sickle cell disease. | Bush A, Vu C, Choi S, Borzage M, Miao X, Li W, Qin Q, Nederveen AJ, Coates TD, Wood JC | Magn Reson Med | 2021 |
| Cardiac pathophysiology in sickle cell disease. | Gbotosho OT, Taylor M, Malik P | J Thromb Thrombolysis | 2021 |
| The Impact of Environmental Factors on Monogenic Mendelian Diseases. | Tukker AM, Royal CD, Bowman AB, McAllister KA | Toxicol Sci | 2021 |
| Oxidative status in the β-thalassemia syndromes in Sri Lanka; a cross-sectional survey. | Allen A, Perera S, Mettananda S, Rodrigo R, Perera L, Darshana T, Moggach F, Jackson Crawford A, Heirene L, Fisher C, Olivieri N, Rees D, Premawardhena A, Allen S | Free Radic Biol Med | 2021 |
| Anti-sickling activities of two isolated compounds from the root of Combretum racemosum P. beauv. (Combretaceae). | Famojuro TI, Adeyemi AA, Ajayi TO, Fasola FA, Fukushi Y, Omotade OO, Moody JO | J Ethnopharmacol | 2021 |
| Hb Maruchi [α165 (E14) Ala>Pro; HBA1: c.196G>C]: A new thalassemia hemoglobinopathy related to the alpha1 globin gene. | Ropero P, M Nieto J, González Fernández FA, Villegas A, Benavente C | Clin Biochem | 2021 |
| Pituitary Volume and Iron Overload Evaluation by 3T MRI in Thalassemia. | Nayak AM, Choudhari A, Patkar DP, Merchant RH | Indian J Pediatr | 2021 |
| Pain Experiences of Adults With Sickle Cell Disease and Hematopoietic Stem Cell Transplantation: A Qualitative Study. | Abu Al Hamayel N, Waldfogel JM, Hannum SM, Brodsky RA, Bolaños-Meade J, Gamper CJ, Jones RJ, Dy SM | Pain Med | 2021 |
| Nephrotic syndrome on sickle cell disease: the impact of Hydroxyurea. | Cunha M, Simão C, Ferrão A, Palaré MJ | BMJ Case Rep | 2021 |
| Lysophosphatidic Acid-Activated Calcium Signaling Is Elevated in Red Cells from Sickle Cell Disease Patients. | Wang J, Hertz L, Ruppenthal S, El Nemer W, Connes P, Goede JS, Bogdanova A, Birnbaumer L, Kaestner L | Cells | 2021 |
| Automated Red Cell Exchange in the Management of Sickle Cell Disease. | Tsitsikas DA, Badle S, Hall R, Meenan J, Bello-Sanyaolu O, Orebayo F, Abukar J, Elmi M, Mulla A, Dave S, Lewis N, Sharma M, Chatterjee B, Amos RJ | J Clin Med | 2021 |
| and Its Virulence Factors HO and Pneumolysin Are Potent Mediators of the Acute Chest Syndrome in Sickle Cell Disease. | Gonzales J, Chakraborty T, Romero M, Mraheil MA, Kutlar A, Pace B, Lucas R | Toxins (Basel) | 2021 |
| Sickle Cell Disease: Role of Oxidative Stress and Antioxidant Therapy. | Vona R, Sposi NM, Mattia L, Gambardella L, Straface E, Pietraforte D | Antioxidants (Basel) | 2021 |
| Variability of Prognostic Results Based on Biological Parameters in Sickle Cell Disease Cohort Studies in Children: What Should Clinicians Know? | Sommet J, Roux EL, Koehl B, Haouari Z, Mohamed D, Baruchel A, Benkerrou M, Alberti C | Children (Basel) | 2021 |
| Mechanisms of Bone Impairment in Sickle Bone Disease. | Giordano P, Urbano F, Lassandro G, Faienza MF | Int J Environ Res Public Health | 2021 |
| Characterization and statistical modeling of glycosylation changes in sickle cell disease. | Ashwood HE, Ashwood C, Schmidt AP, Gundry RL, Hoffmeister KM, Anani WQ | Blood Adv | 2021 |
| Methylenetetrahydrofolate reductase polymorphisms as genetic markers to predict homocysteinemia and clinical severity in sickle cell disease. | Patel S, Nanda R, Hussain N, Mohapatra E, Patra PK | Biomark Med | 2021 |
| Persistence of CRISPR/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta-analysis of preclinical studies. | Maganti HB, Bailey AJM, Kirkham AM, Shorr R, Pineault N, Allan DS | Stem Cells Transl Med | 2021 |
| Determinants of Care-Seeking Practices for Children with Sickle Cell Disease in Ekiti, Southwest Nigeria. | Olatunya OS, Babatola AO, Adeniyi AT, Lawal OA, Daramola AO, Agbesanwa TA, Olumuyiwa Ojo T, Ajayi PO, Ibijola AA, Komolafe AK, Adekile A | J Blood Med | 2021 |
| Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model. | Nilsri N, Jangprasert P, Pawinwongchai J, Israsena N, Rojnuckarin P | Sci Rep | 2021 |
| Hyperhemolysis Syndrome in a Patient With Sickle Cell Disease and Acute Chest Syndrome. | Shankar K, Shah D, Huffman DL, Peterson C, Bhagavatula R | Cureus | 2021 |
| Luspatercept: A Gigantic Step in the Treatment of Transfusion-Dependent β-Thalassemia Patients-a Quick Review. | Darvishi-Khezri H, Karami H | Adv Ther | 2021 |
| MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease. | Demers M, Sturtevant S, Guertin KR, Gupta D, Desai K, Vieira BF, Li W, Hicks A, Ismail A, Gonçalves BP, Di Caprio G, Schonbrun E, Hansen S, Musayev FN, Safo MK, Wood DK, Higgins JM, Light DR | Blood Adv | 2021 |
| Sickle cell disease, interleukin-18, and arrhythmias. | Zhabyeyev P, Oudit GY | Blood | 2021 |
| Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease. | Tumburu L, Ghosh-Choudhary S, Seifuddin FT, Barbu EA, Yang S, Ahmad MM, Wilkins LHW, Tunc I, Sivakumar I, Nichols JS, Dagur PK, Yang S, Almeida LEF, Quezado ZMN, Combs CA, Lindberg E, Bleck CKE, Zhu J, Shet AS, Chung JH, Pirooznia M, Thein SL | Blood | 2021 |
| Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let's Clear Up That Case With Some Controls. | Remy A, Théorêt Y, Ansari M, Bittencourt H, Ducruet T, Nava T, Pastore Y, Rezgui MA, Krajinovic M, Kleiber N | J Pediatr Hematol Oncol | 2021 |
| A pilot study of the effect of rivaroxaban in sickle cell anemia. | Ataga KI, Elsherif L, Wichlan D, Wogu AF, Matsui N, Pawlinski R, Cai J, Key NS | Transfusion | 2021 |
| Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study. | Jansing T, Sanpakit K, Tharnpanich T, Jiranantakan T, Niphandwongkorn V, Chindavijak B, Suansanae T | Pediatr Hematol Oncol | 2021 |
| Prevalence and association of malaria with ABO blood group and hemoglobin level in individuals visiting Mekaneeyesus Primary Hospital, Estie District, northwest Ethiopia: a cross-sectional study. | Tazebew B, Munshea A, Nibret E | Parasitol Res | 2021 |
| Perspectives on Building Sustainable Newborn Screening Programs for Sickle Cell Disease: Experience from Tanzania. | Bukini D, Nkya S, McCurdy S, Mbekenga C, Manji K, Parker M, Makani J | Int J Neonatal Screen | 2021 |
| A rare complex rearrangement in the β-globin gene cluster causing a novel homozygous γ( γδβ) -thalassemia. | Zhang X, Yang Y, Zhang H, Du Z, Liu H, Shen Y | Am J Hematol | 2021 |
| American Society of Hematology 2020 Podcast Collection: Sickle Cell Anaemia. | Russo G, Colombatti R | Adv Ther | 2021 |
| Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients. | Tamagne M, Pakdaman S, Bartolucci P, Habibi A, Galactéros F, Pirenne F, Vingert B | Blood Adv | 2021 |
| Long-term tolerability of phosphodiesterase-5 inhibitors in pulmonary hypertension of sickle cell disease. | Cramer-Bour C, Ruhl AP, Nouraie SM, Emeh RO, Ruopp NF, Thein SL, Weir NA, Klings ES | Eur J Haematol | 2021 |
| Transcription factor competition at the γ-globin promoters controls hemoglobin switching. | Liu N, Xu S, Yao Q, Zhu Q, Kai Y, Hsu JY, Sakon P, Pinello L, Yuan GC, Bauer DE, Orkin SH | Nat Genet | 2021 |
| Maternal and perinatal outcomes in pregnant women with sickle cell disease: an update. | Sousa VT, Ballas SK, Leite JM, Olivato MCA, Cancado RD | Hematol Transfus Cell Ther | 2021 |
| Primary Immunization Series Coverage of Children With Sickle Cell Disease. | Peng HK, Dombkowski KJ, Freed GL, Creary SE, Smith D, Reeves SL | Am J Prev Med | 2021 |
| Netrin-1 and clusterin: Innovative potential diagnostic biomarkers for early renal damage in β-thalassemia major children. | Abd El-Khalik SR, Sharaby RM, Nasif E, Hamza MB, Ibrahim RR | IUBMB Life | 2021 |
| Sickle cell nephropathy. Clinical manifestations and new mechanisms involved in kidney injury. | Payán-Pernía S, Ruiz Llobet A, Remacha Sevilla ÁF, Egido J, Ballarín Castán JA, Moreno JA | Nefrologia | 2021 |
| Intravenous Acetaminophen vs Intravenous Diclofenac Sodium in Management of Skeletal Vaso-occlusive Crisis Among Children with Homozygous Sickle Cell Disease: A Randomized Controlled Trial. | Panda PC, Mishra NR, Patra CS, Nayak BK, Panda SK | Indian Pediatr | 2021 |
| Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals' views. | Houwing ME, Buddenbaum M, Verheul TCJ, de Pagter APJ, Philipsen JNJ, Hazelzet JA, Cnossen MH | BMC Health Serv Res | 2021 |
| Pain in sickle cell disease: current and potential translational therapies. | Sagi V, Mittal A, Tran H, Gupta K | Transl Res | 2021 |
| A Pragmatic Scoring Tool to Predict Hydroxyurea Response Among β-Thalassemia Major Patients in Pakistan. | Ansari SH, Hussain Z, Zohaib M, Parveen S, Kaleem B, Qamar H, Adil O, Khan MT, Shamsi TS | J Pediatr Hematol Oncol | 2021 |
| Bone marrow necrosis and fat embolism syndrome in sickle cell disease: A rapidly deteriorating complication. | Barouqa M, Szymanski J, Nelson R, Jofre S, Paroder M | Transfusion | 2021 |
| Noninvasive prenatal testing for β-thalassemia by targeted nanopore sequencing combined with relative haplotype dosage (RHDO): a feasibility study. | Jiang F, Liu W, Zhang L, Guo Y, Chen M, Zeng X, Wang Y, Li Y, Xian J, Du B, Xie Y, Ouyang S, Li S, Yang Y, Zhang C, Luo F, Sun X | Sci Rep | 2021 |
| Forager and farmer evolutionary adaptations to malaria evidenced by 7000 years of thalassemia in Southeast Asia. | Vlok M, Buckley HR, Miszkiewicz JJ, Walker MM, Domett K, Willis A, Trinh HH, Minh TT, Nguyen MHT, Nguyen LC, Matsumura H, Wang T, Nghia HT, Oxenham MF | Sci Rep | 2021 |
| Hydroxyurea Use Associated with Nonverbal and Executive Skills in Sickle Cell Anemia. | Tarazi RA, Patrick KE, Iampietro M, Apollonsky N | J Pediatr Psychol | 2021 |
| Can subjective pain be inferred from objective physiological data? Evidence from patients with sickle cell disease. | Panaggio MJ, Abrams DM, Yang F, Banerjee T, Shah NR | PLoS Comput Biol | 2021 |
| Regarding chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation. | Janowiak-Majeranowska A, Majeranowski A | Int J Hematol | 2021 |
| Implementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell Disease. | Welch-Coltrane JL, Wachnik AA, Adams MCB, Avants CR, Blumstein HA, Brooks AK, Farland AM, Johnson JB, Pariyadath M, Summers EC, Hurley RW | Pain Med | 2021 |
| Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy. | Rab MAE, Bos J, van Oirschot BA, van Straaten S, Kosinski PA, Chubukov V, Kim H, Mangus H, Schutgens REG, Pasterkamp G, Dang L, Kung C, van Beers EJ, van Wijk R | Blood | 2021 |
| PIEZO1 and the mechanism of the long circulatory longevity of human red blood cells. | Rogers S, Lew VL | PLoS Comput Biol | 2021 |
| Allele-Specific Recombinase Polymerase Amplification to Detect Sickle Cell Disease in Low-Resource Settings. | Natoli ME, Chang MM, Kundrod KA, Coole JB, Airewele GE, Tubman VN, Richards-Kortum RR | Anal Chem | 2021 |
| Compound Heterozygote Hemoglobin Lepore-Baltimore Haplotype with β-Thalassemia. | Dixit S, Das H, Bal M, Khuntia HK, Ranjit M | Indian J Pediatr | 2021 |
| A Novel Frameshift Mutation, Deletion of HBB:c.199_202delAAAG [Codon 66/67 (-AAAG)] in β-Thalassemia Major Patients from the Western Region of Uttar Pradesh, India. | Chauhan W, Afzal M, Zaka-Ur-Rab Z, Noorani MS | Appl Clin Genet | 2021 |
| Severe Acute Chest Syndrome in a Sickle Cell Patient That Required Repeated Exchange Transfusion. | Saleh M, Asemota J | Cureus | 2021 |
| A novel deletion of the major regulatory element flanking the α-globin gene cluster as a cause of α -thalassemia. | Jiang F, Xu LL, Tang XW, Li DZ | Int J Lab Hematol | 2021 |
| The impact of vaso-occlusive crises and disease severity on quality of life and productivity among patients with sickle cell disease in the US. | Shafrin J, Thom HHZ, Keeney E, Gaunt DM, Zhao LM, Bhor M, Rizio AA, Bronté-Hall L, Shah N | Curr Med Res Opin | 2021 |
| Association between left ventricular strain and cardiac iron load in beta-thalassaemia major: a cardiac magnetic resonance study. | Alis D, Asmakutlu O, Topel C, Sahin AA, Karaarslan E | Acta Cardiol | 2021 |
| Pregnancy outcome in homozygous sickle cell disease: observations from the Jamaican Birth Cohort. | Lewis G, Thame M, Howitt C, Hambleton I, Serjeant GR | BJOG | 2021 |
| Sickle Hepatopathy. | Praharaj DL, Anand AC | J Clin Exp Hepatol | 2021 |
| Hydroxyurea Adherence Strategies for Persons with Sickle Cell Disease: A Systematic Review. | Vick L, Potts M, Jaskowiak M, Gibson RW | J Health Care Poor Underserved | 2021 |
| An extensive review to facilitate understanding of CRISPR technology as a gene editing possibility for enhanced therapeutic applications. | Rautela I, Uniyal P, Thapliyal P, Chauhan N, Bhushan Sinha V, Dev Sharma M | Gene | 2021 |
| Sickle Cell Disease Literature. | Alves Dos Santos MP, Limia R, Tavares Pereira Ferreira DM, Cervantes Dias KH | J Am Dent Assoc | 2021 |
| Mild α-Thalassemia Caused by a Mosaic α-Globin Gene Mutation. | Wang RY, Jiang F, Xu LL, Li DZ | Hemoglobin | 2021 |
| Dual-energy CT evidence of pulmonary microvascular occlusion in patients with sickle cell disease experiencing acute chest syndrome. | Dako F, Hossain R, Jeudy J, White C | Clin Imaging | 2021 |
| Gene Therapies for Transfusion-Dependent b-Thalassemia. | Soni S | Indian Pediatr | 2021 |
| Pubertal Development and its Determinants in Adolescents With Transfusion-Dependent Thalassemia. | Singh P, Samaddar S, Parakh N, Chandra J, Seth A | Indian Pediatr | 2021 |
| Vitamin C Deficiency and Oxidant Levels in Children With Transfusion-Dependent b-Thalassemia. | Bhat KV, Sharma RA, Sharma SM, Joshi P, Dias BF, Shah N, Setia M, Manglani MV | Indian Pediatr | 2021 |
| Correlation of dynamic membrane fluctuations in red blood cells with diabetes mellitus and cardiovascular risks. | Sohn M, Lee JE, Ahn M, Park Y, Lim S | Sci Rep | 2021 |
| Spontaneous osteonecrosis of the jaw in a β-Thalassemia intermedia patient. | Shi HA, Teo GN, Qiqi L, Tan BPD | J Stomatol Oral Maxillofac Surg | 2021 |
| Pulmonary thromboendarterectomy for pulmonary hypertension linked to thalassemia. | Izzat MB, Aljasem H, Izzat AW | Clin Case Rep | 2021 |
| COVID-19 pneumonia in a pediatric sickle cell patient requiring red blood cell exchange. | Walker SC, Murphy ML, Hendricks H, Dulek DE, Volanakis EJ, Borinstein SC | Clin Case Rep | 2021 |
| Hydroxyurea Use Among Children With Sickle Cell Disease at King Abdulaziz University Hospital in Jeddah City. | Alzahrani F, Albaz GF, AlSinan F, Alzuhayri J, Barnawi ZM, Melebari N, Al Twairgi TM | Cureus | 2021 |
| β-Hemoglobinopathies lead the way. | Saunthararajah Y | Blood | 2021 |
| Memory CD8 T cell compartment associated with delayed onset of infection and better parasite control in sickle-cell trait children. | Loiseau C, Traore B, Ongoiba A, Kayentao K, Doumbo S, Doumtabe D, de Sousa KP, Brady JL, Proietti C, Crompton PD, Doolan DL | Clin Transl Immunology | 2021 |
| Agonistic Anti-CD40 Antibody Triggers an Acute Liver Crisis With Systemic Inflammation in Humanized Sickle Cell Disease Mice. | Yalamanoglu A, Dubach IL, Schulthess N, Ingoglia G, Swindle DC, Humar R, Schaer DJ, Buehler PW, Irwin DC, Vallelian F | Front Immunol | 2021 |
| Opioids are not a major cause of death of patients with sickle cell disease. | Ballas SK | Ann Hematol | 2021 |
| Commentary: Extramedullary hematopoiesis in the facial sinus, is it the time to search actively for it in some patients with thalassemia intermedia? | Ricchi P | Eur Rev Med Pharmacol Sci | 2021 |
| Deficient mitophagy pathways in sickle cell disease. | Martino S, Arlet JB, Odièvre MH, Jullien V, Moras M, Hattab C, Lefebvre T, Gouya L, Ostuni MA, Lefevre SD, Le Van Kim C | Br J Haematol | 2021 |
| [Transfusions in pediatric care - common situations]. | Deschmann E, Andersson A, Frisk T, Magnusson M | Lakartidningen | 2021 |
| A Cross-Sectional Study of Detection of Beta Globin (HBB) Haplotypes Among Beta Thalassemia Patients. | Alsamiri A, Alzahrani F, Filimban N, Khojah A, Felimban R, Qadah T | Cureus | 2021 |
| Free Tissue Transfer in a Patient With Hemoglobin S-Beta-Thalassemia Disease and Mandibular Osteomyelitis. | Chang K, Bollig C, Sclaroff A, Pipkorn P | Otolaryngol Head Neck Surg | 2021 |
| Kneeling Was the First Step for Sickle Cell Disease. | Desai P, Little J, Kanter J, Bridges K, Andemariam B, Lanzkron S | Ann Intern Med | 2021 |
| A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective. | DeMartino P, Haag MB, Hersh AR, Caughey AB, Roth JA | JAMA Pediatr | 2021 |
| Gene Therapy for Sickle Cell Disease-A Debt to Be Paid. | Ozuah PO | JAMA Pediatr | 2021 |
| Safety and efficacy of deferasirox in patients with transfusion-dependent thalassemia: A 4-year single-center experience. | Zengin Ersoy G, Ayçiçek A, Odaman Al I, Bayram C, Arslantaş E, Özdemir GN, Uysalol EP, Şalcıoğlu Z, Akıcı F, Aydoğan G | Pediatr Hematol Oncol | 2021 |
| Association between carriers of the G allele of the + 45T> G variant of the ADIPOQ gene () and the cardiometabolic profile in sickle cell trait. | Bruno JB, Dal Ponte ES, Retamoso V, Maurer P, Berro LF, Manfredini V, da Costa Escobar Piccoli J | Heliyon | 2021 |
| Impact of oral -arginine supplementation on blood pressure dynamics in children with severe sickle cell vaso-occlusive crisis. | Onalo R, Cilliers A, Cooper P | Am J Cardiovasc Dis | 2021 |
| Evaluation of iron overload by cardiac and liver T2* in β-thalassemia: Correlation with serum ferritin, heart function and liver enzymes. | Khadivi Heris H, Nejati B, Rezazadeh K, Sate H, Dolatkhah R, Ghoreishi Z, Esfahani A | J Cardiovasc Thorac Res | 2021 |
| Pathophysiological Relevance of Renal Medullary Conditions on the Behaviour of Red Cells From Patients With Sickle Cell Anaemia. | Lu DC, Wadud R, Hannemann A, Rees DC, Brewin JN, Gibson JS | Front Physiol | 2021 |
| [Progress in Gene Therapy of Sickle Cell Disease Based on Hemoglobin F--Review]. | Liang H, Wang YX, Li XY, Wang YQ, Su Y | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Analysis of Gene Mutation Types in 141 Cases of α-Thalassemia in Honghe Prefecture, Yunnan Province]. | Zhao HY, Ye X, Wang HX, He YF | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| The effect of endothelial Nitric Oxide Synthase G894T and T786C polymorphisms on Hypoxia-Inducible Factor-1 alpha expression in Sickle Cell Disease. | Armenis I, Kalotychou V, Tzanetea R, Konstantopoulos K, Rombos I | Nitric Oxide | 2021 |
| Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients. | Bhurani D, Kapoor J, Yadav N, Khushoo V, Agrawal N, Ahmed R, Arora JS, Mehta P | Ann Hematol | 2021 |
| Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells. | Papasavva PL, Papaioannou NY, Patsali P, Kurita R, Nakamura Y, Sitarou M, Christou S, Kleanthous M, Lederer CW | Int J Mol Sci | 2021 |
| Proteome of Stored RBC Membrane and Vesicles from Heterozygous Beta Thalassemia Donors. | Tzounakas VL, Anastasiadi AT, Dzieciatkowska M, Karadimas DG, Stamoulis K, Papassideri IS, Hansen KC, D'Alessandro A, Kriebardis AG, Antonelou MH | Int J Mol Sci | 2021 |
| Telomere shortening correlates with disease severity in hemoglobin H disease patients. | Panjawatanan P, Charoenkwan P, Tantiworawit A, Strogatz D, Perry KE, Tuntiwechapikul W | Blood Cells Mol Dis | 2021 |
| Fluorescence spectroscopy as a novel technique for premarital screening of sickle cell disorders. | Devanesan S, AlSalhi MS, Masilamani V, Alqahtany F, Rajasekar A, Alenazi A, Farhat K | Photodiagnosis Photodyn Ther | 2021 |
| Response to: Acute Liver Failure in a Sickle Cell Patient. | Rizvi SA, Pandey A | J Pediatr Gastroenterol Nutr | 2021 |
| Acute Liver Failure in a Sickle Cell Patient. | Maji P, Malik R | J Pediatr Gastroenterol Nutr | 2021 |
| Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor. | Glaros AK, Razvi R, Shah N, Zaidi AU | Ther Adv Hematol | 2021 |
| Improvement of SCD morbimortality in children: experience in a remote area of an African country. | Mbiya BM, Kalombo DK, Mukendi YN, Daubie V, Mpoyi JK, Biboyi PM, Disashi GT, Gulbis B | BMC Health Serv Res | 2021 |
| Sickle cell vaso-occlusion: The dialectic between red cells and white cells. | Conran N, Embury SH | Exp Biol Med (Maywood) | 2021 |
| Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction. | Nader E, Conran N, Romana M, Connes P | Compr Physiol | 2021 |
| Report of Two Novel Thalassemia Variants, : c.181delG and : c.121_126delAAGACC, in Chinese Individuals. | Chen X, Lin Z, Hu J, Chen S, Wen S, Wu A, Wu H, Huang J, Wang H, Sun J, Peng Z, Sun Y, Fu S | Hemoglobin | 2021 |
| Identification of Two Novel Thalassemia Variants, : c.263delA and : c.376dupC, in Chinese Individuals. | Liu L, Sun Y, Chen S, Yu C, Cao P, Sun J, Peng Z, Mao P | Hemoglobin | 2021 |
| One third of alloantibodies in patients with sickle cell disease transfused with African blood are missed by the standard red blood cell test panel. | Boateng LA, Schonewille H, Ligthart PC, Javadi A, Veldhuisen B, Osei-Akoto A, Dei-Adomakoh Y, Bates I, Van der Schoot CE | Haematologica | 2021 |
| Red cell transfusion and alloimmunization in sickle cell disease. | Linder GE, Chou ST | Haematologica | 2021 |
| A Comparative Evaluation of Capillary Electrophoresis, Cation-Exchange High-Performance Liquid Chromatography, and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Screening of Hemoglobin Variants. | Xu M, Wang Y, Xu A | Am J Clin Pathol | 2021 |
| Feasibility Study of the | Kakou Danho JB, Atiméré YN, Koné D, Yéo DD, Couitchéré L | Adv Hematol | 2021 |
| Investigations of Kidney Dysfunction-Related Gene Variants in Sickle Cell Disease Patients in Cameroon (Sub-Saharan Africa). | Ngo-Bitoungui VJ, Belinga S, Mnika K, Masekoameng T, Nembaware V, Essomba RG, Ngo-Sack F, Awandare G, Mazandu GK, Wonkam A | Front Genet | 2021 |
| How Do Red Blood Cells Die? | Thiagarajan P, Parker CJ, Prchal JT | Front Physiol | 2021 |
| Associations between TGF-1 Levels and Markers of Hemolysis, Inflammation, and Tissue Remodeling in Pediatric Sickle Cell Patients. | Santiago RP, Carvalho MOS, Figueiredo CVB, Fiuza LM, Oliveira RM, Yahouédéhou SCMA, Nascimento VML, Lyra IM, Araujo-Santos T, Luz NF, Aleluia MM, Guarda CC, Borges VM, Goncalves MS | Mediators Inflamm | 2021 |
| Complement in Sickle Cell Disease: Are We Ready for Prime Time? | Varelas C, Tampaki A, Sakellari I, Anagnostopoulos Α, Gavriilaki E, Vlachaki E | J Blood Med | 2021 |
| A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease. | Harris EM, Vilk E, Heeney MM, Solodiuk J, Greco C, Archer NM | Pediatr Blood Cancer | 2021 |
| Hydroxyurea in children with sickle cell disease in a resource-poor setting: Monitoring and effects of therapy. A practical perspective. | Nnebe-Agumadu U, Adebayo I, Erigbuem I, James E, Kumode E, Nnodu O, Adekile A | Pediatr Blood Cancer | 2021 |
| Monitoring retinal pathology and cerebral injury in sickle cell disease using spectral-domain optical coherence tomography in pediatric patients. | Jin J, Kandula V, Miller RE | Pediatr Blood Cancer | 2021 |
| Epigenetic effects toward new insights as potential therapeutic target in B-thalassemia. | Eltaweel NH, ElKamah GY, Khairat R, Atia HAE, Amr KS | J Genet Eng Biotechnol | 2021 |
| Evidence for Prophylactic Transfusion during Pregnancy for Women with Sickle Cell Disease. | Whittington JR, Magann EF, Ounpraseuth ST, Chang JN, Whitcombe DD, Morrison JC | South Med J | 2021 |
| Cerebral Hemodynamics and Executive Function in Sickle Cell Anemia. | Prussien KV, Compas BE, Siciliano RE, Ciriegio AE, Lee CA, Kassim AA, DeBaun MR, Donahue MJ, Jordan LC | Stroke | 2021 |
| Will the changing therapeutic landscape meet the needs of patients with sickle cell disease? | Inusa BPD, Casale M, Campbell A, Archer N | Lancet Haematol | 2021 |
| RE: re: manuscript titled, | Felli E, Felli E, Muttillo EM, Memeo R, Giannelli V, Colasanti M, Pellicelli A, Diana M, Ettorre GM | HPB (Oxford) | 2021 |
| A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD). | Mupfudze TG, Preussler JM, Sees JA, SanCartier M, Arnold SD, Devine S | Transplant Cell Ther | 2021 |
| Gaps in Medicaid Coverage and Financial Toxicity: A Health Disparity in Hematopoietic Cell Transplantation for Sickle Cell Disease. | Krishnamurti L | Transplant Cell Ther | 2021 |
| P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab. | Karki NR, Kutlar A | J Pain Res | 2021 |
| Fifteen-minute consultation: Recognition of sickle cell crises in the paediatric emergency department. | Patel S, Dadnam C, Hewitson R, Thakur I, Morgan J | Arch Dis Child Educ Pract Ed | 2021 |
| NLRP3 inflammasome and bruton tyrosine kinase inhibition interferes with upregulated platelet aggregation and in vitro thrombus formation in sickle cell mice. | Vogel S, Kamimura S, Arora T, Smith ML, Almeida LEF, Combs CA, Thein SL, Quezado ZMN | Biochem Biophys Res Commun | 2021 |
| Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with β-Thalassemia Major. | Soltani D, Fakhrzadeh H, Sharifi F, Mahmoudi MJ, Mahmoudi E, Vasheghani-Farahani A | Hemoglobin | 2021 |
| The Changing Trends in Prenatal Diagnosis of Hemoglobinopathies in India: The Quest of a Single Center to Reduce the Burden of Disease over Three Decades. | Colah RB, Nadkarni AH, Gorakshakar AC, Sawant PM, Mehta PR, Gorivale MS, Hariharan P, Mohanty D, Ghosh K | Hemoglobin | 2021 |
| Dissemination of Evidence-Based Recommendations for Sickle Cell Disease to Primary Care and Emergency Department Providers in North Carolina: A Cost Benefit Analysis. | Tanabe P, Blewer AL, Bonnabeau E, Bosworth HB, Clayton DH, Crego N, Earls MF, Eason K, Forlines G, Rains G, Young M, Shah N | J Health Econ Outcomes Res | 2021 |
| Prevalence and clinical phenotype of the triplicated α-globin genes and its ethnic and geographical distribution in Guizhou of China. | Luo X, Zhang XM, Wu LS, Chen J, Chen Y | BMC Med Genomics | 2021 |
| Haematological abnormalities in children with sickle cell disease and non-severe malaria infection in western Kenya. | Kosiyo P, Otieno W, Gitaka J, Munde EO, Ouma C | BMC Infect Dis | 2021 |
| Central macular thickness in patients with sickle cell disease and no signs of retinopathy: a cross-sectional study of Jordanian patients. | Abu-Yaghi NE, AlNawaiseh AM, Khourshid IM, AlRawashdeh TJ, Rawashdeh MMA, Zghoul AM, Shafagoj AN, Alomairi YA, Muhsen SM, AlRyalat SS | J Int Med Res | 2021 |
| Incorrect Migration of Hemoglobin after Capillary Electrophoresis Software Update Complicates Diagnosis of an Infant with Hemoglobin S/Beta+ Thalassemia. | Manthei DM, Harro DM, Keren DF | J Appl Lab Med | 2021 |
| A Randomized Controlled Trial of Working Memory Training in Pediatric Sickle Cell Disease. | Hardy SJ, Bills SE, Meier ER, Schatz JC, Keridan KJ, Wise S, Hardy KK | J Pediatr Psychol | 2021 |
| Red Blood Cell Exchange in a Patient With Extramedullary Hematopoiesis and Cor Pulmonale Secondary to Beta Thalassemia. | Kopparthy P, Kelkar AH, Aggarwal K, De Filippis S, Fletcher B | Cureus | 2021 |
| Telomere length and telomere repeat-binding protein in children with sickle cell disease. | Suliman ME, Ansari MGA, Rayis MA, Hamza MA, Saeed AA, Mohammed AK, Al-Daghri NM | Pediatr Res | 2021 |
| Hb Murcia (β118(G19)His>Gln): A New Hemoglobin Variant Found in a Spanish Woman. | Fernández BG, Campuzano JBN, Rocamora DG, Nieto JM, Fernández FAG, Villegas A, Cuesta CB, Ropero P | Ann Lab Med | 2021 |
| Depression in adults with sickle cell disease: a systematic review of the methodological issues in assessing prevalence of depression. | Oudin Doglioni D, Chabasseur V, Barbot F, Galactéros F, Gay MC | BMC Psychol | 2021 |
| Single laser trapping for optical folding and rotation of red blood cells in sickle cell disease in response to hydroxyurea treatment. | Mohi SM, Saadon HL, Khalaf AA | Biochem Biophys Res Commun | 2021 |
| Compound heterozygotes of Hb Constant Spring and Hb Stanleyville II in HbE/β-thalassemia. | Chen L, Liang L, Liao S, Huang Y, Liang L, Li Y | Clin Chem Lab Med | 2021 |
| The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model. | Matte A, Federti E, Kung C, Kosinski PA, Narayanaswamy R, Russo R, Federico G, Carlomagno F, Desbats MA, Salviati L, Leboeuf C, Valenti MT, Turrini F, Janin A, Yu S, Beneduce E, Ronseaux S, Iatcenko I, Dang L, Ganz T, Jung CL, Iolascon A, Brugnara C, De Franceschi L | J Clin Invest | 2021 |
| Hb Bart's Hydrops Fetalis Syndrome and Hb H Disease Caused by Deletional Chiang Rai (- -) α-Thalassemia in Two Unrelated Thai Families. | Ruengdit C, Khamphikham P, Jinorose N, Pornprasert S | Hemoglobin | 2021 |
| Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter national retrospective cohort study. | Abdulrahman A, Wael M, AlAmmadi F, Almosawi Z, Alsherooqi R, Abduljalil M, Kumar N, AlQahtani M | EJHaem | 2021 |
| Sickle haemoglobin: How critical are laboratory quality measures for accurate identification? | Sana N, Shaikh MS | J Pak Med Assoc | 2021 |
| Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease. | Uchida N, Drysdale CM, Nassehi T, Gamer J, Yapundich M, DiNicola J, Shibata Y, Hinds M, Gudmundsdottir B, Haro-Mora JJ, Demirci S, Tisdale JF | Mol Ther Methods Clin Dev | 2021 |
| Editorial: Frontiers in Hemoglobinopathies: New Insights and Methods. | Risoluti R, Colah R, Materazzi S | Front Mol Biosci | 2021 |
| Exercise-induced haemoglobin oxygen desaturation in patients with SCD. | Antwi-Boasiako C, Asare CP, Afriyie-Mensah JS, Hayfron-Benjamin C, Nuako I, Aryee R, Dankwah GB, Asare MM, Adutwum-Ofosu K | Am J Cardiovasc Dis | 2021 |
| Qualitative and quantitative magnetic resonance imaging evaluation of bone tissue vaso-occlusive events in patients with sickle cell disease. | Lins CF, Salmon CEG, de Souza LA, Moraes RS, Silva-Pinto AC, Matos MA, Nogueira-Barbosa MH | Bone | 2021 |
| Utilization of Discriminant Formulas in the Differentiation of Alpha Thalassemia, Beta Thalassemia, and Iron Deficiency in Premarital Setting. | Saboor M | Clin Lab | 2021 |
| Buprenorphine for Chronic Pain in a Pediatric Patient With Sickle-Cell Disease. | Irwin M, Gunther W, Keefer P, Saul D, Singh SA, Wright J, Smith MA | J Pain Symptom Manage | 2021 |
| Frequency of bacteremia in patients with sickle cell disease: a longitudinal study. | Al-Tawfiq JA, Rabaan AA, AlEdreesi MH | Ann Hematol | 2021 |
| Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease. | Tchernychev B, Li H, Lee SK, Gao X, Ramanarasimhaiah R, Liu G, Hall KC, Bernier SG, Jones JE, Feil S, Feil R, Buys ES, Graul RM, Frenette PS, Masferrer JL | Br J Pharmacol | 2021 |
| Acute stroke in young adult secondary to moyamoya angiopathy unveiling HbE-β thalassemia. | Das S, Karmakar K, Mukherjee R, Panda S, Dubey S, Sarkar N, Ray BK | Ann Hematol | 2021 |
| Co-morbidities and mortality in patients with sickle cell disease in England: A 10-year cohort analysis using hospital episodes statistics (HES) data. | Piel FB, Jobanputra M, Gallagher M, Weber J, Laird SG, McGahan M | Blood Cells Mol Dis | 2021 |
| The flow of sickle blood in glass capillaries: Fundamentals and potential applications. | Brown CD, Aprelev AM, Aliprando M, Harkness EA, Ferrone FA | Biophys J | 2021 |
| Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study. | Luo L, King AA, Carroll Y, Baumann AA, Brambilla D, Carpenter CR, Colla J, Gibson RW, Gollan S, Hall G, Klesges L, Kutlar A, Lyon M, Melvin CL, Norell S, Mueller M, Potter MB, Richesson R, Richardson LD, Ryan G, Siewny L, Treadwell M, Zun L, Armstrong-Brown J, Cox L, Tanabe P | JMIR Res Protoc | 2021 |
| Effectiveness of placental volume measured by virtual organ computer-aided analysis in prediction of fetal hemoglobin Bart's disease in late first trimester. | Bootchaingam P, Charoenratana C, Tongsong T, Luewan S | J Clin Ultrasound | 2021 |
| Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients. | Shafie AA, Chhabra IK, Wong JHY, Mohammed NS | Eur J Health Econ | 2021 |
| Site-Specific Introduction of Negative Charges on the Protein Surface for Improving Global Functions of Recombinant Fetal Hemoglobin. | Kettisen K, Dicko C, Smeds E, Bülow L | Front Mol Biosci | 2021 |
| ZNF410 represses fetal globin by singular control of CHD4. | Vinjamur DS, Yao Q, Cole MA, McGuckin C, Ren C, Zeng J, Hossain M, Luk K, Wolfe SA, Pinello L, Bauer DE | Nat Genet | 2021 |
| Genetic therapies for the first molecular disease. | Doerfler PA, Sharma A, Porter JS, Zheng Y, Tisdale JF, Weiss MJ | J Clin Invest | 2021 |
| Stigma Associated With Sickle Cell Disease in Kumasi, Ghana. | Buser JM, Bakari A, Seidu AA, Paintsil V, Osei-Akoto A, Amoah R, Otoo B, Moyer CA | J Transcult Nurs | 2021 |
| Evaluation of Corneal Epithelial Thickness and Dry Eye Disease Tests in Thalassemic Adolescents. | Ebeid WM, Kenny MA, Badran TA | Clin Ophthalmol | 2021 |
| Patient-controlled analgesia in sickle-cell disease painful vaso-occlusive crises: should we add ketamine to morphine? | Zuccarini F, Aoragh A, Maggiore A, Kapessidou P | Minerva Anestesiol | 2021 |
| Peripartum considerations in sickle cell disease. | Ezihe-Ejiofor A, Jackson J | Curr Opin Anaesthesiol | 2021 |
| Presentation of two new mutations in the 3'untranslated region of the β-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey. | Arpaci A, Gul BU, Ozcan O, Ilhan G, El C, Dirican E, Elmacioglu S, Kaya H | Ann Hematol | 2021 |
| Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity. | Ricchi P, Costantini S, Spasiano A, Cinque P, Esposito S, Filosa A | Ann Hematol | 2021 |
| The effect of scheduled routine blood transfusions on learning achievement of children with thalassemia: A study from Tangerang District Indonesia. | Sari RS, Rianti , Lutbis AA, Hasanah I | Enferm Clin | 2021 |
| The Potential of mHealth as a Game Changer for the Management of Sickle Cell Disease in India. | Kumar R, Das A | JMIR Mhealth Uhealth | 2021 |
| Social support networks of adults with sickle cell disease. | Desine S, Eskin L, Bonham VL, Koehly LM | J Genet Couns | 2021 |
| Characterizing bulk rigidity of rigid red blood cell populations in sickle-cell disease patients. | Gutierrez M, Shamoun M, Seu KG, Tanski T, Kalfa TA, Eniola-Adefeso O | Sci Rep | 2021 |
| Detection of Renal Insufficiency in a Cohort of Patients With Beta-thalassemia Major Using Cystatin-C. | Hamdy M, Shaheen I, El-Gammal ZM, Ramadan YM | J Pediatr Hematol Oncol | 2021 |
| Hb Hezhou [β64(E8)Gly→Ser; : c.193G>A]: A Novel Variant on the β-Globin Gene. | Zhao YL, Lin QF, He XW, Li YQ, Liang L | Hemoglobin | 2021 |
| The use of expanded carrier screening of gamete donors. | Payne MR, Skytte AB, Harper JC | Hum Reprod | 2021 |
| Sickle Cell Trait Modulates the Proteome and Phosphoproteome of -Infected Erythrocytes. | Chauvet M, Chhuon C, Lipecka J, Dechavanne S, Dechavanne C, Lohezic M, Ortalli M, Pineau D, Ribeil JA, Manceau S, Le Van Kim C, Luty AJF, Migot-Nabias F, Azouzi S, Guerrera IC, Merckx A | Front Cell Infect Microbiol | 2021 |
| Red cell alloantibodies in beta-thalassaemia major patients' blood referring to the regional blood transfusion center of Tehran, Iran. | Ebrahimisadr P, Bakhshandeh Z, Majidiani H | Bioimpacts | 2021 |
| Soluble MD-2 and Heme in Sickle Cell Disease Plasma Promote Pro-Inflammatory Signaling in Endothelial Cells. | Zhang P, Nguyen J, Abdulla F, Nelson AT, Beckman JD, Vercellotti GM, Belcher JD | Front Immunol | 2021 |
| Automated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia. | Sadaf A, Seu KG, Thaman E, Fessler R, Konstantinidis DG, Bonar HA, Korpik J, Ware RE, McGann PT, Quinn CT, Kalfa TA | Front Physiol | 2021 |
| Engraftment after autologous hematopoietic stem cell transplantation in patients mobilized with Plerixafor: A retrospective, multicenter study of a large series of patients. | Antelo ML, Altuna A, Gimeno JJ, Ferreiro JJ, Amunárriz C, Mateos JJ, Zalba S, Alkorta A, Rifón J, Arroyo JL, Uresandi A, Moreno JA, Nájera MJ, Pinzón S, García A, Vallejo JC, | Transfus Apher Sci | 2021 |
| Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease. | Mupfudze TG, Meyer C, Preussler JM, Mau LW, Bolon YT, Steinert P, Arnold SD, Saber W, Krishnamurti L | Transplant Cell Ther | 2021 |
| Is CONUT score a predictor of morbidity in patients with adult transfusion dependent beta thalassemia? | Akgun Cagliyan G | Transfus Apher Sci | 2021 |
| Advances in neuroimaging to improve care in sickle cell disease. | Jordan LC, DeBaun MR, Donahue MJ | Lancet Neurol | 2021 |
| Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. | Biemond BJ, Tombak A, Kilinc Y, Al-Khabori M, Abboud M, Nafea M, Inati A, Wali Y, Kristensen J, Kowalski J, Donnelly E, Ohd J, | Lancet Haematol | 2021 |
| Sevuparin trial for acute pain in sickle cell disease: the dog that did not bark. | Ellsworth P, Little JA | Lancet Haematol | 2021 |
| A pilot study of the acceptability, feasibility and safety of yoga for chronic pain in sickle cell disease. | Bakshi N, Cooley A, Ross D, Hawkins L, Sullivan M, Astles R, Sinha C, Katoch D, Peddineni M, Gee BE, Lane PA, Krishnamurti L | Complement Ther Med | 2021 |
| Reduced global cerebral oxygen metabolic rate in sickle cell disease and chronic anemias. | Vu C, Bush A, Choi S, Borzage M, Miao X, Nederveen AJ, Coates TD, Wood JC | Am J Hematol | 2021 |
| PF-07059013: A non-covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease. | Knee KM, Jasuja R, Barakat A, Rao D, Wenzel Z, Jasti J, Novak J, Beaumont K, Piotrowski DW, Jeffrey P, Bulawa C, Murphy JE, Janz JM | Am J Hematol | 2021 |
| Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned. | Segbefia CI, Goka B, Welbeck J, Amegan-Aho K, Dwuma-Badu D, Rao S, Salifu N, Oppong SA, Odei E, Ohene-Frempong K, Odame I | Pediatr Blood Cancer | 2021 |
| Effect of transfusion therapy on intracranial stenosis in a child with sickle cell anaemia. | Brunelli N, Mohamed BP, Fuschi M, Qureshi A, Mazzucco S | Neurol Sci | 2021 |
| Emergency department utilization for sickle cell disease in St. Vincent and the Grenadines. | Williams SA, Henson S, Trimmingham S, Newman J, Kanter J | Pan Afr Med J | 2021 |
| [Osteoarticular infections in patients with sickle cell disease in Lubumbashi: epidemiological study focusing on etiology and management]. | Banza MI, Kapessa ND, Mukakala AK, Ngoie CN, N Dwala YTB, Cabala VPK, Kasanga TK, Unen EW | Pan Afr Med J | 2021 |
| Acute Phase Responses Vary Between Children of HbAS and HbAA Genotypes During Infection. | Tetteh M, Addai-Mensah O, Siedu Z, Kyei-Baafour E, Lamptey H, Williams J, Kupeh E, Egbi G, Kwayie AB, Abbam G, Afrifah DA, Debrah AY, Ofori MF | J Inflamm Res | 2021 |
| Evaluation of the expression of red blood cell CD36, interleukin-6 and interleukin-8 in sickle cell anemia pediatric patients. | Abdul-Hussein HK, Al-Mammori HS, Hassan MK | Cytokine | 2021 |
| Hemoglobin Yamagata [132(H10)Lys→Asn; (: c.399A>T)]: a mosaic to be put together. | Iacomelli I, Barberio G, Pucci P, Monaco V, Maffei M, Mogni M, Curcio C, Maoggi S, Giulietti C, Harteveld CL, Ivaldi G | Clin Chem Lab Med | 2021 |
| Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: The NHLBI TOPMed program. | Hu Y, Stilp AM, McHugh CP, Rao S, Jain D, Zheng X, Lane J, Méric de Bellefon S, Raffield LM, Chen MH, Yanek LR, Wheeler M, Yao Y, Ren C, Broome J, Moon JY, de Vries PS, Hobbs BD, Sun Q, Surendran P, Brody JA, Blackwell TW, Choquet H, Ryan K, Duggirala R, Heard-Costa N, Wang Z, Chami N, Preuss MH, Min N, Ekunwe L, Lange LA, Cushman M, Faraday N, Curran JE, Almasy L, Kundu K, Smith AV, Gabriel S, Rotter JI, Fornage M, Lloyd-Jones DM, Vasan RS, Smith NL, North KE, Boerwinkle E, Becker LC, Lewis JP, Abecasis GR, Hou L, O'Connell JR, Morrison AC, Beaty TH, Kaplan R, Correa A, Blangero J, Jorgenson E, Psaty BM, Kooperberg C, Walton RT, Kleinstiver BP, Tang H, Loos RJF, Soranzo N, Butterworth AS, Nickerson D, Rich SS, Mitchell BD, Johnson AD, Auer PL, Li Y, Mathias RA, Lettre G, Pankratz N, Laurie CC, Laurie CA, Bauer DE, Conomos MP, Reiner AP, | Am J Hum Genet | 2021 |
| Validation of a Questionnaire to Identify Respiratory Tract Infections in Children With Sickle Cell Disease. | De A, Anekwe CV, Kattan M, Yao Y, Jin Z, Brittenham GM, Lee MT | J Pediatr Hematol Oncol | 2021 |
| Spectrum of hemoglobin disorders in southern Odisha, India: a hospital based study. | Sahu P, Purohit P, Mantri S, Tudu R, Nayak J, Agrawalla SK, Behera SK, Patro MK, Karmee N, Tripathy D, Mishra B, Mishra DP | Porto Biomed J | 2021 |
| The Quality of Life of Thalassemic Patients: The Role of Endocrine Defect Compensation. | Mattia L, Samperi I, Monti S, Toscano V, Pugliese G, Poggi M | Endocr Metab Immune Disord Drug Targets | 2021 |
| Survival and causes of death in 2033 patients with non-transfusion-dependent β-thalassemia. | Musallam KM, Vitrano A, Meloni A, Pollina WA, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Ansari SH, Filosa A, Ricchi P, Ceci A, Daar S, Vlachaki E, Singer ST, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Sankaran VG, Vichinsky E, Taher AT, Maggio A | Haematologica | 2021 |
| Brain injury pathophysiology study by a multimodal approach in children with sickle cell anemia with no intra or extra cranial arteriopathy. | Brousse V, Pondarre C, Kossorotoff M, Arnaud C, Kamdem A, de Montalembert M, Boutonnat-Faucher B, Allali S, Bourdeau H, Charlot K, Bertil S, Da Costa L, Connes P, Grévent D, Verlhac S | Haematologica | 2021 |
| Sickle Cell Nephropathy: Screening Provides an Opportunity to Intervene. | Thomas CC, Sinha A | Indian J Pediatr | 2021 |
| Pulmonary complications of sickle cell disease: a narrative clinical review. | Pervaiz A, El-Baba F, Dhillon K, Daoud A, Soubani A | Adv Respir Med | 2021 |
| Hematopoietic stem cell transplantation for people with β-thalassaemia. | Sharma A, Jagannath VA, Puri L | Cochrane Database Syst Rev | 2021 |
| Poloxamer 188 for Sickle Cell Disease. | Zylke J | JAMA | 2021 |
| Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. | Casella JF, Barton BA, Kanter J, Black LV, Majumdar S, Inati A, Wali Y, Drachtman RA, Abboud MR, Kilinc Y, Fuh BR, Al-Khabori MK, Takemoto CM, Salman E, Sarnaik SA, Shah N, Morris CR, Keates-Baleeiro J, Raj A, Alvarez OA, Hsu LL, Thompson AA, Sisler IY, Pace BS, Noronha SA, Lasky JL, de Julian EC, Godder K, Thornburg CD, Kamberos NL, Nuss R, Marsh AM, Owen WC, Schaefer A, Tebbi CK, Chantrain CF, Cohen DE, Karakas Z, Piccone CM, George A, Fixler JM, Singleton TC, Moulton T, Quinn CT, de Castro Lobo CL, Almomen AM, Goyal-Khemka M, Maes P, Emanuele M, Gorney RT, Padgett CS, Parsley E, Kronsberg SS, Kato GJ, Gladwin MT | JAMA | 2021 |
| Rationally Designed Base Editors for Precise Editing of the Sickle Cell Disease Mutation. | Chu SH, Packer M, Rees H, Lam D, Yu Y, Marshall J, Cheng LI, Lam D, Olins J, Ran FA, Liquori A, Gantzer B, Decker J, Born D, Barrera L, Hartigan A, Gaudelli N, Ciaramella G, Slaymaker IM | CRISPR J | 2021 |
| Universal Gene Correction Approaches for β-hemoglobinopathies Using CRISPR-Cas9 and Adeno-Associated Virus Serotype 6 Donor Templates. | Lamsfus-Calle A, Daniel-Moreno A, Ureña-Bailén G, Rottenberger J, Raju J, Epting T, Marciano S, Heumos L, Baskaran P, S Antony J, Handgretinger R, Mezger M | CRISPR J | 2021 |
| Base Editors Flex Sights on Sickle-Cell Disease. | Cereseto A, Cradick TJ, Davies K | CRISPR J | 2021 |
| Optimisation of T2 and T2* sequences in MRI for better quantification of iron on transfused dependent sickle cell patients. | Ahmed A, Baldo A, Sulieman A, Mirghani H, Abolaban FA, Suliman II, Salih I | Sci Rep | 2021 |
| A Case of Hb Aalborg (: c.223G>C) with Chronic Obstructive Pulmonary Disease: A First Familial Presentation in Japan. | Takamura K, Komori T, Hashino Y, Suzuki T, Shiwaku A, Kikuchi H, Yamamoto M, Yamauchi H, Yamashiro Y | Hemoglobin | 2021 |
| Physiological and Aberrant γ-Globin Transcription During Development. | Barbarani G, Labedz A, Stucchi S, Abbiati A, Ronchi AE | Front Cell Dev Biol | 2021 |
| Bone Marrow Fat Distribution in Patients With β-Thalassemia: A Study Using Chemical Shift-Based Water-Fat MRI. | Ismail UN, Azlan CA, Khairullah S, Azman RR, Lee KJ, Yeong CH, Omar NF, Ramli N, Md Shah MN, Jackson N, Ng KH | Acad Radiol | 2021 |
| Development of a community outreach project: An interprofessional partnership for thalassemia families guided by nursing students. | Schmotzer G, Kohlbry P, Strehlow K, Rist E, Bales K, Foe M, Yasmashita R, Yu J | Nurse Educ Pract | 2021 |
| Priapism in Sickle Cell Disease: An Evaluation of the Knowledge of an at Risk Population in Jamaica. | Whyte N, Morrison-Blidgen B, Asnani M | Sex Med | 2021 |
| Predictive SNPs for β-thalassemia/HbE disease severity. | Munkongdee T, Tongsima S, Ngamphiw C, Wangkumhang P, Peerapittayamongkol C, Hashim HB, Fucharoen S, Svasti S | Sci Rep | 2021 |
| Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study. | Badawy SM, Abebe KZ, Reichman CA, Checo G, Hamm ME, Stinson J, Lalloo C, Carroll P, Saraf SL, Gordeuk VR, Desai P, Shah N, Liles D, Trimnell C, Jonassaint CR | JMIR Res Protoc | 2021 |
| Low FEV is associated with fetal death in pregnant women with sickle cell disease. | Hayfron-Benjamin CF, Asare EV, Boafor T, Olayemi E, Dei-Adomakoh Y, Musah L, Mensah E, Beyuo T, Kassim AA, Rodeghier M, DeBaun MR, Oppong SA | Am J Hematol | 2021 |
| Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration. | Cannas G, Dubreuil L, Fichez A, Gerfaud-Valentin M, Debard AL, Hot A | Am J Case Rep | 2021 |
| P-selectin and sickle cell disease: a balancing act. | Manwani D | Blood | 2021 |
| Screening for Cognitive Dysfunction Using the Rowland Universal Dementia Assessment Scale in Adults With Sickle Cell Disease. | Forté S, Blais F, Castonguay M, Fadiga N, Fortier-St-Pierre M, Couette M, Ward R, Béland S, Cohn M, Soulières D, Kuo KHM | JAMA Netw Open | 2021 |
| Intravenous Acetaminophen vs Intravenous Diclofenac in the Management of Painful Crisis in Sickle Cell Disease: Authors' Reply. | Mishra NR | Indian Pediatr | 2021 |
| Intravenous Acetaminophen vs Intravenous Diclofenac in the Management of Painful Crisis in Sickle Cell Disease. | Kumar R, Tripathy SK | Indian Pediatr | 2021 |
| Clinical Features and Outcome of Sickle Cell Disease in a Tertiary Center in Northern Lebanon: A Retrospective Cohort Study in a Local, Hospital-Associated Registry. | Inati A, Al Alam C, El Ojaimi C, Hamad T, Kanakamedala H, Pilipovic V, Sabah R | Hemoglobin | 2021 |
| Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation? | Brousse V, Holvoet L, Pescarmona R, Viel S, Perret M, Visseaux B, Ferre VM, Ithier G, Le Van Kim C, Benkerrou M, Missud F, Koehl B | Haematologica | 2021 |
| [Rare thalassemia caused by novel nucleotide variants in the globin gene: four case reports and literature review]. | Da ZZ, Chen LH, Jiang HM, Wang GP | Zhonghua Xue Ye Xue Za Zhi | 2021 |
| Cardiovascular benefits of a home-based exercise program in patients with sickle cell disease. | de Araujo Junior JA, Antonelli Rossi DA, Carneiro Valadão TF, Milan-Mattos JC, Catai AM, Sato TO, Hueb JC, Zanati Bazan SG, Hokama POM, Hokama NK, Roscani MG | PLoS One | 2021 |
| Individual red blood cell nitric oxide production in sickle cell anemia: Nitric oxide production is increased and sickle shaped cells have unique morphologic change compared to discoid cells. | Suriany S, Xu I, Liu H, Ulker P, Fernandez GE, Sposto R, Borzage M, Wenby R, Meiselman HJ, Forman HJ, Coates TD, Detterich JA | Free Radic Biol Med | 2021 |
| Multifocal Osteonecrosis in a 3-Year-Old Child With Sickle Beta Plus Thalassemia. | Bhasin N, Price N, Desoky SM | J Pediatr Hematol Oncol | 2021 |
| Maintenance of a High Influenza Vaccination Rate and Improvement in Health Outcomes in a Pediatric Sickle Cell Disease Clinic. | Lo ZC, Sobota AE | J Pediatr Hematol Oncol | 2021 |
| The ethics of genetic screening for beta thalassemia in Vietnam. | Riquier MT | Dev World Bioeth | 2021 |
| Levels of angiotensin-converting enzyme 1 and 2 in serum and urine of children with Sickle Cell Disease. | Hsien HC, Casarini DE, Carvalhaes JTA, Ronchi FA, Oliveira LCG, Braga JAP | J Bras Nefrol | 2021 |
| Thalassemia and Priapism: A Literature Review of a Rare Association. | Sardar S, Ali EA, Yassin MA | Cureus | 2021 |
| Transcranial color-coded duplex sonography reliably identifies intracranial vasculopathy in adult patients with sickle cell disease. | Edjlali M, Gobin-Metteil MP, Mélé N, Maïer B, Habibi A, Kauv P, Hosseini H, Mas JL, Oppenheim C, Galactéros F, Bartolucci P, Calvet D | Am J Hematol | 2021 |
| A case of ischemic colitis in a patient with non transfusion dependent thalassemia (NTDT) infected by SARS-COV-2. | Ricchi P, Filosa A | Pediatr Hematol Oncol | 2021 |
| Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia. | Kang C, Syed YY | Drugs | 2021 |
| A double-blind, controlled, crossover trial of amlodipine on iron overload status in transfusion dependent β-thalassemia patients. | Karami H, Khalilzadeh Arjmandi H, Salehifar E, Darvishi-Khezri H, Dabirian M, Kosaryan M, Aliasgharian A, Akbarzadeh R, Naeimayi Aali R, Nasirzadeh A | Int J Clin Pract | 2021 |
| Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm. | Baronciani D, Casale M, De Franceschi L, Graziadei G, Longo F, Origa R, Rigano P, Pinto V, Marchetti M, Gigante A, Forni GL | Hemasphere | 2021 |
| Molecular Spectrum of β-Thalassemia Mutations in Central to Eastern Thailand. | Panichchob P, Iamdeelert P, Wongsariya P, Wongsariya P, Wongwattanasanti P, Tepakhan W, Jomoui W | Hemoglobin | 2021 |
| Impact of a submaximal mono-articular exercise on the skeletal muscle function of patients with sickle cell disease. | Gouraud E, Connes P, Gauthier-Vasserot A, Faes C, Merazga S, Poutrel S, Renoux C, Boisson C, Joly P, Bertrand Y, Hot A, Cannas G, Hautier C | Eur J Appl Physiol | 2021 |
| Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response. | Sadaf A, Quinn CT, Korpik JB, Pfeiffer A, Reynaud M, Niss O, Malik P, Ware RE, Kalfa TA, McGann PT | Blood Cells Mol Dis | 2021 |
| Newborn screening for sickle cell disease in sub-Saharan Africa: Is the glass half-full yet? | Smart LR, Ware RE | Pediatr Blood Cancer | 2021 |
| "It Is Not Easy": Cultural Influences of Sickle Cell Disease Management in Rural, Eastern Sierra Leone | Ibemere SO, Shambley-Ebron DZ, Tanabe P, Jaja C | Qual Health Res | 2021 |
| Sickle Cell Disease in Jordan: The Experience of a Major Referral Center. | Oudat RI, Abualruz HS, Al-Shiek NKA, Al-Mashaqba EA, Al-Hiari RA, Alsoukhni HA, Hammad MAA | Med Arch | 2021 |
| Acyclovir induces fetal hemoglobin via downregulation of γ-globin repressors, BCL11A and SOX6 trans-acting factors. | Ali H, Khan F, Ghulam Musharraf S | Biochem Pharmacol | 2021 |
| Sickle Cell Disease and Pain: Is it all Vaso-occlusive Crises? | Ramsay Z, Bartlett R, Ali A, Grant J, Gordon-Strachan G, Asnani M | Clin J Pain | 2021 |
| Fat Embolism Syndrome in Sickle Cell β-Thalassemia Patient With Osteonecrosis: An Uncommon Presentation in a Young Adult. | Sangani V, Pokal M, Balla M, Merugu GP, Khokher W, Gayam V, Konala VM | J Investig Med High Impact Case Rep | 2021 |
| COVID-19 Mortality in a Pediatric Patient with Hemoglobin SC Disease and Alpha-Thalassemia Trait. | Motelow JE, Kahn S, Wilson PT | Case Rep Crit Care | 2021 |
| Opioid Use in Adults With Sickle Cell Disease Hospitalized During Vaso-Occlusive Crisis: A Systematic Review. | Osborne JC, Osakwe Z, Odlum M | J Hematol | 2021 |
| Novel therapies in β-thalassaemia. | Grech L, Borg K, Borg J | Br J Clin Pharmacol | 2021 |
| Decision making for hematopoietic stem cell transplantation in pediatric, adolescent, and young adult patients with a hemoglobinopathy-Shared or not? | Mekelenkamp H, Smiers F, Camp N, Stubenrouch F, Lankester A, de Vries M | Pediatr Blood Cancer | 2021 |
| Outcomes of allogeneic transplantation for hemoglobin Bart's hydrops fetalis syndrome in Hong Kong. | Chan WYK, Lee PPW, Lee V, Chan GCF, Leung W, Ha SY, Cheuk DKL | Pediatr Transplant | 2021 |
| [Newborn screening for sickle cell disease in France]. | Brousse V, Allaf B, Benkerrou M | Med Sci (Paris) | 2021 |
| Gene Therapy in Global Health: Meeting the Needs of Chinese Patients with Beta-Thalassemia. | Flotte TR | Hum Gene Ther | 2021 |
| The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry. | Castro-Mollo M, Gera S, Ruiz-Martinez M, Feola M, Gumerova A, Planoutene M, Clementelli C, Sangkhae V, Casu C, Kim SM, Ostland V, Han H, Nemeth E, Fleming R, Rivella S, Lizneva D, Yuen T, Zaidi M, Ginzburg Y | Elife | 2021 |
| Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease. | Rankin A, Darbari D, Campbell A, Webb J, Mo YD, Jacquot C, Delaney M, Luban NLC, Nickel RS | Transfusion | 2021 |
| Multisystem Inflammatory Syndrome in a Pediatric Patient With Sickle Cell Disease and COVID-19: A Case Report. | Español MG, Gardner RV, Alicea-Marrero MM, Marrero-Rivera G, Bradford T, LeBlanc DM, Velez MC | J Pediatr Hematol Oncol | 2021 |
| Mortality and Causes of Death From Sickle Cell Disease in The Netherlands, 1985-2017. | Rettenbacher E, Zaal J, Heijboer H, van der Plas EM, Hof M, Biemond BJ, Fijnvandraat K, | J Pediatr Hematol Oncol | 2021 |
| Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework. | Ghafuri DL, Abdullahi SU, Dambatta AH, Galadanci J, Tabari MA, Bello-Manga H, Idris N, Inuwa H, Tijjani A, Suleiman AA, Jibir BW, Gambo S, Gambo AI, Khalifa Y, Haliru L, Abdulrasheed S, Zakari MA, Greene BC, Trevathan E, Jordan LC, Aliyu MH, Baumann AA, DeBaun MR | J Pediatr Hematol Oncol | 2021 |
| Lactate dehydrogenase to carboxyhemoglobin ratio as a biomarker of heme release to heme processing is associated with higher tricuspid regurgitant jet velocity and early death in sickle cell disease. | van Vuren AJ, Minniti CP, Mendelsohn L, Baird JH, Kato GJ, van Beers EJ | Am J Hematol | 2021 |
| GATA zinc finger domain-containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with β-thalassaemia through impaired formation of methyl-binding domain protein 2 (MBD2)-containing nucleosome remodelling and deacetylation (NuRD) complex. | Liang Y, Zhang X, Liu Y, Wang L, Ye Y, Tan X, Pu J, Zhang Q, Bao X, Wei X, Li D, Kurita R, Nakamura Y, Li D, Xu X | Br J Haematol | 2021 |
| Renal Medullary Carcinoma in an Adolescent With Unknown Sickle Cell Trait. | Noreña-Rengifo BD, Ochoa-Gaviria J, Vélez-Escobar A, Muñoz JP, Riveros-Ángel M | Cureus | 2021 |
| Fetal Cytokine Balance, Erythropoietin and Thalassemia but Not Placental Malaria Contribute to Fetal Anemia Risk in Tanzania. | Kabyemela ER, Fried M, Kurtis JD, Moses G, Gorres JP, Muehlenbachs A, Duffy PE | Front Immunol | 2021 |
| Transcranial Doppler Ultrasonography Imaging Studies in Children with Sickle Cell Anaemia in a Tertiary Hospital, Abuja, Nigeria. | Mohammed-Nafi'u R, Oniyangi O, Akano AO, Aikhionbare HA, Okon EJ | West Afr J Med | 2021 |
| Paternal Stress and Child Outcomes in Youth with Sickle Cell Disease. | Moody KL | J Pediatr Psychol | 2021 |
| Gene therapy as the new frontier for Sickle Cell Disease. | Garg H, Tatiossian KJ, Peppel K, Kato GJ, Herzog E | Curr Med Chem | 2021 |
| Inclusion of a shRNA targeting BCL11A into a β-globin expressing vector allows concurrent synthesis of curative adult and fetal hemoglobin. | Pires Lourenco S, Jarocha D, Ghiaccio V, Guerra A, Abdulmalik O, La P, Zezulin A, Smith-Whitley K, Kwiatkowski JL, Guzikowski V, Nakamura Y, Raabe T, Breda L, Rivella S | Haematologica | 2021 |
| Delta-globin gene expression improves sickle cell disease in a humanised mouse model. | Porcu S, Simbula M, Marongiu MF, Perra A, Poddie D, Perseu L, Kowalik MA, Littera R, Barella S, Caria CA, Demartis FR, Ristaldi MS | Br J Haematol | 2021 |
| Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major. | Nuzzi R, Geronazzo G, Tridico F, Nuzzi A, Caselgrandi P, Piga AG | Clin Ophthalmol | 2021 |
| Seizures risk factors in sickle cell disease. The cooperative study of sickle cell disease. | Nawaiseh M, Shaban A, Abualia M, Haddadin R, Nawaiseh Y, AlRyalat SA, Yassin A, Sultan I | Seizure | 2021 |
| Towards manufactured red blood cells for the treatment of inherited anemia. | Pellegrin S, Severn CE, Toye AM | Haematologica | 2021 |
| Exome sequencing in high and low fetal haemoglobin Arab-Indian haplotype sickle cell disease. | Alnafie AN, Alateeq SA, Al-Muhanna FA, Alsulaiman AM, Alfarhan M, Buali W, Vatte CB, Cyrus C, Keating B, Al-Ali AK, Steinberg MH | Br J Haematol | 2021 |
| Corrigendum to: Tranexamic acid use in a patient with sickle cell disease undergoing posterior scoliosis correction surgery: safely mitigating bleeding and vaso-occlusive crises. | Newall M, Hamdan TA, Ajayi B, Weil S, Bishop T, Lui DF | J Surg Case Rep | 2021 |
| Large red cell-derived membrane particles are major contributors to hypercoagulability in sickle cell disease. | Smith RA, Mankelow TJ, Drizou D, Bullock T, Latham T, Trompeter S, Blair A, Anstee DJ | Sci Rep | 2021 |
| First Report of Nondeletional Hb H Disease Caused by an α2-Globin Gene Mutation: : c.184A>T. | Tian Q, Lei YL, Xu LL, Li DZ | Hemoglobin | 2021 |
| Deep sequencing applied to the analysis of viromes in patients with beta-thalassemia. | Valença IN, Santos RBD, Peronni KC, Sauvage V, Vandenbogaert M, Caro V, Silva Junior WAD, Covas DT, Silva-Pinto AC, Laperche S, Kashima S, Slavov SN | Rev Inst Med Trop Sao Paulo | 2021 |
| Hemoglobin F (HbF) inducers; History, Structure and Efficacies. | Hashemi Z, Ebrahimzadeh MA | Mini Rev Med Chem | 2021 |
| Can silymarin ameliorate β-thalassemia major-induced osteopenia/osteoporosis? | Darvishi-Khezri H | J Complement Integr Med | 2021 |
| Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia: Correspondence. | Mungmunpuntipantip R, Wiwanitkit V | Indian J Pediatr | 2021 |
| Development of an Online Reproductive Health Intervention for Individuals with Sickle Cell Disease or Trait. | Johnson-Mallard V, Oguntoye A, Eades N, Aldossary D, Kuenzli G, Ezenwa MO, Gallo AM, Wilkie DJ | Womens Health Rep (New Rochelle) | 2021 |
| Cost-effectiveness of a hypothetical cell or gene therapy cure for sickle cell disease. | Salcedo J, Bulovic J, Young CM | Sci Rep | 2021 |
| Detection of the : c.393T>G Mutation in Two Patients with Hypochromic Microcytic Anemia. | Zhao Q, Zhao SM, Zhang X, Chen SP, Sun J, Peng ZY, Sun Y, Fan C, Xing XD, Li R | Hemoglobin | 2021 |
| Differential Diagnosis of Low Hemoglobin. | Ianni CM, McDowall MP, Zuska IA | Dimens Crit Care Nurs | 2021 |
| Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals. | Boğa C, Asma S, Leblebisatan G, Şen N, Tombak A, Demiroğlu YZ, Yeral M, Akın Ş, Yeşilağaç H, Habeşoğlu MA, Arıboğan A, Kasar M, Korur A, Özdoğu H | Ann Hematol | 2021 |
| Cerebral venous sinus thrombosis and aneurysm in a patient with double heterozygous beta-thalassemia major: A case report. | Gu R, Xiong Y, Li L, Zhao X, Liu Y | Medicine (Baltimore) | 2021 |
| Potential Role of Reticulocyte Hemoglobin in Facilitating Patient Blood Management. | Hönemann C, Doll D, Luedi MM, Zimmermann M | Anesth Analg | 2021 |
| The worldwide molecular spectrum and distribution of thalassaemia: a systematic review. | Ebrahimi M, Mohammadi-Asl J, Rahim F | Ann Hum Biol | 2021 |
| Psychosocial risk and health care utilization in pediatric sickle cell disease. | Woodward KE, Johnson YL, Cohen LL, Dampier C, Sil S | Pediatr Blood Cancer | 2021 |
| Quantitative T2* imaging of iron overload in a non-dedicated center - Normal variation, repeatability and reader variation. | Lidén M, Adrian D, Widell J, Uggla B, Thunberg P | Eur J Radiol Open | 2021 |
| Enlarged pulmonary artery on computed tomography and respiratory failure in sickle cell disease acute chest syndrome. | Simonson JL, Pandya D, Kang J, Talwar A, Zaidi GZ | Pulm Circ | 2021 |
| Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M-hemoglobin variants. | Rangan A, Savedra ME, Dergam-Larson C, Swanson KC, Szuberski J, Go RS, Porter TR, Brunker SE, Shi M, Nguyen PL, Hoyer JD, Oliveira JL | Int J Lab Hematol | 2021 |
| Modulatory effect of single nucleotide polymorphism in Xmn1, BCL11A and HBS1L-MYB loci on foetal haemoglobin levels in β-thalassemia major and Intermedia patients. | Bashir S, Mahmood S, Mohsin S, Tabassum I, Ghafoor M, Sajjad O | J Pak Med Assoc | 2021 |
| Cardiac iron overload evaluation in thalassaemic patients using T2* magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study. | Chapchap EC, Silva MMA, de Assis RA, Kerbauy LN, Diniz MDS, Rosemberg LA, Loggetto SR, Araujo ADS, Fabron Junior A, Verissimo MPA, Baldanzi GR, Esposito BP, Tricta F, Steagall MEA, Vellozo CÂGDS, Fertrin KY, Baroni RH, Hamerschlak N | Hematol Transfus Cell Ther | 2021 |
| Topical Vapocoolant-Associated Vaso-occlusive Event in a 10-year-old with Sickle Cell Disease. | Kothamasu A, MacDougall MS, Mallard J, Hsu LL | Pain Manag Nurs | 2021 |
| Genome-based therapeutic interventions for β-type hemoglobinopathies. | Karamperis K, Tsoumpeli MT, Kounelis F, Koromina M, Mitropoulou C, Moutinho C, Patrinos GP | Hum Genomics | 2021 |
| A scoping review of transition interventions for young adults with sickle cell disease. | Viola A, Porter J, Shipman J, Brooks E, Valrie C | Pediatr Blood Cancer | 2021 |
| Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. | Psatha N, Georgakopoulou A, Li C, Nandakumar V, Georgolopoulos G, Acosta R, Paschoudi K, Nelson J, Chee DR, Athanasiadou A, Kouvatsi A, Funnell A, Lieber A, Yannaki E, Papayannopoulou T | Blood | 2021 |
| Low back pain in beta thalassemia major revealing sacral extramedullay hematopoeisis: A case report. | Ahmad RW, Okar LA, Elhiday A, Almasri H, Ata F, Ahmed Mounir E, Barah A, Abdelrazek M, Gamil A, Sharaf Eldean MZ, Yassin MA | Clin Case Rep | 2021 |
| Hemodynamic and biological correlates of glomerular hyperfiltration in sickle cell patients before and under renin-angiotensin system blocker. | Haymann JP, Hammoudi N, Livrozet M, Santin A, Mattioni S, Letavernier E, Frochot V, Jacques CS, Steichen O, Grateau G, Chaignon M, Lionnet F | Sci Rep | 2021 |
| A Novel Mutation at : c.349G>T Causing α-Thalassemia in a Chinese Family. | Yin Z, Hao Y, Huang X, Chen X, Chen S, Li G, Chen C, Wei F | Hemoglobin | 2021 |
| Acupuncture for chronic pain in adults with sickle cell disease: a mixed-methods pilot study. | Li H, Patil CL, Molokie RE, Njoku F, Steffen AD, Doorenbos AZ, Schlaeger JM | Acupunct Med | 2021 |
| Association between pulmonary function and cardiac enzymes in sickle cell disease. | Antwi-Boasiako C, Asare MM, Baba I, Doku A, Adutwum-Ofosu K, Hayfron-Benjamin C, Asare CP, Aryee R, Dankwah GB, Ahenkorah J | Am J Blood Res | 2021 |
| Lower hair cortisol among patients with sickle cell disease may indicate decreased adrenal reserves. | Hollister BM, Zilbermint M, Minniti CP, Buscetta AJ, Abdallah KE, You S, Soldin SJ, Meyer JS, Stratakis CA, Bonham VL | Am J Blood Res | 2021 |
| Base editing of haematopoietic stem cells rescues sickle cell disease in mice. | Newby GA, Yen JS, Woodard KJ, Mayuranathan T, Lazzarotto CR, Li Y, Sheppard-Tillman H, Porter SN, Yao Y, Mayberry K, Everette KA, Jang Y, Podracky CJ, Thaman E, Lechauve C, Sharma A, Henderson JM, Richter MF, Zhao KT, Miller SM, Wang T, Koblan LW, McCaffrey AP, Tisdale JF, Kalfa TA, Pruett-Miller SM, Tsai SQ, Weiss MJ, Liu DR | Nature | 2021 |
| Troponin elevation in sickle cell disease. | Akkus NI, Rajpal S, Hilbun J, Dwary A, Smith TR, Mina G, Reddy PC | Med Princ Pract | 2021 |
| Stroke and stroke prevention in sickle cell anemia in developed and selected developing countries. | Bhattacharya P, Sarmah D, Dave KR, Goswami A, Watanabe M, Wang X, Kalia K, Plesnila N, Yavagal DR, Alvarez O | J Neurol Sci | 2021 |
| SARS-CoV-2 infection in patients with sickle cell disease. | Argüello-Marina M, López-Rubio M, Morado M | Med Clin (Barc) | 2021 |
| Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing. | Adekile A, Akbulut-Jeradi N, Al Khaldi R, Fernandez MJ, Sukumaran J | J Pers Med | 2021 |
| Dietary ω-3 Fatty Acid Supplementation Improves Murine Sickle Cell Bone Disease and Reprograms Adipogenesis. | Valenti MT, Mattè A, Federti E, Puder M, Anez-Bustillos L, Deiana M, Cheri S, Minoia A, Brugnara C, Di Paolo ML, Dalle Carbonare L, De Franceschi L | Antioxidants (Basel) | 2021 |
| Epigenetic Insights and Potential Modifiers as Therapeutic Targets in -Thalassemia. | Zakaria NA, Islam MA, Abdullah WZ, Bahar R, Mohamed Yusoff AA, Abdul Wahab R, Shamsuddin S, Johan MF | Biomolecules | 2021 |
| Letter to the Editor: Physicians' Opinions of COVID-19 Ambulatory Care Constraints: A Survey of Sickle Cell Clinicians. | Kenney MO, Becerra B, Beatty SA, Smith W | J Ambul Care Manage | 2021 |
| Women with sickle cell disease report low knowledge and use of long acting reversible contraception. | Pecker LH, Hussain S, Lanzkron S, Tao X, Thaler K, Burke AE, Whaley N | J Natl Med Assoc | 2021 |
| Acupuncture as an Adjunctive Treatment for Pain in Hospitalized Children With Sickle Cell Disease. | Reece-Stremtan S, Mahmood L, Margulies S, Martin B, Rohatgi R, Idiokitas R, Cohen IT, Zhang A, Thaniel L, Hardy SJ, Darbari DS | J Pain Symptom Manage | 2021 |
| Association of Sickle Cell Trait on Career and Operational Outcomes in the United States Air Force. | Ebert EP, Escobar JD, Costello AA, Webber BJ | Mil Med | 2021 |
| Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation. | Fu YH, Ou DL, Yang YR, Su KW, Chen CY, Tien HF, Lai ZS, Shen CJ, Chien HF, Lin LI | Cancer Gene Ther | 2021 |
| Sickle-trait hemoglobin reduces adhesion to both CD36 and EPCR by Plasmodium falciparum-infected erythrocytes. | Petersen JEV, Saelens JW, Freedman E, Turner L, Lavstsen T, Fairhurst RM, Diakité M, Taylor SM | PLoS Pathog | 2021 |
| Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both or neither. | Jones RJ, DeBaun MR | Blood | 2021 |
| Risk factors for CKD stage II onset in a prospective cohort of homozygous sickle cell adults. | Roger C, Lionnet F, Mattioni S, Livrozet M, Steichen O, Letavernier E, Hammoudi N, Avellino V, Haymann JP | Am J Hematol | 2021 |
| Prolonged QTc Interval in Nigerian Children with Sickle Cell Anemia. | Anah MU, Nlemadim AC, Uzomba CI, Ineji EO, Odey FA | Hemoglobin | 2021 |
| Discrimination of Iron Deficiency, Alpha and Beta Thalassemia on the Basis of Red Cell Distribution Width and Reticulocyte Indices. | Saboor M | Clin Lab | 2021 |
| CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Reply. | Frangoul H, Ho TW, Corbacioglu S | N Engl J Med | 2021 |
| CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. | Mehta J | N Engl J Med | 2021 |
| CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. | Meisel R | N Engl J Med | 2021 |
| Integrating a problem-solving intervention with routine care to improve psychosocial functioning among mothers of children with sickle cell disease: A randomized controlled trial. | Asnani MR, Francis D, Knight-Madden J, Chang-Lopez S, King L, Walker S | PLoS One | 2021 |
| [Genetic Diagnosis of Thalassemia in Baise, Guangxi Zhuang Autonomous Region]. | Lu H, Qin Q, Li JH, Chen T, Liang SJ, Lu XS | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Analysis of Gene Deficiency Types of Thalassemia in Lingui District of Guilin City]. | Xiang XH, Leng J, Wang D, Mo LJ, Jiang W, Wei CD | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Diagnostic Cut-Off Value of RDW for Screening Thalassemia and the Combined Determination of MCV, MCH, HBA and RDW]. | Song QL, Guo YL, He YJ, He C, Zhang T, Cai Y, Liu W, Zhu XC, Liu QS | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| Base editing rescues sickle cell disease. | Crunkhorn S | Nat Rev Drug Discov | 2021 |
| A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients. | Theppornpitak K, Trakarnsanga B, Lauhasurayotin S, Poparn H, Chiengthong K, Sosothikul D, Techavichit P | Hemoglobin | 2021 |
| Prenatal exposure to maternal β-thalassemia minor and the risk for long-term hematologic morbidity in the offspring: A population-based cohort study. | Adler A, Wainstock T, Sheiner E | Early Hum Dev | 2021 |
| Chronic opioid use in patients with sickle cell disease. | Mo G, Jang T, Stewart C, Khoury L, Ferguson N, Egini O, Muthu J, Dutta D, Salifu M, Lim SH | Hematology | 2021 |
| SNAP: Supportive noninvasive ventilation for acute chest syndrome prevention in children with sickle cell disease. | Guenther CS, Pae VJ, Neri CM, Barry K, Duggan MA, Cohen RT | Pediatr Blood Cancer | 2021 |
| Elevated Hb A is Not Always Indicative of β-Thalassemia. | Luo LP, Ma L, Lin SB, Huang JG | Hemoglobin | 2021 |
| [Gene therapy now enters many clinical disciplines]. | I Edvard Smith C, Blomberg P | Lakartidningen | 2021 |
| Research in Sickle Cell Disease: From Bedside to Bench to Bedside. | Salinas Cisneros G, Thein SL | Hemasphere | 2021 |
| Evaluation of point-of-care International Normalized Ratio in sickle cell disease. | Rahman S, Srisuwananukorn A, Molokie RE, Gowhari M, Njoku F, Hussain FA, Lee J, Nutescu EA, Gordeuk VR, Saraf SL, Han J | Res Pract Thromb Haemost | 2021 |
| MWC allosteric model explains unusual hemoglobin-oxygen binding curves from sickle cell drug binding. | Henry ER, Harper J, Glass KE, Metaferia B, Louis JM, Eaton WA | Biophys J | 2021 |
| Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population. | Gowda L, Vege S, Kessler D, Shaz B, Westhoff CM | Transfusion | 2021 |
| The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients. | Chaosuwannakit N, Makarawate P, Wanitpongpun C | Tomography | 2021 |
| Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease. | Lance EI, Faulcon LM, Fu Z, Yang J, Whyte-Stewart D, Strouse JJ, Barron-Casella E, Jones K, Van Eyk JE, Casella JF, Everett AD | Proteomics Clin Appl | 2021 |
| SARS-CoV-2 infection in patients with β-thalassemia: Experience from Lebanon. | Bou-Fakhredin R, Daadaa H, Koussa S, Abou Nasr T, Noun P, Taher AT | Am J Hematol | 2021 |
| Sustained fetal hemoglobin induction in vivo is achieved by interference and coexpressed truncated erythropoietin receptor. | Uchida N, Ferrara F, Drysdale CM, Yapundich M, Gamer J, Nassehi T, DiNicola J, Shibata Y, Wielgosz M, Kim YS, Bauler M, Throm RE, Haro-Mora JJ, Demirci S, Bonifacino AC, Krouse AE, Linde NS, Donahue RE, Ryu B, Tisdale JF | Sci Transl Med | 2021 |
| Choroid plexus perfusion in sickle cell disease and moyamoya vasculopathy: Implications for glymphatic flow. | Johnson SE, McKnight CD, Jordan LC, Claassen DO, Waddle S, Lee C, Garza M, Patel NJ, Davis LT, Pruthi S, Trujillo P, Chitale R, Fusco M, Donahue MJ | J Cereb Blood Flow Metab | 2021 |
| Health design solutions to improve the care of sickle cell patients with vaso-occlusive crisis in the emergency department. | Morrison G | Eur J Emerg Med | 2021 |
| Insights into the skin microbiome of sickle cell disease leg ulcers. | Byeon J, Blizinsky KD, Persaud A, Findley K, Lee JJ, Buscetta AJ, You S, Bittinger K, Minniti CP, Bonham VL, Grice EA | Wound Repair Regen | 2021 |
| The Influence of Health-Seeking Behaviors on the Health Literacy of Adolescents With Sickle Cell Disease. | Caldwell EP, Rosonet LE | J Pediatr Oncol Nurs | 2021 |
| Hyperhaemolysis in a pregnant woman with a homozygous β -thalassemia mutation and two genetic modifiers. | Jiwu L, Manna S, Lai M, Ying Z, Yanhui L | Mol Genet Genomic Med | 2021 |
| Assessment of Hemoglobin A2 stability at room temperature during 24 or 25 days as measured by high pressure liquid chromatography and capillary electrophoresis. | Hildrum JM, Fjeld B, Risahagen SM, Bernatek BJ, Klingenberg O | Int J Lab Hematol | 2021 |
| Impairment of Cerebrovascular Hemodynamics in Patients With Severe and Milder Forms of Sickle Cell Disease. | Afzali-Hashemi L, Baas KPA, Schrantee A, Coolen BF, van Osch MJP, Spann SM, Nur E, Wood JC, Biemond BJ, Nederveen AJ | Front Physiol | 2021 |
| Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation. | Friedman D, Dozor AJ, Milner J, D'Souza M, Talano JA, Moore TB, Shenoy S, Shi Q, Walters MC, Vichinsky E, Parsons SK, Braniecki S, Moorthy CR, Ayello J, Flower A, Morris E, Mahanti H, Fabricatore S, Klejmont L, van de Ven C, Baxter-Lowe LA, Cairo MS | Bone Marrow Transplant | 2021 |
| Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease. | Leonard A, Sharma A, Uchida N, Stroncek D, Panch SR, West K, Molloy E, Hughes TE, Hauffe S, Taylor T, Fitzhugh C, Hankins JS, Wilson M, Tsai SQ, Weiss MJ, Hsieh M, Tisdale JF | Blood Adv | 2021 |
| Transfusion management of severe anaemia in African children: a consensus algorithm. | Maitland K, Kiguli S, Olupot-Olupot P, Opoka RO, Chimalizeni Y, Alaroker F, Uyoga S, Kyeyune-Byabazaire D, M'baya B, Bates I, Williams TN, Munube D, Mbanya D, Molyneux EM, South A, Walker AS, Gibb DM, George EC, | Br J Haematol | 2021 |
| Iron Status in Newly Diagnosed -Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive. | Susanah S, Rakhmilla LE, Ghozali M, Trisaputra JO, Moestopo O, Sribudiani Y, Idjradinata PS, Maskoen AM | Biomed Res Int | 2021 |
| Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients. | Fianza PI, Rahmawati A, Widihastha SH, Afifah S, Ghozali M, Indrajaya A, Pratama DMA, Prasetya D, Sihite TA, Syamsunarno MRAA, Setiabudi D, Fucharoen S, Panigoro R | Anemia | 2021 |
| Occlusal Disorders in Patients with Sickle Cell Disease: Critical Literature Review. | Lopes CMI, Lira SS, da Silva Oliveira JC, Alves E Luna AC, de Melo Valença PA, de Menezes VA | J Clin Pediatr Dent | 2021 |
| Mobile health use predicts self-efficacy and self-management in adolescents with sickle cell disease. | Hood AM, Nwankwo C, Walton A, McTate E, Joffe N, Quinn CT, Britto MT, Peugh J, Mara CA, Crosby LE | Transl Behav Med | 2021 |
| Living with thalassaemia in Papua New Guinea, the experience of children, adolescents and their families. | Nagiria VR, Vince JD, Duke T | J Paediatr Child Health | 2021 |
| Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial. | Gamberini MR, Fortini M, Stievano A, Calori E, Riontino MV, Ceccherelli G, Venturelli D, Chicchi R, Biguzzi R, Fagnoni F, Portararo GA, Lasagni D, Borotti E, Buonocore R, Govoni M, Reverberi R | Transfusion | 2021 |
| Preclinical evaluation for engraftment of CD34 cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models. | Uchida N, Li L, Nassehi T, Drysdale CM, Yapundich M, Gamer J, Haro-Mora JJ, Demirci S, Leonard A, Bonifacino AC, Krouse AE, Linde NS, Allen C, Peshwa MV, De Ravin SS, Donahue RE, Malech HL, Tisdale JF | Cell Rep Med | 2021 |
| Enhancing fetal haemoglobin induction. | Crunkhorn S | Nat Rev Drug Discov | 2021 |
| The Spectrum of β-Thalassemia Mutations in the Population Migration in Lebanon: A 6-Year Retrospective Study. | Farra C, Abdouni L, Souaid M, Awwad J, Yazbeck N, Abboud M | Hemoglobin | 2021 |
| Accuracy of Pulse Oximetry in the Presence of Fetal Hemoglobin-A Systematic Review. | Pritišanac E, Urlesberger B, Schwaberger B, Pichler G | Children (Basel) | 2021 |
| Anemia at Altitude: Thalassemia, Sickle Cell Disease, and Other Inherited Anemias. | DeLoughery TG | High Alt Med Biol | 2021 |
| Left ventricular systolic dyssynchrony index and endothelial dysfunction parameters as subclinical predictors of cardiovascular involvement in patients with beta-thalassemia major. | Solmaz H, Cabuk AK, Altin Z, Albudak Ozcan E, Ozdogan O | Echocardiography | 2021 |
| FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice. | Shrestha A, Chi M, Wagner K, Malik A, Korpik J, Drake A, Fulzele K, Guichard S, Malik P | Blood Adv | 2021 |
| Natural history of alpha-thalassemia X-linked intellectual disability syndrome: A case report of a 45-year-old man. | Arvio M, Lähdetie J | Am J Med Genet A | 2021 |
| SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia. | Vadolas J, Ng GZ, Kysenius K, Crouch PJ, Dames S, Eisermann M, Nualkaew T, Vilcassim S, Schaeper U, Grigoriadis G | Br J Haematol | 2021 |
| Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleation. | Feola M, Zamperone A, Moskop D, Chen H, Casu C, Lama D, Di Martino J, Djedaini M, Papa L, Martinez MR, Choesang T, Bravo-Cordero JJ, MacKay M, Zumbo P, Brinkman N, Abrams CS, Rivella S, Hattangadi S, Mason CE, Hoffman R, Ji P, Follenzi A, Ginzburg YZ | Commun Biol | 2021 |
| COVID-19 Presentation in Patients with Sickle Cell Disease: A Case Series. | Chen-Goodspeed A, Idowu M | Am J Case Rep | 2021 |
| Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia. | Nualkaew T, Sii-Felice K, Giorgi M, McColl B, Gouzil J, Glaser A, Voon HPJ, Tee HY, Grigoriadis G, Svasti S, Fucharoen S, Hongeng S, Leboulch P, Payen E, Vadolas J | Mol Ther | 2021 |
| Hemodynamic response to sensory stimulation in mice: Comparison between functional ultrasound and optoacoustic imaging. | Robin J, Rau R, Lafci B, Schroeter A, Reiss M, Deán-Ben XL, Goksel O, Razansky D | Neuroimage | 2021 |
| Hemoglobin fractionation by Sebia Capillarys 2 Flex Piercing System as primary method for evaluation of hemoglobinopathies. | Poventud-Fuentes I, Garnett E, Vispo B, Elghetany MT, Devaraj S | Clin Chim Acta | 2021 |
| Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency. | Wessels MW, Cnossen MH, van Dijk TB, Gillemans N, Schmidt KLJ, van Lom K, Vinjamur DS, Coyne S, Kurita R, Nakamura Y, de Man SA, Pfundt R, Azmani Z, Brouwer RWW, Bauer DE, van den Hout MCGN, van IJcken WFJ, Philipsen S | Blood Adv | 2021 |
| Alternating and Concurrent True Hyperkalemia and Pseudohyperkalemia in Adult Sickle Cell Disease. | Onuigbo MA, Tan H, Sherman SE | Rambam Maimonides Med J | 2021 |
| Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease. | Wong TE, Valle J, Paulukonis S | Health Sci Rep | 2021 |
| Cardiac Chamber Quantification by Echocardiography in Adults With Sickle Cell Disease: Need Attention to Eccentric Hypertrophy. | Koyuncu MB, Tombak A, Orscelik O, Koseci T, Turker A, Basir H, Akdeniz A, Tiftik EN | Cureus | 2021 |
| Investigating the Role of Ferritin in Determining Sexual Underdevelopment in Beta-Thalassemia Major Patients: A Cross-Sectional Analysis From Pakistan. | Shahid Z, Hassan S, Ghazanfar S, Kaneez M, Khan MS, Tariq HT, Jawad A, Shuaib A, Bhatti AA, Razzaq MT | Cureus | 2021 |
| Sickle Cell Disease and the Respiratory System: A Tangential Perspective to the Hematopulmonological Dilemma. | Sange I, Cherukuri PB, Parchuri V, Srinivas N, Ramanan SP, Sange AH, Modi S, Khot FA | Cureus | 2021 |
| Opioid-Induced Psychosis in a Patient With Sickle Cell Disease. | Tumenta T, Thanju A, Perera P, Kallikkadan J, Fouron P, Olupona T | Cureus | 2021 |
| A Retrospective Long-Term Study on Age at Menarche and Menstrual Characteristics in 85 Young Women with Transfusion-Dependent β-Thalassemia (TDT). | Di Maio S, Marzuillo P, Mariannis D, Christou S, Ellinides A, Christodoulides C, de Sanctis V | Mediterr J Hematol Infect Dis | 2021 |
| Acute soft head syndrome in a sickle cell disease patient. | Zadeh C, Rameh V, Atweh LA | J Radiol Case Rep | 2021 |
| Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz, Iran. | Nasimzadeh S, Azaran A, Jalilian S, Makvandi M, Seyedian SS, Keikhaei B, Mehr FJ | Arch Virol | 2021 |
| Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience. | John TD, Friend B, Yassine K, Sasa G, Bhar S, Salem B, Omer B, Craddock J, Doherty E, Martinez C, Heslop HE, Krance RA, Leung K | Bone Marrow Transplant | 2021 |
| Impact of hemoglobin biophysical studies on molecular pathogenesis and drug therapy for sickle cell disease. | Eaton WA | Mol Aspects Med | 2021 |
| Platelet counts on peripheral blood and Mean Platelet Volume as markers of clinical severity in Sickle Cell Disease. | Silva CM, de Souza Medina S, de Melo Campos P, Costa FF, Saad STO, Benites BD | Blood Cells Mol Dis | 2021 |
| Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood. | Heitzer AM, Longoria J, Okhomina V, Wang WC, Raches D, Potter B, Jacola LM, Porter J, Schreiber JE, King AA, Kang G, Hankins JS | Br J Haematol | 2021 |
| The effect of sickle cell anemia on the linear growth of Nigerian children. | Chikani UN, Bisi-Onyemaechi A, Ohuche I, Onu J, Ugege S, Ogugua C, Mbanefo N, Chime P, Emodi I | J Pediatr Endocrinol Metab | 2021 |
| Molecular and phenotype characterization of an elongated β-globin variant produced by HBB:C.313delA. | Lin W, Zhang Q, Shen Z, Qu X, Wang Q, Wei L, Qiu Y, Yang J, Xu X, Lao J | Int J Lab Hematol | 2021 |
| Thoracic epidural analgesia for pediatric patients with sickle cell disease acute chest syndrome: The resurgence of an old technique. | Henry T, Wyatt K | Paediatr Anaesth | 2021 |
| Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study. | Njoku F, Zhang X, Shah BN, Machado RF, Han J, Saraf SL, Gordeuk VR | Br J Haematol | 2021 |
| COVID-19 in a pregnant patient with beta-thalassemia major: A case report. | Hailan YMA, Sayed G, Yassin MA | Clin Case Rep | 2021 |
| Comparative Effectiveness of a Six-Week Treatment Course of Vitamin D and D in Children With Sickle Cell Anemia in Steady State With Hypovitaminosis D: A Randomized Clinical Trial. | Adekunle MO, Dada AO, Njokanma FO, Solarin AU, Animasahun BA, Lamina MO | J Hematol | 2021 |
| Frequencies of Beta Thalassemia Mutations Show Different Pattern in Bannu Region than Other Parts of Pashtun Population in Khyber Pakhtunkhwa Province Pakistan. | Rehman SU, Shakeel M, Azam M, Akhtar S, Ziaullah , Niazi R | Indian J Hematol Blood Transfus | 2021 |
| Unmanipulated Stem Cell Boost for Mixed Chimerism in Transfusion Dependent Thalassemia. | Garg A, Shivchhand A, Shah S, Shah K, Patel K, Panchal H, Patel A, Parikh S | Indian J Hematol Blood Transfus | 2021 |
| Role of Red Cell Indices in Screening for Beta Thalassemia Trait: an Assessment of the Individual Indices and Application of Machine Learning Algorithm. | Jahan A, Singh G, Gupta R, Sarin N, Singh S | Indian J Hematol Blood Transfus | 2021 |
| Prenatal Screening and Diagnosis of ß-Thalassemia in India: Is ARMS-PCR Enough? | Ghosh S, Chakrabarti S, Bhattacharyya M | Indian J Hematol Blood Transfus | 2021 |
| Design and Development of Reverse Slot Blot for the Simultaneous Detection of Rare and Regional Specific Mutations in the Beta Globin Gene in Khuzestan Province of Iran. | Galehdari H, Bijanzadeh M, Azarshin SZ, Shafee M, Heydaran S | Indian J Hematol Blood Transfus | 2021 |
| Screening of Dry Blood Spots from Newborns by Two High Performance Liquid Chromatography (HPLC) Systems: A Comparison of Their Ability to Diagnose Both Sickle and Non-sickle Hemoglobinopathies. | Ramani Daruwalla M, Das Gupta A, Pawar R | Indian J Hematol Blood Transfus | 2021 |
| Severe Pain Profiles and Associated Sociodemographic and Clinical Characteristics in Individuals With Sickle Cell Disease. | Knisely MR, Tanabe PJ, Yang Q, Masese R, Jiang M, Shah NR | Clin J Pain | 2021 |
| Methemoglobin formation in mutant hemoglobin α chains: electron transfer parameters and rates. | Dixit VA, Blumberger J, Vyas SK | Biophys J | 2021 |
| Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors. | Gaartman AE, Sayedi AK, Gerritsma JJ, de Back TR, van Tuijn CF, Tang MW, Heijboer H, de Heer K, Biemond BJ, Nur E | Br J Haematol | 2021 |
| Hemoglobinopathies: ocular manifestations in children and adolescents. | Moussa O, Chen RWS | Ther Adv Ophthalmol | 2021 |
| Common, But Neglected: A Comprehensive Review of Leg Ulcers in Sickle Cell Disease. | Sahu T, Verma HK, Ganguly S, Sinha M, Sinha R | Adv Skin Wound Care | 2021 |
| Dengue fever as a potential cause of sickle cell intrahepatic cholestasis: A report of two cases. | Oliveira LR, Costa ALC, Almeida PV, Zago LBR, Silva VAD, Soares-Silva S | Rev Soc Bras Med Trop | 2021 |
| Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching. | Ang AL, Lim CY, Ng WY, Lam JCM | Transfusion | 2021 |
| The Spectrum of Beta-Thalassemia Mutations in Syrian Refugees and Turkish Citizens. | Gunes AK, Gozden HE | Cureus | 2021 |
| Six-point DIXON and Magnetic Resonance Spectroscopy Techniques in Quantifying Bone Marrow Fat in Sickle Cell Disease. | Lins CF, Salmon CEG, de Souza LA, Moraes RS, Silva-Pinto AC, Matos MA, Nogueira-Barbosa MH | Acad Radiol | 2021 |
| Reliability of different estimated glomerular filtration rate as measures of renal function in children with sickle cell disease. | Inusa BPD, Liguoro I, Tayo B, Booth C, Turner C, Dalton NR | Blood Cells Mol Dis | 2021 |
| METABOLIC BONE DISEASES IN SICKLE CELL ANEMIA PATIENTS AND EVALUATION OF ASSOCIATED FACTORS. | Eskiocak Ö, Yılmaz MÖ, İlhan G | Am J Med Sci | 2021 |
| Outcome of survivors with hemoglobin Bart's hydrops fetalis syndrome: The most severe form of α-thalassemia. | Jiang F, Li DZ | Pediatr Transplant | 2021 |
| A Comparison of Two Regimens for Managing Sickle Cell Pain and Reducing Readmissions. | Cheng E, Floroff C, Ingemi AI, Vasist N, Ko A, Goodman BM | J Pain Palliat Care Pharmacother | 2021 |
| Antibiotics to modify sickle cell disease vaso-occlusive crisis? | Stewart C, Jang T, Mo G, Mohamed N, Poplawska M, Egini O, Dutta D, Lim SH | Blood Rev | 2021 |
| Advances in mass spectrometric methods for detection of hemoglobin disorders. | Dasauni P, Chhabra V, Kumar G, Kundu S | Anal Biochem | 2021 |
| Serum Levels of Selected Elements in Patients with Beta Thalassemia Major. | Şahin A, Er EÖ, Öz E, Yıldırmak ZY, Bakırdere S | Biol Trace Elem Res | 2021 |
| Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and Tanzania. | Anie KA, Olayemi E, Paintsil V, Owusu-Dabo E, Adeyemo TA, Sani MU, Galadanci NA, Nnodu O, Tluway F, Adjei DN, Mensah P, Sarfo-Antwi J, Nwokobia H, Gambo A, Benjamin A, Salim A, Osae-Larbi JA, Ofori-Acquah SF, | BMJ Open | 2021 |
| System Level Informatics to Improve Triage Practices for Sickle Cell Disease Vaso-Occlusive Crisis: A Cluster Randomized Controlled Trial. | Linton E, Souffront K, Gordon L, Loo GT, Genes N, Glassberg J | J Emerg Nurs | 2021 |
| Age as a major factor associated with zinc and copper deficiencies in pediatric thalassemia. | Nimkarn N, Songdej D, Dumrongwongsiri O, Sirachainan N, Chuansumrit A, | J Trace Elem Med Biol | 2021 |
| Subclinical atherosclerotic predictive value of inflammatory markers in thalassemia intermedia patients. | Ahmad Ibrahim O, Ahmad AB, Nigm DA, Hussien AN, Mohammad Ibrahim WH | Expert Rev Hematol | 2021 |
| Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts. | Huang C, Qu Y, Liu S, Nie S, Jiang H | Transl Pediatr | 2021 |
| Prejudice impairing quality of life in sickle cell disease patients in a developing country: faces of suffering. | Rodrigues CFA, Rodrigues TA, de Oliveira EJSG, Garcia JBS, Cartágenes MDSS | Hematol Transfus Cell Ther | 2021 |
| Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease: a population-based study in the U.S. | Barbetta A, Goldbeck C, Lim A, Martin SP, Kahn JA, Sheikh MR, Emamaullee J | HPB (Oxford) | 2021 |
| Provider Attitudes, Preferences, and Practices Regarding Sexual and Reproductive Health for Adolescents and Young Adults With Sickle Cell Disease. | Leroy-Melamed M, Jacob S, Shew ML, Kazmerski TM | J Adolesc Health | 2021 |
| Sickle cell hepatopathy with spur cell anemia. | Rice L, Schwartz MR | Blood | 2021 |
| Sickle Cell Disease Care Planning for School Nurses. | Morse BL, Carmichael AE, Bradford VA, Pollard AL | NASN Sch Nurse | 2021 |
| Exploring epigenetic and microRNA approaches for γ-globin gene regulation. | Starlard-Davenport A, Fitzgerald A, Pace BS | Exp Biol Med (Maywood) | 2021 |
| Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. | Rankine-Mullings A, Reid M, Soares D, Taylor-Bryan C, Wisdom-Phipps M, Aldred K, Latham T, Schultz WH, Knight-Madden J, Badaloo A, Lane A, Adams RJ, Ware RE | Br J Haematol | 2021 |
| Correction Notice: Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm. | Baronciani D, Casale M, De Franceschi L, Graziadei G, Longo F, Origa R, Rigano P, Pinto V, Marchetti M, Gigante A, Forni GL. | Hemasphere | 2021 |
| Reactivation of a developmentally silenced embryonic globin gene. | King AJ, Songdej D, Downes DJ, Beagrie RA, Liu S, Buckley M, Hua P, Suciu MC, Marieke Oudelaar A, Hanssen LLP, Jeziorska D, Roberts N, Carpenter SJ, Francis H, Telenius J, Olijnik AA, Sharpe JA, Sloane-Stanley J, Eglinton J, Kassouf MT, Orkin SH, Pennacchio LA, Davies JOJ, Hughes JR, Higgs DR, Babbs C | Nat Commun | 2021 |
| Novel kidney injury biomarkers in a large cohort of children with sickle cell anemia. | Belisário AR, S Filha RD, de Almeida JA, Mendes FG, Rezende PV, Vieira ÉL, E Silva AC | Biomark Med | 2021 |
| Nurses' experiences of psychosocial care needs of children with thalassaemia and their families in Jordan: A phenomenological study. | Abu Shosha GM, Al-Kalaldeh M, Shoqirat N | Nurs Open | 2021 |
| Premarital genetic screening and care of Tanzanian children with sickle cell disease: a qualitative study on parents' views and experiences. | Kisanga E, Mutagonda R, Myemba DT, Njiro BJ, Simon F, Marealle AI, Mikomangwa WP, Kilonzi M, Sambayi G, Bwire GM | J Community Genet | 2021 |
| Contraception and reproductive planning from the perspective of women with sickle cell disease. | Pedrosa EN, Corrêa MSM, Ferreira ALCG, Sousa CEDS, Silva RAD, Souza AI | Rev Gaucha Enferm | 2021 |
| Transition care continuity promotes long-term retention in adult care among young adults with sickle cell disease. | Howell KE, Saulsberry-Abate AC, Mathias JG, Porter JS, Hodges JR, Ataga KI, Anderson S, Nolan V, Hankins JS | Pediatr Blood Cancer | 2021 |
| Characterizing Intracranial Hemodynamics in Sickle Cell Anemia: Impact of Patient-Specific Viscosity. | Keller SB, Bumpus JM, Gatenby JC, Yang E, Kassim AA, Dampier C, Gore JC, Buck AKW | Cardiovasc Eng Technol | 2021 |
| The wide spectrum of β-thalassaemia intermedia-induced pulmonary hypertension: two case reports on the possible role of specific pulmonary arterial hypertension therapy. | Anthi A, Tsiapras D, Karyofyllis P, Voudris V, Armaganidis A, Orfanos SE | Pulm Circ | 2021 |
| Safety of maximal cardiopulmonary exercise testing in individuals with sickle cell disease: a systematic review. | Smith KN, Baynard T, Fischbach PS, Hankins JS, Hsu LL, Murphy PM, Ness KK, Radom-Aizik S, Tang A, Liem RI | Br J Sports Med | 2021 |
| A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease. | Rampersaud E, Kang G, Palmer LE, Rashkin SR, Wang S, Bi W, Alberts NM, Anghelescu D, Barton M, Birch K, Boulos N, Brandow AM, Brooke RJ, Chang TC, Chen W, Cheng Y, Ding J, Easton J, Hodges JR, Kanne CK, Levy S, Mulder H, Patel AP, Puri L, Rosencrance C, Rusch M, Sapkota Y, Sioson E, Sharma A, Tang X, Thrasher A, Wang W, Yao Y, Yasui Y, Yergeau D, Hankins JS, Sheehan VA, Downing JR, Estepp JH, Zhang J, DeBaun M, Wu G, Weiss MJ | Blood Adv | 2021 |
| Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs. | Longo F, Piolatto A, Ferrero GB, Piga A | Int J Mol Sci | 2021 |
| Compound Heterozygosity for Mutations Causing Hemolytic Anemia in Children: A Case Report and Literature Review. | Xu L, Zhu D, Zhang Y, Liang G, Liang M, Wei X, Feng X, Wu X, Shang X | Front Genet | 2021 |
| Genetic counseling and prenatal decision for hemoglobin H disease caused by the rare α2 codon 30 (-GAG) (HBA2: c.91_93delGAG) mutation and the SEA deletion: Case series study. | Guan ZY, Zhong ZY, He HL, Chen D, Zhong GX, Yang KX, Chen JH | Taiwan J Obstet Gynecol | 2021 |
| Pancreatic MR imaging and endocrine complications in patients with beta-thalassemia: a single-center experience. | Sevimli C, Yilmaz Y, Bayramoglu Z, Comert RG, Gul N, Dursun M, Karakas Z | Clin Exp Med | 2021 |
| Spontaneous Reversal of Peripheral Nonperfusion in Sickle Cell Retinopathy. | Ramtohul P, Minvielle W, Couturier A | Ophthalmol Retina | 2021 |
| Epidemiology and disease burden of sickle cell disease in France: A descriptive study based on a French nationwide claim database. | Leleu H, Arlet JB, Habibi A, Etienne-Julan M, Khellaf M, Adjibi Y, Pirenne F, Pitel M, Granghaud A, Sinniah C, De Montalembert M, Galacteros F | PLoS One | 2021 |
| Correlations between Iron Load and CD4 in Adult Transfusion-Dependent Beta Thalassemia. | Atmakusuma TD, Girson R, Koesnoe S | Anemia | 2021 |
| Is the HIV Seroprevalence among Iraqi Patients with β-thalassemia Major Underestimated or not Prevalent? | Al-Mendalawi MD | Oman Med J | 2021 |
| Systemic T Cell Subsets and Cytokines in Patients With Homozygous Sickle Cell Disease and Asymptomatic Urinary Tract Infections in Togo. | Tchopba CN, Katawa G, Padaro E, Tchadié PE, Karou SD, Vovor A, Ameyapoh Y | Ochsner J | 2021 |
| Binasal Visual Field Defects Due to Sickle Cell Maculopathy. | Kwok JM, Jeeva-Patel T, Margolin EA | J Neuroophthalmol | 2021 |
| [Sickle cell disease in pediatric intensive care]. | Cieza-Asenjo R, García-Morín M, Escobar-Fernández L, Cela-de Julián E, Slöcker-Barrio M, Herrera-Castillo L | An Pediatr (Barc) | 2021 |
| Hidden brain iron content in sickle cell disease: impact on neurocognitive functions. | Elalfy MS, Ibrahim AS, Ibrahim GS, Hussein HMAG, Mohammed HGE, Ebeid FSE | Eur J Pediatr | 2021 |
| Digital thermography and vascular involvement in β-thalassemia intermedia. | Abdulhai F, Jaffa MA, Elias J, Zakka P, Hotait M, Bou-Fakhredin R, Arnaout S, Taher AT, Refaat MM | Ann Hematol | 2021 |
| The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease. | Delgado J, Voltz C, Stain M, Lapveteläinen T, Urach S, Lähteenvuo J, Penttilä K, Gisselbrecht C, Enzmann H, Pignatti F | Hemasphere | 2021 |
| Acute Liver Failure From Sickle Cell Hepatopathy Treated With Exchange Transfusion. | Kassem AN, Park C, Rajkumar A | Cureus | 2021 |
| Assessment of Factors Associated with the Effectiveness of Premarital Screening for Hemoglobinopathies in the South of Saudi Arabia. | Gosadi IM, Gohal GA, Dalak AE, Alnami AA, Aljabri NA, Zurayyir AJ | Int J Gen Med | 2021 |
| Graphite Bio: gene editing blood stem cells for sickle cell disease. | Eisenstein M | Nat Biotechnol | 2021 |
| Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients. | Costa TCM, Chiari-Correia R, Salmon CEG, Darrigo-Junior LG, Grecco CES, Pieroni F, Faria JTB, Stracieri ABPL, Dias JBE, de Moraes DA, Oliveira MC, Guerino-Cunha R, Santos AC, Simões BP | Bone Marrow Transplant | 2021 |
| Hb Tacoma: G>T or G>C, and Does It Matter? | Moore JA, Pullon BM, Wang D, Brennan SO | Hemoglobin | 2021 |
| Gene Therapy for Sickle Cell Disease - Moving from the Bench to the Bedside. | Abraham AA, Tisdale JF | Blood | 2021 |
| Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study. | Elsherif L, Scott LC, Wichlan D, Jones SK, Mathias JG, Shen JH, Smeltzer MP, Ataga KI | Br J Haematol | 2021 |
| Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease. | Pecker LH, Sharma D, Nero A, Paidas MJ, Ware RE, James AH, Smith-Whitley K | Br J Haematol | 2021 |
| Ring the Bell for Sickle Cell: Encouraging Advocacy in an Underserved Community. | Bloom EM, Hampton KC, Blackwell K, Gibson GA, Roberson C, Meier ER | Health Promot Pract | 2021 |
| Real-Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT-HU cohort study. | de Montalembert M, Voskaridou E, Oevermann L, Cannas G, Habibi A, Loko G, Joseph L, Colombatti R, Bartolucci P, Brousse V, Galactéros F, | Am J Hematol | 2021 |
| The different facets of sickle cell disease-related pulmonary hypertension. | Prohaska CC, Machado RF | Curr Opin Pulm Med | 2021 |
| One Small Step for Sickle Cell Disease: Many More to Go. | Kanter J | Ann Intern Med | 2021 |
| Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study. | Lanzkron S, Little J, Wang H, Field JJ, Shows JR, Haywood C, Saheed M, Proudford M, Robertson D, Kincaid A, Burgess L, Green C, Seufert R, Brooks J, Piehet A, Griffin B, Arnold N, Frymark S, Wallace M, Al Hamayel NA, Huang CY, Segal JB, Varadhan R | Ann Intern Med | 2021 |
| Sickle-cell anemia gene therapy. | Alam O | Nat Genet | 2021 |
| [Hematologic Phenotype and Genotype Analysis of Patients with Hemoglobin Variants]. | Wang YF, Wu BY, Xia WQ, Chen N, Hu YQ | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Preimplantation Genetic Diagnosis of α/β Complex Thalassemia by Next Generation Sequencing]. | He TW, Lu J, Chen CQ, Zhou WN, Li JS, Dong YQ, DU L, Yin AH | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Genetic Effect Analysis of β-globin Gene 3'UTR+101G>C (HBB:c. *233G>C) Variant]. | DU L, Yao CZ, Bao XQ, Liang J, Yuan TL, Qin DQ, Wang JC | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Genetic Testing for Alpha and Beta Thalassemia in Children in Quanzhou Region of Fujian Province in China]. | Huang SJ, Chen WL, Zhuang JL, Zhuang QM, Zeng JX, Wang YB | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Retrospective Analysis of Hematological Phenotypes in Patients with Gene Mutation and Deletion α-Thalassemia]. | Xie WH, Huang LH, Yu XG, Huang H, Huang JM, Chen PS | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Differential Diagnosis of Three Commonest Deletion β-Thalassemia in Chinese]. | Wang JC, Yao CZ, Huang YL, Liu L, Yuan TL, Qin DQ | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica. | Brown BJ, Madu A, Sangeda RZ, Nkya S, Peprah E, Paintsil V, Mmbando BP, Gyamfi J, Okocha CE, Asala SA, Nembaware V, Jonas M, Kengne AP, Chimusa ER, Nguweneza A, Isa HA, Nnebe-Agumadu U, Adekile AD, Osei-Akoto A, Ohene-Frempong K, Balandya E, Nnodu OE, Wonkam A, Makani J, | Hemoglobin | 2021 |
| Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia. | Manara R, Ponticorvo S, Perrotta S, Barillari MR, Costa G, Brotto D, Di Concilio R, Ciancio A, De Michele E, Carafa PA, Canna A, Russo AG, Troisi D, Caiazza M, Ammendola F, Roberti D, Santoro C, Picariello S, Valentino MS, Inserra E, Carfora R, Cirillo M, Raimo S, Santangelo G, di Salle F, Esposito F, Tartaglione I | Orphanet J Rare Dis | 2021 |
| High Systolic Blood Pressure, Anterior Segment Changes and Visual Impairment Independently Predict Sickle Cell Retinopathy. | Idris IM, Yusuf AA, Gwarzo DH, Kurawa MS, Shuaib A, Galadanci AA, Ibrahim H, Borodo AM, Jobbi YD, Danagundi MB, Borodo SB, Mohammed IY, Galadanci NA, Kuliya-Gwarzo A | Hemoglobin | 2021 |
| Evaluation of interference from hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by fifteen methods. | Rohlfing C, Hanson S, Estey MP, Bordeleau P, Little RR | Clin Chim Acta | 2021 |
| Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease. | Longoria JN, Pugh NL, Gordeuk V, Hsu LL, Treadwell M, King AA, Gibson R, Kayle M, Crego N, Glassberg J, Melvin CL, Hankins JS, Porter J | Am J Hematol | 2021 |
| Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - A fifteen hospital observational study in the Bronx, New York. | Hoogenboom WS, Fleysher R, Soby S, Mirhaji P, Mitchell WB, Morrone KA, Manwani D, Duong TQ | Haematologica | 2021 |
| Assessment of Renal function status in steady state Sickle Cell Anaemic children using urine human Neutrophil Gelatinase-associated Lipocalin and Albumin:Creatinine ratio. | Olawale OO, Adekanmbi AF, Sonuga AA, Sonuga OO, Akodu SO, Ogundeyi MM | Med Princ Pract | 2021 |
| 2021 update on clinical trials in β-thalassemia. | Musallam KM, Bou-Fakhredin R, Cappellini MD, Taher AT | Am J Hematol | 2021 |
| 'Look into Their Hearts' 7-Year-Old Boy with Sickle Cell Disease, Fever, Left Sixth and Seventh Cranial Nerve Palsy and Left Hemiplegia. | Jabateh SM, Mohsenibod H | J Trop Pediatr | 2021 |
| Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case-control study. | Rincón-López EM, Navarro Gómez ML, Hernández-Sampelayo Matos T, Aguilera-Alonso D, Dueñas Moreno E, Saavedra-Lozano J, Santiago García B, Santos Sebastián MDM, García Morín M, Beléndez Bieler C, Lorente Romero J, Cela de Julián E, | BMC Infect Dis | 2021 |
| Sickle Cell Disease and the Kidney: Pathophysiology and Novel Biomarkers. | Lemes RPG, Rocha Laurentino M, Castelo LR, Silva Junior G | Contrib Nephrol | 2021 |
| Analysis of δ-globin gene alleles in Tunisians: description of three new delta-thalassemia mutations. | Kasmi C, Amri Y, Hadj-Fredj S, Oueslati S, Dabboussi M, Mahjoub R, Hammami S, Aljane I, Mami FB, Jamoussi H, Messaoud T, Bibi A | Mol Biol Rep | 2021 |
| Activation of γ-globin gene expression by GATA1 and NF-Y in hereditary persistence of fetal hemoglobin. | Doerfler PA, Feng R, Li Y, Palmer LE, Porter SN, Bell HW, Crossley M, Pruett-Miller SM, Cheng Y, Weiss MJ | Nat Genet | 2021 |
| Evaluation of role of HPLC (Merits & Pitfalls), in the diagnosis of various hemoglobinopathies & thalassemic syndromes. | Baig MA, Swamy KB, Baksh AD, Bahashwan A, Moshrif Y, Al Sawat A, Al Mutairi N, Alharbi N | Indian J Pathol Microbiol | 2021 |
| Neurologic and Cognitive Outcomes in Sickle Cell Disease from Infancy through Adolescence. | Mayer SL, Fields ME, Hulbert ML | Neoreviews | 2021 |
| Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease. | Karkoska K | Br J Haematol | 2021 |
| The promise and role of point of care testing to reduce the global burden of sickle cell disease through early diagnosis and linkage to care. | Dexter D, McGann PT | Br J Haematol | 2021 |
| Impact of the human leucocyte antigen (HLA)-B leader peptide dimorphism and HLA-A expression on outcomes of stem cell transplantation for sickle cell disease. | Cappelli B, Scigliuolo GM, Boukouaci W, Rafii H, Volt F, Kenzey C, Maio KT, Chabannon C, Corbacioglu S, Rocha V, Ruggeri A, Gluckman E, Tamouza R | Br J Haematol | 2021 |
| A qualitative exploration of health-related quality of life and health behaviours in children with sickle cell disease and healthy siblings. | Constantinou C, Payne N, van den Akker O, Inusa B | Psychol Health | 2021 |
| Correction: Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department. | Lanzkron S, Little J, Wang H, Field JJ, Shows JR, Haywood C Jr, Saheed M, Proudford M, Robertson D, Kincaid A, Burgess L, Green C, Seufert R, Brooks J, Piehet A, Griffin B, Arnold N, Frymark S, Wallace M, Al Hamayel NA, Huang CY, Segal JB, Varadhan R. | Ann Intern Med | 2021 |
| Clinical utility of Abbott Alinity hq extended red blood cell parameters in differentiating β-thalassemia trait and iron deficiency anemia. | Mukhtar Z, Valente S, Masi L, Lakos G, Papa F | Int J Lab Hematol | 2021 |
| Pain Intensity Assessment in Sickle Cell Disease Patients Using Vital Signs During Hospital Visits. | Padhee S, Alambo A, Banerjee T, Subramaniam A, Abrams DM, Nave GK, Shah N | Pattern Recognit (2021) | 2021 |
| Increased Prevalence of Alloimmunization in Sickle Cell Disease? Should We Restore Blood Donation in French Guiana? | Conrath S, Vantilcke V, Parisot M, Maire F, Selles P, Elenga N | Front Med (Lausanne) | 2021 |
| Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia. | Kansal AR, Reifsnider OS, Brand SB, Hawkins N, Coughlan A, Li S, Cragin L, Paramore C, Dietz AC, Caro JJ | J Mark Access Health Policy | 2021 |
| Rare Presentation of Right Adrenal Mass: Extramedullary Haematopoiesis in a Patient with Thalassaemia Intermedia. | Wong PS, Yong LS, Karim NAB, Gan EL, Toh SG, Adam NLB | J ASEAN Fed Endocr Soc | 2021 |
| Concurrent Bilateral Central Retinal Artery Occlusion Secondary to Sickle Cell Crisis. | Renganathan G, Natarajan P, Ruck L, Prieto R, Prakash BV, Thangarasu S | J Investig Med High Impact Case Rep | 2021 |
| Genome editing approaches to β-hemoglobinopathies. | Brusson M, Miccio A | Prog Mol Biol Transl Sci | 2021 |
| Increased Endothelial Cell Density in Childhood Patients With Thalassemia Major. | Seyyar SA, Tıskaoğlu NS, Gürbostan G, Pekpak E, Sayglı O | Eye Contact Lens | 2021 |
| Cerebral Oxygen Metabolic Stress, Microstructural Injury, and Infarction in Adults With Sickle Cell Disease. | Wang Y, Fellah S, Fields ME, Guilliams KP, Binkley MM, Eldeniz C, Shimony JS, Reis M, Vo KD, Chen Y, Lee JM, An H, Ford AL | Neurology | 2021 |
| "I can't breathe": how sickle cell disease manifests in the USA today | Zaidi AU | Lancet Haematol | 2021 |
| Newborn screening for sickle cell disease in Africa. | Makoni M | Lancet Haematol | 2021 |
| A Novel β-Thalassemia Mutation, : c.356_357delTT [Codon 118 (-TT)] in an Iraqi Kurd. | Atroshi SD, Al-Allawi N, Chui DHK, Najmabadi H, Khailany RA | Hemoglobin | 2021 |
| A New High Affinity Hemoglobin Variant: Hb San Francisco-KP (: c.104T>C). | Tavakoli J, Ho G, Kavecansky J, Pai AP | Hemoglobin | 2021 |
| Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease. | Liu Y, Pal M, Bao W, Shi P, Lobo C, An X, Manwani D, Zhong H, Yazdanbakhsh K | Blood | 2021 |
| A Systematic Review and Meta-Analysis of Stature Growth Complications in β-thalassemia Major Patients. | Arab-Zozani M, Kheyrandish S, Rastgar A, Miri-Moghaddam E | Ann Glob Health | 2021 |
| Nutritional and Hematological Status of Sudanese Women of Childbearing Age with Steady-state Sickle Cell Anemia. | Ali EH, Alkindi S, Osman MA, Hilali W, Mirgani HM, Adam G, Morsi MM, Hussein IS, Ghebremeskel K | Oman Med J | 2021 |
| Erratum: Deep sequencing applied to the analysis of viromes in patients with beta-thalassemia. | Valença IN, Santos RBD, Peronni KC, Sauvage V, Vandenbogaert M, Caro V, Silva Junior WAD, Covas DT, Silva-Pinto AC, Laperche S, Kashima S, Slavov SN. | Rev Inst Med Trop Sao Paulo | 2021 |
| Why does your pain never get better? Stigma and coping mechanism in people with sickle cell disease. | Carvalho ESS, Carneiro JM, Gomes AS, Freitas KS, Jenerette CM | Rev Bras Enferm | 2021 |
| Biomarkers for the central nervous system complications of sickle cell disease: are we there yet? | Renella R | Proteomics Clin Appl | 2021 |
| Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease. | Avecilla ST, Boulad F, Yazdanbakhsh K, Sadelain M, Shi PA | Transfusion | 2021 |
| Acute Liver Failure in Sickle Cell Disease: A Perfect Storm. | Burley NB, Miller KD | Cureus | 2021 |
| Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias. | Ozturk Z, Gumuslu S, Yalcin K, Kupesiz A | J Pediatr Hematol Oncol | 2021 |
| Upregulation of miR-214 Mediates Oxidative Stress in Hb H Disease Targeting of . | Saensuwanna A, Penglong T, Srinoun K | Hemoglobin | 2021 |
| Enteric Fever Unmasking Hemoglobin Sickle Cell. | Arango-Ferreira C, Rodríguez-González H, Londoño-Restrepo LJ | Am J Trop Med Hyg | 2021 |
| Development of a High Resolution Melting Curve Analysis for the Detection of Hemoglobin δ-Chain Variants in Thailand and Identification of Hb A2-Walsgrave [codon 52 (GAT>CAT), Asp→His; HBD:c.157G>C] in a Pregnant Woman from Southern Thailand. | Prajantasen T, Prayalaw P, Panyasai S, Binlee S, Nongnuan S | Genet Test Mol Biomarkers | 2021 |
| Fostering equity in education and academic outcomes in children with sickle cell disease. | Miller M, Landsman R, Scott JP, Heffelfinger AK | Clin Neuropsychol | 2021 |
| SARS-CoV-2 infection in patients with β-thalassemia: The French experience. | Jean-Mignard E, De Luna G, Pascal L, Agouti I, Thuret I | Transfus Clin Biol | 2021 |
| Analysis of hippocampal subfields in sickle cell disease using ultrahigh field MRI. | Santini T, Koo M, Farhat N, Campos VP, Alkhateeb S, Vieira MAC, Butters MA, Rosano C, Aizenstein HJ, Mettenburg J, Novelli EM, Ibrahim TS | Neuroimage Clin | 2021 |
| Drug utilization study and cost analysis of adult β-thalassemia major patient therapy at Dr. Soetomo General Hospital Surabaya. | Qatrunnada H, Suharjono , Bintoro SUY, Wahyuni S | J Basic Clin Physiol Pharmacol | 2021 |
| Perception to hydroxyurea therapy in patients with sickle cell disease: Report from 3 centers. | Korubo KI, Onodingene NM, Okoye HC, Omunakwe HE | Ann Afr Med | 2021 |
| Increased hemoglobin affinity for oxygen with GBT1118 improves hypoxia tolerance in sickle cell mice. | Dufu K, Williams AT, Muller CR, Walser CM, Lucas A, Eaker AM, Alt C, Cathers BE, Oksenberg D, Cabrales P | Am J Physiol Heart Circ Physiol | 2021 |
| COVID 19 pandemic and lockdown: A double whammy for patients with thalassemia. | Kakkar S, Anand V, Dewan P, Sobti P | Acta Biomed | 2021 |
| The Pancreatic changes affecting glucose homeostasis in transfusion dependent β- thalassemia (TDT): a short review. | De Sanctis V, Soliman A, Tzoulis P, Daar S, Fiscina B, Kattamis C | Acta Biomed | 2021 |
| Relationship Between Disease Severity and Resting Electrocardiograms of Adults With Sickle Cell Anemia in a Tertiary Institution in Southern Nigeria. | Dic-Ijiewere MO, Emorinken A, Obasohan AO, Okokhere PO, Dic-Ijiewere EO, Otumu OS | Cureus | 2021 |
| Follow-up of children with sickle cell anemia screened with transcranial Doppler and enrolled in a primary prevention program of ischemic stroke. | Sabarense AP, Silva CM, Muniz MBSR, Viana MB | Hematol Transfus Cell Ther | 2021 |
| Novel Therapeutic Advances in β-Thalassemia. | Makis A, Voskaridou E, Papassotiriou I, Hatzimichael E | Biology (Basel) | 2021 |
| Unique Polymorphisms at , and Loci Associated with HbF in Kuwaiti Patients with Sickle Cell Disease. | Akbulut-Jeradi N, Fernandez MJ, Al Khaldi R, Sukumaran J, Adekile A | J Pers Med | 2021 |
| Successful Implementation of Newborn Screening for Hemoglobin Disorders in the Philippines. | Padilla CD, Therrell BL, Alcausin MMLB, de Castro RC, Gepte MBP, Reyes MEL, Jomento CM, Suarez RCN, Maceda EBG, Abarquez CG, Posecion JEWC, Andal AP, Elizaga ALG, Halili-Mendoza BC, Otayza MPVK, Hoppe CC | Int J Neonatal Screen | 2021 |
| Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease. | Ashouri R, Fangman M, Burris A, Ezenwa MO, Wilkie DJ, Doré S | Int J Mol Sci | 2021 |
| Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing. | Anurogo D, Yuli Prasetyo Budi N, Thi Ngo MH, Huang YH, Pawitan JA | Int J Mol Sci | 2021 |
| Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin. | Henry ER, Metaferia B, Li Q, Harper J, Best RB, Glass KE, Cellmer T, Dunkelberger EB, Conrey A, Thein SL, Bunn HF, Eaton WA | Blood | 2021 |
| Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease. | Mucalo L, Brandow AM, Dasgupta M, Mason SF, Simpson PM, Singh A, Taylor BW, Woods KJ, Yusuf FI, Panepinto JA | Blood Adv | 2021 |
| Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia. | Hongeng S, Anurathapan U, Songdej D, Phuphuakrat A, Jongrak K, Parsons G, Deary B, Bonner M, Veres G, Asmal M | Blood Adv | 2021 |
| Prevalence and molecular spectrum of α- and β-globin gene mutations in Hainan, China. | Wang Z, Sun W, Chen H, Zhang Y, Wang F, Chen H, Zhou Y, Huang Y, Zhou X, Li Q, Ma Y | Int J Hematol | 2021 |
| Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review. | Hejazi RA, Mandourah NA, Alsulami AS, Bakhsh HT, Diri RM, Noor AO | Saudi Pharm J | 2021 |
| Distribution of β-Thalassemia and Other Hemoglobinopathies in Bangladeshi University Students and Ready-Made Garment Workers. | Islam MM, Hossain F, Sakib N, Zeba Z, Bhuiyan AKMI, Mamun MA, Kaggwa MM, Yoshimura K, Afrin S, Selim S, Hossain M | Risk Manag Healthc Policy | 2021 |
| Further evidence for the benefit of therapeutic plasma exchange for acute multi-organ failure syndrome refractory to red cell exchange in sickle cell disease. | Siddiqui RS, Ferman DA, Shi PA | J Clin Apher | 2021 |
| Severe Persistent Pain and Inflammatory Biomarkers in Sickle Cell Disease: An Exploratory Study. | Knisely MR, Tanabe PJ, Walker JKL, Yang Q, Shah NR | Biol Res Nurs | 2021 |
| A narrative review of in utero gene therapy: advances, challenges, and future considerations. | Yung NK, Maassel NL, Ullrich SJ, Ricciardi AS, Stitelman DH | Transl Pediatr | 2021 |
| Post-transfusion hyperhemolysis syndrome in a patient with beta thalassemia major. | Kasinathan G, Sathar J | Clin Case Rep | 2021 |
| An Autopsy Case of β-Thalassemia Major Illuminating the Pathological Spectrum of the Disease. | Sood R, Rastogi P, Bansal D, Das R, Sharma P, Gude G, Dhankar M | Hemoglobin | 2021 |
| Frequency of beta S globin gene haplotypes among sickle cell patients in Nigeria. | Adabale A, Makanjuola SBL, Akinbami A, Dosunmu A, Akanmu A, Javid FA, Ajonuma LC | J Int Med Res | 2021 |
| Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central Malawi. | Tegha G, Topazian HM, Kamthunzi P, Howard T, Tembo Z, Mvalo T, Chome N, Kumwenda W, Mkochi T, Hernandez A, Ataga KI, Hoffman IF, Ware RE | Int J Public Health | 2021 |
| Total Annual Economic Burden of Patients with Sickle Cell Disease in Steady State in Greece. | Tsolakidis V, Vlachaki E, Papaioannou M, Pantelidou D, Diamantidis M, Eleftheriou P, Kouvelas D, Pourzitaki C | Hemoglobin | 2021 |
| Severe fetal anemia and hydrops fetalis associated with compound heterozygosity for Hb Zurich-Albisrieden (:c.178G>C) and Hb Quong Sze (:c.377T>C). | Du L, Bao X, He W, Qin D, Wang J, Xiong Y, Shi X, Ding H, Yao C, Wu J | J Int Med Res | 2021 |
| Allogeneic hematopoietic stem cell transplant for sickle cell disease: The why, who, and what. | Cimpeanu E, Poplawska M, Jimenez BC, Dutta D, Lim SH | Blood Rev | 2021 |
| Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease. | Hebbel RP, Vercellotti GM | Am J Hematol | 2021 |
| Effects of hydroxyurea on brain function in children with sickle cell anemia. | Wang WC, Zou P, Hwang SN, Kang G, Ding J, Heitzer AM, Schreiber JE, Helton K, Hankins JS | Pediatr Blood Cancer | 2021 |
| Thrombocytopenia in a teen with sickle cell disease following COVID-19 vaccination. | Underdown MJ, Nuss R | Pediatr Blood Cancer | 2021 |
| A novel ATRX splice variant causing acquired HbH disease in myelodysplastic syndrome with excess blasts-1. | Mallik N, Singh N, Jamwal M, Chhabra S, Hira JK, Malhotra P, Das R, Sharma P | Cancer Genet | 2021 |
| Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease. | Tang A, Strat AN, Rahman M, Zhang H, Bao W, Liu Y, Shi D, An X, Manwani D, Shi P, Yazdanbakhsh K, Mendelson A | Blood | 2021 |
| The health literacy disparity in adolescents with sickle cell disease. | Perry Caldwell E, Killingsworth E | J Spec Pediatr Nurs | 2021 |
| Letter to the Editor in response to: Fetal hemoglobin levels in premature newborns. | Teofili L, Bianchi M, Valentini CG, Papacci P | J Pediatr Surg | 2021 |
| Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority. | Colombatti R, Casale M, Russo G | Ital J Pediatr | 2021 |
| Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development. | Porter J, Taher A, Viprakasit V, Kattamis A, Coates TD, Garbowski M, Dürrenberger F, Manolova V, Richard F, Cappellini MD | Expert Rev Hematol | 2021 |
| De novo HBB frameshift mutation in a patient with dominant β-thalassemia major. | Zhou X, Chen T, Zhang Q, Qi M, Zhang L, Du J, Chi H, Shen B, Xu X, Lu Y | Int J Lab Hematol | 2021 |
| Evaluation of myocardial perfusion and function in patients with asymptomatic beta-thalassemia major using myocardial gated single-photon-emission computed tomography. | Omrani A, Rahimzadeh P, Aba A, Jafari E, Amini A, Assadi M | World J Nucl Med | 2021 |
| Content validation of a self-report daily diary in patients with sickle cell disease. | White MK, Saucier C, Bailey M, D'Alessio D, Foster A, St Pierre D, Raymond K | J Patient Rep Outcomes | 2021 |
| Eosinophilic Myocarditis in a Patient With Sickle Cell Disease. | Imran HM, Ather K, Gutman NH, Atalay MK, Poppas A | JACC Case Rep | 2021 |
| Efficacy and Safety of Thalidomide in Patients With Transfusion-Dependent Thalassemia. | Chandra J, Parakh N, Sidharth , Singh N, Sharma S, Goel M, Pemde H | Indian Pediatr | 2021 |
| Management of Thalassemia: Blood and Beyond. | Merchant R | Indian Pediatr | 2021 |
| Investigating the reasons for marriage among couples with thalassemia minor, in Iran. | Hasanshahi F, Khanjani N | J Community Genet | 2021 |
| Cerebral and skeletal muscle tissue oxygenation during exercise challenge in children and young adults with sickle cell anaemia. | Barriteau CM, Chiu A, Rodeghier M, Liem RI | Br J Haematol | 2021 |
| Subglottic concretion masquerading as foreign body in a child with β thalassemia major: an airway nightmare! | Parikh B, Sahu S, Gupta DK, Singh V | BMJ Case Rep | 2021 |
| Hb Calgary (: c.194G>T): A Highly Unstable Hemoglobin Variant with a β-Thalassemia Major Phenotype. | Martin G, Grimholt RM, Le D, Bechensteen AG, Klingenberg O, Fjeld B, Fourie T, Perrier R, Proven M, Henderson SJ, Roy NBA | Hemoglobin | 2021 |
| The Effect of : c.-121C>T Variant [-71 (C>T)] on the β-Globin Promoter: Case Series Study. | Rafat M, Allamehzadeh Z, Shekari M, Afsa M, Malekzadeh K | Hemoglobin | 2021 |
| Hb Lepore-Hong Kong: First Report of a Novel δ/β-Globin Gene Fusion in a Chinese Family. | Jiang F, Tang XW, Li J, Zhou JY, Zuo LD, Li DZ | Hemoglobin | 2021 |
| A Novel α-Globin Chain Variant, Hb Nanchang [: c.46G>A, Codon 15 (GT>GT) (Gly→Ser)], Detected by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. | Xu A, Chen W, Xie W, Zheng H, Zhou Y, Ji L | Hemoglobin | 2021 |
| Identifying elevated risk for future pain crises in sickle-cell disease using photoplethysmogram patterns measured during sleep: A machine learning approach. | Ji Y, Chalacheva P, Rosen CL, DeBaun MR, Coates TD, Khoo MCK | Front Digit Health | 2021 |
| Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine. | Samarah F, Srour MA, Dumaidi K | Biomed Res Int | 2021 |
| Multimodal Imaging in Retinal Vascular Occlusions following Trauma - A Case of Sickle Cell Disease with Negative Sickling Test. | Sahu ES, Sachdeva M, Sen A, Karkhur S | J Ophthalmic Vis Res | 2021 |
| Relationship of oxidative stress and antioxidant response with vaso-occlusive crisis in sickle cell anaemia. | Engwa GA, Okolie A, Chidili JPC, Okore PA, Onu PC, Ugwu MO, Oko DE, Ferdinand PU | Afr Health Sci | 2021 |
| Exploring the potential utilities of 99mTc-labeled RBC-equilibrium radionuclide angiocardiography in transfusion-dependent β-thalassemia major patients. | Vadi SK, Sood A, Khadwal A, Parmar M, Bhatia A, Kashyap S, Bahl A, Mittal BR | Nucl Med Commun | 2021 |
| Altered cardiac reserve is a determinant of exercise intolerance in sickle cell anaemia patients. | Hammoudi N, Ceccaldi A, Haymann JP, Guedeney P, Nicolas-Jilwan F, Zeitouni M, Montalescot G, Lionnet F, Isnard R, Hatem SN | Eur J Clin Invest | 2021 |
| Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy (PIPSICKLE): a randomised controlled trial (study protocol). | Afolabi BB, Babah OA, Adeyemo TA, Odukoya OO, Ezeaka CV, Nwaiwu O, Oshodi YA, Ogunnaike BA | BMJ Open | 2021 |
| Transition Navigator Intervention improves transition readiness to adult care for youth with Sickle Cell Disease. | Manwani D, Doyle M, Davidson L, Mallea M, Silver EJ, Jackson J, Chhabra R, Morrone K, Minniti C, Rastogi D, Stein RE, Oyeku S, Bauman LJ | Acad Pediatr | 2021 |
| Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease. | Menon AV, Liu J, Tsai HP, Zeng L, Yang S, Asnani A, Kim J | Blood | 2021 |
| A Rare and Successfully Managed Complication of Stem Cell Transplantation in an Adult Patient With Sickle Cell Disease: Bone Marrow Necrosis. | Ozdogu H, Boga C, Yeral M, Kozanoglu I, Gereklioglu C, Kocer NE | Exp Clin Transplant | 2021 |
| Analysis of clinical presentation, hematological factors, self-reported bed net usage, and malaria burden in sickle cell disease patients. | Harp KO, Botchway F, Dei-Adomakoh Y, Wilson MD, Mubasher M, Adjei AA, Thompson WE, Stiles JK, Driss A | EClinicalMedicine | 2021 |
| The Evolving Role of Next-Generation Sequencing in Screening and Diagnosis of Hemoglobinopathies. | Achour A, Koopmann TT, Baas F, Harteveld CL | Front Physiol | 2021 |
| Prevalence of β-S Globin Haplotypes in Jazan Region of Saudi Arabia. | Akhter MS, Mobarki AA, Hamali HA, Saboor M, Madkhali AM, Dobie G, Hobani YH, Eisa ZM | Clin Lab | 2021 |
| Transcriptional silencing of fetal hemoglobin expression by NonO. | Li X, Chen M, Liu B, Lu P, Lv X, Zhao X, Cui S, Xu P, Nakamura Y, Kurita R, Chen B, Huang DCS, Liu DP, Liu M, Zhao Q | Nucleic Acids Res | 2021 |
| Alpha haemoglobin-stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment. | Vasseur C, Domingues-Hamdi E, Pakdaman S, Galactéros F, Baudin-Creuza V | Br J Haematol | 2021 |
| Sonographic Assessment of Some Abdominal Organs in Children with Sickle Cell Disease in Ilorin, Nigeria. | Muftaudeen B, Eze JC, Sidi M, Miftaudeen MN | J Med Ultrasound | 2021 |
| Identified barriers and facilitators to stroke risk screening in children with sickle cell anemia: results from the DISPLACE consortium. | Phillips SM, Schlenz AM, Mueller M, Melvin CL, Adams RJ, Kanter J | Implement Sci Commun | 2021 |
| Urinary Kringle Domain-Containing Protein HGFL: A Validated Biomarker of Early Sickle Cell Anemia-Associated Kidney Disease. | Nekhai S, Lin X, Soni S, Taye A, Smith N, Afangbedji N, Saraf SL, Gordeuk VR, Taylor JG, Jerebtsova M | Am J Nephrol | 2021 |
| Indirect Economic Burden of Sickle Cell Disease. | Holdford D, Vendetti N, Sop DM, Johnson S, Smith WR | Value Health | 2021 |
| Core Decompression and Bone Marrow Aspirate Concentrate in the Treatment of Femoral Head Avascular Necrosis in Pediatric Sickle Cell Disease: Can We Improve Natural History? | Griffith MS, Shaw KA, Hattaway JK, Schrader T | J Pediatr Orthop | 2021 |
| Alteration of grey matter volume is associated with pain and quality of life in children with sickle cell disease: Structural brain alteration and association with pain in sickle cell disease. | Wang Y, Hardy SJ, Ichesco E, Zhang P, Harris RE, Darbari DS | Transl Res | 2021 |
| Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease. | Ramadier S, Chalumeau A, Felix T, Othman N, Aknoun S, Casini A, Maule G, Masson C, De Cian A, Frati G, Brusson M, Concordet JP, Cavazzana M, Cereseto A, El Nemer W, Amendola M, Wattellier B, Meneghini V, Miccio A | Mol Ther | 2021 |
| Contraceptive use and preferences among females with sickle cell disease. | Roe AH, Lang B, McAllister A, Gaitors MC, Smith-Whitley K, Schreiber CA, Sayani F | Contraception | 2021 |
| LUSPATERCEPT - A better strategy for thalassemia? | Patel MS, Raza IM, Hassan SZ | J Pak Med Assoc | 2021 |
| Influenza immunization coverage of children with sickle cell disease. | Peng HK, Dombkowski KJ, Freed GL, Creary SE, Smith D, Reeves SL | Vaccine | 2021 |
| Sickle cell trait: an unsound cause of death. | Lichtsinn HS, Weyand AC, McKinney ZJ, Wilson AM | Lancet | 2021 |
| Novel Substituted Piperidine-2,6-dione Derivatives for Treating Sickle Cell Disease and β-Thalassemia. | Sabnis RW | ACS Med Chem Lett | 2021 |
| Validation of Discharge Diagnosis of Sickle Cell Disease Vaso-Occlusive Episodes in the French Hospital Electronic Database. | Walter O, Maquet J, Derumeaux H, Moulis G, Lafaurie M | Clin Epidemiol | 2021 |
| Quality of Life and Related Factors in β-Thalassemia Patients. | Etemad K, Mohseni P, Aghighi M, Bahadorimonfared A, Hantooshzadeh R, Taherpour N, Piri N, Sotoodeh Ghorbani S, Malek F, Kheiry F, Khodami A, Valadbeigi T, Hajipour M | Hemoglobin | 2021 |
| Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline. | Oteng-Ntim E, Pavord S, Howard R, Robinson S, Oakley L, Mackillop L, Pancham S, Howard J, | Br J Haematol | 2021 |
| Standardizing care of those at great risk: the importance of sickle cell in pregnancy practice guidelines. | Stratton P | Br J Haematol | 2021 |
| Analysis of Causes of Hospitalization Among Children with Sickle Cell Disease in a Group of Private Hospitals in Jeddah, Saudi Arabia. | Abd El-Ghany SM, Tabbakh AT, Nur KI, Abdelrahman RY, Etarji SM, Almuzaini BY | J Blood Med | 2021 |
| Evidence of new intragenic HBB haplotypes model for the prediction of beta-thalassemia in the Malaysian population. | Aziz NA, Taib WW, Kharolazaman NK, Ismail I, Al-Jamal HAN, Jamil NWWA, Esa E, Ibrahim H | Sci Rep | 2021 |
| Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia. | Champlin G, Hwang SN, Heitzer A, Ding J, Jacola L, Estepp JH, Wang W, Ataga KI, Owens CL, Newman J, King AA, Davis R, Kang G, Hankins JS | Exp Biol Med (Maywood) | 2021 |
| Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia-Major Patients with the I Polymorphism. | Ghosh D, Panja A, Saha D, Banerjee U, Datta AK, Basu A | Genet Test Mol Biomarkers | 2021 |
| The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies. | Kountouris P, Stephanou C, Archer N, Bonifazi F, Giannuzzi V, Kuo KHM, Maggio A, Makani J, Mañú-Pereira MDM, Michailidou K, Nkya S, Nnodu OE, Trompeter S, Tshilolo L, Wonkam A, Zilfalil BA, Inusa BPD, Kleanthous M, | Am J Hematol | 2021 |
| Predictors associated with sickle cell nephropathy: a systematic review. | Maurício L, Ribeiro S, Santos L, Miranda DB | Rev Assoc Med Bras (1992) | 2021 |
| A unified model of human hemoglobin switching through single-cell genome editing. | Shen Y, Verboon JM, Zhang Y, Liu N, Kim YJ, Marglous S, Nandakumar SK, Voit RA, Fiorini C, Ejaz A, Basak A, Orkin SH, Xu J, Sankaran VG | Nat Commun | 2021 |
| Thalassemia and autoimmune diseases: Absence of evidence or evidence of absence? | El Hasbani G, Musallam KM, Uthman I, Cappellini MD, Taher AT | Blood Rev | 2021 |
| Luspatercept for β-thalassemia: beyond red blood cell transfusions. | Taher AT, Cappellini MD | Expert Opin Biol Ther | 2021 |
| Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease. | Derebail VK, Zhou Q, Ciccone EJ, Cai J, Ataga KI | Br J Haematol | 2021 |
| Developing an emergency department order set to treat acute pain in sickle cell disease. | Duroseau Y, Beenhouwer D, Broder MS, Brown B, Brown T, Gibbs SN, Jackson K, Liang S, Malloy M, Romney ML, Shani D, Simon J, Yermilov I | J Am Coll Emerg Physicians Open | 2021 |
| Incidence and predictors of bacterial infections in febrile children with sickle cell disease. | Alzahrani F, Alaidarous K, Alqarni S, Alharbi S | Int J Pediatr Adolesc Med | 2021 |
| Prevalence of HBV and HCV infection in beta-thalassemia major patients of Tabriz city, Iran. | Mirzaei G, Shamsasenjan K, Jafari B, Bagherizadeh Y, Sadafzadeh A, Bannazadeh-Baghi H, Sadeghi-Deylamdeh Z, Jafari-Sales A | New Microbes New Infect | 2021 |
| Importance of sickle cell trait counseling for adolescents and young adults. | Jacob SA, Meier ER | Pediatr Blood Cancer | 2021 |
| Abnormal regulation of microRNAs and related genes in pediatric β-thalassemia. | Wang H, Chen M, Xu S, Pan Y, Zhang Y, Huang H, Xu L | J Clin Lab Anal | 2021 |
| Compounded with hemoglobin Port Phillip and -α or -- deletions were identified in Chinese population. | Du L, Bao X, Qin D, Wang J, Yao C, Liang J, Chen J, Yin A | Mol Genet Genomic Med | 2021 |
| Preliminary Study of Coping, Perceived Control, and Depressive Symptoms in Youth with Sickle Cell Anemia. | Prussien KV, Siciliano RE, Ciriegio AE, Lee CA, DeBaun MR, Jordan LC, Compas BE | J Dev Behav Pediatr | 2021 |
| Co-Occurrence of Neurodevelopmental Disorders in Pediatric Sickle Cell Disease. | Lance EI, Cannon AD, Shapiro BK, Lee LC, Johnston MV, Casella JF | J Dev Behav Pediatr | 2021 |
| Hyperhaemolytic transfusion reaction in two β-thalassaemia major patients: The role of eculizumab. | Pantelidou D, Pilalas D, Daios S, Polychronopoulos G, Papadopoulou D, Perifanis V, Savopoulos C, Kaiafa G | J Clin Pharm Ther | 2021 |
| Refractory acquired thrombotic thrombocytopenic purpura in a patient with sickle cell trait successfully treated with caplacizumab. | Aggarwal V, Singer Z, Ledingham D, Othman I | Hematology | 2021 |
| IVS-II-16 (G>C) (: c.315+16G>C) or IVS-II-666 (C>T) (: c.316-185C>T) Mutations Trigger an Hb S (: c.20A>T)/β-Thalassemia Phenotype in an Hb S Trait Patient. | Uçucu S, Karabıyık T, Azik FM | Hemoglobin | 2021 |
| Developmental screening of three-year-old children with sickle cell disease compared to controls. | Wang W, Freeman M, Hamilton L, Carroll Y, Kang G, Moen J, Smeltzer MP, Schreiber J, Heitzer AM, Estepp J, Aygun B | Br J Haematol | 2021 |
| Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without α-thalassaemia. | Boisson C, Renoux C, Nader E, Gauthier A, Poutrel S, Rab M, Fort R, Bertrand Y, Stauffer E, Cannas G, Kebaili K, Virot E, Hot A, Sheehan V, van Beers E, van Wijk R, Joly P, Connes P | Br J Haematol | 2021 |
| Acute chest syndrome in sickle cell disease/HBE patient, A case report. | Khamees I, Rozi W, Yassin MA | Clin Case Rep | 2021 |
| Fatal sickling-associated microvascular occlusive crisis in a young with sickle cell trait. | Mutreja D, K BP, Tvsvgk T | Autops Case Rep | 2021 |
| A Randomized Clinical Hypnosis Pilot Study: Improvements in Self-Reported Pain Impact in Adults with Sickle Cell Disease. | Wallen GR, Middleton KR, Kazmi NB, Yang L, Brooks AT | Evid Based Complement Alternat Med | 2021 |
| Quality of Life and Related Paraclinical Factors in Iranian Patients with Transfusion-Dependent Thalassemia. | Khodashenas M, Mardi P, Taherzadeh-Ghahfarokhi N, Tavakoli-Far B, Jamee M, Ghodrati N | J Environ Public Health | 2021 |
| Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study. | Li X, Hu S, Liu Y, Huang J, Hong W, Xu L, Xu H, Fang J | Front Pharmacol | 2021 |
| Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing. | Asmamaw M, Zawdie B | Biologics | 2021 |
| The transfusion management of beta thalassemia in the United States. | Lal A, Wong T, Keel S, Pagano M, Chung J, Kamdar A, Rao L, Ikeda A, Puthenveetil G, Shah S, Yu J, Vichinsky E | Transfusion | 2021 |
| Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients. | Chenou F, Hounkpe BW, Domingos IF, Tonassé WV, Batista THC, Santana RM, Arcanjo GDS, Alagbe AE, Araújo ADS, Lucena-Araújo AR, Bezerra MAC, Costa FF, Sonati MF, De Paula EV, Dos Santos MNN | Ann Hematol | 2021 |
| Pregnancy outcomes in women affected by fetal alpha-thalassemia: a case control study. | Li J, Yan J, Huang Y, Wei J, Xie B, Zhu M, Jiang W | Sci Rep | 2021 |
| [Black sunburst in sickle cell retinopathy]. | Troumani Y, Miere A, Capuano V, Cartry G, Querques G, Souied EH | J Fr Ophtalmol | 2021 |
| Improving the Solubility and Oral Bioavailability of a Novel Aromatic Aldehyde Antisickling Agent (PP10) for the Treatment of Sickle Cell Disease. | Ahmed TA, El-Say KM, Abd-Allah FI, Omar AM, El-Araby ME, Muhammad YA, Pagare PP, Zhang Y, Mohmmad KA, Abdulmalik O, Safo MK | Pharmaceutics | 2021 |
| Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease. | Penkert RR, Chandramouli S, Dormitzer PR, Settembre EC, Sealy RE, Wong S, Young NS, Sun Y, Tang L, Cotton A, Dowdy J, Hayden RT, Hankins JS, Hurwitz JL | Vaccines (Basel) | 2021 |
| Suspected Severe Malaria in a Sudanese Patient Affected by Sickle Cell Disease Who Was Treated with Hydroxyurea. | Chiopris G, Maccario S, Eisa Artaiga TH, Ibrahim Mohamed A, Valenti M, Esposito S | Pathogens | 2021 |
| Changes in heme levels during acute vaso-occlusive crisis in sickle cell anemia. | Cardoso EC, Silva-Neto PV, Hounkpe BW, Chenou F, Albuquerque CCMX, Garcia NP, Silva-Junior AL, Malheiro A, Cesar P, de Lima F, De Paula EV, Fraiji NA | Hematol Oncol Stem Cell Ther | 2021 |
| Advocating for and raising awareness of sickle cell disease in Sierra Leone. | Deen K | Lancet Haematol | 2021 |
| Ketamine Administration for Acute Painful Sickle Cell Crisis: A Randomized Controlled Trial. | Alshahrani MS, AlSulaibikh AH, ElTahan MR, AlFaraj SZ, Asonto LP, AlMulhim AA, Al Abbad MF, Almaghraby N, AlJumaan MA, AlJunaid TO, Darweesh MN, AlHawaj FM, Mahmoud AM, Alossaimi BK, Alotaibi SK, AlMutairi TM, AlSulaiman DA, Alfaraj D, Alhawwas R, Mbuagbaw L, Lewis K, Verhovsek M, Crowther M, Guyatt G, Alhazzani W, | Acad Emerg Med | 2021 |
| Author Correction: Optimisation of T2 and T2* sequences in MRI for better quantification of iron on transfused dependent sickle cell patients. | Ahmed A, Baldo A, Sulieman A, Mirghani H, Abolaban FA, Suliman II, Salih I | Sci Rep | 2021 |
| Transfusion-induced Plasmodium falciparum malaria in a beta thalassaemia patient during the prevention of re-establishment phase in Sri Lanka. | Chulasiri P, Ranaweera P, Sudarshan P, Jayasinghe M, Harishchandra J, Gunasekera K, Vitharana H, Silva P, Ringwald P, Fernandopulle R, Mendis K, Fernando D | Malar J | 2021 |
| Why the Middle East is a sickle-cell hotspot. | Plackett B | Nature | 2021 |
| No adult left behind: bridge the health-care gap for sickle-cell disease. | Nowogrodzki A | Nature | 2021 |
| Why severe sickle-cell pain has been neglected. | Nogrady B | Nature | 2021 |
| The sickle-cell drug boon. | Plackett B | Nature | 2021 |
| Sickle-cell disease. | Brody H | Nature | 2021 |
| Gene therapies close in on a cure for sickle-cell disease. | Eisenstein M | Nature | 2021 |
| The burden of sleep disordered breathing in children with sickle cell disease. | Liguoro I, Arigliani M, Tan HL, Gupta A | Pediatr Pulmonol | 2021 |
| The gut microbiome in sickle cell disease: Characterization and potential implications. | Brim H, Taylor J, Abbas M, Vilmenay K, Daremipouran M, Varma S, Lee E, Pace B, Song-Naba WL, Gupta K, Nekhai S, O'Neil P, Ashktorab H | PLoS One | 2021 |
| Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide. | El-Khazragy N, Matbouly S, Hanna DH, Mahran NA, Mostafa SA, Abdelrehim BA, Farouk YK, Abuelela S | Ann Hematol | 2021 |
| Nocturnal Enuresis in Sickle Cell: Sociodemographic, Medical, and Quality of Life Factors. | Porter JS, Paladino AJ, Russell K, Rupff R, Griffith J, Mai Y, Zhang H, Hankins JS, Wang WC | J Pediatr Psychol | 2021 |
| Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety project. | Badawy SM, Payne AB, Hulihan MM, Coates TD, Majumdar S, Smith D, Thompson AA | Br J Haematol | 2021 |
| Genotypes of thalassemia in children: an analysis of 30 417 cases. | Li DM, He S | Zhongguo Dang Dai Er Ke Za Zhi | 2021 |
| Caffeic acid: an antioxidant with novel antisickling properties. | Kassa T, Whalin JG, Richards MP, Alayash AI | FEBS Open Bio | 2021 |
| Adapting the ACMG/AMP variant classification framework: a perspective from the ClinGen Hemoglobinopathy Variant Curation Expert Panel. | Kountouris P, Stephanou C, Lederer CW, Synodinos JT, Bento C, Harteveld CL, Fylaktou E, Koopmann TT, Fikri HH, Michailidou K, Nfonsam LE, Waye JS, Zilfalil BA, Kleanthous M, | Hum Mutat | 2021 |
| A re-analysis of pain crises data from the pivotal l-glutamine in sickle cell disease trial. | Zaidi AU, Estepp J, Shah N, Alkindi S, Ezzat H, Lam H, Minniti CP | Contemp Clin Trials | 2021 |
| Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation. | Abuelgasim KA, Damlaj M, Bosaeed M, Altamimi S, Abdullah H, Ramli RM, Alzahrani R, Alzughaibi N, Alahmari B, Alhejazi A, Alaskar A, Alzahrani M | Bone Marrow Transplant | 2021 |
| Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study. | Abulhamail A, AlShebli A, Merdad L, Wali S, Jastaniah W, Abaalkhail B | Ann Hematol | 2021 |
| Psychological intervention in children with transfusion-dependent β-thalassaemia. | Wang M, Huang M, Hong Y | Vox Sang | 2021 |
| Downregulation of KLF4 activates embryonic and fetal globin mRNA expression in human erythroid progenitor cells. | Khamphikham P, Jearawiriyapaisarn N, Tangprasittipap A, Hongeng S | Exp Ther Med | 2021 |
| Oxidative stress, malaria, sickle cell disease, and innate immunity. | Cao H, Vickers MA | Trends Immunol | 2021 |
| [Gene therapy in beta-thalassemia]. | Thuret I | Transfus Clin Biol | 2021 |
| Primary myelofibrosis in a patient with sickle cell disease. | Green SE, Singh ZN, Baer MR | Am J Hematol | 2021 |
| [Thalassemia in Japan]. | Wada H | Rinsho Ketsueki | 2021 |
| Eight Cases of Hb Winnipeg [: c.226G>T (or )]: A Detailed Study. | Khalil MSM, Timbs AT, Henderson SJ, Schuh A, Old JM | Hemoglobin | 2021 |
| Restriction of HIV-1 Infection in Sickle Cell Trait. | Kumari N, Nouraie SM, Ahmad A, Lassiter H, Khan JI, Diaz SF, Afangbedji N, Wang S, Houston PE, Ammosova T, de Mulder Rougvie M, Rana S, Nixon D, Anastos K, Lazar J, French A, Gange S, Adimora AA, Weitzmann MN, Fischl MA, Kempf MC, Kassaye S, Taylor JG, Nekhai S | Blood Adv | 2021 |
| Thalassemia, a human blood disorder. | Shafique F, Ali S, Almansouri T, Van Eeden F, Shafi N, Khalid M, Khawaja S, Andleeb S, Hassan MU | Braz J Biol | 2021 |
| (Lack of) knowledge of mothers about sickle cell trait and disease: a qualitative study. | Rocha R, Souza TV, Morais RCM, Nascimento LCN, Couto LLD, Farias IFA | Rev Bras Enferm | 2021 |
| Impact of COVID-19 pandemic on rare diseases - A case study on thalassaemia patients in Bangladesh. | Hossain MS, Runa F, Al Mosabbir A | Public Health Pract (Oxf) | 2021 |
| Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI). | Adair JE, Androski L, Bayigga L, Bazira D, Brandon E, Dee L, Deeks S, Draz M, Dubé K, Dybul M, Gurkan U, Harlow E, Kityo C, Louella M, Malik P, Mathews V, McKemey A, Mugerwa H, Muyanja D, Olayiwola O, Orentas RJ, Popovski A, Sheehy J, Ssali F, Nsubuga MS, Tisdale JF, Verhoeyen E, Dropulić B | Gene Ther | 2021 |
| Variations and characteristics of the various clinical phenotypes in a cohort of Nigerian sickle cell patients. | Duru A, Madu AJ, Okoye H, Nonyelu C, Obodo O, Okereke K, Madu K | Hematology | 2021 |
| Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies. | Taher AT, Bou-Fakhredin R, Kattamis A, Viprakasit V, Cappellini MD | Expert Rev Hematol | 2021 |
| Strategies to improve pharmacogenomic-guided treatment options for patients with β-hemoglobinopathies. | Patrinos GP, Chui DHK, Hardison RC, Steinberg MH | Expert Rev Hematol | 2021 |
| Amniotic fluid metabolomic and lipidomic alterations associated with hemoglobin Bart's diseases. | Chen X, Chen H, Nie H, Li G, Su J, Cao X, Cao Y, Wei F | Metabolomics | 2021 |
| Extracellular Vesicles in Sickle Cell Disease: Plasma Concentration, Blood Cell Types Origin Distribution and Biological Properties. | Nader E, Garnier Y, Connes P, Romana M | Front Med (Lausanne) | 2021 |
| Complete neurological recovery from fat embolism syndrome in sickle cell disease after sequential red cell exchange transfusion and therapeutic plasma exchange. | Tsitsikas DA, Mihalca D, Bello-Sanyaolu O, Amposah R, Olasoji S, Orebayo F, Tham L, Rowe S | Transfus Apher Sci | 2021 |
| Erythrapheresis in children with sickle cell disease, experience of a paediatric apheresis unit. | Lesprit E, Missud F, Arnould A, Smaine D, Benkerrou M | Transfus Clin Biol | 2021 |
| The Effects of Treatment with Blood Transfusion, Iron Chelation and Hydroxyurea on Puberty, Growth and Spermatogenesis in Sickle Cell Disease (SCD): A short update. | Soliman AT, Alaaraj N, Yassin M | Acta Biomed | 2021 |
| Foreword: Advances in Hemoglobinopathies. | De Sanctis V | Acta Biomed | 2021 |
| Immigration and screening programs for hemoglobinopathies in Italy, Spain and Turkey. | Canatan D, Vives Corrons JL, Piacentini G, Kara F, Keskinkılıç B, Tezel B, Külekçi Uğur A, Babayiğit M, Krishnevskaya E, Millimaggi G, Erinekçi O, Özdemir Z, De Sanctis V | Acta Biomed | 2021 |
| Coadministration of silymarin with iron chelators in transfusion-dependent β-thalassemia patients: a systematic review and meta-analysis for effect on iron overload. | Darvishi-Khezri H, Naderisorki M, Zahedi M, Mortazavi P, Tajik F, Nasirzadeh A, Karami H | Expert Rev Clin Pharmacol | 2021 |
| Associations Between Transcranial Doppler Flow Velocities, Laboratory Parameters, and Clinical Features in Turkish Children With Sickle Cell Disease. | Aydin S, Yeral H, Oktay G, Çoban Y, Akbaş Y, Köker A, Öz Tunçer G | J Pediatr Hematol Oncol | 2021 |
| Nutrition in Thalassemia: A Systematic Review of Deficiency, Relations to Morbidity, and Supplementation Recommendations. | Goldberg EK, Lal A, Fung EB | J Pediatr Hematol Oncol | 2021 |
| A Case Series of Kawasaki Disease in Children With Sickle Cell Disease. | Towerman AS, Reich PJ, Hulbert ML | J Pediatr Hematol Oncol | 2021 |
| Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort. | Galadanci NA, Sohail M, Akinyelure OP, Kanter J, Ojesina AI | J Pediatr Hematol Oncol | 2021 |
| Change of RBC Deformability During Hematopoietic Stem Cell Transplantation. | Kim YK, Lee JM | J Pediatr Hematol Oncol | 2021 |
| Prevalence of COVID-19 in Egyptian Children With Hemoglobinopathies and Inherited Anemias. | Ismail AM, Mahmoud NMS, Ghazawy ER, Mousa SO | J Pediatr Hematol Oncol | 2021 |
| How to Facilitate Decision-Making for Hematopoietic Stem Cell Transplantation in Patients With Hemoglobinopathies. The Perspectives of Healthcare Professionals. | Mekelenkamp H, van Zanten H, de Vries M, Lankester A, Smiers F | Front Pediatr | 2021 |
| Lower respiratory tract infection with in sickle-cell adult patients with severe acute chest syndrome - the STAPHACS Study. | Elabbadi A, Voiriot G, Tristan A, Gibelin A, Verdet C, Djibré M, Santin A, Jutant EM, Lopinto J, Vandenesch F, Lionnet F, Fartoukh M | Haematologica | 2021 |
| Executive Functioning Predicts Adaptive Functioning and Self-Care Independence in Pediatric Sickle Cell Disease. | Jones KE, Nyman TN, Daly BP, Jacobson LA, Tarazi RA | J Pediatr Psychol | 2021 |
| Operational analysis of the national sickle cell screening programme in the Republic of Uganda. | Hernandez AG, Kiyaga C, Howard TA, Ssewanyana I, Ndeezi G, Aceng JR, Ware RE | Afr J Lab Med | 2021 |
| Syndrome of Inappropriate Antidiuretic Hormone Secretion and Lead Toxicity in a Child With Sickle Cell Disease and Pica. | Gupta A, Amaducci A, Koons A, Lindmark JD, Beauchamp GA | Cureus | 2021 |
| Clonal hematopoiesis in sickle cell disease. | Pincez T, Lee SSK, Ilboudo Y, Preuss MH, Pham Hung d'Alexandry d'Orengiani AL, Bartolucci P, Galacteros F, Joly P, Bauer DE, Loos R, Lindsley RC, Lettre G | Blood | 2021 |
| Efficacy and safety of ruxolitinib in ineffective erythropoiesis suppression as a pretransplantation treatment for pediatric patients with beta-thalassemia major. | Ovsyannikova G, Balashov D, Demina I, Shelikhova L, Pshonkin A, Maschan M, Novichkova G, Maschan A, Smetanina N | Pediatr Blood Cancer | 2021 |
| Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease. | Kenter MJH, Cohen AF | JAMA | 2021 |
| Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease. | Gurkan UA | JAMA | 2021 |
| Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease-Reply. | Casella JF, Kronsberg SS, Gorney RT | JAMA | 2021 |
| The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey. | Hall R, Meenan J, Mihalca D, Katumba A, Badle S, Osakonor DK, Bello-Sanyaolu O, Orebayo F, Lewis N, Chatterjee B, Coughlin S, Tsitsikas DA | Br J Haematol | 2021 |
| Daily briefing: Adults with sickle-cell disease are being left behind. | Graham F | Nature | 2021 |
| Droplet-based digital PCR for non-invasive prenatal genetic diagnosis of α and β-thalassemia. | Sawakwongpra K, Tangmansakulchai K, Ngonsawan W, Promwan S, Chanchamroen S, Quangkananurug W, Sriswasdi S, Jantarasaengaram S, Ponnikorn S | Biomed Rep | 2021 |
| Challenging the dogma of the healthy heterozygote: Implications for newborn screening policies and practices. | Farrell PM, Langfelder-Schwind E, Farrell MH | Mol Genet Metab | 2021 |
| Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and care. | Esoh K, Wonkam-Tingang E, Wonkam A | Lancet Haematol | 2021 |
| Modelling the mortality of sickle cell disease in Africa. | Wonkam A, Kengne AP | Lancet Haematol | 2021 |
| Living with sickle cell disease: voices from sub-Saharan Africa. | Salim AS, Mwita E, Antwi JS, Agunkejoye O, Mdliva P | Lancet Haematol | 2021 |
| Endocrinal Complications in Children and Adolescents with Thalassemia Major in Central India: An Observational Study. | Dixit N, Shaw CK, Varshney GA, Kumar R, Saini PA, Verma P | Indian J Pediatr | 2021 |
| Correction: Increased non-typhoidal Salmonella hospitalizations in transfusion-naïve thalassemia children: a nationwide population-based cohort study. | Sheen JM, Lin FJ, Yang YH, Kuo KC | Pediatr Res | 2021 |
| Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease. | Buehler PW, Swindle D, Pak DI, Ferguson SK, Majka SM, Karoor V, Moldovan R, Sintas C, Black J, Gentinetta T, Buzzi RM, Vallelian F, Wassmer A, Edler M, Bain J, Schu D, Hassell K, Nuss R, Schaer DJ, Irwin DC | Free Radic Biol Med | 2021 |
| [Hemoglobin]. | Schmidmaier R | MMW Fortschr Med | 2021 |
| Sickle cell disease children's gut colonization by extended-spectrum β-lactamase (ESBL)-producing : an antibiotic prophylaxis effect? | Monteiro ASS, Oliveira EG, Santos DBD, Cordeiro SM, Couto RD, Couto FD | J Med Microbiol | 2021 |
| Effectiveness of Using Mean Corpuscular Volume and Mean Corpuscular Hemoglobin for Beta-thalassemia Carrier Screening in the Guangdong Population of China. | Gu H, Wang YX, Du MX, Xu SS, Zhou BY, Li MZ | Biomed Environ Sci | 2021 |
| Co-existing sickle cell anaemia and inflammatory bowel disease: case report and review of the literature. | Adepoju AA, Akere A, Ogun GO, Ogunbosi BO, Asinobi AO, Bello O, Orimadegun AE, Allen S, Akinyinka OO | Paediatr Int Child Health | 2021 |
| Which adults with sickle cell disease need an evaluation for pulmonary embolism? | El-Amin N, Lauzon SD, Nietert PJ, Kanter J | Br J Haematol | 2021 |
| Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease. | Hines PC, Callaghan MU, Zaidi AU, Gao X, Liu K, White J, Tarasev M | Br J Haematol | 2021 |
| Aortic valve replacement in a patient with sickle cell disease-Are we justified to perform surgery in the TAVI era? | Ravishankar R, Turkistani L, Elghoneimy Y, Manoly I | Clin Case Rep | 2021 |
| Decreased parasite burden and altered host response in children with sickle cell anemia and severe anemia with malaria. | Henrici RC, Sautter CL, Bond C, Opoka RO, Namazzi R, Datta D, Ware RE, Conroy AL, John CC | Blood Adv | 2021 |
| Prenatal Hemoglobinopathy Evaluation. | Manthei DM, Li SH, Keren DF, Gherasim C | Clin Chem | 2021 |
| Decision-Making Involvement, Self-Efficacy, and Transition Readiness in Youth With Sickle Cell Disease. | Varty M, Speller-Brown B, Wakefield BJ, Ravert RD, Kelly KP, Popejoy LL | Nurs Res | 2021 |
| Recommendations for diagnosis and treatment of methemoglobinemia. | Iolascon A, Bianchi P, Andolfo I, Russo R, Barcellini W, Fermo E, Toldi G, Ghirardello S, Rees D, Van Wijk R, Kattamis A, Gallagher PG, Roy N, Taher A, Mohty R, Kulozik A, De Franceschi L, Gambale A, De Montalembert M, Forni GL, Harteveld CL, Prchal J, | Am J Hematol | 2021 |
| A Fresh Breath of Oxygen: Red Blood Cell Exchange Transfusion in Sickle Cell and COVID-19. | Nguyen V, Alcius P, Peles S, Hodgin K | Clin Case Rep | 2021 |
| A rare case of compartment syndrome and myonecrosis in a patient with hemoglobin SC disease. | Al Moosawi M, Ezzat H | Clin Case Rep | 2021 |
| Peripheral blood smear and hemoglobin electrophoresis of unsuspected hemoglobin Bart's hydrops fetalis in a newborn. | Shevtsov A, Parada M, Burks EJ, Quillen K | Int J Lab Hematol | 2021 |
| Molecular Dynamics of Hemoglobin Reveals Structural Alterations and Explains the Interactions Driving Sickle Cell Fibrillation. | Maity D, Pal D | J Phys Chem B | 2021 |
| Red blood cell reduction of a sickle cell disease stem cell product. | Tanhehco YC, Delgado AC | Transfusion | 2021 |
| Nocturnal Hypoxemia Rather Than Obstructive Sleep Apnea Is Associated With Decreased Red Blood Cell Deformability and Enhanced Hemolysis in Patients With Sickle Cell Disease. | Stauffer E, Poutrel S, Cannas G, Gauthier A, Fort R, Bertrand Y, Renoux C, Joly P, Boisson C, Hot A, Peter-Derex L, Pialoux V, PetitJean T, Connes P | Front Physiol | 2021 |
| Rheological Impact of GBT1118 Cessation in a Sickle Mouse Model. | Kanne CK, Nebor D, Pochron M, Oksenberg D, Sheehan VA | Front Physiol | 2021 |
| Assessing Patient Preferences for Treatment Options for Pediatric Sickle Cell Disease: A Critical Review of Quantitative and Qualitative Studies. | Katoch D, Krishnamurti L | Patient Prefer Adherence | 2021 |
| Study of montelukast in children with sickle cell disease (SMILES): a study protocol for a randomised controlled trial. | Hood AM, Stotesbury H, Kölbel M, DeHaan M, Downes M, Kawadler JM, Sahota S, Dimitriou D, Inusa B, Wilkey O, Pelidis M, Trompeter S, Leigh A, Younis J, Drasar E, Chakravorty S, Rees DC, Height S, Lawson S, Gavlak J, Gupta A, Ridout D, Clark CA, Kirkham FJ | Trials | 2021 |
| Hematopoietic Stem Cell Transplant for Sickle Cell Disease: PATIENT SELEction and Timing Based on Sickle Cell-Related Multiple Chronic Conditions. | Jang T, Mo G, Stewart C, Khoury L, Ferguson N, Egini O, Muthu J, Dutta D, Salifu M, Lim SH | Cell Transplant | 2021 |
| ALPHA- AND BETA-GLOBIN GENE MUTATIONS IN GEORGIA AND ARMENIA. | Oberkanins C, Pagava K, Babikyan D, Korinteli IA, Phagava H, Hayrapetian H, Kriegshäuser G, Sarkisian T | Georgian Med News | 2021 |
| Editing outside the body: ex vivo gene-modification for β-hemoglobinopathy cellular therapy. | Rosanwo TO, Bauer DE | Mol Ther | 2021 |
| [Research Progress on Gene Therapy for β-thalassemia---Review]. | Hong WC, Fang JP, Xu LH | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Application of DNA Microarray in Genetic Mutation Detection in Patients with Thalassemia]. | Qin LQ, Yan TZ, Luo SQ, Cai PF, Chen LZ, Zhong QY, Wang JR, Wang QH, Yuan DJ, Huang J | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Gene Detection Analysis of Thalassemia in 2 494 Cases of Childbearing Couples in Haikou City]. | He JL, Fu YG, Yan YL, Xia WY, Wu CP, Jiang HM | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| Genetic contribution and functional impairment of inflammasome in sickle cell disease. | de Freitas Dutra V, Leal VNC, Fernandes FP, Souza CRL, Figueiredo MS, Pontillo A | Cytokine | 2021 |
| Primary myelofibrosis in untreated sickle cell disease: Are adult patients at higher risk for developing hematological myeloid neoplasms? | Ribeil JA | Am J Hematol | 2021 |
| Exercise-induced changes of vital signs in adults with sickle cell disease. | Johnson S, Gordeuk VR, Machado R, Gibbs JSR, Hildesheim M, Little JA, Kato GJ, Gladwin MT, Nouraie M | Am J Hematol | 2021 |
| Rare case of pyogenic hepatic abscess in a paediatric patient with sickle cell anaemia. | Ganesh Kumar A, Andreou A | J Paediatr Child Health | 2021 |
| Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report. | Ahmed IO, Ochogwu LO, Owojuyigbe TO, Akinola NO, Durosinmi MA | J Med Case Rep | 2021 |
| Stroke Following Acute Chest Syndrome in a Child With Sickle Cell Disease: A Possible Novel Mechanism. | Kendel NE, Lo WD, Villella AD | Pediatr Neurol | 2021 |
| Evaluation of electrocardiography, echocardiography and cardiac T2* for cardiac complications in beta thalassemia major. | Ersoy Dursun F, Açıksarı G, Özkök S, İncealtın O | Int J Cardiovasc Imaging | 2021 |
| Exertional Rhabdomyolysis, Sickle Cell Trait, and | Webber BJ, Nye NS, Harmon KG, O'Connor FG | Curr Sports Med Rep | 2021 |
| Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias. | Shah FT, Porter JB, Sadasivam N, Kaya B, Moon JC, Velangi M, Ako E, Pancham S | Br J Haematol | 2021 |
| Productivity Loss and Associated Costs Among Patients with Transfusion-Dependent Thalassemia in Dubai, United Arab Emirates. | Alshamsi S, Hamidi S, Ozgen Narci H | Clinicoecon Outcomes Res | 2021 |
| Identification of optimal thalassemia screening strategies for migrant populations in Thailand using a qualitative approach. | Xu JZ, Foe M, Tanongsaksakul W, Suksangpleng T, Ekwattanakit S, Riolueang S, Telen MJ, Kaiser BN, Viprakasit V | BMC Public Health | 2021 |
| Correction to: Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide. | El-Khazragy N, Matbouly S, Hanna DH, Mahran NA, Mostafa SA, Abdelrehim BA, Farouk YK, Abuelela S | Ann Hematol | 2021 |
| Pitfalls in the Diagnosis of β-Thalassemia Intermedia. | Perera S, Allen A, Rees DC, Premawardhena A | Hemoglobin | 2021 |
| Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study. | Liles DK, Shah NR, Scullin B, Gordeuk VR, Smith WR, Kanter J, Achebe MM, Boccia R, Crary SE, Kraft WK, Archer N, Cataldo V, Hardesty BM, Idowu M, Desai PC, Ikeda A, Puthenveetil G, Hassell KL, Sarnaik S, Kutlar A | Br J Haematol | 2021 |
| Correlation of Serum Ferritin and Cardiac Iron Toxicity with Cardiac Function in Transfusion Dependent Beta-Thalassemia Major Patients. | Atmakusuma TD, Kalwani R, Nasution SA, Rumende CM | Acta Med Indones | 2021 |
| Time trends, sociodemographic and health factors associated with discharge and length of stay of hospitalised patients with sickle cell disease in Ghana: a retrospective analysis of national routine health database. | Narh CT, Der J, Ofosu A, Blettner M, Wollschlaeger D | BMJ Open | 2021 |
| Erratum to: The Histopathologic Features of Sickle Cell Hepatopathy: A Multi-Institutional Study. | Saeed O, Panarelli N, Umrau K, Lee H, Westerhoff M, Cheng J, Lin J | Am J Clin Pathol | 2021 |
| Cascade screening for beta-thalassaemia in Pakistan: relatives' experiences of a decision support intervention in routine practice. | Ahmed S, Jafri H, Faran M, Ahmed WN, Rashid Y, Ehsan Y, Ahmed M | Eur J Hum Genet | 2021 |
| Evaluation of Macular Flow Voids on Optical Coherence Tomography Angiography [OCT-A] as Potential Biomarkers for Silent Cerebral Infarction in Sickle Cell Disease. | Thangamathesvaran L, Ong SS, Wang J, Lance E, Tekes A, Scott AW | Retina | 2021 |
| Occult Hepatitis B Virus Infection among β-Thalassemia Major Patients in Ahvaz City, Iran. | Amirhashchi F, Azaran A, Seyedian SS, Jalilian S, Keikhaei B | Am J Trop Med Hyg | 2021 |
| Effects of Renin-Angiotensin Blockade and on Kidney Function in Sickle Cell Disease. | Han J, Srisuwananukorn A, Shah BN, Molokie RE, Lash JP, Gordeuk VR, Saraf SL | EJHaem | 2021 |
| Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia. | Albagshi MH, Saad M, Aljassem AM, Bushehab AA, Ahmed NH, Alabbad MM, Omer N, Alhamad OA, Sultan TA, Bahgat S | Cureus | 2021 |
| Biopsychosocial factors related to transition among adolescents and young adults with sickle cell disease: A systematic review. | Rea KE, Cushman GK, Santee T, Mee L | Crit Rev Oncol Hematol | 2021 |
| Prevalence of Red Blood Cell Alloimmunization Among Beta-Thalassemia and Sickle Cell Anemia Patients: a Study from Saudi Arabia. | Felimban R, Alsharyufi A, Aljehani J, Sahlool A, Aljabri H, Qadah T | Clin Lab | 2021 |
| Investigation of the relationship between periodontal and systemic inflammation in children with Sickle Cell Disease: A case- control study. | Tonguç MÖ, Öztürk C, Polat G, Bobuşoğlu O, Tek SA, Taşdelen B, Ünal S | Cytokine | 2021 |
| External validation of the priapism impact profile in a Jamaican cohort of patients with sickle cell disease. | Morrison BF, Madden W, Asnani M, Sotimehin A, Anele U, Jing Y, Trock BJ, Burnett AL | PLoS One | 2021 |
| Incidence of SARS-COV-2 infection in sickle cell patients presenting with a painful crisis: A 12-month prospective cohort study. | Konté K, Nur E, Tang MW, Heijmans J, van Tuijn CFJ, Biemond BJ | Int J Lab Hematol | 2021 |
| The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia. | Pereira-Martins DA, Coelho-Silva JL, Domingos IF, Weinhäuser I, Franca-Neto PL, Araujo AS, Franca RF, Bezerra MA, Lucena-Araujo AR | Ann Hematol | 2021 |
| Digital behavioural interventions for people with sickle cell disease. | Badawy SM, Cronin RM, Liem RI, Palermo TM | Cochrane Libr | 2021 |
| Human mA-mRNA and lncRNA epitranscriptomic microarray reveal function of RNA methylation in hemoglobin H-constant spring disease. | Ruan H, Yang F, Deng L, Yang D, Zhang X, Li X, Pang L | Sci Rep | 2021 |
| Thalassemias: From gene to therapy. | De Simone G, Quattrocchi A, Mancini B, di Masi A, Nervi C, Ascenzi P | Mol Aspects Med | 2021 |
| The Prevalence of Depression and Anxiety Among Sickle Cell Disease Patients in King Abdulaziz University Hospital. | Al-Marzouki AF, Alrefaie NI, Aljohani NA, Alandanusi RA, Alghamdi AA, Radhwi OO | Cureus | 2021 |
| Perception of Parents of Thalassemic Child to Thalassemia in Pakistan. | Saleem N, Anwar A, Shahid NUA, Saleem R, Saleem Z, Asghar H, Zubair M, Ellahi H, Iqbal S | Cureus | 2021 |
| Alectinib-induced red cell morphological changes in a patient with underlying α-thalassaemia trait. | Li THS, Chik YKJ, Wong WS | Int J Lab Hematol | 2021 |
| Red Blood Cell Alloimmunization Rates and Related Factors of Patients with Thalassemia in Shiraz, Iran. | Kasraian L, Khodadi E, Talei A, Morvarid MR, Haddadi D, Foruozandeh H | Lab Med | 2021 |
| Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance. | Mathias JG, Nolan VG, Klesges LM, Badawy SM, Cooper WO, Hankins JS, Smeltzer MP | JAMA Netw Open | 2021 |
| Hyaluronic acid injections for treatment of pediatric sickle cell avascular necrosis of the humeral head. | Wong JY, Le S, Lo C, Costandi A, Chernishof V, Kim E | Reg Anesth Pain Med | 2021 |
| Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011-2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome. | Kunz JB, Schlotmann A, Daubenbüchel A, Lobitz S, Jarisch A, Grosse R, Cario H, Oevermann L, Hakimeh D, Tagliaferri L, Kulozik AE | J Clin Med | 2021 |
| Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. | Hussein N, Henneman L, Kai J, Qureshi N | Cochrane Database Syst Rev | 2021 |
| Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing. | Shen Y, Li R, Teichert K, Montbleau KE, Verboon JM, Voit RA, Sankaran VG | PLoS Genet | 2021 |
| Iron Chelation Reduces DNA Damage in Sickle Cell Anemia. | Al-Khateeb RS, Althagafy HS, ElAssouli MZ, Nori DA, AlFattani M, Al-Najjar SA, Al Amri T, Hashem AM, Harakeh S, Helmi N | Clin Appl Thromb Hemost | 2021 |
| Awareness and Use of the Sickle Cell Disease Toolbox by Primary Care Providers in North Carolina. | Ibemere SO, Tanabe P, Bonnabeau E, Rains G, Eason K, Earls MF, Shah N | J Prim Care Community Health | 2021 |
| Intestinal pathophysiological abnormalities in steady state and after vaso-occlusive crisis in murine sickle cell disease. | Poplawska M, Dutta D, Jayaram M, Salifu M, Chong NS, Lim SH | Br J Haematol | 2021 |
| Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease. | Gerritsma J, Bongaerts V, Eckhardt C, Heijboer H, Nur E, Biemond B, van der Schoot E, Fijnvandraat K, | Br J Haematol | 2021 |
| A novel index to evaluate ineffective erythropoiesis in hematological diseases offers insights into sickle cell disease. | Brewin J, El Hoss S, Strouboulis J, Rees D | Haematologica | 2021 |
| Alemtuzumab Clearance, Lymphocyte Count, and T-Cell Chimerism After Hematopoietic Stem Cell Transplant in Sickle Cell Disease. | Furstenau D, Peer CJ, Hughes TE, Uchida N, Tisdale J, Hall OM, Figg WD, Hsieh M | Pharmacotherapy | 2021 |
| Pregnancy outcome in women with transfused beta-thalassemia in France. | Virot E, Thuret I, Jardel S, Herbrecht R, Lachenal F, Lionnet F, Lucchini MJ, Machin J, Nimubona S, Ribeil JA, Galacteros F, Cannas G, Hot A | Ann Hematol | 2021 |
| Impact of Sickle Cell Trait Hemoglobin on the Intraerythrocytic Transcriptional Program of Plasmodium falciparum. | Saelens JW, Petersen JEV, Freedman E, Moseley RC, Konaté D, Diakité SAS, Traoré K, Vance N, Fairhurst RM, Diakité M, Haase SB, Taylor SM | mSphere | 2021 |
| Bloodstream bacterial infections in thalassemic pediatric and adolescent patients after hematopoietic stem cell transplantation. | Chaya W, Anurathapan U, Rattanasiri S, Techasaensiri C, Pakakasama S, Apiwattanakul N | Pediatr Transplant | 2021 |
| coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials. | Tambor E, Robinson M, Hsu L, Chang HY, Al Naber J, | BMC Med Res Methodol | 2021 |
| Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1? | Martins SR, Toledo SLO, da Silva AJ, Mendes FS, de Oliveira MM, Ferreira LGR, Dusse LMS, Carvalho MDG, Rios DRA, Alpoim PN, Pinheiro MB | Ann Hematol | 2021 |
| Success Stories and Challenges Ahead in Hematopoietic Stem Cell Gene Therapy: Hemoglobinopathies as Disease Models. | Yannaki E, Psatha N, Papadopoulou A, Athanasopoulos T, Gravanis A, Roubelakis MG, Tsirigotis P, Anagnostopoulos A, Anagnou NP, Vassilopoulos G | Hum Gene Ther | 2021 |
| Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease. | Miodownik H, Curtis SA, Olivia Ogu U, Bradford C, Starrels JL, Cunningham CO, Arnsten JH, Choi J, Eisenberg R, Minniti CP | Br J Haematol | 2021 |
| Molecular Characterization Analysis of Thalassemia and Hemoglobinopathy in Quanzhou, Southeast China: A Large-Scale Retrospective Study. | Zhuang J, Zhang N, Wang Y, Zhang H, Zheng Y, Jiang Y, Xie Y, Chen D | Front Genet | 2021 |
| The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells. | Rattananon P, Anurathapan U, Bhukhai K, Hongeng S | Front Pharmacol | 2021 |
| Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property. | Pagare PP, Rastegar A, Abdulmalik O, Omar AM, Zhang Y, Fleischman A, Safo MK | Expert Opin Ther Pat | 2021 |
| Interrelationship between liver T2*-weighted magnetic resonance imaging and acoustic radiation force impulse elastography measurement results and plasma ferritin levels in children with β-thalassemia major. | Kaban S, Damar Ç | J Clin Ultrasound | 2021 |
| Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium. | Masese RV, Bulgin D, Knisely MR, Preiss L, Stevenson E, Hankins JS, Treadwell MJ, King AA, Gordeuk VR, Kanter J, Gibson R, Glassberg JA, Tanabe P, Shah N, | PLoS One | 2021 |
| The association between obstructive sleep apnea and stroke in sickle-cell disease children. | Abulhamail A, Selati S, Alasqah R | Eur Arch Otorhinolaryngol | 2021 |
| Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene. | Mettananda S | Front Genome Ed | 2021 |
| Plasma Concentration of 12-Hydroxyeicosatetraenoic Acid, Single Nucleotide Polymorphisms of 12-Lipooxygenase Gene and Vaso-Occlusion in Sickle Cell Disease. | Duru AN, Ocheni S, Ibegbulam O, Okpala I | Front Genome Ed | 2021 |
| The Promise and the Hope of Gene Therapy. | Papanikolaou E, Bosio A | Front Genome Ed | 2021 |
| Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies. | Mussolino C, Strouboulis J | Front Genome Ed | 2021 |
| Toward a Conversational Agent to Support the Self-Management of Adults and Young Adults With Sickle Cell Disease: Usability and Usefulness Study. | Issom DZ, Hardy-Dessources MD, Romana M, Hartvigsen G, Lovis C | Front Digit Health | 2021 |
| Effect of Baseline Resistance-Associated Substitutions on Thalassemia Patients with Chronic HCV Infection: A Two-Year Follow-Up. | Safarnezhad Tameshkel F, Karbalaie Niya MH, Khoonsari M, Ajdarkosh H, Faraji AH, Nikkhah M, Motamed N, Azarkeivan A, Gholami A, Sohrabi MR, Keyvani H, Zamani F | Middle East J Dig Dis | 2021 |
| Altered mental status as a presentation of rhabdomyolysis in a patient with sickle cell anemia. | Gunn E, Fleisher S, Lebensburger J, Wolfson J | Pediatr Blood Cancer | 2021 |
| A Decision Support Tool for Allogeneic Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease: Acceptability and Usability Study. | Veludhandi A, Ross D, Sinha CB, McCracken C, Bakshi N, Krishnamurti L | JMIR Form Res | 2021 |
| Profile of bacterial pathogens causing infections in children with sickle cell anaemia in Maiduguri. | Ibrahim HA, Yakubu YM, Farouk AG, Ambe P, Gadzama GB | Niger Postgrad Med J | 2021 |
| Who will guard the guardians? Cross-sectional study on prevalence of psychiatric morbidity, quality of life, and coping skills in caregivers of children with thalassemia major. | Angane AY, Kadam KS, Ghorpade GS, Unnithan VB | J Postgrad Med | 2021 |
| Five novel globin gene mutations identified in five Chinese families by next-generation sequencing. | Zhang J, Xie M, Peng Z, Zhou X, Zhao T, Jin C, Yan Y, Zeng X, Li D, Zhang Y, Su J, Feng N, He J, Yao X, Lv T, Zhu B | Mol Genet Genomic Med | 2021 |
| Iron overload in inherited anaemias: why one size can't fit all. | Roy NBA | Br J Haematol | 2021 |
| Recent advances in lentiviral vectors for gene therapy. | Wang X, Ma C, Rodríguez Labrada R, Qin Z, Xu T, He Z, Wei Y | Sci China Life Sci | 2021 |
| Does the world need germline editing for ß-thalassemia? | Kulozik AE | Haematologica | 2021 |
| Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea. | Allard P, Alhaj N, Lobitz S, Cario H, Jarisch A, Grosse R, Oevermann L, Hakimeh D, Tagliaferri L, Kohne E, Kopp-Schneider A, Kulozik AE, Kunz JB | Haematologica | 2021 |
| Ionophore-mediated swelling of erythrocytes as a therapeutic mechanism in sickle cell disease. | Geisness AC, Azul M, Williams D, Szafraniec H, De Souza DC, Higgins JM, Wood DK | Haematologica | 2021 |
| Correction of RNA splicing defect in β-thalassemia mice using CRISPR/Cas9 gene-editing technology. | Lu D, Gong X, Fang Y, Guo X, Chen Y, Yang F, Zhao G, Ma Q, Zeng Y, Zeng F | Haematologica | 2021 |
| Anesthetic experience: congenital methemoglobinemia due to hemoglobin M. | Ri H, Park Y, Jeon Y | J Dent Anesth Pain Med | 2021 |
| A Traditional Review of Sickle Cell Disease and the Associated Onset of Dementia: Hematological and Neurocognitive Crossroads. | Ojinnaka U, Ahmed Z, Kannan A, Quadir H, Hakobyan K, Gaddam M, Mostafa JA | Cureus | 2021 |
| Bone health in pediatric transfusion-dependent beta-thalassemia: Circulating osteoprotegerin and RANKL system. | Youssry I, Saad N, Madboly M, Samy RM, Hamed ST, Tawfik H, Elbatrawy SR, Kaddah N, Abd Elaziz D | Pediatr Blood Cancer | 2021 |
| Health-related quality of life in infants, toddlers and young children with sickle cell disease. | Houwing ME, Muntendam MJ, van Muilekom MM, Teela L, Fijnvandraat K, de Pagter APJ, Heijboer H, van Oers HA, Cnossen MH, Haverman L | Pediatr Blood Cancer | 2021 |
| Intestinal mycobiota composition and changes in children with thalassemia who underwent allogeneic hematopoietic stem cell transplantation. | Yalcin SS, Aksu T, Kuskonmaz B, Ozbek NY, Pérez-Brocal V, Celik M, Uckan Cetinkaya D, Moya A, Dinleyici EC | Pediatr Blood Cancer | 2021 |
| Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia. | Musallam KM, Vitrano A, Meloni A, Addario Pollina S, Di Marco V, Hussain Ansari S, Filosa A, Ricchi P, Ceci A, Daar S, Vlachaki E, Singer ST, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Karimi M, El-Beshlawy A, Hajipour M, Bonifazi F, Vichinsky E, Taher AT, Sankaran VG, Maggio A, | Br J Haematol | 2021 |
| Advancing the care of β-thalassaemia patients with novel therapies. | Bou-Fakhredin R, Motta I, Cappellini MD | Blood Transfus | 2021 |
| Comprehensive management of refractory autoimmune hemolytic anemia in pediatric beta-thalassemia major patient: A case report. | William V, Rusmawatiningtyas D, Makrufardi F, Widjajanto PH | Ann Med Surg (Lond) | 2021 |
| Current status of beta-thalassemia and its treatment strategies. | Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi SAR, Sadia , Irfan M, Khan MA | Mol Genet Genomic Med | 2021 |
| Phenotypic characterisation and associations of leg ulcers in adult sickle cell patients. | Madu A, Madu K, Anigbogu I, Ugwu AO, Okwulehie VA, Ololo U, Ugwu C, Chikezie K | Wound Repair Regen | 2021 |
| Circular RNA Mitochondrial Translation Optimization 1 homologue (CircMTO1) induced by Zinc Finger Protein 460 (ZNF460) promotes oral squamous cell carcinoma progression through the microRNA miR-320a / Alpha Thalassemia/Mental Retardation, X-linked (ATRX) axis. | Zou C, Li X, Lv X, Wu S, Song J, Tang Z, Luo H, Wei H, Ai Y | Bioengineered | 2021 |
| Evaluation of retinal nerve fiber layer and choroidal thickness with spectral domain optical coherence tomography in children with sickle cell anemia. | Yılmaz K, Öncül H, Uzel H, Öncel K, Yılmaz ED, Söker M | Turk J Pediatr | 2021 |
| Screening of Some Indicators for Alpha-Thalassemia in Fujian Province of Southern China. | Zheng L, Huang H, Wu X, Su L, Shen Q, Wang M, Lin N, Xu L | Int J Gen Med | 2021 |
| Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients. | Morales NP, Rodrat S, Piromkraipak P, Yamanont P, Paiboonsukwong K, Fucharoen S | Biomed Pharmacother | 2021 |
| Treatment decision-making in sickle cell disease patients. | Booth A, Bonham V, Porteus M, Ormond KE | J Community Genet | 2021 |
| Evaluation of Intravenous Diphenhydramine Use in Patients with Sickle Cell Vaso-Occlusive Crisis. | Rector K, Merchant S, Crawford R, Arnall JR, Symanowski J, Veeramreddy P, Osunkwo I | Hosp Pharm | 2021 |
| Polymyositis in a child with thalassemia after hematopoietic stem cell transplantation: A case report. | Tan Y, Lin J, Hong X, Lu J, Lu Q | Medicine (Baltimore) | 2021 |
| CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease. | Demirci S, Leonard A, Essawi K, Tisdale JF | Mol Ther Methods Clin Dev | 2021 |
| A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease. | Zaidi AU, Glaros AK, Lee S, Wang T, Bhojwani R, Morris E, Donohue B, Paulose J, Iorga ŞR, Nellesen D | Orphanet J Rare Dis | 2021 |
| Genetic variation patterns of β-thalassemia in western Andalusia (Spain) reveal a structure of specific mutations within the Iberian Peninsula. | Sánchez-Martínez LJ, Hernández CL, Rodríguez JN, Dugoujon JM, Novelletto A, Ropero P, Pereira L, Calderón R | Ann Hum Biol | 2021 |
| The correlation of cardiac biomarkers and myocardial iron overload based on T2* MRI in major beta-thalassemia. | Saadatifar H, Niayeshfar A, Mard-Soltani M, Bahrampour E, Khalili S, Alinezhad Dezfuli D, Pouriamehr S | Int J Cardiovasc Imaging | 2021 |
| Artifactual hypoglycemia in a patient with sickle cell anemia. | Wang LR, Morein J, McCudden C, Sorisky A | CMAJ | 2021 |
| Safety of intravenous arginine therapy in children with sickle cell disease hospitalized for vaso-occlusive pain: A randomized placebo-controlled trial in progress. | Reyes LZ, Figueroa J, Leake D, Khemani K, Kumari P, Bakshi N, Lane PA, Dampier C, Morris CR | Am J Hematol | 2021 |
| COVID-19 and Hemoglobinopathies: A Systematic Review of Clinical Presentations, Investigations, and Outcomes. | Lee JX, Chieng WK, Lau SCD, Tan CE | Front Med (Lausanne) | 2021 |
| Evaluation of Microchip-Based Point-Of-Care Device | Shrivas S, Patel M, Kumar R, Gwal A, Uikey R, Tiwari SK, Verma AK, Thota P, Das A, Bharti PK, Shanmugam R | Front Med (Lausanne) | 2021 |
| Orofacial Manifestation and Dental Management of Sickle Cell Disease: A Scoping Review. | Kakkar M, Holderle K, Sheth M, Arany S, Schiff L, Planerova A | Anemia | 2021 |
| Legitimate suffering: a case of belonging and sickle cell trait in Brazil. | Creary M | Biosocieties | 2021 |
| Haptoglobin Gene Polymorphism among Sickle Cell Patients in West Cameroon: Hematological and Clinical Implications. | Bernard Kengne Fotsing C, Anatole Pieme C, Cabral Biapa Nya P, Paul Chedjou J, Ashusong S, Njindam G, Nengom JT, Teto G, Nguemeni C, Fon Mbacham W, Gatsing D | Adv Hematol | 2021 |
| A Comparative Study of Salivary Flow Rate, pH, Buffer Capacity, Total Antioxidant Capacity, and Ferritin Levels in Children with Beta Thalassemia Major and Healthy Children. | Rao GV, Preethi V, Daneswari V, Reddy V, Sivakalyan V, Garge R | Int J Clin Pediatr Dent | 2021 |
| Application of Bayesian Decision Tree in Hematology Research: Differential Diagnosis of -Thalassemia Trait from Iron Deficiency Anemia. | Jahangiri M, Rahim F, Saki N, Saki Malehi A | Comput Math Methods Med | 2021 |
| Psycho-social problems of adolescents with sickle-cell anaemia in Ekiti State, Nigeria. | Adegboyega LO | Afr Health Sci | 2021 |
| Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria. | Ofakunrin AO, Okpe ES, Afolaranmi TO, Olaosebikan RR, Kanhu PU, Adekola K, Dami N, Sagay AS | Afr Health Sci | 2021 |
| Relationship between disease severity and folate status of children with sickle cell anaemia in Enugu, South East Nigeria. | Nnajekwu UC, Nnajekwu CO, Onukwuli VO, Uwaezuoke NA, Ezenwosu OU, Ikefuna AN, Emodi IJ | Afr Health Sci | 2021 |
| Burden of iron overload among non-chronically blood transfused preschool children with sickle cell anaemia. | Olufemi AS, Folashade AA, Adetutu OT | Afr Health Sci | 2021 |
| Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial. | Chen JM, Zhu WJ, Liu J, Wang GZ, Chen XQ, Tan Y, Xu WW, Qu LW, Li JY, Yang HJ, Huang L, Cai N, Wang WD, Huang K, Xu JQ, Li GH, He S, Luo TY, Huang Y, Liu SH, Wu WQ, Lu QY, Zhou MG, Chen SY, Li RL, Hu ML, Huang Y, Wei JH, Li JM, Chen SJ, Zhou GB | Signal Transduct Target Ther | 2021 |
| Updated Molecular Spectrum of β-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration. | Atroshi SD, Al-Allawi NAS, Eissa AA | Hemoglobin | 2021 |
| Prevalence and risk factors of cognitive impairment in children with sickle cell disease in Egypt. | Youssry I, ElGhamrawy M, Seif H, Balsamo L, Pashankar F, Mahrous M, Salama N | Int J Hematol | 2021 |
| Hemoglobinopathy gone astray-three novel forms of α-thalassemia in Norwegian patients characterized by quantitative real-time PCR and DNA sequencing. | Grimholt RM, Fjeld B, Klingenberg O | Scand J Clin Lab Invest | 2021 |
| Storage Duration and Red Blood Cell-Derived Microparticles in Packed Red Blood Cells Obtained from Donors with Thalassemia. | Noulsri E, Lerdwana S, Palasuwan D, Palasuwan A | Lab Med | 2021 |
| Eculizumab as a Treatment for Hyper-Haemolytic and Aplastic Crisis in Sickle Cell Disease. | Patel I, Odak M, Douedi S, Alshami A, Upadhyaya VD, Hossain M, Anne M, Patel SV | Eur J Case Rep Intern Med | 2021 |
| Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA. | Smeltzer MP, Howell KE, Treadwell M, Preiss L, King AA, Glassberg JA, Tanabe P, Badawy SM, DiMartino L, Gibson R, Kanter J, Klesges LM, Hankins JS, | BMJ Open | 2021 |
| Content validation of observer-reported sickle cell pain diaries (SCPD-CS and SCPD-CN): results from interviews with caregivers. | White MK, Foster AM, Bailey M, D'Alessio D, Rizio A, Stebbins P, Pierre DS, Saucier C | Health Qual Life Outcomes | 2021 |
| Cyanosis, hemolysis, decreased HbA1c and abnormal co-oximetry in a patient with hemoglobin M Saskatoon [HBB:c.190C > T p.His64Tyr]. | Göttgens EL, Baks K, Harteveld CL, Goossens K, van Gammeren AJ | Hematology | 2021 |
| Beta thalassemia major: the invaluable role of electrocardiography and echocardiography. | Patsourakos D, Delicou S, Tsioufis K, Aggeli C | Int J Cardiovasc Imaging | 2021 |
| Use of infusion ports in patients with sickle cell disease: Indications and complications. | Ilonze C, Anderson M, Stubblefield A, Journeycake J, Sinha AA | Pediatr Blood Cancer | 2021 |
| Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sickling. | Venugopal J, Wang J, Guo C, Eitzman DT | Br J Haematol | 2021 |
| Bridging the implementation gap in medication adherence. If you build it, will they come? | Hankins JS, Klesges LM | Br J Haematol | 2021 |
| A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence. | Smith WR, McClish DK, Lottenberg R, Sisler IY, Sop D, Johnson S, Villella A, Liles D, Yang E, Chen I | Br J Haematol | 2021 |
| Hydroxyurea usage awareness among patients with sickle-cell disease in Saudi Arabia. | Alsalman M, Alkhalifa H, Alkhalifa A, Alsubie M, AlMurayhil N, Althafar A, Albarqi M, Alnaim A, Khan AS | Health Sci Rep | 2021 |
| Genetic and non-genetic factors affecting hemoglobin A expression in a large cohort of Thai individuals: implication for population screening for thalassemia. | Singha K, Sanchaisuriya K, Fucharoen G, Fucharoen S | Am J Transl Res | 2021 |
| Eleven Cases of Hb J-Paris-I [: c.38C>A (or )]: A Stable α Chain Variant Elutes in the P3 Window on High-Performance Liquid Chromatography. | Khalil MSM, Timbs AT, Henderson SJ, Schuh A, Old JM | Hemoglobin | 2021 |
| Non-crisis related pain occurs in adult patients with sickle cell disease despite chronic red blood cell exchange transfusion therapy. | Curtis SA, Raisa BM, Roberts JD, Hendrickson JE, Starrels J, Lesley D, Michelle D, Daniel Z, Brandow AM | Transfus Apher Sci | 2021 |
| Molecular Spectrum of α- and β-Thalassemia among Young Individuals of Marriageable Age in Guangdong Province, China. | Zhou BY, Wang YX, Xu SS, Gu H, Li MZ | Biomed Environ Sci | 2021 |
| Evaluation of Vascular Health of E-Beta Thalassemia Patients: Effect of Iron Overload. | De D, Nath UK, Chakrabarti P | J Assoc Physicians India | 2021 |
| Altered Dynamic Brain Connectivity in Individuals With Sickle Cell Disease and Chronic Pain Secondary to Hip Osteonecrosis. | Santana JERS, Baptista AF, Lucena R, Lopes TDS, do Rosário RS, Xavier MR, Fonseca A, Miranda JGV | Clin EEG Neurosci | 2021 |
| Murine models of sickle cell disease and beta-thalassemia demonstrate pulmonary hypertension with distinctive features. | Buehler PW, Swindle D, Pak DI, Fini MA, Hassell K, Nuss R, Wilkerson RB, D'Alessandro A, Irwin DC | Pulm Circ | 2021 |
| Left ventricular function and cardiac valvar annular dimensions among children with sickle cell anemia compared to those with hemoglobin AA type in Enugu, Nigeria. | Chinawa JM, Chinawa AT, Ossai EN, Chukwu BF, Ndu IK, Asinobi IN | Malawi Med J | 2021 |
| Shared molecular basis, diagnosis, and co-inheritance of alpha and beta thalassemia. | Khatri G, Sahito AM, Ansari SA | Blood Res | 2021 |
| Can ruxolitinib avert splenectomy in patients with thalassaemia: a short term case series. | Taneja K, Verma C, Mahajan A | Br J Haematol | 2021 |
| Hb Jishui [ HBA1: c.225C>G, Codon 74 ( GAC> GAG), Asp→Glu]: A Novel α Chain Hemoglobin Variant Detected During Hb A 1c Measurement | Weijie Xie, Huiqi Zheng, Anping Xu, Ling Ji | Hemoglobin . | 2021 |
| Growing Up With Sickle Cell Disease: Hospital Medicine and Health Care Transitions. | Mennito S, Martin T | Hosp Pediatr | 2021 |
| Baby boy blue … and mommy too! A rare case of methaemoglobinaemia presenting simultaneously in a mother-neonate pair. | Foong SC, Hwang YC, Foong WC, Tan ML | Med J Malaysia | 2021 |
| High prevalence of central hypothyroidism among patients with transfusion dependent thalassemia in Hospital Pulau Pinang: A cross sectional study. | Seow CE, Goh AS, Lim SL | Med J Malaysia | 2021 |
| The Prevalence of Hypothyroidism among Patients With β-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies. | Haghpanah S, Hosseini-Bensenjan M, Sayadi M, Karimi M, de Sanctis V, Ramzi M, Mousavi MR | Hemoglobin | 2021 |
| Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study. | Serjeant GR | Front Med (Lausanne) | 2021 |
| Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing. | Buaboonnam J, Takpradit C, Viprakasit V, Narkbunnam N, Vathana N, Phuakpet K, Sanpakit K, Pongtanakul B | Mediterr J Hematol Infect Dis | 2021 |
| Vasoconstriction Response to Mental Stress in Sickle Cell Disease: The Role of the Cardiac and Vascular Baroreflexes. | Thuptimdang W, Shah P, Khaleel M, Sunwoo J, Veluswamy S, Kato RM, Coates TD, Khoo MCK | Front Physiol | 2021 |
| Navigating Ethical Challenges for Pediatric Sickle Cell Pain Management in the Context of the Opioid Epidemic. | Mulchan SS, Wakefield EO, Martin SR, Ayr-Volta L, Krenicki K, Zempsky WT | Clin J Pain | 2021 |
| Polysplenia syndrome and sickle cell trait: extensive deep venous thrombosis from venous stasis and hypercoagulability. | Shahrouki P, Lee EW, Ruehm S | Clin Imaging | 2021 |
| Food insecurity, housing instability, and dietary quality among children with sickle cell disease: Assessment from a single urban center. | Fernández CR, Licursi M, Wolf R, Lee MT, Green NS | Pediatr Blood Cancer | 2021 |
| Hospital Use and Mortality in Transition-Aged Patients With Sickle Cell Disease. | Fasipe T, Dongarwar D, Lopez E, Brown R, Abadom M, Mahoney DH, Salihu HM | Hosp Pediatr | 2021 |
| Hematological and molecular analysis of patients with G6PD deficiency revealed coexistent hereditary spherocytosis and alpha thalassemia. | Rizo-delaTorre LDC, Herrera-Tirado IM, Hernández-Peña R, Ibarra-Cortés B, Perea-Díaz FJ | Ann Hum Genet | 2021 |
| Treatment strategies for haemoglobin E thalassaemia. | Charoenkwan P, Tantiworawit A | Lancet Glob Health | 2021 |
| Integrating deep learning with microfluidics for biophysical classification of sickle red blood cells adhered to laminin. | Praljak N, Iram S, Goreke U, Singh G, Hill A, Gurkan UA, Hinczewski M | PLoS Comput Biol | 2021 |
| The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing. | Zhou JR, Ridsdale R, MacNeil L, Lilley M, Hoang S, Christian S, Blumenschein P, Wolan V, Bruce A, Singh G, Wright N, Parboosingh JS, Lamont RE, Sosova I | Int J Neonatal Screen | 2021 |
| Case report of active pulmonary TB in a sickle cell disease patient. | Okar L, Rezek M, Abdelhamid MT, Yassin MA | Ann Med Surg (Lond) | 2021 |
| Improved Characterization of Complex β-Globin Gene Cluster Structural Variants Using Long-Read Sequencing. | Rangan A, Hein MS, Jenkinson WG, Koganti T, Aleff RA, Hilker CA, Blommel JH, Porter TR, Swanson KC, Lundquist P, Nguyen PL, Shi M, He R, Viswanatha DS, Jen J, Klee EW, Kipp BR, Hoyer JD, Wieben ED, Oliveira JL | J Mol Diagn | 2021 |
| Neurodevelopmental Outcomes in Preterm Children with Sickle Cell Disease. | Bills SE, Schatz J, Hunt E, Varanasi S, Johnston J, Bradshaw J | J Int Neuropsychol Soc | 2021 |
| Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature. | Hoogenboom WS, Alamuri TT, McMahon DM, Balanchivadze N, Dabak V, Mitchell WB, Morrone KB, Manwani D, Duong TQ | Blood Rev | 2021 |
| Safety: A Primary Concern in Thalidomide Use in Thalassemia. | Khera S | Indian Pediatr | 2021 |
| Sickle Cell Anemia and Infection. | Beri D, Singh M, Rodriguez M, Yazdanbakhsh K, Lobo CA | Pathogens | 2021 |
| The Post-Storage Performance of RBCs from Beta-Thalassemia Trait Donors Is Related to Their Storability Profile. | Anastasiadi AT, Paronis EC, Arvaniti VZ, Velentzas AD, Apostolidou AC, Balafas EG, Dzieciatkowska M, Kostomitsopoulos NG, Stamoulis K, Papassideri IS, D'Alessandro A, Kriebardis AG, Antonelou MH, Tzounakas VL | Int J Mol Sci | 2021 |
| Comparison of Two Alternative Procedures to Obtain Packed Red Blood Cells for β-Thalassemia Major Transfusion Therapy. | Schiroli D, Merolle L, Quartieri E, Chicchi R, Fasano T, De Luca T, Molinari G, Pulcini S, Pertinhez TA, Di Bartolomeo E, Biguzzi R, Baricchi R, Marraccini C | Biomolecules | 2021 |
| Cell erythroid maturation approach: a new paradigm in the road map towards a cure for β-thalassaemia syndromes. | Maggio A | Br J Haematol | 2021 |
| Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies. | Mukherjee M, Rahaman M, Ray SK, Shukla PC, Dolai TK, Chakravorty N | Mol Biol Rep | 2021 |
| Total Hip Replacement in Sickle Cell Disease Patients with Avascular Necrosis of Head of Femur: A Retrospective Observational Study. | Al-Otaibi ML, Waliullah S, Kumar V | Indian J Orthop | 2021 |
| A call to start hydroxyurea by 6 months of age and before the advent of sickle cell disease complications. | Elenga N, Kayemba-Kay's S, Nacher M, Archer N | Pediatr Blood Cancer | 2021 |
| Evaluation of Stillbirth Among Pregnant People With Sickle Cell Trait. | Canelón SP, Butts S, Boland MR | JAMA Netw Open | 2021 |
| Rapid molecular diagnostics of large deletional β-thalassemia (3.5 kb and 45 kb) using colorimetric LAMP in various thalassemia genotypes. | Tepakhan W, Jomoui W | Heliyon | 2021 |
| Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital. | Delicou S, Aggeli K, Magganas K, Patsourakos D, Xydaki A, Koskinas J | Hemoglobin | 2021 |
| Nationwide retrospective study of critically ill adults with sickle cell disease in France. | Agbakou M, Mekontso-Dessap A, Pere M, Voiriot G, Picard M, Bourenne J, Ehrmann S, Canet E, Boyer A, Nseir S, Tamion F, Thille AW, Argaud L, Pontis E, Quenot JP, Schneider F, Hot A, Capellier G, Aubron C, Razazi K, Masseau A, Brule N, Reignier J, Lascarrou JB | Sci Rep | 2021 |
| Clinical depression in children and adolescents with sickle cell anaemia: influencing factors in a resource-limited setting. | Ezenwosu O, Chukwu B, Ezenwosu I, Uwaezuoke N, Eke C, Udorah M, Idoko C, Ikefuna A, Emodi I | BMC Pediatr | 2021 |
| Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label, noninferiority study. | Kwiatkowski JL, Hamdy M, El Beshlawy A, Ebeid FSE, Badr M, AlShehri AAM, Kanter J, Inusa BDP, Adly A, Williams S, Kilinc Y, Lee D, Tricta F, Elalfy MS | Blood Adv | 2021 |
| Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis. | Mohzari YA, Alshuraim R, Asdaq SMB, Aljobair F, Alrashed A, Alsowaida YS, Alamer A, Al Munjem MF, Al Musawa MI, Hatata M, Alzaaqi MA, Binrokan A, Alajlan SA, Abraham I, Alamer A | J Infect Public Health | 2021 |
| Preferences for Using a Mobile App in Sickle Cell Disease Self-management: Descriptive Qualitative Study. | Mayo-Gamble TL, Quasie-Woode D, Cunningham-Erves J, Rollins M, Schlundt D, Bonnet K, Murry VM | JMIR Form Res | 2021 |
| Sickle cell disease patients in two London trusts: Genotyping including RH variants. | Hui YMT, Gurung K, Layton DM, Ibidapo M, Grimsley S, Regan F | Transfus Med | 2021 |
| Longitudinal assessment of adhesion to vascular cell adhesion molecule-1 at steady state and during vaso-occlusive crises in sickle cell disease. | White J, Callaghan MU, Gao X, Liu K, Zaidi A, Tarasev M, Hines PC | Br J Haematol | 2021 |
| Non-Invasive Prenatal Test for β-Thalassemia and Sickle Cell Disease Using Probe Capture Enrichment and Next-Generation Sequencing of DNA in Maternal Plasma. | Erlich HA, López-Peña C, Carlberg KT, Shih S, Bali G, Yamaguchi KD, Salamon H, Das R, Lal A, Calloway CD | J Appl Lab Med | 2021 |
| Performance of an HRP-2 based (First Response®) and p-LDH-based (Optimal®) rapid diagnostic tests for diagnosis of malaria in paediatric sickle cell disease patients. | Adjei GO, Sulley AM, Goka BQ, Enweronu-Laryea C, Renner L, Alifrangis M, Kurtzhals JAL | Clin Infect Dis | 2021 |
| Myocardial longitudinal strain as the first herald of cardiac impairment in very early iron overload state: an echocardiography and biosusceptometry study on beta-thalassemia patients. | Barbero U, Fornari F, Gagliardi M, Fava A, Giorgi M, Alunni G, Gaglioti CM, Piga A, Ferrero GB, Longo F | Am J Cardiovasc Dis | 2021 |
| Risk of mortality from anemia and iron overload in non-transfusion-dependent β-thalassemia. | Musallam KM, Vitrano A, Meloni A, Addario Pollina S, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Ansari SH, Filosa A, Ricchi P, Ceci A, Daar S, Vlachaki E, Singer ST, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Sankaran VG, Vichinsky E, Taher AT, Maggio A, | Am J Hematol | 2021 |
| Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia. | Nardo-Marino A, Petersen J, Brewin JN, Birgens H, Williams TN, Kurtzhals JAL, Rees DC, Glenthøj A | Br J Haematol | 2021 |
| Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Sickle Cell Anemia. | Shook LM, Haygood D, Quinn CT | Front Med (Lausanne) | 2021 |
| Diminished ovarian reserve in young women with sickle cell anemia. | Pecker L, Hussain S, Mahesh J, Varadhan R, Christianson MS, Lanzkron S | Blood | 2021 |
| Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects. | Junker LH, Li B, Zhu X, Koti S, Cerbone RE, Hendrick CL, Sangerman J, Perrine S, Pace BS | Blood Cells Mol Dis | 2021 |
| Hepcidin-to-Ferritin Ratio: A Potential Novel Index to Predict Iron Overload-Liver Fibrosis in ß-Thalassemia Major. | Zaman BA, Rasool SO, Merza MA, Abdulah DM | Transfus Clin Biol | 2021 |
| Predicting risk factors for thromboembolic complications in patients with sickle cell anaemia - lessons learned for prophylaxis. | Alkindi S, Al-Ghadani AR, Al-Zeheimi SR, Alkindi SY, Fawaz N, Ballas SK, Pathare AV | J Int Med Res | 2021 |
| Hepatobiliary Findings in Nigerian Children with Sickle Cell Anaemia. | Adeniyi OF, Akinsete AM, Odeghe EA, Okeke OF, Mokwenyei O, Kene-Udemezue B, Seyi-Olajide JO, Akinsulie A, Adeniran O, Adeniran O, Oyeleke G | West Afr J Med | 2021 |
| Trends in quality of care among children with sickle cell anemia. | Reeves SL, Freed GL, Madden B, Wu M, Miller L, Cogan L, Anders D, Creary SE, McCormick J, Dombkowski KJ | Pediatr Blood Cancer | 2021 |
| A novel SUPT5H variant associated with a beta-thalassaemia trait. | Charnay T, Cerino M, Gonnet K, Bonello-Palot N, Bréchard MP, Badens C | Br J Haematol | 2021 |
| Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations. | Samuelson C, Radtke S, Zhu H, Llewellyn M, Fields E, Cook S, Huang MW, Jerome KR, Kiem HP, Humbert O | Mol Ther Methods Clin Dev | 2021 |
| Safety, clinical and laboratory characteristics of donors with thalassemia minor in living donor kidney transplant: a case series. | Dinh NH, Beaupha SMC | BMC Nephrol | 2021 |
| Splenic infarction in sickle cell trait: A comprehensive systematic review of case studies. | Jefferson JM, Sims WM, Umeh N, Byeon YJJ, Abdallah KE, Bonham VL, Naik RP, Smith-Whitley K | EJHaem | 2021 |
| Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell. | Shojaei Baghini S, Gardanova ZR, Zekiy AO, Shomali N, Tosan F, Jarahian M | Front Bioeng Biotechnol | 2021 |
| Coexistence of Relapsing Polychondritis and Sickle Cell Disease in a Child. | Tetteh BO, Yebuah FB, Amissah-Arthur MB, Dey D | Case Rep Rheumatol | 2021 |
| Cognitive Function in Adults with Beta-Thalassemia Major in Oman: A Pilot Study. | Daar S, Al Saadoon M, Wali Y, Al Mujaini R, Al Rahbi S, Chan MF, Al-Siyabi A, Alansary N, Mahadevan S, Al-Adawi S | Oman Med J | 2021 |
| Alterations of panoramic radiomorphometric indices in children and adolescents with beta-thalassemia major: A fractal analysis study. | Yagmur B, Tercanli-Alkis H, Tayfun-Kupesiz F, Karayilmaz H, Kupesiz OA | Med Oral Patol Oral Cir Bucal | 2021 |
| Tocilizumab for severe acute chest syndrome in a child with sickle cell disease and dramatically high interleukin-6 values in endotracheal and pleural fluids. | Allali S, Chhun S, de Montalembert M, Heilbronner C, Taylor M, Brice J, Elie J, Rignault-Bricard R, Maciel TT, Chareyre J, Hermine O | Am J Hematol | 2021 |
| Myocardial Performance Index Among Patients of Sickle Cell Disorder in Rural Teaching Hospital: A Case-Control Study. | Chaturvedi A, Kumar S, Acharya S, Gaidhane SA, Wanjari A, Talwar D | Cureus | 2021 |
| Two Sides of a Coin: Case Report of Unilateral Synangiosis and Contralateral Stroke Highlighting Consequences of Disease Progression and Efficacy of Revascularization in Sickle Cell Disease Associated Moyamoya Syndrome. | Slingerland AL, Karsten MB, Smith ER, Sobota AE, See AP | Acta Haematol | 2021 |
| Long noncoding RNAs transcribed downstream of the human β-globin locus regulate β-globin gene expression. | Higashi M, Ikehara T, Nakagawa T, Yoneda M, Hattori N, Ikeda M, Ito T | J Biochem | 2021 |
| Screening by Self-Report Underestimates Sickle Cell Trait in High-School Athletes. | Allen G, Smith MS, Bruner M, Agrawal K, Clugston JR, Prine BR | Cureus | 2021 |
| Fear of abortion and emotional divorce in women with minor thalassemia: a population-based study in Yazd, Iran. | Rahaei Z, Sahami MA, Bidaki R | BMC Womens Health | 2021 |
| Malaria protection due to sickle haemoglobin depends on parasite genotype. | Band G, Leffler EM, Jallow M, Sisay-Joof F, Ndila CM, Macharia AW, Hubbart C, Jeffreys AE, Rowlands K, Nguyen T, Gonçalves S, Ariani CV, Stalker J, Pearson RD, Amato R, Drury E, Sirugo G, d'Alessandro U, Bojang KA, Marsh K, Peshu N, Saelens JW, Diakité M, Taylor SM, Conway DJ, Williams TN, Rockett KA, Kwiatkowski DP | Nature | 2021 |
| An online alpha-thalassemia carrier discrimination model based on random forest and red blood cell parameters for low HbA cases. | Feng P, Li Y, Liao Z, Yao Z, Lin W, Xie S, Hu B, Huang C, Liu W, Xu H, Liu M, Gan W | Clin Chim Acta | 2021 |
| Oxidative stress and hepcidin expression in pediatric sickle cell anemia with iron overload. | Elbostany EA, Elghoroury EA, Thabet EH, Rashad AA, Rasheed EA, El-Saeed GSM, Abdelhalim DA, Abdelfattah SN, Salama II | Hematol Oncol Stem Cell Ther | 2021 |
| Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK. | Oakley LL, Mitchell S, von Rege I, Hadebe R, Howard J, Robinson SE, Oteng-Ntim E | Br J Haematol | 2021 |
| Practice Patterns for the Acceptance of Medically Complex Living Kidney Donors with Hematuria, Sickle Cell Trait, Smoking, Illegal Drug Use, or Urological Issues: A Multinational Survey. | Arabi Z, Hamad A, Bukhari M, Altheaby A, Kaysi S | Avicenna J Med | 2021 |
| Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation. | Leonard A, Bertaina A, Bonfim C, Cohen S, Prockop S, Purtill D, Russell A, Boelens JJ, Wynn R, Ruggeri A, Abraham A | Cytotherapy | 2021 |
| Early testicular maturation is sensitive to depletion of spermatogonial pool in sickle cell disease. | Benninghoven-Frey KM, Neuhaus N, Lahtinen AK, Krallmann C, Portela JMD, Jarisch A, Nordhoff V, Soave A, Ba Omar HAM, Sundin M, Langenskiöld C, Kliesch S, Stukenborg JB, Jahnukainen K | Haematologica | 2021 |
| Reasons for Hospitalization of Sickle Cell Disease Patients in the Eastern Province of Saudi Arabia: A Single-Center Study. | Zakaria OM, Buhalim RA, Al Jabr FA, AlSaeed MN, Al-Hajji IA, Al Saleh YA, Buhalim MA, Al Dehailan AM | Cureus | 2021 |
| Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease. | Goyal S, Tisdale J, Schmidt M, Kanter J, Jaroscak J, Whitney D, Bitter H, Gregory PD, Parsons G, Foos M, Yeri A, Gioia M, Voytek SB, Miller A, Lynch J, Colvin RA, Bonner M | N Engl J Med | 2021 |
| Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. | Kanter J, Walters MC, Krishnamurti L, Mapara MY, Kwiatkowski JL, Rifkin-Zenenberg S, Aygun B, Kasow KA, Pierciey FJ, Bonner M, Miller A, Zhang X, Lynch J, Kim D, Ribeil JA, Asmal M, Goyal S, Thompson AA, Tisdale JF | N Engl J Med | 2021 |
| Impact of hydroxyurea on lymphocyte subsets in children with sickle cell anemia. | Elsayh KI, Saad K, Hetta HF, Youssef MAM, Embaby MM, Mohamed IL, Abdel-Aziz SM, Zahran ZAM, Elhoufey A, Ghandour AMA, Zahran AM | Pediatr Res | 2021 |
| Ovarian reserve in nigerian women with sickle cell anaemia: a cross- sectional study. | Garba SR, Makwe CC, Osunkalu VO, Kalejaiye OO, Soibi-Harry AP, Aliyu AU, Afolabi BB | J Ovarian Res | 2021 |
| Generation of a single-tube quality control material for hemoglobin and DNA analyses of hemoglobinopathies. | Pansuwan A, Changtrakul D, Chaibunruang A, Yamsri S, Sanchaisuriya K, Fucharoen G, Fucharoen S | Int J Lab Hematol | 2021 |
| Advances in the management of α-thalassemia major: reasons to be optimistic. | Horvei P, MacKenzie T, Kharbanda S | Hematology Am Soc Hematol Educ Program | 2021 |
| β-Thalassemia: evolving treatment options beyond transfusion and iron chelation. | Langer AL, Esrick EB | Hematology Am Soc Hematol Educ Program | 2021 |
| Indications for transfusion in the management of sickle cell disease. | Han H, Hensch L, Tubman VN | Hematology Am Soc Hematol Educ Program | 2021 |
| Management of hemolytic transfusion reactions. | Hendrickson JE, Fasano RM | Hematology Am Soc Hematol Educ Program | 2021 |
| Optimal strategies for carrier screening and prenatal diagnosis of α- and β-thalassemia. | Mensah C, Sheth S | Hematology Am Soc Hematol Educ Program | 2021 |
| Clinical trial considerations in sickle cell disease: patient-reported outcomes, data elements, and the stakeholder engagement framework. | Badawy SM | Hematology Am Soc Hematol Educ Program | 2021 |
| Optimizing management of sickle cell disease in patients undergoing surgery. | Oyedeji CI, Welsby IJ | Hematology Am Soc Hematol Educ Program | 2021 |
| Treatment dilemmas: strategies for priapism, chronic leg ulcer disease, and pulmonary hypertension in sickle cell disease. | Azbell RCG, Desai PC | Hematology Am Soc Hematol Educ Program | 2021 |
| How to avoid the problem of erythrocyte alloimmunization in sickle cell disease. | Pirenne F, Floch A, Habibi A | Hematology Am Soc Hematol Educ Program | 2021 |
| Evidence-Based Minireview: In young children with severe sickle cell disease, do the benefits of HLA-identical sibling donor HCT outweigh the risks? | Shah N, Krishnamurti L | Hematology Am Soc Hematol Educ Program | 2021 |
| Hematopoietic cell transplantation for sickle cell disease: updates and future directions. | Krishnamurti L | Hematology Am Soc Hematol Educ Program | 2021 |
| Gene therapy for sickle cell disease: where we are now? | Kanter J, Falcon C | Hematology Am Soc Hematol Educ Program | 2021 |
| System's failure: Poor adherence to guidelines for children with sickle cell disease. | Vistica Sampino E, McGann PT | Pediatr Blood Cancer | 2021 |
| First Report of the 3'-Untranslated Region +1506 (A>C) [NM_000518.5: c.*32A>C] mutation on the β-Globin Gene in the Indian Population. | Sen A, Seenappa V, Chakrabarti P, Dolai TK | Hemoglobin | 2021 |
| Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies. | Shapiro DD, Soeung M, Perelli L, Dondossola E, Surasi DS, Tripathi DN, Bertocchio JP, Carbone F, Starbuck MW, Van Alstine ML, Rao P, Katz MHG, Parker NH, Shah AY, Carugo A, Heffernan TP, Schadler KL, Logothetis C, Walker CL, Wood CG, Karam JA, Draetta GF, Tannir NM, Genovese G, Msaouel P | Cancers (Basel) | 2021 |
| Anemia Diagnostic System Based on Impedance Measurement of Red Blood Cells. | Cho H, Lee SR, Baek Y | Sensors (Basel) | 2021 |
| Borderline HbA levels: Dilemma in diagnosis of beta-thalassemia carriers. | Colaco S, Nadkarni A | Mutat Res Rev Mutat Res | 2021 |
| [Hb Bart's Quantitative Analysis in the Screening of α-Thalassemia]. | Yi S, Wang B, Li H, Zhang H, Song JP | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Analysis of Thalassemia Gene Carriers in 19 482 Pregnant Women from 2015 to 2019 in Guilin, Guangxi]. | Zheng HQ, Yu XY, Zeng D, Feng Q, Zhu CJ | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Gene Mutation Types and Ethnic Distribution Characteristic of Thalassemia in Guiyang]. | Wang F, Zhang RY, Deng DY, Xu D, Zou Y, Zhou YY | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [Prevalence Rate and Risk Factors of Hypothyroidism in Children with Beta Thalassemia Major in Zhuhai Area]. | Chen M, Duan L, Zhou CX, Fang JP | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| [The Genotypes and Clinical Characteristics of Thalassemia on Children in Wuhan Region]. | Yang Y, Lu YH, Zhang Y, Zhao AL, Zhan XY, Wu B, Tan P, Wan LJ, Huang J | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 |
| Betibeglogene Autotemcel Gene Therapy for Non-β/β Genotype β-Thalassemia. | Locatelli F, Thompson AA, Kwiatkowski JL, Porter JB, Thrasher AJ, Hongeng S, Sauer MG, Thuret I, Lal A, Algeri M, Schneiderman J, Olson TS, Carpenter B, Amrolia PJ, Anurathapan U, Schambach A, Chabannon C, Schmidt M, Labik I, Elliot H, Guo R, Asmal M, Colvin RA, Walters MC | N Engl J Med | 2021 |
| A successful booster umbilical cord blood transplantation for a 10-year-old patient with beta-thalassemia major in India. | Ramanan V | Asian J Transfus Sci | 2021 |
| A case series of hemorrhagic neurological complications of sickle cell disease: Multiple faces of an underestimated problem! | Kamath SD, Pai MG | Asian J Transfus Sci | 2021 |
| National networking in rare diseases and reduction of cardiac burden in thalassemia major. | Pepe A, Pistoia L, Gamberini MR, Cuccia L, Lisi R, Cecinati V, Maggio A, Sorrentino F, Filosa A, Rosso R, Messina G, Missere M, Righi R, Renne S, Vallone A, Dalmiani S, Positano V, Midiri M, Meloni A | Eur Heart J | 2021 |
| Investigational curative gene therapy approaches to sickle cell disease. | Williams DA, Esrick E | Blood Adv | 2021 |
| Telehealth acceptability and opioid prescribing patterns of providers of painful chronic diseases during the COVID-19 pandemic: A survey of sickle cell providers. | Kenney MO, Becerra B, Beatty SA, Smith WR | J Opioid Manag | 2021 |
| Right ventricular function in β-thalassemia children: comparing three-dimensional echocardiography with other functional parameters. | Elhawary EE, Tolba OA, Elkaffas AA, Shabana AH | Pediatr Res | 2021 |
| Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. | Sasongko TH, Nagalla S | Cochrane Database Syst Rev | 2021 |
| Ineffective erythropoiesis and its treatment. | Cazzola M | Blood | 2021 |
| Point-of-care lung ultrasound is more reliable than chest X-ray for ruling out acute chest syndrome in sickle cell pediatric patients: A prospective study. | Preto-Zamperlini M, Giorno EPC, Bou Ghosn DSN, Sá FVM, Suzuki AS, Suzuki L, Farhat SC, Weerdenburg K, Schvartsman C | Pediatr Blood Cancer | 2021 |
| The effect of rigid cells on blood viscosity: linking rheology and sickle cell anemia. | Perazzo A, Peng Z, Young YN, Feng Z, Wood DK, Higgins JM, Stone HA | Soft Matter | 2021 |
| Sickle cell anemia: hierarchical cluster analysis and clinical profile in a cohort in Brazil. | Dutra VF, Biassi TP, Figueiredo MS | Hematol Transfus Cell Ther | 2021 |
| Renal function in β-thalassemia major patients treated with two different iron-chelation regimes. | Tanous O, Azulay Y, Halevy R, Dujovny T, Swartz N, Colodner R, Koren A, Levin C | BMC Nephrol | 2021 |
| Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease. | Bhat DK, Olkhanud PB, Gangaplara A, Seifuddin F, Pirooznia M, Biancotto A, Fantoni G, Pittman C, Francis B, Dagur PK, Saxena A, McCoy JP, Pfeiffer RM, Fitzhugh CD | Front Immunol | 2021 |
| Using DNA testing for the precise, definite, and low-cost diagnosis of sickle cell disease and other Haemoglobinopathies: findings from Tanzania. | Christopher H, Burns A, Josephat E, Makani J, Schuh A, Nkya S | BMC Genomics | 2021 |
| Molecular Detection of Alpha Thalassemia: A Review of Prevalent Techniques. | Vijian D, Wan Ab Rahman WS, Ponnuraj KT, Zulkafli Z, Mohd Noor NH | Medeni Med J | 2021 |
| Pediatric sickle cell pain-sleep relationships: The roles of positive and negative affect. | Valrie CR, Alston K, Morgan K, Kilpatrick R, Sisler I, Fuh B | Health Psychol | 2021 |
| Patient-focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease. | Bradford C, Miodownik H, Thomas M, Ogu UO, Minniti CP | Am J Hematol | 2021 |
| Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome. | Jutant EM, Voiriot G, Labbé V, Savale L, Mokrani H, Van Dreden P, Gerotziafas G, Fartoukh M | ERJ Open Res | 2021 |
| Radiographic Features of the Maxillofacial Anomalies in Beta-Thalassemia Major: With New View. | Bayati S, Keikhaei B, Bahadoram M, Mahmoudian-Sani MR, Vaneshani M, Behbahani F | World J Plast Surg | 2021 |
| PfEMP1-Specific Immunoglobulin G Reactivity Among Beninese Pregnant Women With Sickle Cell Trait. | Lopez-Perez M, Viwami F, Seidu Z, Jensen ATR, Doritchamou J, Ndam NT, Hviid L | Open Forum Infect Dis | 2021 |
| Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia. | Zhou X, Huang L, Wu J, Qu Y, Jiang H, Zhang J, Qiu S, Liao C, Xu X, Xia J, Lian Q | Biomed Pharmacother | 2021 |
| Assessment of the Nutritional Status, Bone Mineralization, and Anthropometrics of Children with Thalassemia Major. | Bulgurcu SC, Canbolat Ayhan A, Emeksiz HC, Ovali F | Medeni Med J | 2021 |
| Correction to: Treatment decision‑making in sickle cell disease patients. | Booth A, Bonham V, Porteus M, Ormond KE | J Community Genet | 2021 |
| , Sickle Cell Trait, and CKD in the Jackson Heart Study. | Young BA, Wilson JG, Reiner A, Kestenbaum B, Franceschini N, Bansal N, Correa A, Himmelfarb J, Katz R | Kidney Med | 2021 |
| Oral Function and Feeding Management in a Child with Alpha Thalassemia X-Linked Intellectual Disability Syndrome. | Nakamura Y, Hanasaki M, Sano T, Hayasaki H, Iwase Y, Saitoh I | J Dent Child (Chic) | 2021 |
| Nitrous Oxide for Dental Procedures in Pediatric Patients with Sickle Cell Disease: A Pilot Study. | Hill B, da Fonseca MA, Hsu LL | Pediatr Dent | 2021 |
| Molecular and cellular mechanisms that regulate human erythropoiesis. | Caulier AL, Sankaran VG | Blood | 2021 |
| Placental transcriptome sequencing combined with bioinformatics predicts potential genes and circular RNAs associated with hemoglobin Bart's hydrops fetalis syndrome. | Deng L, Lu Y, Yang D, Yang F, Ruan H, Wei C, Lai K, Pang L | J Obstet Gynaecol Res | 2021 |
| Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with Alkaloids: Induction of Fetal Hemoglobin Production. | Zuccato C, Cosenza LC, Zurlo M, Lampronti I, Borgatti M, Scapoli C, Gambari R, Finotti A | Int J Mol Sci | 2021 |
| The Practices of Anaesthesiologists in the Management of Patients with Sickle Cell Disease: Empirical Evidence from Cameroon. | Djomo Tamchom D, Kuitchet A, Ndikontar R, Nga Nomo S, Fouda H, Van Obbergh L | Healthcare (Basel) | 2021 |
| Cranial masses in sickle cell disease. | Gonçalves JRDS, Tribovane D, Pires M, Silva Lopes R, Inacio de Oliveira MR, Conceição C | J Pediatr | 2021 |
| A critical evaluation of crizanlizumab for the treatment of sickle cell disease. | Karki NR, Saunders K, Kutlar A | Expert Rev Hematol | 2021 |
| Retinopathy in Egyptian patients with sickle cell disease: A cross-sectional study. | Hassan T, Badr M, Hanna D, Arafa M, Elhewala A, Dabour S, Shehata S, Rahman DA | Medicine (Baltimore) | 2021 |
| Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report. | Rozi W, Ali EAH, Al-Mashdali AF, Abdelrazek M, Yassin MA | Medicine (Baltimore) | 2021 |
| Newborn Screening Practices for Beta-Thalassemia in the United States. | Bender MA, Hulihan M, Dorley MC, Aguinaga MDP, Ojodu J, Yusuf C | Int J Neonatal Screen | 2021 |
| Impact of a Residential Summer Camp Experience on Children With Sickle Cell Disease. | Yan AP, Sawhney M, Kirby-Allen M | Ochsner J | 2021 |
| Molecular and Haematological Characteristics of alpha-Thalassemia Deletions in Yogyakarta Special Region, Indonesia. | Husna N, Handayani NSN | Rep Biochem Mol Biol | 2021 |
| Response to Hydroxyurea in a Patient With Sickle Cell Hepatopathy: A Case Report. | Safhi MA, Baghdadi RM, Al-Marzouki AF, Al-Sayes F | Cureus | 2021 |
| The Epidemiology of Neurological Complications in Adults With Sickle Cell Disease: A Retrospective Cohort Study. | Maduakor C, Alakbarzade V, Sammaraiee Y, Vakrinou A, Corobana A, Sikorska J, Rhodes E, Pereira AC | Front Neurol | 2021 |
| NESTROFT-A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden. | Gosavi M, Chavan R, Bellad MB | J Lab Physicians | 2021 |
| Neurocognitive functioning in preschool children with sickle cell disease. | Heitzer AM, Cohen DL, Okhomina VI, Trpchevska A, Potter B, Longoria J, Porter JS, Estepp JH, King A, Henley M, Kang G, Hankins JS | Pediatr Blood Cancer | 2021 |
| COVID-19-associated rhabdomyolysis in a paediatric patient with sickle cell trait. | Kermond R, Cavazzoni E, Kilo T, Britton PN, Durkan A | J Paediatr Child Health | 2021 |
| Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature. | Bou Zerdan M, Diacovo MJ, Chaulagain CP | Am J Case Rep | 2021 |
| Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease. | Cook O, Cervi A, Laureano M, Gangji AS, Verhovsek M | Transfus Apher Sci | 2021 |
| High Dickkopf-1 levels are associated with chronic inflammation in children with sickle cell disease. | Giordano P, Vecchio GCD, Russo G, Palmieri VV, Piacente L, Fidone C, Urbano F, Faienza MF | Eur J Haematol | 2021 |
| What does the term 'sickle cell disease' mean? | Bain BJ, Littlewood T, Rees DC | Br J Haematol | 2021 |
| Publisher Correction: Sickle cell gene therapies approach watershed. | Sheridan C | Nat Biotechnol | 2021 |
| Stable Luminescent Poly(Allylaminehydrochloride)-Templated Copper Nanoclusters for Selectively Turn-Off Sensing of Deferasirox in β-Thalassemia Plasma. | Lin HJ, Wang CC, Kou HS, Cheng CW, Wu SM | Pharmaceuticals (Basel) | 2021 |
| Granulocyte Colony-Stimulating Factor is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. | Shah NC, Bhoopatiraju S, Abraham A, Anderson E, Andreansky M, Bhatia M, Chaudhury S, Cuvelier GDE, Godder K, Grimley M, Hale G, Kamani N, Jacobsohn D, Ngwube A, Gilman AL, Skiles J, Yu LC, Shenoy S | Transplant Cell Ther | 2021 |
| SOD2 V16A Amplifies Vascular Dysfunction in Sickle Cell Patients by Curtailing Mitochondria Complex IV Activity. | Dosunmu-Ogunbi A, Yuan S, Reynolds M, Giordano L, Sanker S, Sullivan M, Stolz DB, Kaufman BA, Wood KC, Zhang Y, Shiva S, Nouraie SM, Straub AC | Blood | 2021 |
| Hb Dahua [β59(E3)Lys→Met; : c.179A>T] a Novel Variant on the β-Globin Gene. | Qin YY, Huang XJ, Ma YL, Qin JX, Liang L, Li YQ | Hemoglobin | 2021 |
| Dominant β-Thalassemia Phenotype Caused by Hb Dieppe (: c.383A>G): Another Case Report. | Chen HQ, Wu LS, Jiang F, Li DZ | Hemoglobin | 2021 |
| Stigma and quality of life in adults with sickle cell disease in Jamaica and the United States. | Bulgin D, Asnani M, Vorderstrasse A, Royal C, Pan W, Tanabe P | Psychol Health Med | 2021 |
| Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion-dependent β-thalassaemia of a severe genotype. | Constantinou V, Papayanni PG, Mallouri D, Batsis I, Bouinta A, Papadopoulou D, Papadimitriou V, Kammenou M, Pantelidou D, Sotiropoulos D, Sakellari I, Anagnostopoulos A, Yannaki E | Br J Haematol | 2021 |
| Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients. | de Azevedo JTC, Costa TCM, Lima KC, Maciel TT, Palma PVB, Darrigo-Júnior LG, Setanni Grecco CE, Stracieri ABPL, Elias JB, Pieroni F, Guerino-Cunha RL, Pinto ACS, De Santis GC, Covas DT, Hermine O, Simões BP, Oliveira MC, Malmegrim KCR | Front Immunol | 2021 |
| Multisystem Inflammatory Syndrome in a Previously Vaccinated Adolescent Female With Sickle Cell Disease. | DeJong J, Sainato R, Forouhar M, Robinson D, Kunz A | Pediatr Infect Dis J | 2021 |
| Accelerated low-density neutrophil transition in sickle cell anaemia may contribute to disease pathophysiology. | Torres LS, Teles LIM, Shaul ME, Fridlender ZG, Santos I, Leonardo FC, de Melo Campos P, Benites BD, Olalla Saad ST, Costa FF, Conran N | Br J Haematol | 2021 |
| Clinical and genetic characteristics of hemoglobin H disease in Iran. | Abolghasemi H, Kamfar S, Azarkeivan A, Karimi M, Keikhaei B, Abolghasemi F, Radfar MH, Eshghi P, Alavi S | Pediatr Hematol Oncol | 2021 |
| Genetic research and clinical analysis of β-globin gene cluster deletions in the Chinese population of Fujian province: A 14-year single-center experience. | Chen M, Zhang M, Chen L, Lin N, Wang Y, Xu L, Huang H | J Clin Lab Anal | 2021 |
| Setting for | Spasiano A, Meloni A, Costantini S, Quaia E, Cademartiri F, Cinque P, Pepe A, Ricchi P | J Clin Med | 2021 |
| VCAM1, HMOX1 and NOS3 differential endothelial expression may impact sickle cell anemia vasculopathy. | Silva M, Coelho A, Vargas S, Faustino P | Blood Cells Mol Dis | 2021 |
| Acute venous thromboembolism after initiation of voxelotor for treatment of sickle cell disease. | Lemon N, Sterk E, Rech MA | Am J Emerg Med | 2021 |
| Health Status of Patients With β-Thalassemia in the West Bank: A Retrospective-Cohort Study. | Aldwaik R, Abu Mohor T, Idyabi I, Warasna S, Abdeen S, Karmi B, Abu Seir R | Front Med (Lausanne) | 2021 |
| Correlation between Serum Fatty Acid Binding Protein 4 (FABP4) Levels and Cardiac Function in Patients with Thalassemia Major. | Fianza PI, Rahmawati A, Afifah S, Praptama S, Ghozali M, Sihite TA, Setiabudi D, Syamsunarno MRAA, Fucharoen S, Panigoro R | Dis Markers | 2021 |
| Analyzing Effects of Sickle Cell Disease on Morphometric and Cranial Growth in Indian Population. | Menka K, Anand K, Jha MS, Goel A, Nasreen S, Palve DH | J Pharm Bioallied Sci | 2021 |
| Sickle Cell Disease and Psychosocial Well-Being: Comparison of Patients With Preclinical and Clinical Avascular Necrosis of the Femoral Head. | Tezol O, Karahan F, Unal S | Turk Arch Pediatr | 2021 |
| Priming With Red Blood Cells Allows Red Blood Cell Exchange for Sickle Cell Disease in Low-Weight Children. | Hequet O, Boisson C, Joly P, Revesz D, Kebaili K, Gauthier A, Renoux C, Creppy S, Nader E, Nicolas JF, Berard F, Cognasse F, Vocanson M, Bertrand Y, Connes P | Front Med (Lausanne) | 2021 |
| Life-Threatening Acute Chest Syndrome in a Patient With Sickle Cell Disease After Switching From Hydroxyurea Therapy to Partial Exchange Transfusions: A Case Report. | Kvam AK, Torp HA, Iversen PO | Cureus | 2021 |
| Lysine-specific histone demethylase 1 inhibition enhances robust fetal hemoglobin induction in human β-thalassemia/hemoglobin E erythroid cells. | Kaewsakulthong W, Pongpaksupasin P, Nualkaew T, Hongeng S, Fucharoen S, Jearawiriyapaisarn N, Sripichai O | Hematol Rep | 2021 |
| Aggravated Dental and Periodontal Status in Patients with Sickle Cell Disease and Its Association with Serum Ferritin. | Davidopoulou S, Pikilidou M, Yavropoulou MP, Kalogirou TE, Zebekakis P, Kalfas S | J Contemp Dent Pract | 2021 |
| Genotypic and Clinical Analysis of a Thalassemia Major Cohort: An Observational Study. | A T, Lambrou GI, Samartzi A, Vlachou E, Papassotiriou I, Geronikolou SA, Kanaka-Gantenbein C, Chrousos GP, Kattamis A | Adv Exp Med Biol | 2021 |
| Hidradenitis suppurativa is associated with iron deficiency anemia, anemia of chronic disease, and sickle cell anemia-A single-center retrospective cohort study. | Parameswaran A, Garshick MS, Revankar R, Lu CP, Chiu ES, Sicco KIL | Int J Womens Dermatol | 2021 |
| Hearing Loss in Beta-Thalassemia: Systematic Review. | Tartaglione I, Carfora R, Brotto D, Barillari MR, Costa G, Perrotta S, Manara R | J Clin Med | 2021 |
| Quality of Life and Burden of Disease in Italian Patients with Transfusion-Dependent Beta-Thalassemia. | Tedone F, Lamendola P, Lopatriello S, Cafiero D, Piovani D, Forni GL | J Clin Med | 2021 |
| The Impact of Sickle Cell Disease on Academic Performance among Affected Students. | Alhazmi A, Hakami K, Abusageah F, Jaawna E, Khawaji M, Alhazmi E, Zogel B, Qahl S, Qumayri G | Children (Basel) | 2021 |
| Retained Splenic Function in an Indian Population with Homozygous Sickle Cell Disease May Have Important Clinical Significance. | Serjeant B, Hambleton I, Serjeant G | Indian J Community Med | 2021 |
| A Novel Mutation in ATRX Causes Alpha-Thalassemia X-Linked Intellectual Disability Syndrome in a Han Chinese Family. | Wu S, Zheng Y, Xu C, Fu J, Xiong F, Yang F | Front Pediatr | 2021 |
| Barriers to Therapeutic Use of Hydroxyurea for Sickle Cell Disease in Nigeria: A Cross-Sectional Survey. | Okocha EC, Gyamfi J, Ryan N, Babalola O, Etuk EA, Chianumba R, Nwegbu M, Isa H, Madu AJ, Adegoke S, Nnebe-Agumandu U, Brown B, Peprah E, Nnodu OE | Front Genet | 2021 |
| Improved Non-Invasive Preimplantation Genetic Testing for Beta-Thalassemia Using Spent Embryo Culture Medium Containing Blastocoelic Fluid. | Ou Z, Deng Y, Liang Y, Chen Z, Sun L | Front Endocrinol (Lausanne) | 2021 |
| Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis. | Sales RR, Nogueira BL, Tosatti JAG, Gomes KB, Luizon MR | Front Pharmacol | 2021 |
| Spontaneous epidural hematoma: A case report of rare crisis of sickle cell disease. | Takroni SY, Nasiri AM, Ahmed E, Alkharras RA | J Family Med Prim Care | 2021 |
| Inhibition of the Aquaporin-1 Cation Conductance by Selected Furan Compounds Reduces Red Blood Cell Sickling. | Chow PH, Cox CD, Pei JV, Anabaraonye N, Nourmohammadi S, Henderson SW, Martinac B, Abdulmalik O, Yool AJ | Front Pharmacol | 2021 |
| Free Flap Reconstruction and Its Management in Sickle Cell Trait: Lessons Learned from a Case. | Mehta R, Rao KN, Nagarkar NM, Aggarwal A | Indian J Surg Oncol | 2021 |
| Whole Blood Transcriptome Analysis in Children with Sickle Cell Anemia. | Gee BE, Pearson A, Buchanan-Perry I, Simon RP, Archer DR, Meller R | Front Genet | 2021 |
| Influence of High Hemoglobin-Oxygen Affinity on Humans During Hypoxia. | Webb KL, Dominelli PB, Baker SE, Klassen SA, Joyner MJ, Senefeld JW, Wiggins CC | Front Physiol | 2021 |
| Investigating the Efficacy and Safety of Thalidomide for Treating Patients With -Thalassemia: A Meta-Analysis. | Lu Y, Wei Z, Yang G, Lai Y, Liu R | Front Pharmacol | 2021 |
| Timed Average Mean Maximum Velocity (TAMMV) of Cerebral Blood Flow of Children and Adolescents with Sickle cell Disease: correlation with clinical and hematological profiles in country. | Chukwu B, Menezes L, Fukuda T, Filho J, Goncalves M | Malawi Med J | 2021 |
| Iron profile of pregnant sickle cell anemia patients in Odisha, India. | Sukla SK, Mohanty PK, Patel S, Das K, Hiregoudar M, Soren UK, Meher S | Hematol Transfus Cell Ther | 2021 |
| [Disease genotype, haplotypes, diagnosis and associated studies in sickle cell anemia]. | Díaz-Matallana M, Márquez-Benítez Y, Martínez-Lozano JC, Briceño-Balcázar I, Benavides-Benítez E, Bernal JE | Rev Med Chil | 2021 |
| Hematuria and Flank Pain in a Patient with Sickle Cell Trait Who Is Taking NSAIDs. | Homan TD, Buck JB, Miyata KN | Kidney360 | 2021 |
| Routine management, healthcare resource use and patient and carer-reported outcomes of patients with transfusion-dependent β-thalassaemia in the United Kingdom: A mixed methods observational study. | Shah F, Telfer P, Velangi M, Pancham S, Wynn R, Pollard S, Chalmers E, Kell J, Carter AM, Hickey J, Paramore C, Jobanputra M, Ryan K | EJHaem | 2021 |
| Homozygous sickle cell disease related mortality in Senegal (2011-2020). | Seck M, Ba O, Faye BF, Touré SA, Guèye YB, Dieng N, Sall A, Gadji M, Touré AO, Diop S | EJHaem | 2021 |
| Alpha-globin gene triplication and its effect in beta-thalassemia carrier, sickle cell trait, and healthy individual. | Hamid M, Keikhaei B, Galehdari H, Saberi A, Sedaghat A, Shariati G, Mohammadi-Anaei M | EJHaem | 2021 |
| A mutant fibrinogen that is unable to form fibrin can improve renal phenotype in mice with sickle cell anemia. | Narciso MG, Hoeting B, James JM, VandenHeuvel K, Nasimuzzaman M | EJHaem | 2021 |
| Genetic heterogeneity of beta thalassemia mutations in Kahramanmaraş province in Southern Turkey: preliminary report. | Kurutaş EB, Aksan ME, Curuk P, Curuk MA | Folia Med (Plovdiv) | 2021 |
